<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7062565/results/search/disease/results.xml">
   <result pre="doi: 10.1016/j.ijporl.2019.109838 109838 : Article Panel 7 – Pathogenesis of" exact="otitis media" post="– a review of the literature between 2015 and"/>
   <result pre="from July 2015 to June 2019 on the pathogenesis of" exact="otitis media." post="Bacteria, viruses and the role of the microbiome as"/>
   <result pre="OM published between July 2015 and June 2019. Keywords included" exact="otitis media" post="and Streptococcus pneumoniae (Spn), nontypeable Haemophilus influenzae (NTHi), or"/>
   <result pre="retrospective database analysis from Germany of over 65,000 patients demonstrating" exact="otitis media" post="was present at a higher rate in patients with"/>
   <result pre="media was present at a higher rate in patients with" exact="influenza" post="compared to non-influenza-infected patients, and this was especially true"/>
   <result pre="the study, which might explain the low incidence of e.g." exact="influenza" post="viruses [ 3]. Children with recurrent viral respiratory infections"/>
   <result pre="respiratory viruses, along with bacteria, also have a role in" exact="otitis media" post="with effusion (OME) by presenting a pathogen reservoir in"/>
   <result pre="were detected in 8.3% of samples, coronaviruses in 4% and" exact="influenza" post="virus B in 2% of samples [ 11]. Recent"/>
   <result pre="composition and architecture of biofilms formed by multiple NTHi clinical" exact="otitis media" post="isolates [ 62]. Hardison et al. identified a microevolutionary"/>
   <result pre="the genomes of three H. influenzae strains isolated from sputum," exact="otitis media" post="and blood [ 66]. All sequence data generated from"/>
   <result pre="matrix fibrils that are significantly upregulated in patients suffering from" exact="chronic obstructive pulmonary disease" post="(COPD). The alpha2-chain is the primary M. catarrhalis targeted"/>
   <result pre="in 2017, researchers observed 5 cases of complicated cases of" exact="otitis media" post="caused by T. otitidis [ 100]. It was suggested"/>
   <result pre="Korea and shown to cause a number of illnesses, including" exact="otomycosis" post="[ 103]. It was mostly confined to East Asia"/>
   <result pre="mostly confined to East Asia until recently, when cases of" exact="otomycosis" post="caused by C. auris were confirmed in the Gulf"/>
   <result pre="years of age that were hospitalized with AOM or acute" exact="mastoiditis" post="(AM) the most common organisms identified were S. pneumoniae"/>
   <result pre="more severe symptoms. For example, S. pyogenes from OM or" exact="mastoiditis" post="represents the second most common reason for subsequent intracranial,"/>
   <result pre="the mouse [ 131]. Co-infection with virus, in particular the" exact="influenza" post="virus, can enable middle ear infection following intranasal inoculation"/>
   <result pre="the authors propose a potential application of ROCK inhibition in" exact="otitis media" post="[ 186]. Another study by Toivenean et al., have"/>
   <result pre="been described both from conducting research into the pathogenesis of" exact="otitis media" post="and from the findings that have been published. The"/>
   <result pre="warrants increased monitoring of their incidence in future studies of" exact="otitis media" post="and 5) the increased incidence of these species, some"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7079810/results/search/disease/results.xml">
   <result pre=": Review MMPs and ADAMs in neurological infectious diseases and" exact="multiple sclerosis" post="Muri Lukas 1 2 Leppert David 3 Grandgirard Denis"/>
   <result pre="with excessive neuroinflammation as a common denominator, such as pneumococcal" exact="meningitis" post="and multiple sclerosis, thereby improving the disease outcome. Timing"/>
   <result pre="neuroinflammation as a common denominator, such as pneumococcal meningitis and" exact="multiple sclerosis," post="thereby improving the disease outcome. Timing of metalloproteinase inhibition"/>
   <result pre="the outcome of different neuroinflammatory diseases. Keywords Neuroinfection Neuroinflammation Bacterial" exact="meningitis" post="Metalloproteinase MMP Multiple sclerosis MMPs and ADAMs and their"/>
   <result pre="injury [ 1, 33, 34]. MMP-9 levels critically increase during" exact="bacterial meningitis" post="and elevated MMP-9 levels are associated with BBB damage"/>
   <result pre="[ 1, 33, 34]. MMP-9 levels critically increase during bacterial" exact="meningitis" post="and elevated MMP-9 levels are associated with BBB damage"/>
   <result pre="upregulated in vessels with BBB impairment [ 38– 40]. In" exact="bacterial meningitis," post="cerebrospinal fluid (CSF) levels of MMP-13 and MMP-8 are"/>
   <result pre="associated with BBB damage [ 35]. Repeated lumbar punctures in" exact="bacterial meningitis" post="patients revealed that MMP-8 levels were regulated independently and"/>
   <result pre="with BBB damage [ 35]. Repeated lumbar punctures in bacterial" exact="meningitis" post="patients revealed that MMP-8 levels were regulated independently and"/>
   <result pre="might be detrimental [ 102, 103]. MMPs and ADAMs in" exact="infectious disease" post="of the CNS The brain is protected from infectious"/>
   <result pre="a microbiologically sterile site under physiologic conditions [ 104]. Subsequently," exact="infectious disease" post="of the CNS—such as bacterial meningitis—occur at comparatively low"/>
   <result pre="inflammation, thereby being essentially involved in CNS infections. Metalloproteinases in" exact="bacterial meningitis" post="Pathophysiology of brain injury during bacterial meningitis To establish"/>
   <result pre="thereby being essentially involved in CNS infections. Metalloproteinases in bacterial" exact="meningitis" post="Pathophysiology of brain injury during bacterial meningitis To establish"/>
   <result pre="infections. Metalloproteinases in bacterial meningitis Pathophysiology of brain injury during" exact="bacterial meningitis" post="To establish a CNS infection, the bacterial pathogens have"/>
   <result pre="Metalloproteinases in bacterial meningitis Pathophysiology of brain injury during bacterial" exact="meningitis" post="To establish a CNS infection, the bacterial pathogens have"/>
   <result pre="transmitted via the respiratory route [ 105]. Most cases of" exact="bacterial meningitis" post="originate from bacteremia, where the nasopharyngal pathogen gains access"/>
   <result pre="via the respiratory route [ 105]. Most cases of bacterial" exact="meningitis" post="originate from bacteremia, where the nasopharyngal pathogen gains access"/>
   <result pre="blood–CSF barrier (BCSFB). Other causative pathogens of bacterial meningitis—which cause" exact="meningitis" post="mostly in neonates, elderly and immunocompromized patients (group B"/>
   <result pre="access the circulation and invade the brain [ 105]. Bacterial" exact="meningitis" post="might also arise from focal infection in the vicinity"/>
   <result pre="from focal infection in the vicinity of the brain (i.e.," exact="otitis media," post="sinusitis, dental abscess), where local spread rather than bacteremia"/>
   <result pre="anatomical brain barriers (trauma or surgery) may also lead to" exact="bacterial meningitis." post="Among bacterial meningitis, pneumococcal meningitis (PM) is especially detrimental"/>
   <result pre="(trauma or surgery) may also lead to bacterial meningitis. Among" exact="bacterial meningitis," post="pneumococcal meningitis (PM) is especially detrimental as it causes"/>
   <result pre="may also lead to bacterial meningitis. Among bacterial meningitis, pneumococcal" exact="meningitis" post="(PM) is especially detrimental as it causes high mortality"/>
   <result pre="107, 108]. Neurofunctional sequelae after PM include hearing loss, epilepsy," exact="cerebral palsy," post="as well as behavioral and cognitive deficits [ 107–"/>
   <result pre="and involvement of inflammatory processes in inducing brain damage during" exact="meningitis" post="have been intensively studied in different animal models. Upon"/>
   <result pre="via leakage of plasma into the CNS, increased intracranial pressure," exact="hydrocephalus" post="and cerebral ischemia [ 116]. In patients with bacterial"/>
   <result pre="pressure, hydrocephalus and cerebral ischemia [ 116]. In patients with" exact="bacterial meningitis," post="cerebrovascular complications are frequently observed [ 124] with vasculitis"/>
   <result pre="bacterial meningitis, cerebrovascular complications are frequently observed [ 124] with" exact="vasculitis" post="being the cause for cerebral infarction, hemorrhages and subsequent"/>
   <result pre="frequently observed [ 124] with vasculitis being the cause for" exact="cerebral infarction," post="hemorrhages and subsequent cortical damage during meningitis [ 18,"/>
   <result pre="cause for cerebral infarction, hemorrhages and subsequent cortical damage during" exact="meningitis" post="[ 18, 116, 124]. Metalloproteinases in the pathogenesis of"/>
   <result pre="meningitis [ 18, 116, 124]. Metalloproteinases in the pathogenesis of" exact="bacterial meningitis" post="Data from clinical and experimental studies have shed light"/>
   <result pre="[ 18, 116, 124]. Metalloproteinases in the pathogenesis of bacterial" exact="meningitis" post="Data from clinical and experimental studies have shed light"/>
   <result pre="light onto the crucial role of metalloproteinases during pathogenesis of" exact="bacterial meningitis" post="and other neuro-infectious diseases. Metalloproteinases—expressed or activated in response"/>
   <result pre="onto the crucial role of metalloproteinases during pathogenesis of bacterial" exact="meningitis" post="and other neuro-infectious diseases. Metalloproteinases—expressed or activated in response"/>
   <result pre="of inflammation and repair mechanisms [ 41, 127– 129]. During" exact="bacterial meningitis," post="the expression and activation of metalloproteinases and their inhibitors"/>
   <result pre="(mostly released from infiltrating neutrophils) is a specific hallmark of" exact="bacterial meningitis," post="which is not found in other neuroinflammatory disease ["/>
   <result pre="occludin in meningococcal neuroinfection [ 131]. Other experimental data of" exact="meningitis" post="caused by heat-inactivated N. meningitidis showed a significant upregulation"/>
   <result pre="potent TNF-α activator apart from ADAM17 [ 65]—remains unchanged in" exact="bacterial meningitis" post="[ 127] emphasizes the importance of ADAM17 during this"/>
   <result pre="TNF-α activator apart from ADAM17 [ 65]—remains unchanged in bacterial" exact="meningitis" post="[ 127] emphasizes the importance of ADAM17 during this"/>
   <result pre="the acute phase. This imbalance between MMPs and TIMPs during" exact="bacterial meningitis" post="has, therefore, been implicated as a key event during"/>
   <result pre="acute phase. This imbalance between MMPs and TIMPs during bacterial" exact="meningitis" post="has, therefore, been implicated as a key event during"/>
   <result pre="[ 136, 137]. Matrix metalloproteinase expression profiles in patients with" exact="bacterial meningitis" post="are consistent with the data generated in experimental settings."/>
   <result pre="136, 137]. Matrix metalloproteinase expression profiles in patients with bacterial" exact="meningitis" post="are consistent with the data generated in experimental settings."/>
   <result pre="with the data generated in experimental settings. In patients with" exact="bacterial meningitis," post="CSF levels of MMP-1, -3, -7, -8, -9 and"/>
   <result pre="The causative pathogen determines the inflammatory response in patients with" exact="bacterial meningitis." post="Pneumococcal meningitis is associated with significantly increased mortality and"/>
   <result pre="determines the inflammatory response in patients with bacterial meningitis. Pneumococcal" exact="meningitis" post="is associated with significantly increased mortality and elevated levels"/>
   <result pre="and elevated levels of IFN-γ, MCP-1 and MMP-9 compared to" exact="meningitis" post="caused by N. meningitidis or H. influenzae [ 145]."/>
   <result pre="caused by N. meningitidis or H. influenzae [ 145]. Tuberculous" exact="meningitis" post="(TBM), which arises rarely as an extrapulmonary form of"/>
   <result pre="intensively reviewed elsewhere [ 151]. Clinical data from patients with" exact="viral meningitis" post="report elevated CSF levels of MMP-9 and TIMP-1 compared"/>
   <result pre="reviewed elsewhere [ 151]. Clinical data from patients with viral" exact="meningitis" post="report elevated CSF levels of MMP-9 and TIMP-1 compared"/>
   <result pre="neuroinfection has mostly been analyzed in experimental studies, though. Japanese" exact="encephalitis" post="virus (JEV) is an arthropod-borne virus and a major"/>
   <result pre="is an arthropod-borne virus and a major cause of acute" exact="encephalopathy" post="in children [ 153]. In vitro, MMP-9 expression after"/>
   <result pre="associated with disease severity [ 154]. In experimental herpes-simplex virus" exact="encephalitis" post="(HSE), MMP-9 is upregulated and insufficiently counterbalanced by TIMP-1"/>
   <result pre="mouse encephalitic adenovirus-1, which might contribute to BBB disruption and" exact="encephalitis" post="[ 163]. MAV-1 may also induce BBB breakdown by"/>
   <result pre="TJ proteins occludin and claudin-5 [ 164]. Murine coronavirus-induced viral" exact="encephalitis" post="induces expression of MMP-3 and -12 plus TIMP-1, with"/>
   <result pre="are also associated with increased viral replication during neurotropic mouse" exact="hepatitis" post="infection [ 166]. MMP and ADAM inhibitors as potential"/>
   <result pre="166]. MMP and ADAM inhibitors as potential treatment options in" exact="bacterial meningitis" post="Since MMPs and ADAMs are central regulators and mediators"/>
   <result pre="MMP and ADAM inhibitors as potential treatment options in bacterial" exact="meningitis" post="Since MMPs and ADAMs are central regulators and mediators"/>
   <result pre="and mediators during neuroinflammation and development of neuronal damage in" exact="bacterial meningitis," post="inhibition of theses enzymes during acute infection has been"/>
   <result pre="decades, many different inhibitors were tested in rodent models of" exact="bacterial meningitis" post="(Table 2). Table 2 MMP and ADAM inhibitors improve"/>
   <result pre="many different inhibitors were tested in rodent models of bacterial" exact="meningitis" post="(Table 2). Table 2 MMP and ADAM inhibitors improve"/>
   <result pre="and ADAM inhibitors improve acute and neurofuncitonal outcome in rodent" exact="bacterial meningitis." post="Many data derive from proof-of-principle studies with early- or"/>
   <result pre="breakdown and production of inflammatory cytokines [ 15]. In experimental" exact="bacterial meningitis," post="MMP and ADAM inhibitors significantly reduce CSF levels of"/>
   <result pre="LPS-induced neuroinflammation [ 171]. Cortical necrosis As a consequence of" exact="bacterial meningitis" post="and its associated inflammatory reaction, cerebrovascular complications are frequently"/>
   <result pre="neuroinflammation [ 171]. Cortical necrosis As a consequence of bacterial" exact="meningitis" post="and its associated inflammatory reaction, cerebrovascular complications are frequently"/>
   <result pre="frequently observed in patients [ 124]. Focal ischemia caused by" exact="vasculitis" post="results in cortical necrosis during meningitis [ 116, 124]."/>
   <result pre="Focal ischemia caused by vasculitis results in cortical necrosis during" exact="meningitis" post="[ 116, 124]. Breakdown of the BBB during the"/>
   <result pre="116]. Since metalloproteinases are central regulators of BBB breakdown during" exact="bacterial meningitis" post="(discussed above), their inhibition during the acute disease is"/>
   <result pre="Since metalloproteinases are central regulators of BBB breakdown during bacterial" exact="meningitis" post="(discussed above), their inhibition during the acute disease is"/>
   <result pre="with MMPIs is associated with reduced cortical necrosis in pneumococcal" exact="meningitis" post="[ 128, 132, 167, 168, 172, 173] and with"/>
   <result pre="173] and with lower rates of intracerebral hemorrhage in meningococcal" exact="meningitis" post="[ 169]. This neuroprotective effect is, however, reduced when"/>
   <result pre="symptoms [ 127, 174]. The early inhibition of MMPs during" exact="bacterial meningitis" post="might be responsible for an overall reduction of the"/>
   <result pre="[ 127, 174]. The early inhibition of MMPs during bacterial" exact="meningitis" post="might be responsible for an overall reduction of the"/>
   <result pre="immature neurons in the dentate gyrus of the hippocampus during" exact="bacterial meningitis" post="is caused by bacterial toxins, but also by an"/>
   <result pre="neurons in the dentate gyrus of the hippocampus during bacterial" exact="meningitis" post="is caused by bacterial toxins, but also by an"/>
   <result pre="MMP-9—rather than ADAM17—might explain this neuroprotective effect of Trocade during" exact="bacterial meningitis." post="The protective effect on hippocampal neurons is lower—but still"/>
   <result pre="the hippocampus of humans [ 114] and animal models with" exact="bacterial meningitis" post="[ 175, 176] correlates with behavioural and learning deficits"/>
   <result pre="hippocampus of humans [ 114] and animal models with bacterial" exact="meningitis" post="[ 175, 176] correlates with behavioural and learning deficits"/>
   <result pre="during acute infection [ 178]. Bacterial meningitis-induced hearing loss Bacterial" exact="meningitis" post="induces sensorineural hearing loss by damaging hair cells and"/>
   <result pre="infection [ 178]. Bacterial meningitis-induced hearing loss Bacterial meningitis induces" exact="sensorineural hearing loss" post="by damaging hair cells and spiral ganglion neurons in"/>
   <result pre="high specificity for ADAM17—were reported to increase mortality during acute" exact="bacterial meningitis" post="when administrated early after infection [ 132, 167]. In"/>
   <result pre="specificity for ADAM17—were reported to increase mortality during acute bacterial" exact="meningitis" post="when administrated early after infection [ 132, 167]. In"/>
   <result pre="major contributor of the initial host response. Matrix metalloproteinases in" exact="multiple sclerosis" post="Multiple sclerosis (MS) is a chronic autoimmune disease of"/>
   <result pre="metalloproteinases in multiple sclerosis Multiple sclerosis (MS) is a chronic" exact="autoimmune disease" post="of the CNS, leading to progressive deterioration of motor,"/>
   <result pre="correlated with inflammatory activity in lesions. In the experimental autoimmune" exact="encephalitis" post="(EAE) model of MS, the upregulation of MMP-7 and"/>
   <result pre="less susceptible to EAE induction [ 191]. In the delayed-type" exact="hypersensitivity" post="(DTH) rat model, protein and transcriptional expression of several"/>
   <result pre="of tumor cells, which were thought to be transferable to" exact="suppression" post="of BBB transmigration of blood-derived leukocytes in MS. This"/>
   <result pre="confirmed in clinical trials. The same was the case in" exact="rheumatoid arthritis." post="Additionally, depending on their enzymatic target profile, adverse events"/>
   <result pre="CNS Central nervous system CSF Cerebrospinal fluid EAE Experimental autoimmune" exact="encephalitis" post="EBV Epstein–Barr virus ECM Extracellular matrix HSE Herpes-simplex virus"/>
   <result pre="Epstein–Barr virus ECM Extracellular matrix HSE Herpes-simplex virus JEV Japanese" exact="encephalitis" post="virus MAV-1 Mouse adenovirus type-1 MBP Myelin basic protein"/>
   <result pre="Matrix metalloproteinase MMPI MMP inhibitor MS Multiple sclerosis PM Pneumococcal" exact="meningitis" post="PPMS Primary progressive MS ROS Reactive oxygen species RRMS"/>
   <result pre="MS SPMS Secondary progressive MS TACE TNF-α-converting enzyme TBM Tuberculous" exact="meningitis" post="TIMP Tissue inhibitor of metalloproteinase TJ Tight junction WNV"/>
   <result pre="A Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic" exact="stroke" post="Front Neurol 2013 4 32 10.3389/fneur.2013.00032 23565108 23. Sellner"/>
   <result pre="4 32 10.3389/fneur.2013.00032 23565108 23. Sellner J Leib SL In" exact="bacterial meningitis" post="cortical brain damage is associated with changes in parenchymal"/>
   <result pre="32 10.3389/fneur.2013.00032 23565108 23. Sellner J Leib SL In bacterial" exact="meningitis" post="cortical brain damage is associated with changes in parenchymal"/>
   <result pre="alters the kinetics of cerebrovascular tight junction disruption after experimental" exact="stroke" post="in mice J Neurosci 2008 28 9451 9462 10.1523/JNEUROSCI.2674-08.2008"/>
   <result pre="Koedel U et al. Differential expression of matrix metalloproteinases in" exact="bacterial meningitis" post="Brain 1999 122 Pt 8 1579 1587 10.1093/brain/122.8.1579 10430840"/>
   <result pre="U et al. Differential expression of matrix metalloproteinases in bacterial" exact="meningitis" post="Brain 1999 122 Pt 8 1579 1587 10.1093/brain/122.8.1579 10430840"/>
   <result pre="metalloproteinase processing of the chemokine stromal cell derived factor-1 causes" exact="neurodegeneration" post="Nat Neurosci 2003 6 1064 1071 10.1038/nn1127 14502291 51."/>
   <result pre="metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1-induced" exact="peritonitis" post="J Immunol 2013 190 401 410 10.4049/jimmunol.1202286 23225890 52."/>
   <result pre="al. Microglia and monocytes/macrophages polarization reveal novel therapeutic mechanism against" exact="stroke" post="Int J Mol Sci 2017 18 2135 10.3390/ijms18102135 97."/>
   <result pre="metalloproteinase in neuroblast cell migration from the subventricular zone after" exact="stroke" post="J Neurosci 2006 26 3491 3495 10.1523/JNEUROSCI.4085-05.2006 16571756 99."/>
   <result pre="al. Role of matrix metalloproteinases in delayed cortical responses after" exact="stroke" post="Nat Med 2006 12 441 445 10.1038/nm1387 16565723 101."/>
   <result pre="Rosell A Lo E Multiphasic roles for matrix metalloproteinases after" exact="stroke" post="Curr Opin Pharmacol 2008 8 82 89 10.1016/j.coph.2007.12.001 18226583"/>
   <result pre="by magnetic resonance imaging countered by impaired long-term recovery after" exact="stroke" post="in rat brain J Cereb Blood Flow Metab 2008"/>
   <result pre="17700631 104. Agyeman P Grandgirard D Leib SL Neuroinflammation in" exact="bacterial meningitis" post="The blood brain barrier and inflammation 2017 Cham Springer"/>
   <result pre="104. Agyeman P Grandgirard D Leib SL Neuroinflammation in bacterial" exact="meningitis" post="The blood brain barrier and inflammation 2017 Cham Springer"/>
   <result pre="O et al. ESCMID guideline: diagnosis and treatment of acute" exact="bacterial meningitis" post="Clin Microbiol Infect 2016 22 S37 S62 10.1016/j.cmi.2016.01.007 27062097"/>
   <result pre="et al. ESCMID guideline: diagnosis and treatment of acute bacterial" exact="meningitis" post="Clin Microbiol Infect 2016 22 S37 S62 10.1016/j.cmi.2016.01.007 27062097"/>
   <result pre="U Scheld WM Pfister H-W Pathogenesis and pathophysiology of pneumococcal" exact="meningitis" post="Lancet Infect Dis 2002 2 721 736 10.1016/S1473-3099(02)00450-4 12467688"/>
   <result pre="de Beek D Epidemiology, diagnosis, and antimicrobial treatment of acute" exact="bacterial meningitis" post="Clin Microbiol Rev 2010 23 467 492 10.1128/CMR.00070-09 20610819"/>
   <result pre="Beek D Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial" exact="meningitis" post="Clin Microbiol Rev 2010 23 467 492 10.1128/CMR.00070-09 20610819"/>
   <result pre="et al. Spatial memory and learning deficits after experimental pneumococcal" exact="meningitis" post="in mice Neurosci Lett 2000 296 137 140 10.1016/S0304-3940(00)01645-1"/>
   <result pre="nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal" exact="meningitis" post="J Infect Dis 2001 183 247 252 10.1086/317921 11110643"/>
   <result pre="al. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal" exact="meningitis" post="in infant rats Pediatr Res 2003 54 353 357"/>
   <result pre="of neurons in the dentate gyrus in humans suffering from" exact="bacterial meningitis" post="J Neuropathol Exp Neurol 1999 58 265 274 10.1097/00005072-199903000-00006"/>
   <result pre="neurons in the dentate gyrus in humans suffering from bacterial" exact="meningitis" post="J Neuropathol Exp Neurol 1999 58 265 274 10.1097/00005072-199903000-00006"/>
   <result pre="10197818 115. Gerber J Nau R Mechanisms of injury in" exact="bacterial meningitis" post="Curr Opin Neurol 2010 23 312 318 10.1097/WCO.0b013e32833950dd 20442574"/>
   <result pre="115. Gerber J Nau R Mechanisms of injury in bacterial" exact="meningitis" post="Curr Opin Neurol 2010 23 312 318 10.1097/WCO.0b013e32833950dd 20442574"/>
   <result pre="T van de Beek D Pathogenesis and pathophysiology of pneumococcal" exact="meningitis" post="Clin Microbiol Rev 2011 24 557 591 10.1128/CMR.00008-11 21734248"/>
   <result pre="Braun JS et al. Dual phases of apoptosis in pneumococcal" exact="meningitis" post="J Infect Dis 2004 190 2039 2046 10.1086/425520 15529270"/>
   <result pre="Imboden H et al. Caspase-3 mediates hippocampal apoptosis in pneumococcal" exact="meningitis" post="Acta Neuropathol 2003 105 499 507 10.1007/s00401-003-0672-7 12677451 119."/>
   <result pre="cellular source of inducible nitric oxide synthase during experimental herpes" exact="encephalitis" post="J Neurovirol 2008 14 229 238 10.1080/13550280802093927 18569457 121."/>
   <result pre="of infection determines the localization of damage and extent of" exact="sensorineural hearing loss" post="in experimental pneumococcal meningitis J Neurosci 2016 36 7740"/>
   <result pre="damage and extent of sensorineural hearing loss in experimental pneumococcal" exact="meningitis" post="J Neurosci 2016 36 7740 7749 10.1523/JNEUROSCI.0554-16.2016 27445150 123."/>
   <result pre="correlates of acute and permanent hearing loss during experimental pneumococcal" exact="meningitis" post="Brain Pathol 2003 13 123 132 10.1111/j.1750-3639.2003.tb00012.x 12744466 124."/>
   <result pre="et al. Clinical features and prognostic factors in adults with" exact="bacterial meningitis" post="N Engl J Med 2004 351 1849 1859 10.1056/NEJMoa040845"/>
   <result pre="al. Clinical features and prognostic factors in adults with bacterial" exact="meningitis" post="N Engl J Med 2004 351 1849 1859 10.1056/NEJMoa040845"/>
   <result pre="R Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of" exact="bacterial meningitis" post="and effect of adjunctive therapy Infect Immun 1996 64"/>
   <result pre="Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial" exact="meningitis" post="and effect of adjunctive therapy Infect Immun 1996 64"/>
   <result pre="necrosis factor α converting enzyme as adjuvant therapy in pneumococcal" exact="meningitis" post="Brain 2001 124 1734 1742 10.1093/brain/124.9.1734 11522576 128. Leib"/>
   <result pre="MG Matrix metalloproteinases contribute to brain damage in experimental pneumococcal" exact="meningitis" post="Infect Immun 2000 68 615 620 10.1128/IAI.68.2.615-620.2000 10639424 129."/>
   <result pre="L Leib SL Matrix metalloproteinases: multifunctional effectors of inflammation in" exact="multiple sclerosis" post="and bacterial meningitis Brain Res Rev 2001 36 249"/>
   <result pre="Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and" exact="bacterial meningitis" post="Brain Res Rev 2001 36 249 257 10.1016/S0165-0173(01)00101-1 11690622"/>
   <result pre="metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial" exact="meningitis" post="Brain Res Rev 2001 36 249 257 10.1016/S0165-0173(01)00101-1 11690622"/>
   <result pre="Meli D Loeffler J Baumann P et al. In pneumococcal" exact="meningitis" post="a novel water-soluble inhibitor of matrix metalloproteinases and TNF-α"/>
   <result pre="defense mechanisms against Streptococcus pneumoniae in a mouse model of" exact="bacterial meningitis" post="Neurosci Lett 2003 338 201 204 10.1016/S0304-3940(02)01406-4 12581831 136."/>
   <result pre="mechanisms against Streptococcus pneumoniae in a mouse model of bacterial" exact="meningitis" post="Neurosci Lett 2003 338 201 204 10.1016/S0304-3940(02)01406-4 12581831 136."/>
   <result pre="collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and" exact="bacterial meningitis" post="in children Neuropathol Appl Neurobiol 2006 32 304 317"/>
   <result pre="(MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial" exact="meningitis" post="in children Neuropathol Appl Neurobiol 2006 32 304 317"/>
   <result pre="matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with" exact="meningitis" post="J Neurol Sci 2003 206 43 48 10.1016/S0022-510X(02)00317-9 12480084"/>
   <result pre="inhibitors in the serum and cerebrospinal fluid of patients with" exact="meningitis" post="Clin Microbiol Infect 2011 17 780 784 10.1111/j.1469-0691.2010.03393.x 21521415"/>
   <result pre="al. Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes" exact="meningitis" post="BBA Clin 2014 1 44 51 10.1016/J.BBACLI.2014.06.001 25960946 144."/>
   <result pre="in cerebrospinal fluid after 1 week of treatment of childhood" exact="bacterial meningitis" post="J Clin Microbiol 2015 53 2340 2342 10.1128/JCM.00714-15 25903567"/>
   <result pre="cerebrospinal fluid after 1 week of treatment of childhood bacterial" exact="meningitis" post="J Clin Microbiol 2015 53 2340 2342 10.1128/JCM.00714-15 25903567"/>
   <result pre="inflammatory profile in cerebrospinal fluid and outcome in patients with" exact="bacterial meningitis" post="Mediat Inflamm 2013 2013 1 12 10.1155/2013/312476 146. Majeed"/>
   <result pre="profile in cerebrospinal fluid and outcome in patients with bacterial" exact="meningitis" post="Mediat Inflamm 2013 2013 1 12 10.1155/2013/312476 146. Majeed"/>
   <result pre="MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous" exact="meningitis" post="Int J Exp Pathol 2016 97 230 237 10.1111/iep.12191"/>
   <result pre="Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous" exact="meningitis" post="J Neurol Sci 2004 220 73 78 10.1016/j.jns.2004.02.008 15140609"/>
   <result pre="cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous" exact="meningitis" post="PLoS One 2009 4 e7277 10.1371/journal.pone.0007277 19789647 150. Thwaites"/>
   <result pre="Dung NH et al. Dexamethasone for the treatment of tuberculous" exact="meningitis" post="in adolescents and adults N Engl J Med 2004"/>
   <result pre="153. Tung W-H Tsai H-W Lee I-T et al. Japanese" exact="encephalitis" post="virus induces matrix metalloproteinase-9 in rat brain astrocytes via"/>
   <result pre="of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese" exact="encephalitis" post="virus NeuroImmunoModulation 2012 19 241 254 10.1159/000335182 22441541 155."/>
   <result pre="Sellner J Simon F Meyding-Lamade U Leib SL Herpes-simplex virus" exact="encephalitis" post="is characterized by an early MMP-9 increase and collagen"/>
   <result pre="and 9 are elevated in association with human immunodeficiency virus" exact="dementia" post="Ann Neurol 1999 46 391 398 10.1002/1531-8249(199909)46:3&amp;lt;391::AID-ANA15&amp;gt;3.0.CO;2-0 10482270 161."/>
   <result pre="Expression of matrix metalloproteinases and their tissue inhibitor during viral" exact="encephalitis" post="J Virol 2005 79 4764 4773 10.1128/JVI.79.8.4764-4773.2005 15795262 166."/>
   <result pre="al. Matrix metalloproteinase expression correlates with virulence following neurotropic mouse" exact="hepatitis" post="virus infection J Virol 2002 76 7374 7384 10.1128/JVI.76.15.7374-7384.2002"/>
   <result pre="metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal" exact="meningitis" post="Infect Immun 2014 82 1710 1718 10.1128/IAI.00073-14 24491581 168."/>
   <result pre="matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal" exact="meningitis" post="J Neuroinflamm 2015 12 43 10.1186/s12974-015-0257-0 169. Ricci S"/>
   <result pre="Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal" exact="meningitis" post="BMC Infect Dis 2014 14 726 10.1186/s12879-014-0726-6 25551808 170."/>
   <result pre="the outcome of TLR2 − /− -mice with experimental pneumococcal" exact="meningitis" post="BMC Infect Dis 2007 7 25 10.1186/1471-2334-7-25 17428319 171."/>
   <result pre="al. Matrix metalloproteinases contribute to the blood-brain barrier disruption during" exact="bacterial meningitis" post="Ann Neurol 1998 44 592 600 10.1002/ana.410440404 9778257 173."/>
   <result pre="Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial" exact="meningitis" post="Ann Neurol 1998 44 592 600 10.1002/ana.410440404 9778257 173."/>
   <result pre="and injury to the brain and cochlea in experimental pneumococcal" exact="meningitis" post="Infect Immun 2006 74 3890 3896 10.1128/IAI.01949-05 16790761 174."/>
   <result pre="preserves learning, memory and hearing function in experimental paediatric pneumococcal" exact="meningitis" post="J Neuroinflamm 2018 15 233 10.1186/s12974-018-1272-8 175. Grandgirard D"/>
   <result pre="SL An infant mouse model of brain damage in pneumococcal" exact="meningitis" post="Acta Neuropathol 2007 114 609 617 10.1007/s00401-007-0304-8 17938941 176."/>
   <result pre="176. Bifrare Y-D Gianinazzi C Imboden H et al. Bacterial" exact="meningitis" post="causes two distinct forms of cellular damage in the"/>
   <result pre="to ceftriaxone in a neonatal rat model of Streptococcus pneumoniae" exact="meningitis" post="Acta Neurobiol Exp (Wars) 2014 74 489 496 25576979"/>
   <result pre="matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal" exact="meningitis" post="in Wistar rats Exp Biol Med (Maywood) 2014 239"/>
   <result pre="spatial memory deficits in TNF-α-deficient mice in ceftriaxone-treated experimental pneumococcal" exact="meningitis" post="Neurobiol Dis 2004 16 133 138 10.1016/J.NBD.2004.01.013 15207270 180."/>
   <result pre="et al. Cortical demyelination and diffuse white matter injury in" exact="multiple sclerosis" post="Brain 2005 128 2705 2712 10.1093/brain/awh641 16230320 183. Trapp"/>
   <result pre="and TIMP-1 levels are related to MRI activity in relapsing" exact="multiple sclerosis" post="Neurology 1999 53 1397 1401 10.1212/WNL.53.7.1397 10534241 186. Anthony"/>
   <result pre="MK et al. Differential matrix metalloproteinase expression in cases of" exact="multiple sclerosis" post="and stroke Neuropathol Appl Neurobiol 1997 23 406 415"/>
   <result pre="Differential matrix metalloproteinase expression in cases of multiple sclerosis and" exact="stroke" post="Neuropathol Appl Neurobiol 1997 23 406 415 10.1111/j.1365-2990.1997.tb01315.x 9364466"/>
   <result pre="et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating" exact="multiple sclerosis" post="lesions Acta Neuropathol 1997 94 590 598 10.1007/s004010050754 9444361"/>
   <result pre="in the normal human central nervous system, microglial nodules, and" exact="multiple sclerosis" post="lesions J Neuropathol Exp Neurol 1996 55 300 309"/>
   <result pre="inhibitors (TIMPs) in lesions and normal appearing white matter of" exact="multiple sclerosis" post="Brain 2001 124 1743 1753 10.1093/brain/124.9.1743 11522577 190. Kieseier"/>
   <result pre="al. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune" exact="encephalomyelitis" post="Brain 1998 121 Pt 1 159 166 10.1093/brain/121.1.159 9549496"/>
   <result pre="al. Resistance of young gelatinase B-deficient mice to experimental autoimmune" exact="encephalomyelitis" post="and necrotizing tail lesions J Clin Invest 1999 104"/>
   <result pre="al. Matrix metalloproteinase expression in an experimentally-induced DTH model of" exact="multiple sclerosis" post="in the rat CNS J Neuroimmunol 1998 87 62"/>
   <result pre="F Börnsen L Ammitzbøll C et al. Defining active progressive" exact="multiple sclerosis" post="Mult Scler J 2017 23 1727 1735 10.1177/1352458517726592 195."/>
   <result pre="selectively elevated in CSF during relapses and stable phases of" exact="multiple sclerosis" post="Brain 1998 121 Pt 12 2327 2334 10.1093/brain/121.12.2327 9874483"/>
   <result pre="Opdenakker G Gelatinase in the cerebrospinal fluid of patients with" exact="multiple sclerosis" post="and other inflammatory neurological disorders J Neuroimmunol 1992 41"/>
   <result pre="et al. Serum gelatinase B, TIMP-1 and TIMP-2 levels in" exact="multiple sclerosis." post="A longitudinal clinical and MRI study Brain 1999 122"/>
   <result pre="antibodies against IFN- in multiple sclerosis: antagonization of IFN- mediated" exact="suppression" post="of MMPs Brain 2004 127 259 268 10.1093/brain/awh028 14607790"/>
   <result pre="members in leukocytes emphasize monocytes as major inflammatory mediators in" exact="multiple sclerosis" post="Brain 2003 126 2738 2749 10.1093/brain/awg285 14506071 202. Kouwenhoven"/>
   <result pre="remyelination-impairing fibronectin aggregates and its expression is reduced in chronic" exact="multiple sclerosis" post="lesions Glia 2018 66 1625 1643 10.1002/glia.23328 29600597 205."/>
   <result pre="human T cells: a possible mechanism for treatment efficacy in" exact="multiple sclerosis" post="Ann Neurol 1996 40 846 852 10.1002/ana.410400606 9007089 210."/>
   <result pre="Wells GM et al. Matrix metalloproteinase expression during experimental autoimmune" exact="encephalomyelitis" post="and effects of a combined matrix metalloproteinase and tumour"/>
   <result pre="Smith T Leonard JP Cuzner ML Suppression of experimental allergic" exact="encephalomyelitis" post="in the Lewis rat by the matrix metalloproteinase inhibitor"/>
   <result pre="Gijbels K Galardy RE Steinman L Reversal of experimental autoimmune" exact="encephalomyelitis" post="with a hydroxamate inhibitor of matrix metalloproteases J Clin"/>
   <result pre="7722295 214. Keystone E Treatments no longer in development for" exact="rheumatoid arthritis" post="Ann Rheum Dis 2002 61 Suppl 2 ii43 ii45"/>
   <result pre="214. Keystone E Treatments no longer in development for rheumatoid" exact="arthritis" post="Ann Rheum Dis 2002 61 Suppl 2 ii43 ii45"/>
   <result pre="et al. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in" exact="multiple sclerosis" post="Ann Neurol 2004 55 756 10.1002/ana.20111 15122721 217. Metz"/>
   <result pre="al. Trial of minocycline in a clinically isolated syndrome of" exact="multiple sclerosis" post="N Engl J Med 2017 376 2122 2133 10.1056/NEJMoa1608889"/>
   <result pre="minocycline on extracellular matrix metalloproteinase inducer, a factor implicated in" exact="multiple sclerosis" post="immunopathogenesis J Immunol 2016 197 3850 3860 10.4049/jimmunol.1600436 27733550"/>
   <result pre="and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with" exact="rheumatoid arthritis" post="Rheumatology (Oxford) 2001 40 537 543 10.1093/rheumatology/40.5.537 11371662 220."/>
   <result pre="pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid" exact="arthritis" post="Rheumatology (Oxford) 2001 40 537 543 10.1093/rheumatology/40.5.537 11371662 220."/>
   <result pre="on clinical investigation of medicinal products for the treatment of" exact="multiple sclerosis." post="Committee for medicinal products for human use (CHMP). EMA/CHMP/771815/2011,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7094556/results/search/disease/results.xml">
   <result pre="that ZIKV infection can cause severe fetal neurologic malformations, including" exact="microcephaly" post="or fetal death (referred to as congenital Zika syndrome)."/>
   <result pre="is analogous to that of other Flaviviridae RNA viruses (ie," exact="yellow fever," post="Japanese encephalitis, West Nile, tick-borne encephalitis, and dengue type"/>
   <result pre="Flaviviridae RNA viruses (ie, yellow fever, Japanese encephalitis, West Nile," exact="tick-borne encephalitis," post="and dengue type 1-4 viruses) and encodes for 3"/>
   <result pre="the immediate recipient (eg, GBS) and in the fetus (eg," exact="microcephaly" post="and other congenital conditions), be safe and highly effective,"/>
   <result pre="issue for diagnostic tests in areas where diseases such as" exact="dengue fever," post="West Nile virus, and yellow fever are endemic. In"/>
   <result pre="where diseases such as dengue fever, West Nile virus, and" exact="yellow fever" post="are endemic. In these geographic areas, coinfection with multiple"/>
   <result pre="E proteins. 65 This has also been observed for Japanese" exact="encephalitis" post="virus. 66 In a mouse model, both vaginal and"/>
   <result pre="research Live poxvirus recombinant Themis Bioscience GmbH Early-stage research Live" exact="measles" post="recombinant Valneva SE Early-stage research Purified inactivated virus Mayo"/>
   <result pre="DENV= dengue virus; mRNA = messenger RNA; MVA = modified" exact="vaccinia virus" post="ankara; NIH = National Institutes of Health; R&amp;amp;D ="/>
   <result pre="= research and development; VLP = virus-like particles; VSV= vesicular" exact="stomatitis" post="virus; WRAIR = Walter Reed Army Institute of Research;"/>
   <result pre="against viral challenge (ie, no detectable viremia). MV-ZIKA, a recombinant" exact="measles" post="virus expressing the prM and E proteins ( NCT02996890),"/>
   <result pre="by Themis Bioscience GmbH. This construct is based on the" exact="measles" post="virus vaccine backbone, which is an approach that has"/>
   <result pre="which is an approach that has also shown promise with" exact="chikungunya" post="virus. The measles vaccine has an excellent safety record"/>
   <result pre="approach that has also shown promise with chikungunya virus. The" exact="measles" post="vaccine has an excellent safety record and results in"/>
   <result pre="characteristics are retained when novel antigens are added to the" exact="measles" post="vaccine virus genome. The most advanced vaccine candidates to"/>
   <result pre="was developed using the same platform as the IXIARO Japanese" exact="encephalitis" post="vaccine. After 2016, the number of ZIKV cases has"/>
   <result pre="be sustained as the epidemic wanes. The recent lessons of" exact="severe acute respiratory syndrome," post="Middle East respiratory syndrome, Lassa fever, and to a"/>
   <result pre="J. Gilboa S.M. Hills S.L. Zika and the risk of" exact="microcephaly" post="[published correction appears in N Engl J Med. 2016;375(5):498]"/>
   <result pre="F.T. Tesla B. Simchick G. Zika virus induced mortality and" exact="microcephaly" post="in chicken embryos Stem Cells Dev 25 22 2016"/>
   <result pre="burden of disease caused by co-circulation and co-infection of dengue," exact="chikungunya" post="and Zika in the Americas Travel Med Infect Dis"/>
   <result pre="Bali T. Buxton G. Human T cell responses to Japanese" exact="encephalitis" post="virus in health and disease J Exp Med 213"/>
   <result pre="2017 1200 1208 28838639 72 Julander J.G. Animal models of" exact="yellow fever" post="and their application in clinical research Curr Opin Virol"/>
   <result pre="Poland and Ovsyannikova hold 3 patents related to vaccinia and" exact="measles" post="peptide vaccines. Dr Kennedy holds a patent related to"/>
   <result pre="funding from Merck Research Laboratories to study waning immunity to" exact="mumps" post="vaccine. These activities have been reviewed by the Mayo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7094616/results/search/disease/results.xml">
   <result pre="undergoing inflammatory response to a number of disease conditions, including" exact="cancer" post="[ 3, 4]. Human CRP tends to form pentameric"/>
   <result pre="proteins are often found in amyloid deposits such as in" exact="atherosclerosis" post="disease [ 10, 11]. CRP and SAP are known"/>
   <result pre="29] mouse binding to virus particle [ [30], [31]] Swine" exact="influenza" post="(SIV) CRP, SAA pig – [ [32], [33]] PTX3"/>
   <result pre="– [ [32], [33]] PTX3 pig – [ 106] Equine" exact="influenza" post="(EIV) SAA horse – [ 34] Porcine reproductive and"/>
   <result pre="human – [ 40] PTX3 human – [ 41] Murine" exact="hepatitis" post="(MHV) PTX3 mouse binding to virus particle [ 42]"/>
   <result pre="Puumala hantavirus (PUUV) PTX3 human – [ [51], [52]] Avian" exact="influenza" post="SAA chicken – [ 53] Infectious bursal disease (IBDV)"/>
   <result pre="found in patients infected with the most virulent types of" exact="influenza" post="A virus. Thus, human influenza disease outcome has been"/>
   <result pre="the most virulent types of influenza A virus. Thus, human" exact="influenza" post="disease outcome has been associated with enhanced production of"/>
   <result pre="[ 20, 21, 24]. CRP induction may vary amongst different" exact="avian influenza" post="A virus subtypes: H7N9 is a more powerful inductor"/>
   <result pre="20, 21, 24]. CRP induction may vary amongst different avian" exact="influenza" post="A virus subtypes: H7N9 is a more powerful inductor"/>
   <result pre="the H1N1 subtype [ 23]. In fact, the highly pathogenic" exact="influenza" post="A H7N9 subtype induces high serum levels of CRP"/>
   <result pre="CRP, SAA and PTX3 became the best predictor of severe" exact="respiratory disease" post="in hospitalized children [ 57]. In influenza virus infected"/>
   <result pre="of severe respiratory disease in hospitalized children [ 57]. In" exact="influenza" post="virus infected mice SAA concentration in serum rises several-hundred"/>
   <result pre="20-fold, respectively, have been reported in pigs infected with swine" exact="influenza" post="[ 33, 58]. Overall, there is a good correlation"/>
   <result pre="of disease and CRP serum concentrations after infection with swine" exact="influenza" post="virus [ 58]. SAA was demonstrated to be a"/>
   <result pre="to be the best indicators of disease progression in swine" exact="influenza" post="cases [ 32]. The infection of the respiratory tract"/>
   <result pre="pig, particularly in the lungs [ 35]. Infection with pandemic" exact="influenza" post="viruses causes increased levels of SAA in other non-human"/>
   <result pre="60]. Thus, it is not surprising that patients undergoing chronic" exact="hepatitis" post="C infection showed higher levels of CRPs than healthy"/>
   <result pre="Similarly, high levels of CRP have been reported in chronic" exact="hepatitis" post="B patients in association to liver damage [ 38,"/>
   <result pre="is considered to be a useful predictor of mortality in" exact="hepatitis" post="B infected individuals suffering from cirrhosis [ 61]. In"/>
   <result pre="predictor of mortality in hepatitis B infected individuals suffering from" exact="cirrhosis" post="[ 61]. In the same way, elevated plasma levels"/>
   <result pre="of dengue disease severity [ 50]. The inflammatory response after" exact="chikungunya" post="virus (CHIKV) infection is associated to higher amounts of"/>
   <result pre="magnitude of the response may vary among species: avian H5N1" exact="influenza" post="virus causes a rapid elevation of SAA levels in"/>
   <result pre="the corresponding virus infection. That is the case of the" exact="influenza" post="virus vaccine where CRP response to vaccination is normally"/>
   <result pre="depending on host conditions, particularly age. Elder patients respond to" exact="herpes zoster" post="vaccination with lower levels of CRP, which has been"/>
   <result pre="observed in non-human species: the CRP response of mice to" exact="influenza" post="virus vaccination is also affected by age, with neonatal"/>
   <result pre="CRP/PTX host ref Influenza A CRP mouse [ 25] Swine" exact="influenza" post="CRP, SAA pig [ 59] Canine distemper &amp;amp; canine"/>
   <result pre="subsequently block virus-cell interaction. Human PTX3 and SAP binding to" exact="influenza" post="virus inhibits virus-induced hemagglutination [ 30]. Interestingly, PTX3 and"/>
   <result pre="PTX and SAP during viral infection [ 28]. By analyzing" exact="influenza" post="A virus mutants resistant to the inhibitory effect of"/>
   <result pre="the recognition of HA by PTX3 in mice. Treatment of" exact="influenza" post="virus-infected mice with human PTX3 has been successful in"/>
   <result pre="the antiviral response of pentraxins, showing higher susceptibility to mouse" exact="hepatitis" post="coronavirus MHV in PTX3-deficient mice [ 42]. Moreover, the"/>
   <result pre="clearance of the virus in the lung. SAP binding to" exact="influenza" post="virus HA results in the inhibition of infection in"/>
   <result pre="between up-regulation of CRP and autophagy has been reported. In" exact="renal cell carcinoma" post="there is a correlation between expression of CRP and"/>
   <result pre="and SAA are indicative of bacterial infection in cases on" exact="infectious mononucleosis," post="while elevated SAA (only) points to a viral infection"/>
   <result pre="of CRP profiles has contributed to validate a diagnostic of" exact="influenza" post="virus infection, ruling out rhinovirus infection [ 102]. Several"/>
   <result pre="cats receiving interferon therapy against feline immunodeficiency virus and feline" exact="leukemia" post="virus. In that model SAA/CRP levels can be taken"/>
   <result pre="of SAA in serum are associated with the inhibition of" exact="influenza" post="virus replication in oseltamivir-treated individuals [ 27]. Due to"/>
   <result pre="CRP levels can be used as an early marker of" exact="viral disease" post="in fish, before the outcome of the symptoms. However,"/>
   <result pre="Tonon M. Cozzi F. Doria A. Pentraxins, anti-pentraxin antibodies, and" exact="atherosclerosis" post="Clin. Rev. Allergy Immunol. 37 2009 36 43 19016000"/>
   <result pre="protein mediating immunopathological lesions: a potential treatment option for severe" exact="influenza" post="a diseases EBioMedicine 22 2017 133 142 28734805 21"/>
   <result pre="Correlation of C-reactive protein to severity of symptoms in acute" exact="influenza" post="A infection J. Emergencies, Trauma, Shock 5 2012 149"/>
   <result pre="factors associated with clinical outcome in patients with the novel" exact="influenza" post="A H7N9 infection Clin. Microbiol. Infect. 20 2014 493"/>
   <result pre="Kapmaz M. Yilmaz-Karadag F. Ergonul O. Predictors of fatality in" exact="influenza" post="A virus subtype infections among inpatients in the 2015-2016"/>
   <result pre="J.U. Zhong Z. Groves H.T. Tregonin J.S. Inflammatory responses to" exact="influenza" post="vaccination at the extremes of age Immunology 151 2017"/>
   <result pre="463 28375554 26 Martínez-Orellana P. Clinical response to pandemic H1N1" exact="influenza" post="virus from a fatal and mild case in ferrets"/>
   <result pre="D.L. Serum amyloid A (SAA) is an early biomarker of" exact="influenza" post="virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice"/>
   <result pre="P.C. Serum amyloid P is a syalylated glycoprotein inhibitor of" exact="influenza" post="A viruses PLoS One 8 2013 e59623 23544079 29"/>
   <result pre="Mantovani A. Antiviral activity of the long pentraxin PTX3 against" exact="influenza" post="viruses J. Immunol. 180 2008 3391 3398 18292565 31"/>
   <result pre="single amino acid substitution in the hemagglutinin of H3N2 subtype" exact="influenza" post="A viruses is associated with resistance to the long"/>
   <result pre="acute phase response in pigs experimentally infected with H1N2 swine" exact="influenza" post="virus FEMS Immunol. Med. Microbiol. 66 2012 334 342"/>
   <result pre="Pejsak Z. Immune and inflammatory response in pigs during acute" exact="influenza" post="caused by H1N1 swine influenza virus Arch. Virol. 159"/>
   <result pre="response in pigs during acute influenza caused by H1N1 swine" exact="influenza" post="virus Arch. Virol. 159 2014 2605 2614 24846450 34"/>
   <result pre="serum amyloid A (SAA) as an inflammatory marker in equine" exact="influenza" post="virus infection Acta Vet. Scand. 40 1999 323 333"/>
   <result pre="Acute phase protein changes in calves during an outbreak of" exact="respiratory disease" post="caused by bovine respiratory syncytial virus Comp. Immunol. Microbiol."/>
   <result pre="HBV replication, liver damage and fibrosis in patients with chronic" exact="hepatitis" post="B Hepato-Gastroenterol. 62 2015 368 372 40 Huang C.F."/>
   <result pre="response to pegylated interferon and ribavirin combination therapy in chronic" exact="hepatitis" post="C patients Hepatol. Int. 4 2010 621 627 21063486"/>
   <result pre="M.S. Genetic variation in PTX3 and plasma levels associated with" exact="hepatocellular carcinoma" post="in patients with HCV J. Viral Hepat. 23 2016"/>
   <result pre="effects of long pentraxin PTX3 on lung injury in a" exact="severe acute respiratory syndrome" post="model in mice Lab. Investig. 92 2012 1285 1296"/>
   <result pre="and fibrinolysis variables during acute Puumala hantavirus infection and associated" exact="thrombocytopenia" post="Blood Coagul. Fibrinolysis 25 2014 612 617 24751477 52"/>
   <result pre="Syrjanen J. Mustonen J. High pentraxin-3 plasma levels associate with" exact="thrombocytopenia" post="in acute Puumala hantavirus-induced nephropathia epidemica Eur. J. Clin."/>
   <result pre="pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced" exact="nephropathia epidemica" post="Eur. J. Clin. Microbiol. Infect. Dis. 31 2012 957"/>
   <result pre="in pigs to clinical and subclinical infection with H3N2 swine" exact="influenza" post="virus Influenza Other Respir. Viruses 8 2014 228 234"/>
   <result pre="phase protein response in pigs simultaneously infected with H1N1 swine" exact="influenza" post="virus and Pasteurella multocida BMC Vet. Res. 2013 60"/>
   <result pre="protein predicts early mortality in hospitalized patients with HBV-related decompensated" exact="cirrhosis" post="Medicine (Baltim.) 2017 62 Fraser C. Lythgoe K. Leventhal"/>
   <result pre="Johnstone J. Loeb M.B. Bowdish D.M.E. Serum C-reactive protein and" exact="congestive heart failure" post="as significant predictors of herpes zoster vaccine response in"/>
   <result pre="C-reactive protein and congestive heart failure as significant predictors of" exact="herpes zoster" post="vaccine response in elderly nursing home residents J. Infect."/>
   <result pre="Kuzawa C.W. Perez T.L. Adair L.S. C-reactive protein response to" exact="influenza" post="vaccination as a model of mild inflammatory stimulation in"/>
   <result pre="E. Erdei A. Svehag S.E. Serum amyloid P component inhibits" exact="influenza" post="A virus infections: in vitro and in vivo studies"/>
   <result pre="C. Dubuisson J. Serum amyloid A has antiviral activity against" exact="hepatitis" post="C virus by inhibiting virus entry in a cell"/>
   <result pre="Westhuyzen D.R. Luo G. Human serum amyloid A protein inhibits" exact="hepatitis" post="C virus entry into cells J. Virol. 81 2007"/>
   <result pre="The role of CRP and ATG9B expression in clear cell" exact="renal cell carcinoma" post="Biosci. Rep. 2017 88 Deban L. Jaillon S. Garlanda"/>
   <result pre="Association of C-reactive protein with bacterial and respiratory syncytial virus-associated" exact="pneumonia" post="among children aged &amp;lt;5 Years in the PERCH study"/>
   <result pre="levels in cerebrospinal fluid and serum to differentiate bacterial from" exact="viral meningitis" post="Ann. Clin. Lab. Sci. 48 2018 506 510 30143494"/>
   <result pre="in cerebrospinal fluid and serum to differentiate bacterial from viral" exact="meningitis" post="Ann. Clin. Lab. Sci. 48 2018 506 510 30143494"/>
   <result pre="potential of C-reactive protein, cytokines, and fecal markers in infectious" exact="gastroenteritis" post="in adults Diagn. Microbiol. Infect. Dis. 77 2013 79"/>
   <result pre="Popcheva G. Serum amyloid A protein in the course of" exact="infectious mononucleosis" post="Ther. Adv. Infect. Dis. 2019 101 Kutsuna S. Hayakawa"/>
   <result pre="serum C-reactive protein and total bilirubin levels for distinguishing between" exact="dengue fever" post="and malaria in returned travelers Am. J. Trop. Med."/>
   <result pre="and total bilirubin levels for distinguishing between dengue fever and" exact="malaria" post="in returned travelers Am. J. Trop. Med. Hyg. 90"/>
   <result pre="Immune characterization of long pentraxin 3 in pigs infected with" exact="influenza" post="virus Vet. Microbiol. 168 2014 185 192 24238985 107"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7096726/results/search/disease/results.xml">
   <result pre="to primate studies and learnings from outbreak responses. Recognizing emerging" exact="infectious disease" post="threats, key leaders in the United States developed consensus"/>
   <result pre="transmission via droplet nuclei (and thus requiring airborne precautions), namely" exact="severe acute respiratory syndrome," post="Middle East respiratory syndrome, and certain novel, avian, and"/>
   <result pre="challenges and potentially warrant biocontainment care. Smallpox, monkeypox, Nipah, Hendra," exact="pneumonic plague," post="and extensively drug-resistant tuberculosis are among these. Although these"/>
   <result pre="care. Smallpox, monkeypox, Nipah, Hendra, pneumonic plague, and extensively drug-resistant" exact="tuberculosis" post="are among these. Although these diseases differ in their"/>
   <result pre="airway. 23 Patients with EVD commonly develop copious amounts of" exact="diarrhea" post="that can lead to dehydration and this alone or"/>
   <result pre="coverage of US Ebola policies: implications for communication during future" exact="infectious disease" post="threats Prev Med 93 2016 15 120 4 Liddell"/>
   <result pre="Ebola who are clinically unstable or have bleeding, vomiting, or" exact="diarrhea" post="in U.S. hospitals, including procedures for donning and doffing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7098028/results/search/disease/results.xml">
   <result pre="Abstract The outbreak of Coronavirus disease 2019 (COVID-19), caused by" exact="severe acute respiratory syndrome" post="(SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over"/>
   <result pre="in the understanding and eradication of the threatening disease. Coronavirus" exact="pneumonia" post="outbreak SARS-CoV-2 COVID-19 Introduction The Spring Festival on January"/>
   <result pre="many weeks after due to the outbreak of a novel" exact="viral disease." post="The virus is highly homologous to the coronavirus (CoV)"/>
   <result pre="homologous to the coronavirus (CoV) that caused an outbreak of" exact="severe acute respiratory syndrome" post="(SARS) in 2003; thus, it was named SARS-CoV-2 by"/>
   <result pre="history of humans. As shown in Fig. 1, clusters of" exact="pneumonia" post="that had unknown origins were first reported from Wuhan"/>
   <result pre="by no symptom or other symptoms such as dry cough," exact="shortness" post="of breath, muscle ache, dizziness, headache, sore throat, rhinorrhea,"/>
   <result pre="patients quickly progressed to develop acute respiratory syndrome, septic shock," exact="metabolic acidosis," post="and coagulopathy. Patients with fever and/or respiratory symptoms and"/>
   <result pre="been demonstrated that fever (99%-100%), dry cough (29%-75%), dyspnea (40%-42%)," exact="diarrhea" post="(20-25%), and sore throat (13-25%) were the major symptoms"/>
   <result pre="Patients often develop an atypical pneumonia, acute lung injury, and" exact="acute respiratory distress syndrome" post="(ARDS) 34. When ARDS happens, uncontrolled inflammation, fluid accumulation,"/>
   <result pre="bypass technique used for the treatment of life-threatening cardiac or" exact="respiratory failure." post="In addition, the maintenance of electrolyte balance, the prevention"/>
   <result pre="used in severe SARS patients, many survivors suffered from avascular" exact="osteonecrosis" post="with life-long disability and poor life quality 105. Thus,"/>
   <result pre="and infectivity of 2019-nCoV, a new coronavirus which caused a" exact="pneumonia" post="outbreak in Wuhan, China. DOI: https://doi.org/10.1101/2020.01.20.913368 15 Xu X"/>
   <result pre="2020. Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin bioRxiv"/>
   <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan. Emerg. Microb Infect 2020 9 221"/>
   <result pre="2004 194 1 6 27 NHC: Diagnosis and treatment of" exact="pneumonia" post="caused by 2019 new coronavirus (trial version5) http://www.nhc.gov.cn/yzygj/s7652m/202002/e84bd30142ab4d8982326326e4db22ea.shtml 28"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet. DOI:10.1016/S0140-6736(20)30211-7 40"/>
   <result pre="et al. 2020. Identification of a novel coronavirus causing severe" exact="pneumonia" post="in human: a descriptive study Chin Med J (Engl)"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet 2020 395"/>
   <result pre="F Walmrath D et al. Surfactant alteration and replacement in" exact="acute respiratory distress syndrome" post="Respir Res 2001 2 353 64 11737935 54 Gralinski"/>
   <result pre="Chao Zhang et al. Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome" post="Lacet Respir Med 2020; DOI:https://doi.org/10.1016/S2213-2600(20)30076-X 57 Ding Y Wang"/>
   <result pre="Geng J Han H et al. The clinical pathology of" exact="severe acute respiratory syndrome" post="(SARS): a report from China The Journal of pathology"/>
   <result pre="Chang SC Clinical findings, treatment and prognosis in patients with" exact="severe acute respiratory syndrome" post="(SARS) J Chin Med Assoc 2005 68 106 7"/>
   <result pre="in the development of fibrotic lesions associated with reovirus 1/L-induced" exact="bronchiolitis" post="obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome Am"/>
   <result pre="of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing" exact="pneumonia" post="versus Acute Respiratory Distress Syndrome Am J Respir Cell"/>
   <result pre="protects against severe cytokine storm and enhances viral clearance during" exact="influenza" post="infection PLoS pathogens 2014 10 e1004134 24809749 72 Li"/>
   <result pre="et al. Osteonecrosis of hip and knee in patients with" exact="severe acute respiratory syndrome" post="treated with steroids Radiology 2005 235 168 75 15703312"/>
   <result pre="R Cao B On the use of corticosteroids for 2019-nCoV" exact="pneumonia" post="The Lancet 2020 DOI:https://doi.org/10.1016/S0140-6736(20)30361-5 76 Warren TK Jordan R"/>
   <result pre="Lo SV Tsang T et al. Clinical prognostic rules for" exact="severe acute respiratory syndrome" post="in low- and high-resource settings Arch Intern Med 2006"/>
   <result pre="et al. Induction of proinflammatory cytokines in human macrophages by" exact="influenza" post="A (H5N1) viruses: a mechanism for the unusual severity"/>
   <result pre="105 Hong N Du XK Avascular necrosis of bone in" exact="severe acute respiratory syndrome" post="Clinical radiology 2004 59 602 8 15208066 106 Chan"/>
   <result pre="Chu H Yang J et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="107 Peiris JS Yuen KY Osterhaus AD Stohr K The" exact="severe acute respiratory syndrome" post="N Engl J Med 2003 349 2431 41 14681510"/>
   <result pre="case of 2019 novel coronavirus in Canada, presenting as mild" exact="pneumonia" post="Lancet (London, England) 2020 6736 20 30370 112 Bradol"/>
   <result pre="of the efficacy of surgical and N95 masks to filter" exact="influenza" post="virus in patients with acute influenza infection Clin Infect"/>
   <result pre="N95 masks to filter influenza virus in patients with acute" exact="influenza" post="infection Clin Infect Dis 2009 49 275 7 19522650"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7099688/results/search/disease/results.xml">
   <result pre="presentations. Therefore, to apply the PM principles to the various" exact="rhinitis" post="subtypes rise as a meaningful strategy to improve evaluation"/>
   <result pre="resolved diagnosis (CRD) bring more precision to allergen immunotherapy for" exact="allergic rhinitis." post="Monoclonal antibodies against various cytokines involved in inflammatory allergic"/>
   <result pre="antibodies against various cytokines involved in inflammatory allergic and nonallergic" exact="rhinitis" post="endotypes show promissory results. Summary Better understanding of pathogenic"/>
   <result pre="together with an accurate phenotype classification of patients presented with" exact="rhinitis" post="symptoms contributes to point out clinical usefulness of biomarkers"/>
   <result pre="and incoming developments for each step in PM approach to" exact="rhinitis" post="evaluation and management. Rhinitis subtypes, phenotypes, endotypes, and biomarkers"/>
   <result pre="evaluation and management. Rhinitis subtypes, phenotypes, endotypes, and biomarkers Chronic" exact="rhinitis" post="is one of the most prevalent pathologic conditions of"/>
   <result pre="pathophysiologic mechanisms and clinical phenotypes. The three most widely accepted" exact="rhinitis" post="subgroups thus far are allergic rhinitis (AR), infectious rhinitis,"/>
   <result pre="The three most widely accepted rhinitis subgroups thus far are" exact="allergic rhinitis" post="(AR), infectious rhinitis, and nonallergic noninfectious rhinitis (NAR) ["/>
   <result pre="three most widely accepted rhinitis subgroups thus far are allergic" exact="rhinitis" post="(AR), infectious rhinitis, and nonallergic noninfectious rhinitis (NAR) ["/>
   <result pre="far are allergic rhinitis (AR), infectious rhinitis, and nonallergic noninfectious" exact="rhinitis" post="(NAR) [ 6], the last one recognizing a wide"/>
   <result pre="relevant pathophysiologic mechanism involved in those types and subtypes of" exact="rhinitis" post="(Table 1), as well as potential biomarkers for each"/>
   <result pre="each endotype, will be briefly discussed. Table 1 Classification of" exact="rhinitis" post="phenotypes and endotypes Allergic rhinitis AR is among the"/>
   <result pre="discussed. Table 1 Classification of rhinitis phenotypes and endotypes Allergic" exact="rhinitis" post="AR is among the most common diseases worldwide and"/>
   <result pre="more than 40% in adults [ 8]. Common symptoms of" exact="allergic rhinitis" post="include sneezing, a runny, stuffy, itchy nose, coughing, a"/>
   <result pre="than 40% in adults [ 8]. Common symptoms of allergic" exact="rhinitis" post="include sneezing, a runny, stuffy, itchy nose, coughing, a"/>
   <result pre="obtain the so-termed component resolved diagnosis (CRD) [ 17]. Local" exact="allergic rhinitis" post="Local allergic rhinitis, also called entopic rhinitis, is a"/>
   <result pre="the so-termed component resolved diagnosis (CRD) [ 17]. Local allergic" exact="rhinitis" post="Local allergic rhinitis, also called entopic rhinitis, is a"/>
   <result pre="component resolved diagnosis (CRD) [ 17]. Local allergic rhinitis Local" exact="allergic rhinitis," post="also called entopic rhinitis, is a distinct phenotype characterized"/>
   <result pre="with positive nasal allergen provocation test (NAPT) [ 18••]. Local" exact="allergic rhinitis" post="(LAR) is a form of chronic rhinitis with localized"/>
   <result pre="positive nasal allergen provocation test (NAPT) [ 18••]. Local allergic" exact="rhinitis" post="(LAR) is a form of chronic rhinitis with localized"/>
   <result pre="[ 18••]. Local allergic rhinitis (LAR) is a form of" exact="chronic rhinitis" post="with localized antigen-specific IgE production to common aeroallergens such"/>
   <result pre="18••]. Local allergic rhinitis (LAR) is a form of chronic" exact="rhinitis" post="with localized antigen-specific IgE production to common aeroallergens such"/>
   <result pre="21]. Nowadays, in clinical practice, efforts in endotyping patients with" exact="rhinitis" post="are mainly limited to measuring total and allergen-specific IgE"/>
   <result pre="3 may be also useful as biomarkers to predict seasonal" exact="allergic rhinitis" post="persistence and future onset of comorbidities, such as asthma"/>
   <result pre="may be also useful as biomarkers to predict seasonal allergic" exact="rhinitis" post="persistence and future onset of comorbidities, such as asthma"/>
   <result pre="allergic rhinitis persistence and future onset of comorbidities, such as" exact="asthma" post="and/or oral allergy syndrome [ 25]. In the case"/>
   <result pre="and future onset of comorbidities, such as asthma and/or oral" exact="allergy" post="syndrome [ 25]. In the case of extremely low"/>
   <result pre="patients with AR compared with normal subjects [ 31]. Infectious" exact="rhinitis" post="Rhinitis frequently coexists with sinusitis because the nose and"/>
   <result pre="normal subjects [ 31]. Infectious rhinitis Rhinitis frequently coexists with" exact="sinusitis" post="because the nose and sinuses share vascular, neuronal, and"/>
   <result pre="levels of IL-4, IL-5, and IL-13 manifested as significant mucosal" exact="eosinophilia" post="and increased levels of total and specific IgE ["/>
   <result pre="2). Table 2 Potential biomarkers for immune-mediated inflammatory endotypes in" exact="rhinitis" post="and chronic rhinosinusitis Endotypes Source AR LAR NARES CRSwNP"/>
   <result pre="inflammation Nasal fluids Nasal biopsy IL-6, IL-8, MPO Neutrophils AR" exact="allergic rhinitis," post="LAR local allergic rhinitis, CRSsNP chronic rhinosinusitis without nasal"/>
   <result pre="biopsy IL-6, IL-8, MPO Neutrophils AR allergic rhinitis, LAR local" exact="allergic rhinitis," post="CRSsNP chronic rhinosinusitis without nasal polyps, CRSwNP chronic rhinosinusitis"/>
   <result pre="nasal polyps, CRSwNP chronic rhinosinusitis with nasal polyps, NARES nonallergic" exact="rhinitis" post="with eosinophilia syndrome, SE-IgE specific IgE to S. aureus"/>
   <result pre="CRSwNP chronic rhinosinusitis with nasal polyps, NARES nonallergic rhinitis with" exact="eosinophilia" post="syndrome, SE-IgE specific IgE to S. aureus enterotoxin E,"/>
   <result pre="nitric oxide, ECP eosinophilic cationic protein, MPO myeloperoxidase Noninfectious nonallergic" exact="rhinitis" post="Although it is questionable to define something for what"/>
   <result pre="those subtypes in which PM can provide greater benefits. Nonallergic" exact="rhinitis" post="with eosinophilia syndrome Nonallergic rhinitis with eosinophilia syndrome (NARES)"/>
   <result pre="in which PM can provide greater benefits. Nonallergic rhinitis with" exact="eosinophilia" post="syndrome Nonallergic rhinitis with eosinophilia syndrome (NARES) was originally"/>
   <result pre="can provide greater benefits. Nonallergic rhinitis with eosinophilia syndrome Nonallergic" exact="rhinitis" post="with eosinophilia syndrome (NARES) was originally defined by the"/>
   <result pre="greater benefits. Nonallergic rhinitis with eosinophilia syndrome Nonallergic rhinitis with" exact="eosinophilia" post="syndrome (NARES) was originally defined by the presence of"/>
   <result pre="development of nasal polyposis, aspirin sensitivity, bronchial hyperreactivity, and nonallergic" exact="asthma" post="[ 43]. The pathophysiology is poorly understood, but a"/>
   <result pre="cationic protein (ECP), which constitutes a well-standardized marker for tissue" exact="eosinophilia" post="and activation [ 44]. ECP levels in nasal secretions"/>
   <result pre="be used to monitor eosinophilic inflammation in different kinds of" exact="rhinitis" post="with eosinophilic involvement, and they constitute an indicator of"/>
   <result pre="of treatment [ 44]. NARES is not associated with local" exact="allergy" post="(entopy) nor with a local inflammation driven by Staphylococcus"/>
   <result pre="inflammation driven by Staphylococcus aureus enterotoxin [ 45]. Idiopathic rhinitis/vasomotor" exact="rhinitis" post="Idiopathic rhinitis (IR) is the most prevalent subtype of"/>
   <result pre="by Staphylococcus aureus enterotoxin [ 45]. Idiopathic rhinitis/vasomotor rhinitis Idiopathic" exact="rhinitis" post="(IR) is the most prevalent subtype of the NAR"/>
   <result pre="and mucus-secreting glands, leading to symptoms of IR. The neurogenic" exact="rhinitis" post="endotype could also help to explain gustatory rhinitis and"/>
   <result pre="The neurogenic rhinitis endotype could also help to explain gustatory" exact="rhinitis" post="and rhinitis of the elderly as well as some"/>
   <result pre="rhinitis endotype could also help to explain gustatory rhinitis and" exact="rhinitis" post="of the elderly as well as some features of"/>
   <result pre="the elderly as well as some features of acute viral" exact="rhinitis" post="(cold air responsiveness) and even AR (which have neural"/>
   <result pre="to nasal hyperresponsiveness of the parasympathetic system [ 50]. Gustatory" exact="rhinitis" post="defined by the acute onset of profuse watery rhinorrhea"/>
   <result pre="occluding has been used for similar purposes [ 53]. Hormonal" exact="rhinitis" post="Hormonal rhinitis subtypes include rhinitis of pregnancy and menstrual"/>
   <result pre="been used for similar purposes [ 53]. Hormonal rhinitis Hormonal" exact="rhinitis" post="subtypes include rhinitis of pregnancy and menstrual cycle–related rhinitis."/>
   <result pre="similar purposes [ 53]. Hormonal rhinitis Hormonal rhinitis subtypes include" exact="rhinitis" post="of pregnancy and menstrual cycle–related rhinitis. Rhinitis of pregnancy"/>
   <result pre="spontaneously within 2 weeks postpartum [ 54], whereas menstrual cycle–related" exact="rhinitis" post="consists of symptoms appearing in the last few days"/>
   <result pre="of a placental growth hormone variant, or of prolactin. Drug-induced" exact="rhinitis" post="From a pathophysiologic perspective, systemic drug-induced rhinitis may be"/>
   <result pre="of prolactin. Drug-induced rhinitis From a pathophysiologic perspective, systemic drug-induced" exact="rhinitis" post="may be classified into three subtypes: local inflammatory, neurogenic,"/>
   <result pre="The prototype of the inflammatory endotype is represented by aspirin-exacerbated" exact="respiratory disease" post="(AERD). This condition is characterized by hypersensitivity to aspirin"/>
   <result pre="by aspirin-exacerbated respiratory disease (AERD). This condition is characterized by" exact="hypersensitivity" post="to aspirin and other nonsteroidal antiinflammatory drugs leading to"/>
   <result pre="and lower airway inflammation, and resulting in severe rhinosinusitis and" exact="asthma" post="symptoms [ 56]. Inhibition of cyclooxygenase-1 shifts the metabolism"/>
   <result pre="Alpha-adrenergic and beta-adrenergic antagonists (clonidine, methyldopa) could mediate symptoms of" exact="rhinitis" post="throughout a neurogenic endotype. Downregulation of the sympathetic tone"/>
   <result pre="(e.g., beta-blockers, calcium channel blockers, antipsychotics) [ 46] could induce" exact="rhinitis" post="by still unknown pathophysiologic mechanisms (idiopathic endotype). Rhinitis medicamentosa"/>
   <result pre="seems obvious, then pathophysiological mechanism merits not further discussion. Occupational" exact="rhinitis" post="Work-related rhinitis includes the development of nasal symptoms caused"/>
   <result pre="then pathophysiological mechanism merits not further discussion. Occupational rhinitis Work-related" exact="rhinitis" post="includes the development of nasal symptoms caused by factors"/>
   <result pre="well as work-exacerbated rhinitis, in which a preexisting or concurrent" exact="rhinitis" post="is worsened by occupational factors. The nature of the"/>
   <result pre="as reactive upper airway dysfunction syndrome, irritant-induced rhinitis, or corrosive" exact="rhinitis" post="depending on the severity and long lasting of the"/>
   <result pre="rhinosinusitis with or without polyps, or any evidence of atrophic" exact="rhinitis" post="[ 62]. Treatment of rhinitis subtypes following PM principles"/>
   <result pre="or any evidence of atrophic rhinitis [ 62]. Treatment of" exact="rhinitis" post="subtypes following PM principles Patients with moderate-to-severe rhinitis who"/>
   <result pre="Treatment of rhinitis subtypes following PM principles Patients with moderate-to-severe" exact="rhinitis" post="who are inadequately controlled despite treatment according to current"/>
   <result pre="rhinitis who are inadequately controlled despite treatment according to current" exact="rhinitis" post="management guidelines have a negative impact on daily functioning"/>
   <result pre="and are at risk of developing serious comorbidities, such as" exact="asthma" post="and chronic rhinosinusitis. PM strategies, based on endotype-driven management,"/>
   <result pre="PM strategies, based on endotype-driven management, represent the future of" exact="rhinitis" post="care in patients whose symptoms are not fully controlled"/>
   <result pre="are not fully controlled despite evidence-based treatment. Current definition of" exact="rhinitis" post="relies on the combination of history, physical examination, and"/>
   <result pre="rhinitis relies on the combination of history, physical examination, and" exact="allergy" post="diagnostic testing, which allows the distinction of the previously"/>
   <result pre="assess the efficacy and safety of omalizumab in poorly controlled" exact="allergic rhinitis," post="which included 11 studies and 2870 patients, concluded that"/>
   <result pre="be considered in combination with AIT for highly sensitive poly-allergic" exact="rhinitis" post="patients with increased risk of anaphylaxis [ 68]. Monoclonal"/>
   <result pre="clinically meaningful improvements in endoscopic, radiologic, clinical, patient-reported sino-nasal, and" exact="asthma" post="outcomes in patients with CRSwNP [ 71]. Other biological"/>
   <result pre="be of some benefit in reducing dust mite load and" exact="rhinitis" post="symptoms [ 78]. One of the main problems to"/>
   <result pre="Irritant avoidance and smoking stop should be advised to all" exact="rhinitis" post="patients [ 80•]. In the same way, treatment of"/>
   <result pre="benefit from aspirin desensitization [ 81]. The inflammatory group (occupational" exact="rhinitis" post="and drug-induced rhinitis) may benefit from antiinflammatory treatment such"/>
   <result pre="is an anticholinergic drug and the first treatment option in" exact="rhinitis" post="in the elderly [ 82]. Another example of endotype-driven"/>
   <result pre="better understanding of the critical causal pathways. Although often underestimated," exact="rhinitis" post="is one of the most common chronic diseases worldwide,"/>
   <result pre="respiratory medicine (IMPERA) [ 84]. The three most widely accepted" exact="rhinitis" post="subgroups thus far are infectious rhinitis, AR, and NAR."/>
   <result pre="overlapping, making a clear demarcation challenging. A PM approach to" exact="rhinitis" post="evaluation and management is schematically summarized in Fig. 1."/>
   <result pre="and idiopathic endotypes. Fig. 1 A precision medicine approach to" exact="rhinitis" post="evaluation and management. NHR nasal hyperreactivity, nNO nasal nitric"/>
   <result pre="test, ECP eosinophylic cationic protein, HMW high molecular weight, AR" exact="allergic rhinitis," post="ARIA allergic rhinitis and its impact on asthma guide,"/>
   <result pre="cationic protein, HMW high molecular weight, AR allergic rhinitis, ARIA" exact="allergic rhinitis" post="and its impact on asthma guide, NAPT nasal allergen"/>
   <result pre="protein, HMW high molecular weight, AR allergic rhinitis, ARIA allergic" exact="rhinitis" post="and its impact on asthma guide, NAPT nasal allergen"/>
   <result pre="AR allergic rhinitis, ARIA allergic rhinitis and its impact on" exact="asthma" post="guide, NAPT nasal allergen provocation test, AIT allergen immunotherapy,"/>
   <result pre="provocation test, AIT allergen immunotherapy, NAR nonallergic rhinitis, NARES nonallergic" exact="rhinitis" post="with eosinophilia syndrome, CRSwNP chronic rhinosinusitis with nasal polyps,"/>
   <result pre="AIT allergen immunotherapy, NAR nonallergic rhinitis, NARES nonallergic rhinitis with" exact="eosinophilia" post="syndrome, CRSwNP chronic rhinosinusitis with nasal polyps, CRSsNP chronic"/>
   <result pre="channel subfamily V member 1, LTE4 leukotriene E4, AERD aspirin-exacerbated" exact="respiratory disease," post="Mab monoclonal antibody. Asterisk indicates Mab target cytokines IL-4/IL-13"/>
   <result pre="S84 10.1016/j.jaci.2008.06.003 18662584 6. Mastin T Recognizing and treating non-infectious" exact="rhinitis" post="J Am Acad Nurse Pract 2003 15 398 409"/>
   <result pre="398 409 10.1111/j.1745-7599.2003.tb00414.x 14560436 7. Kaliner M Classification of nonallergic" exact="rhinitis" post="syndromes with a focus on vasomotor rhinitis, proposed to"/>
   <result pre="M Classification of nonallergic rhinitis syndromes with a focus on" exact="vasomotor rhinitis," post="proposed to be known henceforth as nonallergic rhinopathy World"/>
   <result pre="CE Bonini S Canonica GW Casale TB et al. Allergic" exact="rhinitis" post="and its impact on asthma (ARIA) guidelines: 2010 revision"/>
   <result pre="Casale TB et al. Allergic rhinitis and its impact on" exact="asthma" post="(ARIA) guidelines: 2010 revision J Allergy Clin Immunol 2010"/>
   <result pre="Khaltaev N collab: ARIA workshop group; World Health Organization Allergic" exact="rhinitis" post="and its impact on asthma J Allergy Clin Immunol"/>
   <result pre="group; World Health Organization Allergic rhinitis and its impact on" exact="asthma" post="J Allergy Clin Immunol 2001 108 S147 S334 10.1067/mai.2001.118891"/>
   <result pre="Wise SK Lin SY Toskala E International consensus statement on" exact="allergy" post="and rhinology: allergic rhinitis—executive summary Int Forum Allergy Rhinol"/>
   <result pre="2019;49:6–16. 10.1111/cea.13192This paper is a very good review on local" exact="allergic rhinitis." post="19. Rondón C Romero JJ Lopez S et al."/>
   <result pre="and positive nasal provocation test in patients with persistent nonallergic" exact="rhinitis" post="J Allergy Clin Immunol 2007 119 899 905 10.1016/j.jaci.2007.01.006"/>
   <result pre="Rondoó C Dona I Lopez S et al. Seasonal idiopathic" exact="rhinitis" post="with local inflammatory response and specific IgE in absence"/>
   <result pre="et al. Mucosal T-cell phenotypes in persistent atopic and nonatopic" exact="rhinitis" post="show an association with mast cells Allergy 2004 59"/>
   <result pre="Fokkens W Hellings PW et al. Phenotypes and endotypes of" exact="rhinitis" post="and their impact on management: a PRACTALL report Allergy"/>
   <result pre="V et al. Early molecular biomarkers predicting the evolution of" exact="allergic rhinitis" post="and its comorbidities: a longitudinal multicenter study of a"/>
   <result pre="et al. Early molecular biomarkers predicting the evolution of allergic" exact="rhinitis" post="and its comorbidities: a longitudinal multicenter study of a"/>
   <result pre="Van Gasse AL Mangodt EA Faber M et al. Molecular" exact="allergy" post="diagnosis: status anno 2015 Clin Chim Acta 2015 444"/>
   <result pre="Serrano E, et al. Nasal nitric oxide is increased in" exact="allergic rhinitis." post="Clin Exp Allergy. 1997;27:358–62. 32. Passioti M Maggina P"/>
   <result pre="O Carenfelt C Rystedt G Anggård A Occurrence of asymptomatic" exact="sinusitis" post="in common cold and other acute ENT-infections Rhinology 1986"/>
   <result pre="C Rystedt G Anggård A Occurrence of asymptomatic sinusitis in" exact="common cold" post="and other acute ENT-infections Rhinology 1986 24 223 225"/>
   <result pre="19 23 34 17153005 41. Ellis AK Keith PK Nonallergic" exact="rhinitis" post="with eosinophilia syndrome and related disorders Clin Allergy Immunol."/>
   <result pre="34 17153005 41. Ellis AK Keith PK Nonallergic rhinitis with" exact="eosinophilia" post="syndrome and related disorders Clin Allergy Immunol. 2007 19"/>
   <result pre="Bruaene N Toskala E et al. Important research questions in" exact="allergy" post="and related diseases: 3-chronic rhinosinusitis and nasal polyposis—a GALEN"/>
   <result pre="V Wayoff M Guyot JL Mouton C Maria Y Nonallergic" exact="rhinitis" post="with eosinophilia syndrome a precursor of the triad: nasal"/>
   <result pre="M Guyot JL Mouton C Maria Y Nonallergic rhinitis with" exact="eosinophilia" post="syndrome a precursor of the triad: nasal polyposis, intrinsic"/>
   <result pre="with eosinophilia syndrome a precursor of the triad: nasal polyposis," exact="intrinsic asthma," post="and intolerance to aspirin Ann Allergy 1990 64 513"/>
   <result pre="64 513 518 2346237 44. Ellis AK Keith PK Nonallergic" exact="rhinitis" post="with eosinophilia syndrome Curr Allergy Asthma Rep 2006 6"/>
   <result pre="518 2346237 44. Ellis AK Keith PK Nonallergic rhinitis with" exact="eosinophilia" post="syndrome Curr Allergy Asthma Rep 2006 6 215 220"/>
   <result pre="Eder Katharina Berghaus Alexander Kramer Matthias F. Gröger Moritz Non-allergic" exact="rhinitis" post="with eosinophilia syndrome is not associated with local production"/>
   <result pre="Berghaus Alexander Kramer Matthias F. Gröger Moritz Non-allergic rhinitis with" exact="eosinophilia" post="syndrome is not associated with local production of specific"/>
   <result pre="6 1469 1475 10.1007/s00405-015-3769-4 26342925 46. Settipane G Epidemiology of" exact="vasomotor rhinitis" post="World Allergy Organ J 2009 2 115 118 10.1097/WOX.0b013e3181ac91ae"/>
   <result pre="1469 1475 10.1007/s00405-015-3769-4 26342925 46. Settipane G Epidemiology of vasomotor" exact="rhinitis" post="World Allergy Organ J 2009 2 115 118 10.1097/WOX.0b013e3181ac91ae"/>
   <result pre="P Up-date on neuro-immune mechanisms involved in allergic and non-allergic" exact="rhinitis" post="Rhinology 2012 50 227 235 10.4193/Rhin11.152 22888478 49. Sarin"/>
   <result pre="A et al. The role of the nervous system in" exact="rhinitis" post="J Allergy Clin Immunol 2006 118 999 1016 10.1016/j.jaci.2006.09.013"/>
   <result pre="19 209 219 17153015 51. Georgalas C Jovancevic L Gustatory" exact="rhinitis" post="Curr Opin Otolaryngol Head Neck Surg 2012 20 1"/>
   <result pre="diseases and atopic dermatitis—PRACTALL document of the European academy of" exact="allergy" post="and clinical immunology and the American Academy of Allergy,"/>
   <result pre="subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic" exact="rhinitis" post="J Allergy Clin Immunol 2014 133 1332 1339 10.1016/j.jaci.2013.08.026"/>
   <result pre="10.2500/ajra.2016.30.4370 28124651 57. Varghese M Glaum MC Lockey RF Drug-induced" exact="rhinitis" post="Clin Exp Allergy 2010 40 381 384 10.1111/j.1365-2222.2009.03450.x 20210811"/>
   <result pre="J. L. Girard D. Dufour J. G. Gautrin D. Chronic" exact="rhinitis" post="in workers at risk of reactive airways dysfunction syndrome"/>
   <result pre="Siracusa Andrea Folletti Ilenia Moscato Gianna Non-IgE-mediated and irritant-induced work-related" exact="rhinitis" post="Current Opinion in Allergy and Clinical Immunology 2013 13"/>
   <result pre="K. Lin Sandra Y. Toskala Elina International consensus statement on" exact="allergy" post="and rhinology: allergic rhinitis—executive summary International Forum of Allergy"/>
   <result pre="1650 10.1016/S0140-6736(19)31881-1 72. Ghadersohi S Tan BK Contemporary pharmacotherapy for" exact="allergic rhinitis" post="and chronic rhinosinusitis Otolaryngol Clin N Am 2017 50"/>
   <result pre="10.1016/S0140-6736(19)31881-1 72. Ghadersohi S Tan BK Contemporary pharmacotherapy for allergic" exact="rhinitis" post="and chronic rhinosinusitis Otolaryngol Clin N Am 2017 50"/>
   <result pre="Fenández Caldas E The association between ambient air pollution and" exact="allergic rhinitis" post="inception and control Curr Treat Options Allergy 2018 5"/>
   <result pre="Caldas E The association between ambient air pollution and allergic" exact="rhinitis" post="inception and control Curr Treat Options Allergy 2018 5"/>
   <result pre="al. Non-allergic rhinitis: position paper of the European academy of" exact="allergy" post="and clinical immunology Allergy 2017 72 11 1657 1665"/>
   <result pre="treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated" exact="respiratory disease" post="(AERD)? Curr Allergy Asthma Rep 2014 14 441 10.1007/s11882-014-0441-9"/>
   <result pre="Holopainen E Binder E Ipratropium (Atrovent) in the treatment of" exact="vasomotor rhinitis" post="of elderly patients Clin Otolaryngol Allied Sci 1983 8"/>
   <result pre="E Binder E Ipratropium (Atrovent) in the treatment of vasomotor" exact="rhinitis" post="of elderly patients Clin Otolaryngol Allied Sci 1983 8"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7101061/results/search/disease/results.xml">
   <result pre="collab: RADAR-CNS consortium Remote assessment of disease and relapse in" exact="major depressive disorder" post="(RADAR-MDD): a multi-centre prospective cohort study protocol BMC Psychiatry"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7101506/results/search/disease/results.xml">
   <result pre="https://jamanetwork.com/journals/cardiology/fullarticle/10.1001/jamacardio.2020.1017 This case series study evaluates the association of underlying" exact="cardiovascular disease" post="and myocardial injury on fatal outcomes in patients with"/>
   <result pre="(COVID-19). Key Points Question What is the impact of underlying" exact="cardiovascular disease" post="(CVD) and myocardial injury on fatal outcomes in patients"/>
   <result pre="outcome is scarce. Objective To evaluate the association of underlying" exact="cardiovascular disease" post="(CVD) and myocardial injury with fatal outcomes in patients"/>
   <result pre="years. Overall, 66 (35.3%) had underlying CVD including hypertension, coronary" exact="heart disease," post="and cardiomyopathy, and 52 (27.8%) exhibited myocardial injury as"/>
   <result pre="China Introduction Coronavirus disease 2019 (COVID-19) is a newly recognized" exact="infectious disease" post="that has spread rapidly throughout Wuhan, Hubei, China, to"/>
   <result pre="clinical data, in addition to the common clinical presentation of" exact="respiratory failure" post="caused by COVID-19, the cardiovascular manifestations induced by this"/>
   <result pre="present, specific information characterizing whether patients with COVID-19 with underlying" exact="cardiovascular disease" post="(CVD) who develop myocardial injury during hospitalization face greater"/>
   <result pre="187 patients, 66 (35.3%) had underlying CVD including hypertension, coronary" exact="heart disease," post="and cardiomyopathy, and 52 (27.8%) exhibited myocardial injury as"/>
   <result pre="by elevated TnT levels. On admission, none showed evidence of" exact="acute myocardial infarction," post="chronic liver disease, thromboembolic diseases, or rheumatism. In patients"/>
   <result pre="On admission, none showed evidence of acute myocardial infarction, chronic" exact="liver disease," post="thromboembolic diseases, or rheumatism. In patients with elevated plasma"/>
   <result pre="&amp;lt;.001 COPD 4 (2.1) 0 (0) 4 (7.7) .001 Malignant" exact="neoplasm" post="13 (7.0) 7 (5.2) 6 (11.5) .13 Chronic kidney"/>
   <result pre="Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARDS," exact="acute respiratory distress syndrome;" post="CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease;"/>
   <result pre="angiotensin receptor blocker; ARDS, acute respiratory distress syndrome; CHD, coronary" exact="heart disease;" post="COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019;"/>
   <result pre="ARDS, acute respiratory distress syndrome; CHD, coronary heart disease; COPD," exact="chronic obstructive pulmonary disease;" post="COVID-19, coronavirus disease 2019; NA, not applicable; TnT, troponin"/>
   <result pre="of comorbidities including hypertension (33 [63.5%] vs 28 [20.7%]), coronary" exact="heart disease" post="(17 [32.7%] vs 4 [3.0%]), cardiomyopathy (8 [15.4%] vs"/>
   <result pre="28 [20.7%]), coronary heart disease (17 [32.7%] vs 4 [3.0%])," exact="cardiomyopathy" post="(8 [15.4%] vs 0), diabetes (16 [30.8%] vs 12"/>
   <result pre="(8 [15.4%] vs 0), diabetes (16 [30.8%] vs 12 [8.9%])," exact="chronic obstructive pulmonary disease" post="(4 [7.7%] vs 0), and chronic kidney disease (1"/>
   <result pre="[8.9%]), chronic obstructive pulmonary disease (4 [7.7%] vs 0), and" exact="chronic kidney disease" post="(1 [0.7%] vs 5 [9.6%]). Rates of smoking and"/>
   <result pre="TnT levels developed more frequent complications ( Table 1), including" exact="acute respiratory distress syndrome" post="(30 [57.7%] vs 16 [11.9%]), malignant arrhythmias (6 [11.5%]"/>
   <result pre="of COVID-19. For patients with underlying CVD, including hypertension, coronary" exact="heart disease," post="and cardiomyopathy, viral illness can further damage myocardial cells"/>
   <result pre="previous report showed that in 35% of the patients with" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) infection, the SARS-CoV genome was positively detected"/>
   <result pre="showed a beneficial effect of ACEI/ARB in patients admitted with" exact="viral pneumonia," post="as it significantly reduced the pulmonary inflammatory response and"/>
   <result pre="Lu H , Stratton CW , Tang YW Outbreak of" exact="pneumonia" post="of unknown etiology in Wuhan, China: the mystery and"/>
   <result pre="HD , Fauci AS Coronavirus infections: more than just the" exact="common cold." post="JAMA. Published online January 23, 2020. doi: 10.1001/jama.2020.0757 31971553"/>
   <result pre="10.1001/jama.2020.0757 31971553 4 Wuhan Municipal Health Commission. Report of clustering" exact="pneumonia" post="of unknown etiology in Wuhan City. Published December 31,"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China . JAMA. Published February 7, 2020."/>
   <result pre="Investigating and Research Team A Novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med. 2020; 382("/>
   <result pre="White HD Impact of angiotensin-converting enzyme inhibitors and statins on" exact="viral pneumonia." post="Proc (Bayl Univ Med Cent). 2018; 31( 4): 419-"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102551/results/search/disease/results.xml">
   <result pre="in COVID-19 patients are similar to those who suffered from" exact="severe acute respiratory syndrome" post="(SARS) during the 2003 epidemic [ 4]. Based on"/>
   <result pre="Instead, it appears to be no more concerning than the" exact="influenza" post="virus [ 5]. This geographic discrepancy in pathogenesis may"/>
   <result pre="lung and elsewhere. This may lead to acute respiratory injury," exact="acute respiratory distress syndrome," post="and other observed inflammation-based sequelae as seen in many"/>
   <result pre="similar coronaviruses that were asymptomatic or mistaken for a regular" exact="common cold" post="virus. A few potential candidates have been isolated in"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet 395 10223"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected" exact="pneumonia" post="in Wuhan, China J Am Med Assoc 2020 4"/>
   <result pre="I.H.Y. Luk W. Sia S.-F. Wu M.H.S. Cytokine responses in" exact="severe acute respiratory syndrome" post="coronavirus-infected macrophages in vitro: possible relevance to pathogenesis J"/>
   <result pre="Traggiai E. Lanzavecchia A. Evasion of antibody neutralization in emerging" exact="severe acute respiratory syndrome" post="coronaviruses Proc Natl Acad Sci U S A 102"/>
   <result pre="Lee H.H.Y. Daëron M. Antibody-dependent infection of human macrophages by" exact="severe acute respiratory syndrome" post="coronavirus Virol J 11 2014 82 24885320 9 Jaume"/>
   <result pre="Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal" exact="pneumonia" post="in SARS-CoV-infected mice Cell Host Microbe 19 2016 181"/>
   <result pre="A.C. Riley S. Ferguson N.M. Epidemiological and genetic analysis of" exact="severe acute respiratory syndrome" post="Lancet Infect Dis 4 2004 672 683 15522679 14"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102577/results/search/disease/results.xml">
   <result pre="are most common causative agents responsible for outbreak of human" exact="hand, foot and mouth disease" post="(HFMD), most often affecting children [ 54, 55]. Though"/>
   <result pre="causative agents responsible for outbreak of human hand, foot and" exact="mouth disease" post="(HFMD), most often affecting children [ 54, 55]. Though"/>
   <result pre="poliovirus, was one of the most horrible pathogens that caused" exact="poliomyelitis" post="in last century, affecting numerous of children each year,"/>
   <result pre="by World Health Assembly (WHA) in 1988, global incidence of" exact="poliomyelitis" post="caused by poliovirus infection has been dramatically reduced to"/>
   <result pre="1%; through broad epidemiological surveillance and highly effective vaccination program," exact="poliomyelitis" post="caused by poliovirus has been reported by only three"/>
   <result pre="(CVB3), which has been the major causative agent of viral" exact="myocarditis" post="associated with heart dysfunction, also commonly affecting children and"/>
   <result pre="commonly affecting children and young adults [ 64, 65]. CVB3-induced" exact="myocarditis" post="can lead to dilated cardiomyopathy (DCM), which is a"/>
   <result pre="adults [ 64, 65]. CVB3-induced myocarditis can lead to dilated" exact="cardiomyopathy" post="(DCM), which is a common cause of heart transplantation"/>
   <result pre="S.F. Chisari F.V. The autophagy machinery is required to initiate" exact="hepatitis" post="C virus replication Proc. Natl. Acad. Sci. 106 2009"/>
   <result pre="S. Arunkumar G. Alidjinou E. Hober D. Hand, foot and" exact="mouth disease" post="(HFMD): emerging epidemiology and the need for a vaccine"/>
   <result pre="M. Liang Z. Coxsackievirus A6: a new emerging pathogen causing" exact="hand, foot and mouth disease" post="outbreaks worldwide Expert Rev. Anti. Ther. 13 2015 1061"/>
   <result pre="Coxsackievirus A6: a new emerging pathogen causing hand, foot and" exact="mouth disease" post="outbreaks worldwide Expert Rev. Anti. Ther. 13 2015 1061"/>
   <result pre="Esfandiarei M. McManus B.M. Molecular biology and pathogenesis of viral" exact="myocarditis" post="Annu. Rev. Pathmechdis. Mech. Dis. 3 2008 127 155"/>
   <result pre="Fairweather D. Stafford K.A. Sung Y.K. Update on coxsackievirus B3" exact="myocarditis" post="Curr. Opin. Rheumatol. 24 2012 401 22488075 67 Massilamany"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102592/results/search/disease/results.xml">
   <result pre="parameters of ECMO; seven-point ordinal scale; APACHE II score; CURB-65" exact="pneumonia" post="severity score; Murray lung injury score; NEWS 2; SOFA"/>
   <result pre="36-item short-form health survey; MODS: multiple organ dysfunction syndrome; ARDS:" exact="acute respiratory distress syndrome;" post="DIC: disseminated intravascular coagulation; ICU: intensive care unit; ECMO:"/>
   <result pre="multiple organ dysfunction syndrome; ARDS: acute respiratory distress syndrome; DIC:" exact="disseminated intravascular coagulation;" post="ICU: intensive care unit; ECMO: extracorporeal membrane oxygenation; APACHE:"/>
   <result pre="national early warning score; SOFA: sequential organ failure assessment; PSI:" exact="pneumonia" post="severity index. This list of outcomes was too long"/>
   <result pre="of mechanical ventilation; duration (d) of ECMO; NEWS2 score; CURB-65" exact="pneumonia" post="severity score; PSI score; curative effects of TCM syndromes"/>
   <result pre="mechanical ventilation; duration (d) of ECMO; APACHE II score; CURB-65" exact="pneumonia" post="severity score; PSI score Rehabilitation period (6) Chest X-ray"/>
   <result pre="(rate/rate/time); blood oxygen saturation; PaO 2/FiO 2; NEWS2 score; CURB-65" exact="pneumonia" post="severity score; PSI score; SOFA score; DIC score; chest"/>
   <result pre="2; duration (d) of mechanical ventilation; APACHE II score; CURB-65" exact="pneumonia" post="severity score; PSI score; SOFA score; lymphocyte (count/ratio); 2019-nCoV"/>
   <result pre="and the incidence of sequelae and the rate of interstitial" exact="pneumonia" post="would be combined into the incidence of sequelae. Finally,"/>
   <result pre="pulmonary imaging. Critical type (meeting any of the following): ①" exact="respiratory failure" post="occurred and mechanical ventilation required; ② shock occurred; ③"/>
   <result pre="six common and important clinical symptoms, including fever, cough, fatigue," exact="shortness" post="of breath, diarrhea, and body pain, each of which"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102648/results/search/disease/results.xml">
   <result pre="2019, the world is facing a novel outbreak of an" exact="infectious disease," post="known as COVID-19, caused by an unidentified viral agent."/>
   <result pre="fatality rate when compared with the virus of the seasonal" exact="influenza" post="(3.4%, WHO Situation Report-37, 25/02/2020), outside the primordial outbreak"/>
   <result pre="I.H.Y. Luk W. Sia S.-F. Wu M.H.S. Cytokine responses in" exact="severe acute respiratory syndrome" post="coronavirus-infected macrophages in vitro: possible relevance to pathogenesis J"/>
   <result pre="A.C. Riley S. Ferguson N.M. Epidemiological and genetic analysis of" exact="severe acute respiratory syndrome" post="Lancet Infect Dis 4 2004 672 683 15522679 8"/>
   <result pre="Traggiai E. Lanzavecchia A. Evasion of antibody neutralization in emerging" exact="severe acute respiratory syndrome" post="coronaviruses Proc Natl Acad Sci U S A 102"/>
   <result pre="Lee H.H.Y. Daëron M. Antibody-dependent infection of human macrophages by" exact="severe acute respiratory syndrome" post="coronavirus Virol J 11 2014 82 24885320 17 Jaume"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102656/results/search/disease/results.xml">
   <result pre="burden of coronavirus disease 2019 (COVID-19) with a focus on" exact="congenital heart disease" post="Tan Weiyi weiyitan@mednet.ucla.edu ⁎ Aboulhosn Jamil [], ⁎Corresponding author."/>
   <result pre="of coronavirus disease 2019 (COVID-19) with a focus on congenital" exact="heart disease" post="Tan Weiyi weiyitan@mednet.ucla.edu ⁎ Aboulhosn Jamil [], ⁎Corresponding author."/>
   <result pre="Abstract Coronavirus disease 2019 (COVID-19), caused by a novel betacoronavirus" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), was first described in a cluster"/>
   <result pre="was first described in a cluster of patients presenting with" exact="pneumonia" post="symptoms in Wuhan, China, in December of 2019. Over"/>
   <result pre="those with underlying medical comorbidities. Since this is an emerging" exact="infectious disease," post="there is, as of yet, limited data on the"/>
   <result pre="data on the effects of this infection on patients with" exact="cardiovascular disease," post="particularly so for those with congenital heart disease. We"/>
   <result pre="on patients with cardiovascular disease, particularly so for those with" exact="congenital heart disease." post="We summarize herewith the early experience with COVID-19 and"/>
   <result pre="patients with cardiovascular disease, particularly so for those with congenital" exact="heart disease." post="We summarize herewith the early experience with COVID-19 and"/>
   <result pre="consider the potential applicability to and implications for patients with" exact="cardiovascular disease" post="in general and congenital heart disease in particular. Highlights"/>
   <result pre="and implications for patients with cardiovascular disease in general and" exact="congenital heart disease" post="in particular. Highlights • The global COVID-19 pandemic is"/>
   <result pre="implications for patients with cardiovascular disease in general and congenital" exact="heart disease" post="in particular. Highlights • The global COVID-19 pandemic is"/>
   <result pre="was first described in a cluster of patients presenting with" exact="pneumonia" post="symptoms in Wuhan, China [ 1] in December of"/>
   <result pre="in December of 2019. Two previous epidemics caused by betacoronaviruses," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) [ 2] and Middle East respiratory syndrome"/>
   <result pre="with over 400,000 cases globally. Since this is an emerging" exact="infectious disease," post="there is, as of yet, a paucity of data"/>
   <result pre="data about the effects of this infection on patients with" exact="congenital heart disease." post="We aim to summarize the initial experience with COVID-19"/>
   <result pre="about the effects of this infection on patients with congenital" exact="heart disease." post="We aim to summarize the initial experience with COVID-19"/>
   <result pre="consider the potential applicability to and implications for patients with" exact="congenital heart disease." post="2 Background 2.1 Viral effects on the heart and"/>
   <result pre="the potential applicability to and implications for patients with congenital" exact="heart disease." post="2 Background 2.1 Viral effects on the heart and"/>
   <result pre="and on patients with cardiovascular conditions Based on data from" exact="influenza" post="viral infections and the previous coronavirus epidemics (SARS and"/>
   <result pre="and MERS), these viral infections mainly cause pulmonary issues like" exact="pneumonia" post="and acute respiratory distress syndrome [ 2, 3]. That"/>
   <result pre="these viral infections mainly cause pulmonary issues like pneumonia and" exact="acute respiratory distress syndrome" post="[ 2, 3]. That being said, these viruses have"/>
   <result pre="cause direct myocardial injury, as there are known cases of" exact="myocarditis" post="caused by both influenza and coronaviruses [ [6], [7],"/>
   <result pre="as there are known cases of myocarditis caused by both" exact="influenza" post="and coronaviruses [ [6], [7], [8]]. Furthermore, patients with"/>
   <result pre="and coronaviruses [ [6], [7], [8]]. Furthermore, patients with underlying" exact="heart disease" post="(both congenital or acquired) seem to have increased morbidity"/>
   <result pre="is why there is a strong recommendation to vaccinate against" exact="influenza" post="to prevent poor outcomes in them [ 11, 12]."/>
   <result pre="is also some data to suggest that patients with underlying" exact="heart disease" post="may be more susceptible to contracting coronavirus infection ["/>
   <result pre="to pneumocytes via a viral cytopathic effect, but also caused" exact="acute respiratory distress syndrome" post="(ARDS) characterized by diffuse alveolar damage [ 26]. No"/>
   <result pre="direct damage to lung epithelia, which can lead to severe" exact="pneumonia" post="and ARDS. The COVID-19 virus also causes an inflammatory"/>
   <result pre="in infected patients, which may lead to multi-organ failure and" exact="disseminated intravascular coagulation" post="(DIC) in certain patients [ 30]. Furthermore, the hypoxia"/>
   <result pre="[ 30]. Furthermore, the hypoxia seen in patients with severe" exact="pneumonia" post="and ARDS may also lead to further end-organ dysfunction/damage"/>
   <result pre="patients with COVID-19 will present with fever, dry cough, and" exact="shortness" post="of breath. They will have findings of pneumonia on"/>
   <result pre="cough, and shortness of breath. They will have findings of" exact="pneumonia" post="on chest X-ray and computed tomography scans of the"/>
   <result pre="can also develop gastrointestinal symptoms like abdominal pain, nausea, and" exact="diarrhea" post="[ 32]. As mentioned earlier, lymphopenia is seen commonly"/>
   <result pre="[ 29] and 33% ( n = 7) of patients developed a" exact="cardiomyopathy" post="[ 34]. Another study documented that among a group"/>
   <result pre="27]. The authors hypothesized that the initial group died of" exact="respiratory failure," post="but the second group had myocardial damage and significant"/>
   <result pre="group had myocardial damage and significant cardiovascular collapse concerning for" exact="myocarditis" post="[ 27]. There have been a few case reports"/>
   <result pre="27]. There have been a few case reports documenting clinical" exact="myocarditis" post="with COVID-19 [ 36, 37]. This is consistent with"/>
   <result pre="[ 36, 37]. This is consistent with previous reports of" exact="myocarditis" post="caused by coronaviruses, including MERS [ 7, 8, 27,"/>
   <result pre="performed to investigate COVID-19 and its possible role in fulminant" exact="myocarditis" post="[ 35]. 4.2 COVID-19 and adult patients with cardiovascular"/>
   <result pre="fulminant myocarditis [ 35]. 4.2 COVID-19 and adult patients with" exact="cardiovascular disease" post="While most patients who contract COVID-19 recover [ 39],"/>
   <result pre="of having severe disease/requiring ICU care compared to those without" exact="cardiovascular disease" post="[ 41]. When analyzing the largest case series to"/>
   <result pre="Center for Disease Control and Prevention reported that patients with" exact="cardiovascular disease" post="had a case fatality rate of 10.5% and those"/>
   <result pre="but they comprised 32% of the COVID-19 deaths. Patients with" exact="cardiovascular disease" post="made up 4.2% of the COVID-19 cases, but were"/>
   <result pre="To date, there are no published reports of patients with" exact="congenital heart disease" post="and COVID-19 infection, albeit they are bound to come."/>
   <result pre="date, there are no published reports of patients with congenital" exact="heart disease" post="and COVID-19 infection, albeit they are bound to come."/>
   <result pre="only 6 (3.5%) patients. A 10-month-old child with history of" exact="intussusception" post="died from multiorgan failure, and this was the only"/>
   <result pre="infectious [ 45]. None of the studies described children with" exact="congenital heart disease" post="and COVID-19, and thus the effect of the virus"/>
   <result pre="[ 45]. None of the studies described children with congenital" exact="heart disease" post="and COVID-19, and thus the effect of the virus"/>
   <result pre="of COVID-19 on pregnancy. 5 COVID-19 and the adult with" exact="congenital heart disease" post="To date, there are no published studies on COVID-19"/>
   <result pre="COVID-19 on pregnancy. 5 COVID-19 and the adult with congenital" exact="heart disease" post="To date, there are no published studies on COVID-19"/>
   <result pre="are no published studies on COVID-19 in adult patients with" exact="congenital heart disease." post="Thus, all of the current management strategies are extrapolated"/>
   <result pre="no published studies on COVID-19 in adult patients with congenital" exact="heart disease." post="Thus, all of the current management strategies are extrapolated"/>
   <result pre="effect of COVID-19 on adult patients and adult patients with" exact="cardiovascular disease." post="That being said, efforts are under way through the"/>
   <result pre="of an evidence base. 5.1 Diagnosis When a patient with" exact="congenital heart disease" post="is suspected of having COVID-19, the first step is"/>
   <result pre="an evidence base. 5.1 Diagnosis When a patient with congenital" exact="heart disease" post="is suspected of having COVID-19, the first step is"/>
   <result pre="the risk of individual cardiovascular complications in patients with underlying" exact="cardiovascular disease" post="who are infected with SARS-CoV-2. While no studies on"/>
   <result pre="SARS-CoV-2. While no studies on COVID-19 have included patients with" exact="congenital heart disease," post="it stands to reason that patients with congenital heart"/>
   <result pre="While no studies on COVID-19 have included patients with congenital" exact="heart disease," post="it stands to reason that patients with congenital heart"/>
   <result pre="congenital heart disease, it stands to reason that patients with" exact="congenital heart disease" post="could be considered at higher risk for complications from"/>
   <result pre="heart disease, it stands to reason that patients with congenital" exact="heart disease" post="could be considered at higher risk for complications from"/>
   <result pre="higher risk for complications from COVID-19. Certain adult patients with" exact="congenital heart disease" post="(ACHD) are likely at higher risk than others. Based"/>
   <result pre="risk for complications from COVID-19. Certain adult patients with congenital" exact="heart disease" post="(ACHD) are likely at higher risk than others. Based"/>
   <result pre="ACHD Anatomy and Physiological Stage Classification, any patient with complex" exact="congenital heart disease" post="(Anatomy Stage III) or Physiological Stage B, C, or"/>
   <result pre="Anatomy and Physiological Stage Classification, any patient with complex congenital" exact="heart disease" post="(Anatomy Stage III) or Physiological Stage B, C, or"/>
   <result pre="infection. Studies have tried to risk-stratify patients suffering from a" exact="viral pneumonia" post="[ 51], and the MuLBSTA score may be a"/>
   <result pre="Studies have tried to risk-stratify patients suffering from a viral" exact="pneumonia" post="[ 51], and the MuLBSTA score may be a"/>
   <result pre="patients). [alt-text] Table 2 Complex congenital anatomy Any patient with" exact="congenital heart disease," post="regardless of the complexity of the anatomy. All physiological"/>
   <result pre="[alt-text] Table 2 Complex congenital anatomy Any patient with congenital" exact="heart disease," post="regardless of the complexity of the anatomy. All physiological"/>
   <result pre="to treatment • Severe hypoxemia (associated with cyanosis) • Severe" exact="pulmonary hypertension" post="• Eisenmenger syndrome • Refractory end-organ dysfunction 5.3 Prevention"/>
   <result pre="• Refractory end-organ dysfunction 5.3 Prevention Since patients with underlying" exact="cardiovascular disease" post="are at higher risk of morbidity and mortality, patients"/>
   <result pre="cleaning and disinfecting commonly touched surfaces [ 52]. Patients with" exact="congenital heart disease" post="should be vaccinated against influenza and pneumococcal pneumonia ["/>
   <result pre="and disinfecting commonly touched surfaces [ 52]. Patients with congenital" exact="heart disease" post="should be vaccinated against influenza and pneumococcal pneumonia ["/>
   <result pre="52]. Patients with congenital heart disease should be vaccinated against" exact="influenza" post="and pneumococcal pneumonia [ 11, 12]. If possible, regularly"/>
   <result pre="congenital heart disease should be vaccinated against influenza and pneumococcal" exact="pneumonia" post="[ 11, 12]. If possible, regularly scheduled clinic visits"/>
   <result pre="of in-person visits for some patients, e.g. those with decompensated" exact="congestive heart failure" post="or arrhythmias. The advent of wearable technology and wide"/>
   <result pre="from direct viral invasion of cardiomyocytes, hypoxia due to severe" exact="pneumonia" post="leading to ischemic cardiac tissue, or an overwhelming inflammatory"/>
   <result pre="function with increased metabolic demand, acute coronary syndrome, and fulminant" exact="myocarditis" post="will be important as each of these clinical scenarios"/>
   <result pre="55], there have been reports of patients recovering from fulminant" exact="myocarditis" post="with intravenous immunoglobulin and steroids [ 36]. More studies"/>
   <result pre="caution must be used when applying them to patients with" exact="congenital heart disease." post="Vaccine development is also underway and is one of"/>
   <result pre="must be used when applying them to patients with congenital" exact="heart disease." post="Vaccine development is also underway and is one of"/>
   <result pre="to be beneficial, such as heart failure, hypertension, or ischemic" exact="heart disease" post="[ 60].&quot; This position has also been echoed by"/>
   <result pre="are no studies currently documenting COVID-19 infections in patients with" exact="congenital heart disease," post="it is highly likely that with over 300,000 cases"/>
   <result pre="no studies currently documenting COVID-19 infections in patients with congenital" exact="heart disease," post="it is highly likely that with over 300,000 cases"/>
   <result pre="(as of 3/22/2020) there have already been a number of" exact="congenital heart disease" post="patients infected by SARS-CoV-2. It is imperative that individual"/>
   <result pre="of 3/22/2020) there have already been a number of congenital" exact="heart disease" post="patients infected by SARS-CoV-2. It is imperative that individual"/>
   <result pre="T.G. Erdman D. Goldsmith C.S. A novel coronavirus associated with" exact="severe acute respiratory syndrome" post="N. Engl. J. Med. 348 20 2003 May 15"/>
   <result pre="T.M. Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N. Engl. J. Med. 367 19"/>
   <result pre="6 Ukimura A. Satomi H. Ooi Y. Myocarditis associated with" exact="influenza" post="A H1N1pdm2009 Influenza Res. Treat. 2012 2012 1 8"/>
   <result pre="7 Rao S. Sasser W. Diaz F. Coronavirus associated fulminant" exact="myocarditis" post="successfully treated with intravenous immunoglobulin and extracorporeal membrane oxygenation"/>
   <result pre="2014 336A [Internet]. Available from: 10.1378/chest.1992018 8 Alhogbani T. Acute" exact="myocarditis" post="associated with novel Middle East respiratory syndrome coronavirus Ann."/>
   <result pre="factors for hospitalization and severe outcomes of 2009 pandemic H1N1" exact="influenza" post="in Quebec, Canada Influenza Other Respir. Viruses 5 4"/>
   <result pre="10 Yu C.M. Wong R.S.M. Wu E.B. Cardiovascular complications of" exact="severe acute respiratory syndrome" post="Postgrad. Med. J. 82 964 2006 140 144 16461478"/>
   <result pre="Bare I. Crawford J. Pon K. Frequency and consequences of" exact="influenza" post="vaccination in adults with congenital heart disease Am. J."/>
   <result pre="K. Frequency and consequences of influenza vaccination in adults with" exact="congenital heart disease" post="Am. J. Cardiol. 121 4 2018 491 494 [Internet]."/>
   <result pre="Frequency and consequences of influenza vaccination in adults with congenital" exact="heart disease" post="Am. J. Cardiol. 121 4 2018 491 494 [Internet]."/>
   <result pre="Jia H.P. Look D.C. Shi L. ACE2 receptor expression and" exact="severe acute respiratory syndrome" post="coronavirus infection depend on differentiation of human airway epithelia"/>
   <result pre="P. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected" exact="pneumonia" post="N. Engl. J. Med. 2020 1 9 31826359 19"/>
   <result pre="Shi L. Wang Y. Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome" post="Lancet Respir. Med. 2600 20 2020 19 21 [Internet."/>
   <result pre="Wu C. Chen X. Cai Y. Risk factors associated with" exact="acute respiratory distress syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
   <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China JAMA Intern. Med. 2020 1 10"/>
   <result pre="Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study Lancet"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet 395 10223"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China J. Am. Med. Assoc. 323 11"/>
   <result pre="Y. Wang D.W. SARS-CoV-2: a potential novel etiology of fulminant" exact="myocarditis" post="Herz 5 2020 Mar 10 12 [Internet]. Available from:"/>
   <result pre="http://link.springer.com/10.1007/s00059-020-04909-z 36 Hu H. Ma F. Wei X. Coronavirus fulminant" exact="myocarditis" post="saved with glucocorticoid and human immunoglobulin Eur. Heart J."/>
   <result pre="David Small J. Edwards S. An experimental model for dilated" exact="cardiomyopathy" post="after rabbit coronavirus infection J. Infect. Dis. 166 5"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102825/results/search/disease/results.xml">
   <result pre="EV D68 positive child aged two years and presented with" exact="asthma" post="like symptoms for which he was admitted to ICU."/>
   <result pre="in 1962 among four Californian children admitted in hospital with" exact="pneumonia" post="[ 1]. After its discovery, EV-D68 detection has rarely"/>
   <result pre="discharge and cough with sputum. There was no history of" exact="diarrhea" post="or vomiting. On general examination, the child was conscious"/>
   <result pre="(387000/ micro liter). The X-ray chest suggested left lower lobe" exact="pneumonia" post="with pleural effusion. Confirming diagnosis Nasal swab collected on"/>
   <result pre="of the test negative sample. EV-D68 positive child presented with" exact="asthma" post="like symptoms. Similar presentation among pediatric age was observed"/>
   <result pre="V.L. Lennette E.H. A probable new human picornavirus associated with" exact="respiratory disease" post="Am J Epidemiol 85 1967 297 310 4960233 2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7102861/results/search/disease/results.xml">
   <result pre="exceptionally long life span and for being less prone to" exact="cancer" post="[ 8]. Bats are not only rich in species"/>
   <result pre="to cause severe diseases in humans before the emergence of" exact="severe acute respiratory syndrome" post="(SARS) coronavirus (CoV). The SARS outbreak in 2002–2003 remains"/>
   <result pre="workers with high-level exposure developing a serious influenza-like illness and" exact="rash" post="during the outbreak. These individuals also developed neutralizing antibodies"/>
   <result pre="means of viral transmission. The identification of sequences similar to" exact="mumps" post="virus (MuV) in bats revealed that a virus that"/>
   <result pre="neck stiffness, a metallic taste, sore throat and a maculopapular" exact="rash" post="that was present later in the infection. The biologist"/>
   <result pre="and Caliciviridae, respectively, are the major etiologic agents of acute" exact="gastroenteritis" post="and several reports have identified rotavirus [ 98, 99,"/>
   <result pre="novel subtypes were discovered in bats. In 2012, a new" exact="influenza" post="virus genomic sequence was identified in frugivorous yellow-shouldered bats"/>
   <result pre="was designated H17N10 [ 110]. The following year, a distinct" exact="influenza" post="genome, classified as H18N11, was characterized from the flat-faced"/>
   <result pre="subsequent research highlighted the differences between these viruses and conventional" exact="influenza" post="viruses. Identification of these viruses in bats not only"/>
   <result pre="viruses in bats not only expanded the host reservoir of" exact="influenza" post="and the genetic diversity of the viruses, but immediately"/>
   <result pre="a group of previous unknown bunyaviruses, including severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) virus and Heartland virus (HRTV), emerged during"/>
   <result pre="emerging viruses where viral pathogenesis and transmission route is unknown," exact="rabies" post="has long been recognized throughout history, due to the"/>
   <result pre="with the disease [ 124, 125]. Infection with lyssaviruses, including" exact="rabies" post="virus and Australian bat lyssavirus leads to rabies disease"/>
   <result pre="lyssaviruses, including rabies virus and Australian bat lyssavirus leads to" exact="rabies" post="disease [ 126]. Although bites and scratches from infected"/>
   <result pre="13 Peiris J.S. Yuen K.Y. Osterhaus A.D. Stohr K. The" exact="severe acute respiratory syndrome" post="N Engl J Med 349 2003 2431 2441 14681510"/>
   <result pre="R.A. Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N Engl J Med 367 2012"/>
   <result pre="T.G. Zaki S.R. Paul G. Lam S.K. Tan C.T. Fatal" exact="encephalitis" post="due to Nipah virus among pig-farmers in Malaysia [see"/>
   <result pre="Niezgoda M. Rupprecht C. Bresee J. Breiman R.F. Nipah virus" exact="encephalitis" post="reemergence, Bangladesh Emerg Infect Dis 10 2004 2082 2087"/>
   <result pre="Takeda M. Kidokoro M. Cross-neutralization between human and African Bat" exact="mumps" post="viruses Emerg Infect Dis 22 2016 703 706 26982800"/>
   <result pre="26982800 For the first time, it is demonstrated that a" exact="mumps" post="virus close relative exists in non-human mammals. 61 Krüger"/>
   <result pre="genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a" exact="mumps" post="virus-like bat virus J Virol 89 2015 4539 4548"/>
   <result pre="Duprex W.P. Krammer F. Cross-reactive and cross-neutralizing activity of human" exact="mumps" post="antibodies against a novel mumps virus from bats J"/>
   <result pre="and cross-neutralizing activity of human mumps antibodies against a novel" exact="mumps" post="virus from bats J Infect Dis 215 2017 209"/>
   <result pre="Entry, replication, immune evasion, and neurotoxicity of synthetically engineered bat-borne" exact="mumps" post="virus Cell Rep 25 2018 312 320 e317 30304672"/>
   <result pre="Mde L. Schnell G.D. Schmid R.K. Aguilar-Setien A. Prevalence of" exact="rabies" post="and LPM paramyxovirus antibody in non-hematophagous bats captured in"/>
   <result pre="unknown reovirus of bat origin is associated with an acute" exact="respiratory disease" post="in humans Proc Natl Acad Sci U S A"/>
   <result pre="W. A novel reovirus isolated from a patient with acute" exact="respiratory disease" post="J Clin Virol 45 2009 79 80 19356975 88"/>
   <result pre="Ellison J.A. Davis C.T. York I.A. A distinct lineage of" exact="influenza" post="A virus from bats Proc Nat Acad Sci U"/>
   <result pre="X. Recuenco S. Gomez J. New world bats harbor diverse" exact="influenza" post="A viruses PLOS Pathog 9 2013e1003657 112 Moreira ÉA."/>
   <result pre="T. García-Sastre A. Schwemmle M. Zimmer G. Synthetically derived bat" exact="influenza" post="A-like viruses reveal a cell type- but not species-specific"/>
   <result pre="Lee J. Lang Y. Cao N. Characterization of uncultivable bat" exact="influenza" post="virus using a replicative synthetic virus PLoS Pathog 10"/>
   <result pre="Thamamongood T. Zimmer G. Schwemmle M. Novel insights into bat" exact="influenza" post="A viruses J Gen Virol 98 2017 2393 2400"/>
   <result pre="Tang X. Wang H. Kang K. Metagenomic analysis of fever," exact="thrombocytopenia" post="and leukopenia syndrome (FTLS) in Henan Province, China: discovery"/>
   <result pre="Wang H. Kang K. Metagenomic analysis of fever, thrombocytopenia and" exact="leukopenia" post="syndrome (FTLS) in Henan Province, China: discovery of a"/>
   <result pre="novel bat phlebovirus, is closely related to severe fever with" exact="thrombocytopenia" post="syndrome virus and heartland virus J Virol 88 2014"/>
   <result pre="125 Waterman J.A. The history of the outbreak of paralytic" exact="rabies" post="in Trinidad transmitted by bats to human beings and"/>
   <result pre="L.J. Animal coronaviruses: what can they teach us about the" exact="severe acute respiratory syndrome?" post="Rev Sci Tech 23 2004 643 660 15702725 134"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7104151/results/search/disease/results.xml">
   <result pre="V pmcid: 7104151 S2211-0348(18)30358-4 doi: 10.1016/j.msard.2018.09.035 : Article Thymosins in" exact="multiple sclerosis" post="and its experimental models: moving from basic to clinical"/>
   <result pre="of Tβ4 in clinical practice. Keywords Multiple sclerosis Experimental autoimmune" exact="encephalomyelitis" post="Thymosin-β4 Thymosin-α1 Immunomodulation Neuroprotection Remyelination Abbreviations Abs, antibodies Breg,"/>
   <result pre="regulatory B cells CNS, central nervous system EAE, experimental autoimmune" exact="encephalomyelitis" post="HIV, human immunodeficiency virus IL, interleukin MBP, myelin basic"/>
   <result pre="oligodendrocytes OPCs, oligodendrocyte progenitor cells PLP, proteolipid protein peptide RA," exact="rheumatoid arthritis" post="RRMS, relapsing-remitting Multiple Sclerosis SLE, systemic lupus erythematosus Tα1,"/>
   <result pre="OPCs, oligodendrocyte progenitor cells PLP, proteolipid protein peptide RA, rheumatoid" exact="arthritis" post="RRMS, relapsing-remitting Multiple Sclerosis SLE, systemic lupus erythematosus Tα1,"/>
   <result pre="protein peptide RA, rheumatoid arthritis RRMS, relapsing-remitting Multiple Sclerosis SLE," exact="systemic lupus erythematosus" post="Tα1, thymosin-α1 Tβ4, thymosin-β4 TLR, toll-like receptor Treg, regulatory"/>
   <result pre="peptide RA, rheumatoid arthritis RRMS, relapsing-remitting Multiple Sclerosis SLE, systemic" exact="lupus erythematosus" post="Tα1, thymosin-α1 Tβ4, thymosin-β4 TLR, toll-like receptor Treg, regulatory"/>
   <result pre="disease of the central nervous system (CNS) displays a progressive" exact="neurodegeneration" post="due to immune attacks directly against myelin constituents that"/>
   <result pre="al., 1985) subjected to the model of MS experimental autoimmune" exact="encephalomyelitis" post="(EAE), the treatment showed no suppressive effect on incidence"/>
   <result pre="differently from that observed by other groups describing an intensive" exact="suppression" post="of EAE symptoms ( Nagai et al., 1982). Moreover,"/>
   <result pre="rat, mice, human motility, progression and metastatis of non-small cell" exact="lung cancer" post="( Banyard et al., 2007) Thymosins are divided into"/>
   <result pre="mice, human motility, progression and metastatis of non-small cell lung" exact="cancer" post="( Banyard et al., 2007) Thymosins are divided into"/>
   <result pre="and apoptosis, and ProTα was also found overexpressed in different" exact="cancer" post="types ( Mosoian, 2011). The extracellular ProTα shares many"/>
   <result pre="data, Tα1 was then used for the treatment of chronic" exact="hepatitis" post="B and C ( Iino et al., 2005, You"/>
   <result pre="2006), cytomegalovirus infection ( Bozza et al., 2007) and invasive" exact="aspergillosis" post="( Romani et al., 2004). In addition, the post-marketing"/>
   <result pre="confirmed Tα1 immunomodulatory activities and related therapeutic potential also in" exact="cancer" post="(such as Hepatocellular carcinoma, lung cancer, and melanoma), infectious"/>
   <result pre="related therapeutic potential also in cancer (such as Hepatocellular carcinoma," exact="lung cancer," post="and melanoma), infectious diseases (sepsis, infections after bone marrow"/>
   <result pre="found only up-regulated in different malignancies, such as the human" exact="prostate cancer," post="representing a potential biomarker ( Bao et al., 1996),"/>
   <result pre="Girardi et al., 2003, Sosne et al., 2007) via the" exact="suppression" post="of nuclear factor-kappa B (NF-kB) activation ( Sosne et"/>
   <result pre="white matter damage and result in neurological deficits, including stroke," exact="peripheral neuropathy" post="and traumatic brain injury, likewise show the benefits of"/>
   <result pre="matter damage and result in neurological deficits, including stroke, peripheral" exact="neuropathy" post="and traumatic brain injury, likewise show the benefits of"/>
   <result pre="( Morris et al., 2010). In a model of diabetes-induced" exact="peripheral neuropathy," post="extended Tβ4 treatment of diabetic mice significantly improved neurological"/>
   <result pre="et al., 2006). This characteristic was also recently tested in" exact="cystic fibrosis" post="where Tα1 increases the altered maturation of the cystic"/>
   <result pre="cystic fibrosis where Tα1 increases the altered maturation of the" exact="cystic fibrosis" post="transmembrane conductance regulator and reduces the chronic inflammation caused"/>
   <result pre="in patients affected with chronic inflammatory autoimmune diseases such as" exact="psoriatic arthritis," post="rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), that"/>
   <result pre="affected with chronic inflammatory autoimmune diseases such as psoriatic arthritis," exact="rheumatoid arthritis" post="(RA) and systemic lupus erythematosus (SLE), that have a"/>
   <result pre="with chronic inflammatory autoimmune diseases such as psoriatic arthritis, rheumatoid" exact="arthritis" post="(RA) and systemic lupus erythematosus (SLE), that have a"/>
   <result pre="autoimmune diseases such as psoriatic arthritis, rheumatoid arthritis (RA) and" exact="systemic lupus erythematosus" post="(SLE), that have a much lower level of serum"/>
   <result pre="diseases such as psoriatic arthritis, rheumatoid arthritis (RA) and systemic" exact="lupus erythematosus" post="(SLE), that have a much lower level of serum"/>
   <result pre="cell responses, MS was considered by far a T cell-mediated" exact="autoimmune disease." post="Nonetheless, over the past few years B cells have"/>
   <result pre="proved to be remarkably effective in the induction of long-lasting" exact="suppression" post="of lesion activity and clinical relapses but showed no"/>
   <result pre="Tα1. The clinical usage of Tα1 in the past in" exact="cancer" post="or chronic infections or as adjuvant in vaccine formulations"/>
   <result pre="of patients affected with chronic inflammatory autoimmune diseases such as" exact="psoriatic arthritis," post="RA and SLE ( Pica et al., 2016) as"/>
   <result pre="regimens of chemotherapeutics plus Tα1 adopted for treatment of many" exact="cancer" post="types ( Garaci et al., 2015), in MS a"/>
   <result pre="References References Ascherio A. Munger K.L. Environmental risk factors for" exact="multiple sclerosis." post="Part I: the role of infection. Ann. Neurol. 61"/>
   <result pre="299 17444504 Ascherio A. Munger K.L. Environmental risk factors for" exact="multiple sclerosis." post="Part II: noninfectious factors. Ann. Neurol. 61 6 2007"/>
   <result pre="a novel regulator of tumor cell motility upregulated in metastatic" exact="prostate cancer" post="Nat. Med. 2 12 1996 1322 1328 8946830 Bar-Or"/>
   <result pre="novel regulator of tumor cell motility upregulated in metastatic prostate" exact="cancer" post="Nat. Med. 2 12 1996 1322 1328 8946830 Bar-Or"/>
   <result pre="2010 452 461 20437580 Barun B. Bar-Or A. Treatment of" exact="multiple sclerosis" post="with anti-CD20 antibodies Clin. Immunol. 142 1 2012 31"/>
   <result pre="Prothymosin-alpha enhances HLA-DR antigen expression on monocytes from patients with" exact="multiple sclerosis" post="J. Neuroimmunol. 27 2-3 1990 141 147 2139665 Blair"/>
   <result pre="Development of thymosin beta4 for treatment of patients with ischemic" exact="heart disease" post="Ann. N. Y. Acad. Sci. 1112 2007 385 395"/>
   <result pre="memory and naive human B cell subsets and implication in" exact="multiple sclerosis" post="J. Immunol. 178 10 2007 6092 6099 17475834 Endoh"/>
   <result pre="T. Effect of thymic hormones on induction of experimental allergic" exact="encephalomyelitis" post="in old mice Tohoku J. Exp. Med. 161 4"/>
   <result pre="4 1996 511 525 8734446 Franciotta D. B cells and" exact="multiple sclerosis" post="Lancet Neurol. 7 9 2008 852 858 18703007 Garaci"/>
   <result pre="IFN-beta therapy modulates B-cell and monocyte crosstalk via TLR7 in" exact="multiple sclerosis" post="patients Eur. J. Immunol. 43 7 2013 1963 1972"/>
   <result pre="Thymosin-alpha1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting" exact="multiple sclerosis" post="patients Mult. Scler. 20171352458517695892 Girardi M. Anti-inflammatory effects in"/>
   <result pre="Habib J. Blood B cell and regulatory subset content in" exact="multiple sclerosis" post="patients J. Mult. Scler. (Foster City) 2 2 2015"/>
   <result pre="2015 Harlow D.E. Honce J.M. Miravalle A.A. Remyelination therapy in" exact="multiple sclerosis" post="Front. Neurol. 6 2015 257 26696956 Hoch K. Volk"/>
   <result pre="and safety of thymosin alpha-1 in Japanese patients with chronic" exact="hepatitis" post="B; results from a randomized clinical trial J. Viral"/>
   <result pre="Knippenberg S. Reduction in IL-10 producing B cells (Breg) in" exact="multiple sclerosis" post="is accompanied by a reduced naive/memory Breg ratio during"/>
   <result pre="555 564 27942867 Li R. Proinflammatory GM-CSF-producing B cells in" exact="multiple sclerosis" post="and B cell depletion therapy Sci. Transl. Med. 7"/>
   <result pre="injury J. Cell. Biochem. 2017 Liguori M. Proteomic profiling in" exact="multiple sclerosis" post="clinical courses reveals potential biomarkers of neurodegeneration PLoS One"/>
   <result pre="profiling in multiple sclerosis clinical courses reveals potential biomarkers of" exact="neurodegeneration" post="PLoS One 9 8 2014e103984 Liu F. The efficacy"/>
   <result pre="16 2016 488 27633969 Liu X.S. MicroRNA-146a promotes oligodendrogenesis in" exact="stroke" post="Mol. Neurobiol. 2016 Lu L.F. Function of miR-146a in"/>
   <result pre="L. Unaltered regulatory B-cell frequency and function in patients with" exact="multiple sclerosis" post="Clin. Immunol. 155 2 2014 198 208 25267439 Mizoguchi"/>
   <result pre="improves functional neurological outcome in a rat model of embolic" exact="stroke" post="Neuroscience 169 2 2010 674 682 20627173 Mosoian A."/>
   <result pre="1199 1208 21806381 Nagai Y. Osanai T. Sakakibara K. Intensive" exact="suppression" post="of experimental allergic encephalomyelitis (EAE) by serum thymic factor"/>
   <result pre="Y. Osanai T. Sakakibara K. Intensive suppression of experimental allergic" exact="encephalomyelitis" post="(EAE) by serum thymic factor and therapeutic implication for"/>
   <result pre="encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for" exact="multiple sclerosis" post="Jpn. J. Exp. Med. 52 4 1982 213 219"/>
   <result pre="R. In-situ characterization of mononuclear cell infiltrates in lesions of" exact="multiple sclerosis" post="Neuropathol. Appl. Neurobiol. 8 5 1982 403 411 6983662"/>
   <result pre="alpha on the autologous and allogeneic MLR in patients with" exact="multiple sclerosis." post="Clin. Exp. Immunol. 70 2 1987 336 344 2962790"/>
   <result pre="L. Thymosin alpha1 represents a potential potent single-molecule-based therapy for" exact="cystic fibrosis" post="Nat. Med. 23 5 2017 590 600 28394330 Samara"/>
   <result pre="M. Thymosin beta4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and" exact="suppression" post="of the Toll-like proinflammatory pathway J. Biol. Chem. 289"/>
   <result pre="germinal centers in the meninges of patients with secondary progressive" exact="multiple sclerosis" post="Brain Pathol. 14 2 2004 164 174 15193029 Serafino"/>
   <result pre="1270 2012 13 20 23050812 Sosne G. Thymosin beta 4" exact="suppression" post="of corneal NFkappaB: a potential anti-inflammatory pathway Exp. Eye"/>
   <result pre="beta10 research: differential expression, molecular mechanisms, and clinical implications in" exact="cancer" post="and other conditions Cancer Invest. 27 10 2009 1016"/>
   <result pre="26096077 Walsh M.J. Immunoglobulin G, A, and M–clonal restriction in" exact="multiple sclerosis" post="cerebrospinal fluid and serum–analysis by two-dimensional electrophoresis Clin. Immunol."/>
   <result pre="327 3921302 Wang L. Thymosin beta4 promotes the recovery of" exact="peripheral neuropathy" post="in type II diabetic mice Neurobiol. Dis. 48 3"/>
   <result pre="3921302 Wang L. Thymosin beta4 promotes the recovery of peripheral" exact="neuropathy" post="in type II diabetic mice Neurobiol. Dis. 48 3"/>
   <result pre="is independent of blood glucose level in mice with diabetic" exact="peripheral neuropathy" post="J. Diabetes Res. 2015 2015173656 Wirsching H.G. Thymosin beta4"/>
   <result pre="independent of blood glucose level in mice with diabetic peripheral" exact="neuropathy" post="J. Diabetes Res. 2015 2015173656 Wirsching H.G. Thymosin beta4"/>
   <result pre="Pt 2 2014 433 448 24355709 Wolf S.D. Experimental autoimmune" exact="encephalomyelitis" post="induction in genetically B cell-deficient mice J. Exp. Med."/>
   <result pre="2278 8976182 Woyciechowska J. Goldstein A.L. Driscoll B. Experimental allergic" exact="encephalomyelitis" post="in guinea pigs. Influence of thymosin fraction V on"/>
   <result pre="of thymosin alpha-1 and interferon alpha in treatment of chronic" exact="viral hepatitis" post="B: a randomized controlled study World J. Gastroenterol. 12"/>
   <result pre="thymosin alpha-1 and interferon alpha in treatment of chronic viral" exact="hepatitis" post="B: a randomized controlled study World J. Gastroenterol. 12"/>
   <result pre="recovery after thymosin beta4 treatment in mice with experimental auto" exact="encephalomyelitis" post="Neuroscience 164 4 2009 1887 1893 19782721 Zhang J."/>
   <result pre="of tumorigenesis and metastasis and a novel serum marker in" exact="breast cancer" post="Breast Cancer Res. 19 1 2017 15 28179017 Zhou"/>
   <result pre="tumorigenesis and metastasis and a novel serum marker in breast" exact="cancer" post="Breast Cancer Res. 19 1 2017 15 28179017 Zhou"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7105343/results/search/disease/results.xml">
   <result pre="chemotherapy has been shown to be a specific inhibitor for" exact="severe acute respiratory syndrome" post="coronavirus in in vitro studies, but no specific studies"/>
   <result pre="are associated with severity of pulmonary complications. immune modulation immune" exact="suppression" post="cancer COVID-19 adverse events Introduction Since the outbreak of"/>
   <result pre="associated with severity of pulmonary complications. immune modulation immune suppression" exact="cancer" post="COVID-19 adverse events Introduction Since the outbreak of severe"/>
   <result pre="suppression cancer COVID-19 adverse events Introduction Since the outbreak of" exact="severe acute respiratory syndrome" post="(SARS)-CoV-2 or COVID-19 coronavirus started in China in December"/>
   <result pre="have therapeutic activity as compounds against corona viral strains. Moreover," exact="cancer" post="patients who have undergone chemotherapy may be at increased"/>
   <result pre="one of the most common viral pathogens identified in paediatric" exact="cancer" post="patients undergoing chemotherapy, second to human rhinovirus [ 4]."/>
   <result pre="rhinovirus [ 4]. Viral co-detection was frequent in patients with" exact="cancer" post="and acute respiratory infections. A brain biopsy was HCoV-OC43-positive"/>
   <result pre="5]. A case of a young woman with stage IIIA" exact="breast cancer" post="from 1999 reported that diagnosis of coronavirus following treatment"/>
   <result pre="A case of a young woman with stage IIIA breast" exact="cancer" post="from 1999 reported that diagnosis of coronavirus following treatment"/>
   <result pre="from 1999 reported that diagnosis of coronavirus following treatment for" exact="cancer" post="using a high-dose chemotherapy regimen and autologous bone marrow"/>
   <result pre="marrow and stem cell transplantation. The electron microscopy revealed coronavirus" exact="pneumonia" post="[ 6]. Coronavirus should be potentially considered in the"/>
   <result pre="Coronavirus should be potentially considered in the differential diagnoses of" exact="respiratory failure" post="in patients who have undergone high-dose chemotherapy and autologous"/>
   <result pre="8]. 6-mercaptopurine (6MP) and 6-thioguanine (6TG) have been used in" exact="cancer" post="chemotherapy for treatment of acute lymphoblastic or myeloblastic leukaemia"/>
   <result pre="other than HIV in their entry process and coronaviruses and" exact="influenza" post="viruses are other examples of enveloped viruses that may"/>
   <result pre="one of the most common viral pathogens identified in paediatric" exact="cancer" post="patients undergoing chemotherapy. Patients with pre-B acute lymphoblastic leukaemia"/>
   <result pre="patients undergoing chemotherapy. Patients with pre-B acute lymphoblastic leukaemia and" exact="breast cancer" post="who have undergone chemotherapy have reported cases of coronavirus"/>
   <result pre="undergoing chemotherapy. Patients with pre-B acute lymphoblastic leukaemia and breast" exact="cancer" post="who have undergone chemotherapy have reported cases of coronavirus"/>
   <result pre="have reported cases of coronavirus infection. Cytotoxic therapies used in" exact="cancer" post="chemotherapy such as 6MP and 6TG have shown to"/>
   <result pre="response and inflammation and low-dose steroids are often prescribed to" exact="cancer" post="patients with suppressed immune systems to prevent the development"/>
   <result pre="link between the severity of COVID-19 symptoms in patients with" exact="asthma" post="and hypertension. The only other study to investigate a"/>
   <result pre="pro-inflammatory cytokine involved in autoimmune and immune-mediated disorders such as" exact="rheumatoid arthritis," post="ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and"/>
   <result pre="involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis," exact="ankylosing spondylitis," post="inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma."/>
   <result pre="such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis," exact="hidradenitis suppurativa" post="and refractory asthma. Inhibitors of TNFa may be used"/>
   <result pre="TNFa inhibitors could be a potential treatment for the acute" exact="respiratory disease" post="syndrome caused by coronavirus [ 21] The second study"/>
   <result pre="comparison with other respiratory viruses including respiratory syncytial virus (RSV)," exact="influenza" post="A virus (FluAV), and human parainfluenza virus type 2"/>
   <result pre="24.3 pg/ml, which was the upper limit of no severe" exact="pneumonia" post="[ 28]. The increased expression of IL-2R and IL-6"/>
   <result pre="serum is expected to predict the severity of the 2019-nCoV" exact="pneumonia" post="and the prognosis of patients [ 29]. The serum"/>
   <result pre="IL-6, IL-8 and TNF α between patients with and without" exact="acute respiratory distress syndrome." post="However , CRP and TNFα were associated with worse"/>
   <result pre="that have been suggested as partially responsible for the devastating" exact="acute respiratory distress syndrome." post="Moreover, it has been observed that COVID-19 induces high"/>
   <result pre="in cancer. JAK inhibitors are used in the treatment of" exact="cancer" post="and inflammatory diseases such as rheumatoid arthritis [ 43]."/>
   <result pre="in the treatment of cancer and inflammatory diseases such as" exact="rheumatoid arthritis" post="[ 43]. This review focuses on how the JAK-STAT"/>
   <result pre="the treatment of cancer and inflammatory diseases such as rheumatoid" exact="arthritis" post="[ 43]. This review focuses on how the JAK-STAT"/>
   <result pre="Agency in February 2017 for the treatment of moderate-to-severe active" exact="rheumatoid arthritis" post="in adults with an inadequate response to one or"/>
   <result pre="in February 2017 for the treatment of moderate-to-severe active rheumatoid" exact="arthritis" post="in adults with an inadequate response to one or"/>
   <result pre="or MERS-CoV, wherein a tylophorine compound known to target transmissible" exact="gastroenteritis" post="virus and a JAK2 inhibitor synergise to block the"/>
   <result pre="can cause lung and tissue inflammation, fever and fibrosis. IL-1" exact="suppression" post="has found to be effective in many inflammatory diseases"/>
   <result pre="has found to be effective in many inflammatory diseases including" exact="rheumatoid arthritis" post="[ 24]. It is well established that an over-expression"/>
   <result pre="found to be effective in many inflammatory diseases including rheumatoid" exact="arthritis" post="[ 24]. It is well established that an over-expression"/>
   <result pre="results [ 1] The differential diagnosis of pulmonary infiltrates in" exact="cancer" post="patients during the outbreak of the 2019 novel coronavirus"/>
   <result pre="2020 COVID-19 complicates the clinical scenario of pulmonary infiltrates in" exact="cancer" post="patients. Active treatment against the infection and patient surveillance"/>
   <result pre="against the infection and patient surveillance should be initiated if" exact="infectious disease" post="is considered. [ 2] Chemotherapy strategy for colorectal cancer"/>
   <result pre="if infectious disease is considered. [ 2] Chemotherapy strategy for" exact="colorectal cancer" post="under the outbreak of novel coronavirus pneumonia Li et"/>
   <result pre="infectious disease is considered. [ 2] Chemotherapy strategy for colorectal" exact="cancer" post="under the outbreak of novel coronavirus pneumonia Li et"/>
   <result pre="strategy for colorectal cancer under the outbreak of novel coronavirus" exact="pneumonia" post="Li et al China 2020 Recommendations based on stage"/>
   <result pre="to delay the time of imaging evaluation. [ 3] Fatal" exact="encephalitis" post="associated with coronavirus OC43 in an immunocompromised child Nilsson"/>
   <result pre="one-year-old child with pre-B acute lymphoblastic leukaemia (ALL) developed fatal" exact="encephalitis" post="associated with human coronavirus OC43 (HCoV-OC43). During chemotherapy the"/>
   <result pre="in the other months Conclusion: no increase in mortality of" exact="cancer" post="patients but cause for significant delays to chemotherapy, which"/>
   <result pre="2016 Nasopharyngeal aspirates were collected during 87 episodes of febrile" exact="neutropenia" post="in children age 0-18 years No symptoms were apparent"/>
   <result pre="more symptoms Respiratory viruses play an etiologic role in febrile" exact="neutropenia" post="in children receiving treatment for a malignancy. [ 7]"/>
   <result pre="recipients to those observed with other viruses such as RSV," exact="influenza" post="virus, and PIV. [ 11] Progress in Anti-SARS Coronavirus"/>
   <result pre="of proteases. [ 13] Acute respiratory viral infections in paediatric" exact="cancer" post="patients undergoing chemotherapy Benites et al Brazil 2014 Paediatric"/>
   <result pre="undergoing chemotherapy Benites et al Brazil 2014 Paediatric patients with" exact="cancer" post="and acute respiratory infection [ 14] and/or fever. Coronavirus"/>
   <result pre="morbidity and mortality. Viral co-detection was frequent in patients with" exact="cancer" post="and ARIs. The link of whether severe acute infection"/>
   <result pre="severe acute infection was directly related to the type of" exact="cancer" post="or viral pathogen was not identified in the study."/>
   <result pre="2009 6-mercaptopurine (6MP) and 6-thioguanine (6TG) have been used in" exact="cancer" post="chemotherapy for treatment of acute lymphoblastic or myeloblastic leukaemia"/>
   <result pre="other than HIV in their entry process and coronaviruses and" exact="influenza" post="viruses are other examples of enveloped viruses that may"/>
   <result pre="17] Synthesis of novel test compounds for antiviral chemotherapy of" exact="severe acute respiratory syndrome" post="[ 18]. [Review] Kesel AJ United Arab Emirates 2005"/>
   <result pre="USA 1999 Case report: coronavirus in woman with stage III" exact="breast cancer" post="following treatment with hig-dose chemotherapy and autologous bone marrow"/>
   <result pre="1999 Case report: coronavirus in woman with stage III breast" exact="cancer" post="following treatment with hig-dose chemotherapy and autologous bone marrow"/>
   <result pre="was then discovered… [ 24] Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection? Fang, Karakiulakis and"/>
   <result pre="Hong Kong cohort study also suffered opportunitistic infections such as" exact="aspergillosis" post="and late sequelae (including avascular osteonecrosis) with corticosteroid use."/>
   <result pre="respiratory coronavirus-infected pigs treated with corticosteroids as a model for" exact="severe acute respiratory syndrome." post="Zhang X, Alekseev K, Jung K, Vlasova A, Hadya"/>
   <result pre="reaction. [ 32] Overview of antiviral and anti-inflammatory treatment for" exact="severe acute respiratory syndrome." post="Chihrin S, Loutfy MR Canada 2014 Anti-inflammatory agents heavily"/>
   <result pre="basal. Results suggest corticosteroid may be of limited benefit in" exact="suppression" post="of chemokine production by SARS-CoV infected cells. [ 34]"/>
   <result pre="infected cells. [ 34] Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome." post="Wong CK, Lam CW, Wu AK, Ip WK, Lee"/>
   <result pre="35] Description and clinical treatment of an early outbreak of" exact="severe acute respiratory syndrome" post="[ 18] in Guangzhou, PR China. Zhao Z, Zhang"/>
   <result pre="severe immune-based pulmonary injury which can follow infection with H5N1" exact="influenza" post="and SARS coronavirus. In humans, anti-TNF therapy utilising etanercept"/>
   <result pre="reported to be beneficial for treatment of the non-infectious idiopathic" exact="pneumonia" post="syndrome which can follow stem-cell transplantation, a pulmonary syndrome"/>
   <result pre="can follow stem-cell transplantation, a pulmonary syndrome that resembles SARS" exact="pneumonia" post="in some respect. If the SARS coronavirus does indeed"/>
   <result pre="not ameliorate disease in a model of acute virus-endotoxin mediated" exact="respiratory disease" post="in pigs. Atanasova K; Van Gucht S; Van Reeth"/>
   <result pre="elucidate the role of TNF-α in the development of virus-endotoxin-induced" exact="respiratory disease." post="The study demonstrates that after intratracheal administration etanercept is"/>
   <result pre="very important, is not the sole culprit in development of" exact="respiratory disease" post="and pathology, and possibly other, yet unidentified, components and"/>
   <result pre="IL-8 are related to airway inflammation in COPD and bronchial" exact="asthma" post="exacerbation induced by viral infection. The decreased production of"/>
   <result pre="the inhibitory effects of these drugs on COPD and bronchial" exact="asthma" post="exacerbation. [ 41] Analysis of clinical features of 29"/>
   <result pre="of clinical features of 29 patients with 2019 novel coronavirus" exact="pneumonia" post="Chen, L; Liu, H G; Liu, W; Liu, J;"/>
   <result pre="IL-6 expression correlated with mortality. [ 46] Neutralising antibody against" exact="severe acute respiratory syndrome" post="-coronavirus spike is highly effective for the protection of"/>
   <result pre="Pp and SARS-CoV coinfection. Vaccinated mice were protected from severe" exact="respiratory disease." post="A high level of IL-6 and on days 2"/>
   <result pre="(SARS-CoV) with other respiratory viruses including respiratory syncytial virus (RSV)," exact="influenza" post="A virus (FluAV), and human parainfluenza virus type 2"/>
   <result pre="50] Clinical manifestations and inflammatory cytokine responses in patients with" exact="severe acute respiratory syndrome." post="Sheng WH; Chiang BL; Chang SC; Ho HN; Wang"/>
   <result pre="of IL-6, IL-8 and TNF-alpha between patients with and without" exact="acute respiratory distress syndrome." post="CRP and TNF-alpha are associated with worse outcomes and"/>
   <result pre="2005 Fourteen cytokines or chemokines were analysed on 88 RT-PCR-confirmed" exact="severe acute respiratory syndrome" post="[ 18] patients. IFN-gamma, IL-18, TGF-beta, IL-6, IP-10, MCP-1,"/>
   <result pre="ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with" exact="severe acute respiratory syndrome." post="Wang WK; Chen SY; Liu IJ; Kao CL; Chen"/>
   <result pre="respectively. [ 54] Analysis of serum cytokines in patients with" exact="severe acute respiratory syndrome." post="Zhang Y; Li J; Zhan Y; Wu L; Yu"/>
   <result pre="different groups. [ 34] Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome." post="Wong CK; Lam CW; Wu AK; Ip WK; Lee"/>
   <result pre="55] Dynamic changes and the meanings of blood cytokines in" exact="severe acute respiratory syndrome" post="Wang and Pang China 2003 (Abstract only) This study"/>
   <result pre="results [ 57] Baricitinib as potential treatment for 2019-nCoV acute" exact="respiratory disease" post="Richardson et al England 2020 ACE2 is a cell-surface"/>
   <result pre="of Baricitinib to inhibit AAK1 in patients with 2019-nCoV acute" exact="respiratory disease," post="to reduce both the viral entry and the inflammation"/>
   <result pre="MuLBSTA score, an early warning model for predicting mortality in" exact="viral pneumonia" post="[ 58]. [ 59] The Coronavirus Transmissible Gastroenteritis Virus"/>
   <result pre="score, an early warning model for predicting mortality in viral" exact="pneumonia" post="[ 58]. [ 59] The Coronavirus Transmissible Gastroenteritis Virus"/>
   <result pre="endoplasmic reticulum stress and IFN-I production after infection with transmissible" exact="gastroenteritis" post="virus (TGEV) to understand how coronavirus-elicited ER stress is"/>
   <result pre="SARS. [ 54] Analysis of serum cytokines in patients with" exact="severe acute respiratory syndrome." post="Zhang Y, Li J, Zhan Y, Wu L, Yu"/>
   <result pre="cytokine levels. [ 34] Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome." post="Wong CK, Lam CW, Wu AK, Ip WK, Lee"/>
   <result pre="popular immunosuppressant in solid-organ transplants and autoimmune diseases such as" exact="systemic lupus erythematosus." post="The use of mycophenolic acid monotherapy has not been"/>
   <result pre="immunosuppressant in solid-organ transplants and autoimmune diseases such as systemic" exact="lupus erythematosus." post="The use of mycophenolic acid monotherapy has not been"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet 2020 395"/>
   <result pre="Wang H Zhang L Risk of COVID-19 for patients with" exact="cancer" post="Lancet Oncol 2020 10.1016/S1470-2045(20)30149-2 3. Xia Y Jin R"/>
   <result pre="Jin R Zhao J et al. Risk of COVID-19 for" exact="cancer" post="patients Lancet Oncol 2020 10.1016/S1470-2045(20)30150-9 32142622 4. Benites EC"/>
   <result pre="Silva AC et al. Acute respiratory viral infections in pediatric" exact="cancer" post="patients undergoing chemotherapy J Pediatr (Rio J) 2014 90"/>
   <result pre="5. Nilsson A Edner N Albert J et al. Fatal" exact="encephalitis" post="associated with coronavirus OC43 in an immunocompromised child Infect"/>
   <result pre="(Lond) 2020 1 4 6. Folz RJ Elkordy MA Coronavirus" exact="pneumonia" post="following autologous bone marrow transplantation for breast cancer Chest"/>
   <result pre="Elkordy MA Coronavirus pneumonia following autologous bone marrow transplantation for" exact="breast cancer" post="Chest 1999 115 3 901 905 10.1378/chest.115.3.901 10084516 7."/>
   <result pre="MA Coronavirus pneumonia following autologous bone marrow transplantation for breast" exact="cancer" post="Chest 1999 115 3 901 905 10.1378/chest.115.3.901 10084516 7."/>
   <result pre="L Karakiulakis G Roth M Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection? Lancet Respir Med"/>
   <result pre="S Loutfy MR Overview of antiviral and anti-inflammatory treatment for" exact="severe acute respiratory syndrome" post="Expert Rev Anti Infect Ther 2005 3 2 251"/>
   <result pre="Wu AKL et al. Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome" post="Clin Exp Immunol 2004 136 1 95 103 10.1111/j.1365-2249.2004.02415.x"/>
   <result pre="respiratory coronavirus-infected pigs treated with corticosteroids as a model for" exact="severe acute respiratory syndrome" post="J Virol 2008 82 9 4420 4428 10.1128/JVI.02190-07 18287230"/>
   <result pre="al. Description and clinical treatment of an early outbreak of" exact="severe acute respiratory syndrome" post="(SARS) in Guangzhou, PR China J Med Microbiol 2003"/>
   <result pre="not ameliorate disease in a model of acute virus-endotoxin mediated" exact="respiratory disease" post="in pigs Vet Immunol Immunopathol 2010 137 1–2 12"/>
   <result pre="K Hasegawa H Nagata N et al. Neutralizing antibody against" exact="severe acute respiratory syndrome" post="(SARS)-coronavirus spike is highly effective for the protection of"/>
   <result pre="al. Clinical manifestations and inflammatory cytokine responses in patients with" exact="severe acute respiratory syndrome" post="J Formosan Med Assoc = Taiwan yi zhi 2005"/>
   <result pre="ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with" exact="severe acute respiratory syndrome" post="Clin Infect Dis 2004 39 7 1071 1075 10.1086/423808"/>
   <result pre="Y et al. Analysis of serum cytokines in patients with" exact="severe acute respiratory syndrome" post="Infect Immun 2004 72 8 4410 4415 10.1128/IAI.72.8.4410-4415.2004 15271897"/>
   <result pre="Li AM et al. Inflammatory cytokine profile in children with" exact="severe acute respiratory syndrome" post="Pediatrics 2004 113 e7 e14 10.1542/peds.113.1.e7 14702488 40. Li"/>
   <result pre="et al. Jakinibs: a new class of kinase inhibitors in" exact="cancer" post="and autoimmune disease Curr Opin Pharmacol 2012 12 4"/>
   <result pre="Jakinibs: a new class of kinase inhibitors in cancer and" exact="autoimmune disease" post="Curr Opin Pharmacol 2012 12 4 464 470 10.1016/j.coph.2012.06.008"/>
   <result pre="C et al. Baricitinib as potential treatment for 2019-nCoV acute" exact="respiratory disease" post="Lancet 2020 395 10223 e30 e1 10.1016/S0140-6736(20)30304-4 32032529 46."/>
   <result pre="Y Wang C Xue M et al. The coronavirus transmissible" exact="gastroenteritis" post="virus evades the type I interferon response through IRE1alpha-mediated"/>
   <result pre="as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible" exact="gastroenteritis" post="virus and human severe acute respiratory syndrome coronavirus Antivir"/>
   <result pre="agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human" exact="severe acute respiratory syndrome" post="coronavirus Antivir Res 2010 88 2 160 168 10.1016/j.antiviral.2010.08.009"/>
   <result pre="XH et al. [The differential diagnosis of pulmonary infiltrates in" exact="cancer" post="patients during the outbreak of the 2019 novel coronavirus"/>
   <result pre="2. Li YH Shen L Li J [Chemotherapy strategy for" exact="colorectal cancer" post="under the outbreak of novel coronavirus pneumonia] Zhonghua Wei"/>
   <result pre="Li YH Shen L Li J [Chemotherapy strategy for colorectal" exact="cancer" post="under the outbreak of novel coronavirus pneumonia] Zhonghua Wei"/>
   <result pre="3. Nilsson A Edner N Albert J et al. Fatal" exact="encephalitis" post="associated with coronavirus OC43 in an immunocompromised child Infect"/>
   <result pre="epidemiology of acute respiratory viral infections in pediatric patients with" exact="cancer" post="undergoing chemotherapy J Pediatr Hematol Oncol 2019 41 4"/>
   <result pre="Maron G Hayden RT Respiratory viral infections in patients with" exact="cancer" post="or undergoing hematopoietic cell transplant Front Microbiol 2018 9"/>
   <result pre="Silva AC et al. Acute respiratory viral infections in pediatric" exact="cancer" post="patients undergoing chemotherapy J Pediatr (Rio J) 2014 90"/>
   <result pre="AJ Synthesis of novel test compounds for antiviral chemotherapy of" exact="severe acute respiratory syndrome" post="(SARS) Curr Med Chem 2005 12 18 2095 2162"/>
   <result pre="4599 4613 10.1016/S0968-0896(03)00500-5 14527557 21. Folz RJ Elkordy MA Coronavirus" exact="pneumonia" post="following autologous bone marrow transplantation for breast cancer Chest"/>
   <result pre="Elkordy MA Coronavirus pneumonia following autologous bone marrow transplantation for" exact="breast cancer" post="Chest 1999 115 3 901 905 10.1378/chest.115.3.901 10084516 22."/>
   <result pre="MA Coronavirus pneumonia following autologous bone marrow transplantation for breast" exact="cancer" post="Chest 1999 115 3 901 905 10.1378/chest.115.3.901 10084516 22."/>
   <result pre="10.1007/s12250-020-00207-4 32125642 23. Acland HM Gunson DE Gillette DM Ulcerative" exact="duodenitis" post="in foals Vet Pathol 1983 20 6 653 661"/>
   <result pre="L Karakiulakis G Roth M Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection? Lancet Respir Med"/>
   <result pre="respiratory coronavirus-infected pigs treated with corticosteroids as a model for" exact="severe acute respiratory syndrome" post="J Virol 2008 82 9 4420 4428 10.1128/JVI.02190-07 18287230"/>
   <result pre="S Loutfy MR Overview of antiviral and anti-inflammatory treatment for" exact="severe acute respiratory syndrome" post="Expert Rev Anti-infect Ther 2005 3 2 251 262"/>
   <result pre="Wu AKL et al. Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome" post="Clin Exp Immunol 2004 136 1 95 103 10.1111/j.1365-2249.2004.02415.x"/>
   <result pre="al. Description and clinical treatment of an early outbreak of" exact="severe acute respiratory syndrome" post="(SARS) in Guangzhou, PR China J Med Microbiol 2003"/>
   <result pre="not ameliorate disease in a model of acute virus-endotoxin mediated" exact="respiratory disease" post="in pigs Vet Immunol Immunopathol 2010 137 1–2 12"/>
   <result pre="K Hasegawa H Nagata N et al. Neutralizing antibody against" exact="severe acute respiratory syndrome" post="(SARS)-coronavirus spike is highly effective for the protection of"/>
   <result pre="al. Clinical manifestations and inflammatory cytokine responses in patients with" exact="severe acute respiratory syndrome" post="J Formosan Med Assoc = Taiwan yi zhi 2005"/>
   <result pre="ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with" exact="severe acute respiratory syndrome" post="Clin Infect Dis 2004 39 7 1071 1075 10.1086/423808"/>
   <result pre="Y et al. Analysis of serum cytokines in patients with" exact="severe acute respiratory syndrome" post="Infect Immun 2004 72 8 4410 4415 10.1128/IAI.72.8.4410-4415.2004 15271897"/>
   <result pre="B Dynamic changes and the meanings of blood cytokines in" exact="severe acute respiratory syndrome" post="Chin J Tuberc Respir Dis 2003 26 10 586"/>
   <result pre="Li AM et al. Inflammatory cytokine profile in children with" exact="severe acute respiratory syndrome" post="Pediatrics 2004 113 e7 e14 10.1542/peds.113.1.e7 14702488 57. Richardson"/>
   <result pre="C et al. Baricitinib as potential treatment for 2019-nCoV acute" exact="respiratory disease" post="Lancet 2020 395 10223 e30 e1 10.1016/S0140-6736(20)30304-4 32032529 58."/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet 2020 395"/>
   <result pre="Y Wang C Xue M et al. The coronavirus transmissible" exact="gastroenteritis" post="virus evades the type I interferon response through IRE1alpha-mediated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7106497/results/search/disease/results.xml">
   <result pre="control to date. A One Health approach to tackle zoonotic" exact="cryptosporidiosis" post="looking at new advances in veterinary, public, and environmental"/>
   <result pre="to encourage a One Health approach to tackle cryptosporidiosis. Keywords" exact="cryptosporidiosis" post="One Health veterinary public environment Cryptosporidium and One Health"/>
   <result pre="infection involving persistent abdominal pain, myalgia/arthralgia and fatigue [ 78]," exact="irritable bowel syndrome" post="[ 79], and a recent study has shown a"/>
   <result pre="has shown a strong association between Cryptosporidium infection and human" exact="colon cancer" post="[ 80]. Cryptosporidiosis is a major diarrhoeal disease in"/>
   <result pre="shown a strong association between Cryptosporidium infection and human colon" exact="cancer" post="[ 80]. Cryptosporidiosis is a major diarrhoeal disease in"/>
   <result pre="Long-term production impacts on growth and carcase weights following acute" exact="cryptosporidiosis" post="in lambs was also reported on Australian sheep farms"/>
   <result pre="also reported on Australian sheep farms [ 83]. Outbreaks of" exact="cryptosporidiosis" post="associated with contaminated water supplies can result in significant"/>
   <result pre="50 000 sick leave days were attributed following a waterborne" exact="cryptosporidiosis" post="outbreak where the attack rate was 45% of 60"/>
   <result pre="review. Livestock, in particular young calves, are very vulnerable to" exact="cryptosporidiosis" post="and a recent modelling study estimated the global load"/>
   <result pre="animal cryptosporidiosis. Currently, there are no effective vaccines to prevent" exact="cryptosporidiosis" post="in humans or in livestock and there are few"/>
   <result pre="and 10 days after ingestion of oocysts and arise from" exact="malabsorption" post="and inflammation [ 13]. Some populations are especially vulnerable"/>
   <result pre="recognised in people ( Box 1). Disease in Livestock Globally," exact="cryptosporidiosis" post="affects a large number of animal species, including the"/>
   <result pre="industry [ 29]. Of 199 documented outbreaks of human parasitic" exact="protozoal disease" post="due to water contamination in the period 2004–2010, Cryptosporidium"/>
   <result pre="for Cryptosporidium. One study in Canada attributed source to sporadic" exact="cryptosporidiosis" post="cases from exposure data and found that water was"/>
   <result pre="infecting species and subtypes, the variable transmission and epidemiology of" exact="cryptosporidiosis" post="becomes clearer and interventions can be directly applied, whether"/>
   <result pre="East [ 95]. Transmission varies seasonally; in most European countries" exact="cryptosporidiosis" post="cases are mainly reported in late summer and autumn"/>
   <result pre="Box 2 Diagnostics and Epidemiology The true incidence of human" exact="cryptosporidiosis" post="is not known, although the population at most risk"/>
   <result pre="sample submission, and diagnostic practice contribute to the ascertainment of" exact="cryptosporidiosis" post="and, along with variation in reporting requirements, make interpretation"/>
   <result pre="There are currently few options to help prevent and treat" exact="cryptosporidiosis" post="in humans with no vaccines and only one FDA"/>
   <result pre="Control in Livestock Due to the lack of vaccines for" exact="cryptosporidiosis" post="in livestock, prevention and control of disease currently involves"/>
   <result pre="hydrated lime may help to reduce onset and severity of" exact="cryptosporidiosis" post="in calves [ 49]. It is advisable to house"/>
   <result pre="into an environment contaminated by older calves. Calves affected by" exact="cryptosporidiosis" post="should be housed separately until at least 1 week"/>
   <result pre="water courses [ 52]. Applying measures to prevent and control" exact="cryptosporidiosis" post="in livestock will have significant benefits for livestock health"/>
   <result pre="for Livestock? There are currently no vaccines available to prevent" exact="cryptosporidiosis" post="in farm livestock and as the disease mainly occurs"/>
   <result pre="Water Catchments from Contaminated Livestock Faeces A large outbreak of" exact="cryptosporidiosis" post="that occurred in Scotland in 2000 was associated with"/>
   <result pre="Along with increasing awareness and understanding of the impact of" exact="cryptosporidiosis" post="in people and animals, there is a renewed impetus"/>
   <result pre="and host–pathogen interactions, we have an exciting opportunity to tackle" exact="cryptosporidiosis" post="using a One Health approach. Outstanding Questions Would a"/>
   <result pre="immunity be effective in neonatal calves to reduce incidence of" exact="cryptosporidiosis" post="and shedding of oocysts into the environment? Would an"/>
   <result pre="6. Baxby D. Shedding of oocysts by immunocompetent individuals with" exact="cryptosporidiosis" post="Epidemiol. Infect. 95 1985 703 709 7. Nydam D.V."/>
   <result pre="575 586 24982322 13. Farthing M.J.G. Clinical aspects of human" exact="cryptosporidiosis" post="Petry F. Cryptosporidiosis and Microsporidiosis 2000 Karger 50 74"/>
   <result pre="209 222 23680352 16. Platts-Mills J.A. Pathogen-specific burdens of community" exact="diarrhea" post="in developing countries: a multisite birth cohort study (MAL-ED)"/>
   <result pre="149 235 18. Puleston R.L. The first recorded outbreak of" exact="cryptosporidiosis" post="due to Cryptosporidium cuniculus (formerly rabbit genotype), following a"/>
   <result pre="Parasitol. 197 2013 104 112 23680540 28. Gormley F.J. Zoonotic" exact="cryptosporidiosis" post="from petting farms, England and Wales, 1992-2009 Emerg. Infect."/>
   <result pre="Dis. 17 2011 151 152 21192888 29. Chalmers R.M. Waterborne" exact="cryptosporidiosis" post="outbreaks Ann. Ist. Super. Sanita 48 2012 429 446"/>
   <result pre="exposures and Cryptosporidium infection in cattle on human incidence of" exact="cryptosporidiosis" post="in Southwestern Ontario, Canada PLoS One 13 2018e0196573 32."/>
   <result pre="Pozio E. Advances in the epidemiology, diagnosis and treatment of" exact="cryptosporidiosis" post="Exp. Rev. Anti Infect. Ther. 4 2006 429 443"/>
   <result pre="Raven Press 1107 1128 35. Caccio S.M. Chalmers R.M. Human" exact="cryptosporidiosis" post="in Europe Clin. Microbiol. Infect. 22 2016 471 480"/>
   <result pre="49. Bjorkman C. Disinfection with hydrated lime may help manage" exact="cryptosporidiosis" post="in calves Vet. Parasitol. 264 2018 58 63 30503093"/>
   <result pre="Trotz-Williams I.A. Efficacy of halofuginone lactate in the prevention of" exact="cryptosporidiosis" post="in dairy calves Vet. Rec. 168 2011 509 21546409"/>
   <result pre="509 21546409 51. Grinberg A. Controlling the onset of natural" exact="cryptosporidiosis" post="in calves with paromomycin sulphate Vet. Rec. 151 2002"/>
   <result pre="53. Lendner M. A novel CDPK1 inhibitor--a potential treatment for" exact="cryptosporidiosis" post="in calves? Parasit. Res. 114 2015 335 336 54."/>
   <result pre="C.S. Identification of a potent benzoxaborale drug candidate for treating" exact="cryptosporidiosis" post="Nat. Comm. 10 2019 2816 57. Arnold S.L.M. Necessity"/>
   <result pre="163 21680094 59. Jenkins M.C. Present and future control of" exact="cryptosporidiosis" post="in humans and animals Exp. Rev. Vaccines 3 2004"/>
   <result pre="61. Sateriale A. A genetically tractable, natural mouse model of" exact="cryptosporidiosis" post="offers insights into host protective immunity Cell Host Microbe"/>
   <result pre="26 2019 135 146 31231045 62. Pollock K.G.J. Reduction in" exact="cryptosporidiosis" post="associated with introduction of enhanced filtration of drinking water"/>
   <result pre="the immunodominant p23 antigen and p23 polymorphisms in children with" exact="cryptosporidiosis" post="in Bangladesh Am. J. Trop. Med. Hyg. 86 2012"/>
   <result pre="diarrhoea model for evaluating efficacy of treatment and control of" exact="cryptosporidiosis" post="Hum. Vaccin. Immunother. 15 2019 1445 1452 30036127 70."/>
   <result pre="257 263 30118699 76. Mekonnen Y. A review article on" exact="cryptosporidiosis" post="t Acta Parasit. Glob. 7 2016 94 104 77."/>
   <result pre="Parasit. Glob. 7 2016 94 104 77. Ryan U. Foodborne" exact="cryptosporidiosis" post="Int. J. Parasitol. 48 2018 1 12 29122606 78."/>
   <result pre="78. Insulander M. Molecular epidemiology and clinical manifestations of human" exact="cryptosporidiosis" post="in Sweden Epidemiol. Infect. 141 2012 1009 1020 22877562"/>
   <result pre="1656 28930007 87. Nic Lochlainn L.M. Risk factors for sporadic" exact="cryptosporidiosis" post="in the Netherlands: analysis of a 3 year population"/>
   <result pre="219 234 15567586 90. Majowicz S.E. Descriptive analysis of endemic" exact="cryptosporidiosis" post="cases reported in Ontario, 1996-1997 Can. J. Public Health"/>
   <result pre="92. Pollock K.G.T. Spatial and temporal epidemiology of sporadic human" exact="cryptosporidiosis" post="in Scotland Zoonoses Public Health 57 2010 487 492"/>
   <result pre="Lake I.R. Case-control study of environmental and social factors influencing" exact="cryptosporidiosis" post="Eur. J. Epidemiol. 22 2007 805 811 17891460 94."/>
   <result pre="typing reveals the aetiology and species specific epidemiology of human" exact="cryptosporidiosis" post="in England and Wales 2000-2003 Euro. Surveill. 14 2009"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7106516/results/search/disease/results.xml">
   <result pre="earthquake, a flood, a famine, or the outbreak of an" exact="infectious disease." post="These events limit the genetic variation of a population"/>
   <result pre="selection from those very early days. Among various infectious diseases," exact="malaria" post="has exerted the highest evolutionary pressure on the communities"/>
   <result pre="7]. Populations remaining in sub-Saharan Africa have been exposed to" exact="malaria" post="for such long periods of time that their genetic"/>
   <result pre="their genetic structures have been shaped by the severity of" exact="malaria" post="( Plasmodium sp.) infections. In 1954, Allison described that"/>
   <result pre="to Africa and was associated with the geographical presence of" exact="malaria" post="[ 8]. This finding led to the more recent"/>
   <result pre="of natural selection driven by evolutionary pressure for protection against" exact="malaria" post="[ 9] ( Table 1 ). Similarly to HBB,"/>
   <result pre="some areas of West Africa with a high incidence of" exact="malaria" post="present a high frequency of Hemoglobin-C ( HBC) in"/>
   <result pre="HLA), which have been associated with protection against Plasmodium vivax" exact="malaria" post="in certain areas of Africa where this disease is"/>
   <result pre="of natural selection driven by evolutionary pressure for protection against" exact="malaria" post="are thalassemia (α and β) pathologies, a group of"/>
   <result pre="selection driven by evolutionary pressure for protection against malaria are" exact="thalassemia" post="(α and β) pathologies, a group of hemoglobin disorders"/>
   <result pre="areas of Asia, can modulate immune and inflammatory responses to" exact="malaria" post="by antagonizing interleukin (IL)-1β and NF-κB signaling in innate"/>
   <result pre="humanity. Most human populations with a long history of endemic" exact="malaria" post="have evolved genetic adaptations to malaria parasites due to"/>
   <result pre="long history of endemic malaria have evolved genetic adaptations to" exact="malaria" post="parasites due to the strong selective pressure that this"/>
   <result pre="populations over time, including several abnormal hemoglobins that protect against" exact="malaria" post="but usually cause erythrocyte-associated diseases in the populations where"/>
   <result pre="103] Bacterial sepsis CASP12 (T 125C) Protection [ 14] Mycobacterium" exact="tuberculosis" post="VDR, SLC11A1, TIRAP, HLA, CCL2, IL12A IFNG (874T/A) Protection"/>
   <result pre="CCR5Δ32 Protection [ 98] a Abbreviations: CD, Crohn’s disease; HSV," exact="herpes simplex" post="virus; IBD, inflammatory bowel disease; LPS, lipopolysaccharide; SLE, systemic"/>
   <result pre="herpes simplex virus; IBD, inflammatory bowel disease; LPS, lipopolysaccharide; SLE," exact="systemic lupus erythematosus." post="Tuberculosis Mycobacterium tuberculosis (MTB) has caused infections in our"/>
   <result pre="simplex virus; IBD, inflammatory bowel disease; LPS, lipopolysaccharide; SLE, systemic" exact="lupus erythematosus." post="Tuberculosis Mycobacterium tuberculosis (MTB) has caused infections in our"/>
   <result pre="bowel disease; LPS, lipopolysaccharide; SLE, systemic lupus erythematosus. Tuberculosis Mycobacterium" exact="tuberculosis" post="(MTB) has caused infections in our species and ancestors"/>
   <result pre="expressing the +874T/A variant of IFNG presented higher susceptibility to" exact="tuberculosis" post="MTB infection than individuals without it, which might be"/>
   <result pre="be considered a putative prognostic factor for the development of" exact="tuberculosis" post="[ 40], although this remains to be robustly demonstrated."/>
   <result pre="a large collection of pathogens such as those causing measles," exact="pneumonic plague," post="and influenza infections, which the indigenous populations had never"/>
   <result pre="of pathogens such as those causing measles, pneumonic plague, and" exact="influenza" post="infections, which the indigenous populations had never faced before."/>
   <result pre="colonists migrated to Surinam and encountered epidemics of yellow and" exact="typhoid fever" post="that caused a 60% mortality rate among settlers ["/>
   <result pre="health record data from individuals with connective tissue diseases, including" exact="rheumatoid arthritis" post="and systemic lupus erythematosus (SLE), as well as atherosclerotic"/>
   <result pre="record data from individuals with connective tissue diseases, including rheumatoid" exact="arthritis" post="and systemic lupus erythematosus (SLE), as well as atherosclerotic"/>
   <result pre="from individuals with connective tissue diseases, including rheumatoid arthritis and" exact="systemic lupus erythematosus" post="(SLE), as well as atherosclerotic cardiovascular disease from almost"/>
   <result pre="individuals with connective tissue diseases, including rheumatoid arthritis and systemic" exact="lupus erythematosus" post="(SLE), as well as atherosclerotic cardiovascular disease from almost"/>
   <result pre="arthritis and systemic lupus erythematosus (SLE), as well as atherosclerotic" exact="cardiovascular disease" post="from almost 300 000 African American and European American"/>
   <result pre="the study reported for the latter, a prevalence of atherosclerotic" exact="cardiovascular disease" post="in 29.7% African Americans (particularly high in young individuals),"/>
   <result pre="that require maintained modulation of the balance between inflammation and" exact="suppression" post="of the immune response, the organism can overreact to"/>
   <result pre="of autoimmune syndromes such as inflammation-associated carcinomas, lupus, asthma, and" exact="multiple sclerosis" post="(MS), the overall prevalence of which is up to"/>
   <result pre="transcription factors necessary to trigger the expression of IFNG against" exact="vaccinia virus" post="infection relative to controls [ 57]. Viruses can also"/>
   <result pre="in vitro [ 58]. In one study, patients with chronic" exact="hepatitis" post="C virus (HCV) infection and hepatitis A virus (HAV)"/>
   <result pre="study, patients with chronic hepatitis C virus (HCV) infection and" exact="hepatitis" post="A virus (HAV) superinfection presented lower titers of HCV"/>
   <result pre="the inhibition of tumor necrosis factor (TNF) production, and the" exact="suppression" post="of phagocytosis in human primary monocytes and mouse bone"/>
   <result pre="predisposition, these SNPs have been associated with protective roles against" exact="sleeping sickness" post="and malaria, respectively [ 68, 69]. Figure 4 Key"/>
   <result pre="CD are also linked with a higher risk of developing" exact="ulcerative colitis" post="[ 70] ( Table 1). Many of these loci"/>
   <result pre="are also linked with a higher risk of developing ulcerative" exact="colitis" post="[ 70] ( Table 1). Many of these loci"/>
   <result pre="also associated with the development of other autoimmune diseases, namely" exact="psoriasis" post="and ankylosing spondylitis [ 62]. PBMCs from individuals carrying"/>
   <result pre="with the development of other autoimmune diseases, namely psoriasis and" exact="ankylosing spondylitis" post="[ 62]. PBMCs from individuals carrying the SH2B3 variant"/>
   <result pre="the development of other autoimmune diseases, namely psoriasis and ankylosing" exact="spondylitis" post="[ 62]. PBMCs from individuals carrying the SH2B3 variant"/>
   <result pre="of life is related to a higher risk of developing" exact="hypersensitivity" post="reactions, based on the fact that children that are"/>
   <result pre="growing on farms) are less prone to develop allergies and" exact="asthma" post="[ 75, 76]. Moreover, reduced exposure to infectious agents"/>
   <result pre="potentiate the effects of ETV6–RUNX1 mutations in the pathogenesis of" exact="acute lymphoblastic leukemia" post="[ 77]. By contrast, a meta-analysis of six observational"/>
   <result pre="the effects of ETV6–RUNX1 mutations in the pathogenesis of acute" exact="lymphoblastic leukemia" post="[ 77]. By contrast, a meta-analysis of six observational"/>
   <result pre="effects of ETV6–RUNX1 mutations in the pathogenesis of acute lymphoblastic" exact="leukemia" post="[ 77]. By contrast, a meta-analysis of six observational"/>
   <result pre="Offspring of male rats subjected to a high-fat diet present" exact="glucose intolerance" post="and reduced insulin secretion, linked to reduced methylation at"/>
   <result pre="87, 88]. This was related with higher rates of obesity," exact="heart disease," post="cancer, and depression in individuals whose pregnant mothers suffered"/>
   <result pre="cases of HIV infection, or more recently, SARS-CoV, Ebola, and" exact="chikungunya" post="viruses; as well as the emergence of multiresistant bacteria"/>
   <result pre="populations globally? References References 1 Karlsson E.K. Natural selection and" exact="infectious disease" post="in human populations Nat. Rev. Genet. 15 2014 379"/>
   <result pre="10 Modiano D. Haemoglobin C protects against clinical Plasmodium falciparum" exact="malaria" post="Nature 414 2001 305 308 11713529 11 Sabeti P.C."/>
   <result pre="22951448 14 Labbe K. Caspase-12 dampens the immune response to" exact="malaria" post="independently of the inflammasome by targeting NF-B signaling J."/>
   <result pre="of sub-Saharan African human population: implications for HIV/AIDS, tuberculosis, and" exact="malaria" post="Int. J. Evol. Biol. 2014 2014 108291 25202468 18"/>
   <result pre="M. Association of the TLR1 variant rs5743557 with susceptibility to" exact="tuberculosis" post="J. Thorac. Dis. 11 2019 583 594 30963003 20"/>
   <result pre="is associated with differences in airway inflammation in patients with" exact="asthma" post="J. Allergy Clin. Immunol. 140 2017 257 265 28069248"/>
   <result pre="variant is associated with protection against invasive pneumococcal disease, bacteremia," exact="malaria" post="and tuberculosis Nat. Genet. 39 2007 523 528 17322885"/>
   <result pre="associated with protection against invasive pneumococcal disease, bacteremia, malaria and" exact="tuberculosis" post="Nat. Genet. 39 2007 523 528 17322885 37 Ferwerda"/>
   <result pre="and cytokine plasma levels are associated with susceptibility to Mycobacterium" exact="tuberculosis" post="infection and clinical manifestation of tuberculosis Hum. Immunol. 71"/>
   <result pre="with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of" exact="tuberculosis" post="Hum. Immunol. 71 2010 692 696 20353805 40 Wei"/>
   <result pre="interferon-γ gene (IFNG +874 T/A) is associated with susceptibility to" exact="tuberculosis" post="Oncotarget 8 2017 50415 50429 28881572 41 Skoglund P."/>
   <result pre="2012 502 512 22939635 48 Alenghat F.J. The prevalence of" exact="atherosclerosis" post="in those with inflammatory connective tissue disease by race,"/>
   <result pre="of natural selection to present-day susceptibility to chronic inflammatory and" exact="autoimmune disease" post="Curr. Opin. Immunol. 31 2014 66 78 25458997 51"/>
   <result pre="53 de la Cuesta-Zuluaga J. Gut microbiota is associated with" exact="obesity" post="and cardiometabolic disease in a population in the midst"/>
   <result pre="e0180691 28683106 59 Deterding K. Hepatitis A virus infection suppresses" exact="hepatitis" post="C virus replication and may lead to clearance of"/>
   <result pre="Freedman B.I. End-stage renal disease in African Americans with lupus" exact="nephritis" post="is associated with APOL1 Arthritis Rheumatol. 66 2014 390"/>
   <result pre="defects in the inhibitory receptor Fc RIIb reduce susceptibility to" exact="malaria" post="Proc. Natl. Acad. Sci. U.S.A. 104 2007 7169 7174"/>
   <result pre="17435165 70 Cleynen I. Inherited determinants of Crohn’s disease and" exact="ulcerative colitis" post="phenotypes: a genetic association study Lancet (London, England) 387"/>
   <result pre="70 Cleynen I. Inherited determinants of Crohn’s disease and ulcerative" exact="colitis" post="phenotypes: a genetic association study Lancet (London, England) 387"/>
   <result pre="2017 236 244 27672121 76 Stein M.M. Innate immunity and" exact="asthma" post="risk in Amish and Hutterite farm children N. Engl."/>
   <result pre="27237767 79 Koskderelioglu A. Is Toxoplasma gondii infection protective against" exact="multiple sclerosis" post="risk? Mult. Scler. Relat. Disord. 15 2017 7 10"/>
   <result pre="Pediatrics 124 2009 S159 98 Galvani A.P. Slatkin M. Evaluating" exact="plague" post="and smallpox as historical selective pressures for the CCR5-delta"/>
   <result pre="2009 S159 98 Galvani A.P. Slatkin M. Evaluating plague and" exact="smallpox" post="as historical selective pressures for the CCR5-delta 32 HIV-resistance"/>
   <result pre="evolution in European and Rroma populations reveals pressure exerted by" exact="plague" post="on Toll-like receptors Proc. Natl. Acad. Sci. U S"/>
   <result pre="West African HLA antigens are associated with protection from severe" exact="malaria" post="Nature 352 1991 595 600 1865923 104 Ma X."/>
   <result pre="resequencing reveals Toll-like receptor variants contribute to human susceptibility to" exact="tuberculosis" post="disease PLoS One 2 2007 e1318 18091991 105 Dubois"/>
   <result pre="catastrophic event that decimates the population, such as a widespread" exact="infectious disease." post="Crohn’s disease (CD) chronic inflammatory condition of the gastrointestinal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7106525/results/search/disease/results.xml">
   <result pre="disease was never described in ancient times despite its distinctive" exact="rash" post="in a substantial proportion of patients. In January 1805,"/>
   <result pre="its potential to cause meningitis. 9 The bacteriological study of" exact="meningitis" post="epidemics occurring after 1897 led to Diplococcus intracellularis meningitidis"/>
   <result pre="of those with the worst prognosis, only comparable to the" exact="plague" post="and cholera. 17 Therefore, countless methods were tested over"/>
   <result pre="Opium was believed to be a specific remedy for meningococcal" exact="meningitis" post="because of its stimulant properties. 4, 5, 6, 18,"/>
   <result pre="without concomitant laminectomy, was one of the therapeutic pillars for" exact="bacterial meningitis" post="for over a decade. The idea was to reduce"/>
   <result pre="concomitant laminectomy, was one of the therapeutic pillars for bacterial" exact="meningitis" post="for over a decade. The idea was to reduce"/>
   <result pre="capable of neutralising the effects of Clostridium tetani and Corynebacterium" exact="diphtheria" post="toxins after immunising horses with these bacterial toxins. In"/>
   <result pre="properties of meningococcus and was capable of producing experimental meningococcal" exact="meningitis" post="in Macacus rhesus, thus obtaining a model to validate"/>
   <result pre="Reproduced by permission of AgeFotoStock. From the first observations of" exact="meningitis" post="treated with antimeningococcal serum, it was obvious that the"/>
   <result pre="39 had already shown the existence of cases of meningococcal" exact="meningitis" post="in which the strain responsible was shown to be"/>
   <result pre="Francis Schwentker and colleagues 47 treated ten patients with meningococcal" exact="meningitis" post="and one with sepsis without meningitis with sulphanilamide intrathecally"/>
   <result pre="ten patients with meningococcal meningitis and one with sepsis without" exact="meningitis" post="with sulphanilamide intrathecally and subcutaneously. All ten patients survived."/>
   <result pre="73, 74, 75 Table 2 Outcome of patients with meningococcal" exact="meningitis" post="treated with sulphamides, serum therapy, or both Number treated"/>
   <result pre="least as effective as sulfisoxazole for the treatment of meningococcal" exact="meningitis" post="and that its intrathecal administration was not essential. The"/>
   <result pre="was not essential. The first series of patients with meningococcal" exact="meningitis" post="treated with penicillin is summarised in table 3 ."/>
   <result pre="91 Table 3 Early reports of the outcome of meningococcal" exact="meningitis" post="treated with penicillin Number treated with penicillin Route used"/>
   <result pre="in the treatment of meningococcal disease. 15 patients with meningococcal" exact="meningitis" post="received this drug orally or intravenously. They were all"/>
   <result pre="penicillin. In 1974, José Correa and colleagues 108 treated meningococcal" exact="meningitis" post="with cefacetrile with a good therapeutic response. Since then,"/>
   <result pre="excellent results have been published in the treatment of meningococcal" exact="meningitis" post="with second-generation and third-generation cephalosporins. 109 At present, the"/>
   <result pre="and third-generation cephalosporins. 109 At present, the empirical treatment of" exact="bacterial meningitis" post="acquired in the community always includes a third-generation cephalosporin."/>
   <result pre="third-generation cephalosporins. 109 At present, the empirical treatment of bacterial" exact="meningitis" post="acquired in the community always includes a third-generation cephalosporin."/>
   <result pre="molecule, chemically conjugated to a T-cell-stimulating antigen, such as the" exact="diphtheria" post="or tetanus toxoids. 138 They are immunogenic in children"/>
   <result pre="conjugated to a T-cell-stimulating antigen, such as the diphtheria or" exact="tetanus" post="toxoids. 138 They are immunogenic in children and adults,"/>
   <result pre="eradication or extinction. 142 Back to the future: antibodies for" exact="infectious disease" post="therapy The discovery of sulphamides and later of antibiotics,"/>
   <result pre="treated with antibiotics, such as the treatment and prevention of" exact="hepatitis" post="B virus, rabies virus, respiratory syncytial virus, Clostridium tetani,"/>
   <result pre="such as the treatment and prevention of hepatitis B virus," exact="rabies" post="virus, respiratory syncytial virus, Clostridium tetani, Clostridium botulinum, anthrax,"/>
   <result pre="syncytial virus, Clostridium tetani, Clostridium botulinum, anthrax, Clostridioides difficile colitis," exact="vaccinia virus," post="echovirus, and enterovirus. 148 However, looming threats in the"/>
   <result pre="infections. 149 Moreover, the emergence of new pathogens, such as" exact="severe acute respiratory syndrome," post="Middle East respiratory syndrome, or the re-emergence of old"/>
   <result pre="meningitids&quot;, &quot;cerebro-spinal meningitis&quot;, &quot;epidemic meningitis&quot;, &quot;spotted fever&quot;, &quot;cerebro-spinal fever&quot;, &quot;meningococcal" exact="meningitis" post="therapy&quot;, &quot;sulphamide treatment&quot;, &quot;penicillin&quot;, &quot;chloramphenicol&quot;, &quot;third-generation cephalosporins&quot;, &quot;meningococcal vaccine&quot;,"/>
   <result pre="1 1806 65 69 4 Arnell DR Observations on the" exact="spotted fever," post="as it appeared in Orange County, State of New"/>
   <result pre="BD Jr. A treatise on a malignant epidemic commonly called" exact="spotted fever;" post="interspersed on the nature of fever in general, &amp;amp;"/>
   <result pre="Jr. An inaugural dissertation on the disease termed petechial, or" exact="spotted fever." post="MD thesis, Medical and Philosophical Register 1811: 12–31, 57–74,"/>
   <result pre="1811: 12–31, 57–74, and 96–106. 7 Hirsch A Epidemic cerebro-spinal" exact="meningitis" post="Hirsch A Handbook of geographical and historical pathology, volume"/>
   <result pre="620–26. 10 Councilman WT Mallory FB Wright JH Epidemic cerebro-spinal" exact="meningitis" post="[history of the disease] Councilman WT Mallory FB Wright"/>
   <result pre="the disease] Councilman WT Mallory FB Wright JH Epidemic cerebro-spinal" exact="meningitis" post="and its relation to other forms of meningitis. A"/>
   <result pre="Osler W Ledingham JCG Discussion on the epidemiology of cerebro-spinal" exact="meningitis" post="Lancet 1 1915 553 555 18 Blackfan KD The"/>
   <result pre="1915 553 555 18 Blackfan KD The treatment of meningococcus" exact="meningitis" post="Medicine (Baltimore) 1 1922 139 212 19 Jaccoud S"/>
   <result pre="Arzneykunde Wundarzneykunst 21 1805 181 187 22 Stillé A Epidemic" exact="meningitis" post="or cerebro-spinal meningitis 1867 Lindsay and Blakiston Philadelphia, PA"/>
   <result pre="1805 181 187 22 Stillé A Epidemic meningitis or cerebro-spinal" exact="meningitis" post="1867 Lindsay and Blakiston Philadelphia, PA 23 Foster M"/>
   <result pre="Heiman H Feldstein S. History Heiman H Feldstein S Meningococcus" exact="meningitis" post="1913 J B Lippincott Philadelphia, PA 2 11 25"/>
   <result pre="PA 2 11 25 Wynter WE Four cases of tubercular" exact="meningitis" post="in which paracentesis of the theca vertebralis was performed"/>
   <result pre="fever: the etiology, symptomatology, diagnosis and treatment of epidemic cerebro-spinal" exact="meningitis" post="1919 A &amp;amp; C Black London 393 460 27"/>
   <result pre="Wochenschr 32 1906 788 793 33 Flexner S Experimental cerebro-spinal" exact="meningitis" post="in monkeys J Exp Med 9 1907 142 171"/>
   <result pre="9 1907 142 171 19867079 34 Flexner S Experimental cerebrospinal" exact="meningitis" post="and its serum treatment JAMA 47 1906 560 566"/>
   <result pre="JAMA 47 1906 560 566 35 Sophian A Epidemic cerebrospinal" exact="meningitis" post="1913 CV Mosby Co Saint Louis, MO 36 Cushing"/>
   <result pre="Co Saint Louis, MO 36 Cushing H Sladen FJ Obstructive" exact="hydrocephalus" post="following cerebrospinal meningitis, with intraventricular injection of antimeningitis serum"/>
   <result pre="37 Herrick WW The intravenous serum treatment of epidemic cerebrospinal" exact="meningitis" post="Arch lntern Med 21 1918 541 563 38 Bolduan"/>
   <result pre="of the serum treatment in thirteen hundred cases of epidemic" exact="meningitis" post="J Exp Med 17 1913 553 576 19867668 40"/>
   <result pre="fever: the etiology, symptomatology, diagnosis and treatment of epidemic cerebro-spinal" exact="meningitis" post="1919 A &amp;amp; C Black London 373 392 41"/>
   <result pre="1909 74 76 43 Elser WJ Huntoon FM Studies on" exact="meningitis" post="J Med Res 20 1909 371 541 44 Foster"/>
   <result pre="Schwentker FF Gelman S Long PH The treatment of meningococcic" exact="meningitis" post="with sulfanilamide. Preliminary report JAMA 108 1937 1407 1408"/>
   <result pre="1935 980 983 55 Hoyne AL Intravenous treatment of meningococcic" exact="meningitis" post="with meningococcus antitoxin JAMA 107 1936 478 481 56"/>
   <result pre="Morrow VJ Toomey JA Results in the treatment of meningococcic" exact="meningitis" post="with antitoxin and sulfonamide drugs J Pedriatr 20 1942"/>
   <result pre="meningitis. Including its use in twenty-four consecutive patients with meningococcic" exact="meningitis" post="War Med 2 1942 995 1007 68 Hodes HL"/>
   <result pre="995 1007 68 Hodes HL Strong PS Treatment of meningococcic" exact="meningitis" post="with sulfonamides JAMA 119 1942 691 694 69 Somers"/>
   <result pre="501 504 20784795 74 Scheld WM Mandell GL Sulfonamides and" exact="meningitis" post="JAMA 251 1984 791 794 6363730 75 Horwitz A"/>
   <result pre="1984 791 794 6363730 75 Horwitz A Perroni J Meningococcic" exact="meningitis" post="in Santiago, Chile, 1941 to 1943. An epidemic of"/>
   <result pre="14056528 79 Bristow WM Van Peenen PFD Volk R Epidemic" exact="meningitis" post="in naval recruits Am J Public Health 55 1965"/>
   <result pre="RE Hunter DH Rust JH Gauld RL Epidemiology of meningococcal" exact="meningitis" post="at Fort Ord Am J Epidemiol 82 1965 56"/>
   <result pre="86 Rosenberg DH Arling PA Penicillin in the treatment of" exact="meningitis" post="JAMA 125 1944 1011 1017 87 Meads M Harris"/>
   <result pre="M Harris HW Samper BA Finland M Treatment of meningococcal" exact="meningitis" post="with penicillin N Engl J Med 231 1944 509"/>
   <result pre="Penicillin in the treatment of pneumococcal, meningococcal, streptococcal and staphylococcal" exact="meningitis" post="Am J Med Sci 210 1945 1 17 92"/>
   <result pre="Minar JV Woodward TE Chloramphenicol in the treatment of meningococcal" exact="meningitis" post="Am J Med 10 1951 696 703 14837912 101"/>
   <result pre="1951 696 703 14837912 101 Claudon DB Holbrook AA Fatal" exact="aplastic anemia" post="associated with chloramphenicol (chloromycetin) therapy JAMA 149 1952 912"/>
   <result pre="696 703 14837912 101 Claudon DB Holbrook AA Fatal aplastic" exact="anemia" post="associated with chloramphenicol (chloromycetin) therapy JAMA 149 1952 912"/>
   <result pre="912 914 102 Smiley RK Cartwright GE Wintrobe MM Fatal" exact="aplastic anemia" post="following chloramphenicol (chloromycetin) administration JAMA 149 1952 914 918"/>
   <result pre="914 102 Smiley RK Cartwright GE Wintrobe MM Fatal aplastic" exact="anemia" post="following chloramphenicol (chloromycetin) administration JAMA 149 1952 914 918"/>
   <result pre="1952 914 918 103 Rheingold JJ Spurling CL Chloramphenicol and" exact="aplastic anemia" post="JAMA 149 1952 1301 1304 104 Burns LE Hodgman"/>
   <result pre="914 918 103 Rheingold JJ Spurling CL Chloramphenicol and aplastic" exact="anemia" post="JAMA 149 1952 1301 1304 104 Burns LE Hodgman"/>
   <result pre="specialist societies guideline on the diagnosis and management of acute" exact="meningitis" post="and meningococcal sepsis in immunocompetent adults J Infect 72"/>
   <result pre="C Dzupova O ESCMID guideline: diagnosis and treatment of acute" exact="bacterial meningitis" post="Clin Microbiol Infect 22 2016 S37 S62 27062097 111"/>
   <result pre="Dzupova O ESCMID guideline: diagnosis and treatment of acute bacterial" exact="meningitis" post="Clin Microbiol Infect 22 2016 S37 S62 27062097 111"/>
   <result pre="Brouwer MC Thwaites GE Tunkel AR Advances in treatment of" exact="bacterial meningitis" post="Lancet 380 2012 1693 1702 23141618 112 Goldschneider I"/>
   <result pre="MC Thwaites GE Tunkel AR Advances in treatment of bacterial" exact="meningitis" post="Lancet 380 2012 1693 1702 23141618 112 Goldschneider I"/>
   <result pre="Grupo de estudio de la OMS sobre lucha contra la" exact="meningitis" post="cerebroespinal. Lucha contra la meningitis cerebrospinal (serie de informes"/>
   <result pre="OMS sobre lucha contra la meningitis cerebroespinal. Lucha contra la" exact="meningitis" post="cerebrospinal (serie de informes técnicos numero 588) 1976 World"/>
   <result pre="Jamba G Bytchenko B Causse G Immunization during a cerebrospinal" exact="meningitis" post="epidemic in the Mongolian People's Republic, 1974–75 Bull World"/>
   <result pre="meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal" exact="meningitis" post="caused by Neisseria meningitidis group A Bull World Health"/>
   <result pre="230 128 Whittle HC Evans-Jones G Onyewotu I Group-C meningococcal" exact="meningitis" post="in the northern savanna of Africa Lancet 1 1975"/>
   <result pre="approaches for optimizing polysaccharide-protein conjugate vaccines for prevention of invasive" exact="bacterial disease" post="J Infect Dis 165 suppl 1 1992 S156 S159"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7111310/results/search/disease/results.xml">
   <result pre="Tenerife, Canary Islands (Spain), presented with two months history of" exact="uveitis" post="in the left eye. It had been treated for"/>
   <result pre="is proposed to be a potential cause of feline ischemic" exact="encephalopathy" post="and feline seizure disorders ( Glass et al., 1998;"/>
   <result pre="of this cat. It had a two months history of" exact="uveitis" post="in the left eye, treated with tobramycin/dexamethasone (Tobradex ®,"/>
   <result pre="and the result was favorable. However, it still showed exudative" exact="uveitis" post="with fibrin in the anterior chamber, posterior synechiae and"/>
   <result pre="anterior chamber, posterior synechiae and incipient cataracts, similar to chronic" exact="uveitis" post="in active phase. The hemogram, biochemical (cholesterol, alkaline phosphatase,"/>
   <result pre="G, A, and M analyses showed normal values except for" exact="eosinophilia" post="and a light increase of alkaline phosphatase. Serology was"/>
   <result pre="after surgery the fibrin deposits disappeared and the foci of" exact="chorioretinitis" post="remained stable, but posterior synechiae were persistent, there was"/>
   <result pre="but posterior synechiae were persistent, there was a presence of" exact="corneal edema" post="in the area of the incision, and the individual"/>
   <result pre="Merial solution). Subsequent explorations were positive, and no symptoms of" exact="uveitis" post="reappeared, leaving the foci of chorioretinitis inactive, whereas remnants"/>
   <result pre="and no symptoms of uveitis reappeared, leaving the foci of" exact="chorioretinitis" post="inactive, whereas remnants of posterior synechiae and incipient cataracts"/>
   <result pre="months, the cat is stable and without symptoms, waiting for" exact="cataract" post="surgery. 4 Discussion The distribution and importance of injuries"/>
   <result pre="pathologies, usually invades the leptomeningeal vasculature, causing diffuse meningomyelitis and" exact="thrombophlebitis" post="( Bowman et al., 2002; Gomez et al., 2010;"/>
   <result pre="Alzate G. Aranzazu D. Alzate A. Chaparro J. Domestic cat" exact="paraplegia" post="compatible with Gurltia paralysans nematode. First cases reported in"/>
   <result pre="Cerebrospinal cuterebriasis in cats and its association with feline ischemic" exact="encephalopathy" post="Vet. Pathol. 35 5 1998 330 343 9754538 Appendix"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7112844/results/search/disease/results.xml">
   <result pre="inflammation of the subglottis and larynx. The clinical course of" exact="croup" post="is well-described, however atypical presentations pose a diagnostic and"/>
   <result pre="6 months to 11 years of age presenting with atypical" exact="croup" post="were selected. A variety of definitions of atypical croup"/>
   <result pre="atypical croup were selected. A variety of definitions of atypical" exact="croup" post="were identified based on recurrence, duration of symptoms, severity,"/>
   <result pre="case series, case reports or retrospective chart reviews. Conclusions Atypical" exact="croup" post="is a poorly defined clinical entity that is used"/>
   <result pre="as a management algorithm. Keywords Croup Laryngitis Laryngotracheitis Laryngotracheobronchitis Atypical" exact="croup" post="Pediatric 1 Introduction Croup develops in more than 80,000"/>
   <result pre="age [ 1]. In its current use, a diagnosis of" exact="croup" post="encompasses a number of respiratory illnesses characterized by varying"/>
   <result pre="hoarseness resulting from inflammation and narrowing of the larynx. Viral" exact="croup" post="(acute laryngotracheitits) refers to the typical croup syndrome that"/>
   <result pre="the larynx. Viral croup (acute laryngotracheitits) refers to the typical" exact="croup" post="syndrome that occurs in children at the peak ages"/>
   <result pre="night, and when the child is agitated or crying. Viral" exact="croup" post="is most commonly caused by parainfluenza virus type 1,"/>
   <result pre="to exhaustion from increased work of breathing, hypercapnic or hypoxic" exact="respiratory failure," post="or imminent airway obstruction, treatment with endotracheal intubation is"/>
   <result pre="of intubation is approximately 3% for all patients admitted for" exact="croup" post="[ [8], [9], [10]]. In the medical literature, there"/>
   <result pre="medical literature, there have been attempts to sub-classify and define" exact="croup" post="based on infectious etiology, clinical recurrence or severity. Patients"/>
   <result pre="adapted for the current review. Published studies pertaining to atypical" exact="croup" post="were found utilizing the Ovid MEDLINE ® and EMBASE"/>
   <result pre="relevant articles. Articles with a focus on atypical presentations of" exact="croup" post="were included. Reviews, commentaries, and editorials were excluded. The"/>
   <result pre="the PRISMA guidelines. Results focused on identifying definitions of atypical" exact="croup" post="in the literature. The etiology, incidence, prevalence, diagnosis and"/>
   <result pre="literature. The etiology, incidence, prevalence, diagnosis and management of atypical" exact="croup" post="were secondary objectives. Table 1 Articles included in systematic"/>
   <result pre="younger, older than 3 years, or with recurrent episodes of" exact="croup" post="(4 or more episodes in total) Hatherill et al."/>
   <result pre="Straphylococcus aureus Rigid bronchoscopy IV Nafcillin Erythromycin Intubation *Describes bacterial" exact="tracheitis" post="as an atypical croup like syndrome, consisting of a"/>
   <result pre="IV Nafcillin Erythromycin Intubation *Describes bacterial tracheitis as an atypical" exact="croup" post="like syndrome, consisting of a more severe and prolonged"/>
   <result pre="n = 53 Median age of 2 years Unknown Endoscopy Unknown Recurrent" exact="croup" post="4.1 Definitions of atypical croup Definitions of atypical croup"/>
   <result pre="years Unknown Endoscopy Unknown Recurrent croup 4.1 Definitions of atypical" exact="croup" post="Definitions of atypical croup varied in the examined studies."/>
   <result pre="Recurrent croup 4.1 Definitions of atypical croup Definitions of atypical" exact="croup" post="varied in the examined studies. Several articles included a"/>
   <result pre="within the definition. For instance, Cooper et al. (2012) defined" exact="croup" post="as atypical if a child had more than 4"/>
   <result pre="of symptoms was a common criterion listed in definitions of" exact="croup" post="in the literature search. Inglis Jr. (1993) and O'Niel"/>
   <result pre="search. Inglis Jr. (1993) and O'Niel et al. (2013) defined" exact="croup" post="as atypical if symptoms lasted longer than seven days,"/>
   <result pre="did not provide a specific duration [ 16, 17]. Finally," exact="croup" post="associated with an uncommon pathogen was also defined as"/>
   <result pre="while Miller et al. (1982) reported a case of atypical" exact="croup" post="caused by Chlamydia trachomatis [ [17], [18], [19]]. 4.2"/>
   <result pre="[ [17], [18], [19]]. 4.2 Etiology and incidence of atypical" exact="croup" post="The etiology of atypical croup included several organisms not"/>
   <result pre="Etiology and incidence of atypical croup The etiology of atypical" exact="croup" post="included several organisms not normally associated with croup. Several"/>
   <result pre="several organisms not normally associated with croup. Several studies noted" exact="herpes simplex" post="virus type 1 as the causative organism, associated with"/>
   <result pre="al. (1982) reported Chlamydia trachomatis and Staphylococcus aureus in atypical" exact="croup" post="[ 18, 19]. Hatherill et al. (2001) reported other"/>
   <result pre="unclear if these pathogens were associated with cases of atypical" exact="croup" post="in their chart review [ 15]. The incidence of"/>
   <result pre="in their chart review [ 15]. The incidence of atypical" exact="croup" post="was not reported in any of the studies reviewed."/>
   <result pre="in any of the studies reviewed. 4.3 Diagnosis of atypical" exact="croup" post="Croup is primarily a clinical diagnosis, however the cases"/>
   <result pre="is primarily a clinical diagnosis, however the cases of atypical" exact="croup" post="reviewed often required further investigation. In our review, endoscopy"/>
   <result pre="based on etiology. Ulcerations were reported in cases of herpetic" exact="croup" post="by O'Niel et al. (2013), Inglis Jr (1993), Chauhan"/>
   <result pre="the presence of ulcerative lesions on microlaryngoscopy in children with" exact="croup" post="who were admitted to the PICU [ 15]. Laryngeal"/>
   <result pre="[ 11]. In addition, the authors reported associations between atypical" exact="croup" post="and atopic conditions such as eosinophilic esophagitis. The authors"/>
   <result pre="reported associations between atypical croup and atopic conditions such as" exact="eosinophilic esophagitis." post="The authors recommended that endoscopy be coupled with allergy"/>
   <result pre="eosinophilic esophagitis. The authors recommended that endoscopy be coupled with" exact="allergy" post="and gastrointestinal investigations in children with atypical croup. Barnes"/>
   <result pre="noted an association between gastoesophageal reflex disease (GERD) and recurrent" exact="croup" post="[ 12]. Patients with GERD had shorter time periods"/>
   <result pre="Patients with GERD had shorter time periods between episodes of" exact="croup" post="and younger age of presentation. Findings associated with GERD,"/>
   <result pre="mucosa, were identified in 47% of children assessed for recurrent" exact="croup" post="and 25% showed anatomical airway narrowing with direct laryngoscopy"/>
   <result pre="narrowing with direct laryngoscopy and bronchoscopy. 4.4 Management of atypical" exact="croup" post="The cornerstone of croup management is nebulized epinephrine and"/>
   <result pre="and bronchoscopy. 4.4 Management of atypical croup The cornerstone of" exact="croup" post="management is nebulized epinephrine and systemic corticosteroid. In cases"/>
   <result pre="discussed treatment with corticosteroids in the setting of HSV-induced atypical" exact="laryngitis" post="and suggested that corticosteroid use may delay diagnosis and"/>
   <result pre="Steroid administration was also discouraged with additional causes of atypical" exact="laryngitis" post="including inflammatory processes, such as GERD and alternate viral"/>
   <result pre="that prolonged use of corticosteroids resulted in susceptibility to herpetic" exact="croup" post="and suggested that corticosteroid use be limited to 48 h"/>
   <result pre="following cessation of corticosteroid medication in their case report. Atypical" exact="croup" post="often necessitated definitive airway management in the studies reviewed."/>
   <result pre="out of 148 children (6%) admitted to the PICU for" exact="croup" post="needed intubation with a median duration of 4 days"/>
   <result pre="Intubation was deemed necessary due to subglottic edema in HSV" exact="laryngitis" post="reported by Chauhan et al. (2007), Inglis Jr (1993),"/>
   <result pre="symptoms [ 21]. 5 Discussion Presented is a case of" exact="croup" post="in a child that occurred secondary to RSV infection."/>
   <result pre="repeated operative bronchoscopy for airway assessment. This case report of" exact="croup" post="is atypical in three notable ways: (1) the prolonged"/>
   <result pre="This case offers insight into the diagnostic challenges of atypical" exact="croup" post="and highlights the role of surgical airway management in"/>
   <result pre="surgical airway management in cases unresponsive to medical therapy. Typical" exact="croup" post="syndromes are usually self-limited in nature and responsive to"/>
   <result pre="responsive to medical therapy [ 6]. In unusual cases of" exact="croup" post="presentations, a different approach to diagnosis and management may"/>
   <result pre="atypical croup. Thus, we performed a systematic review on atypical" exact="croup" post="to identify definitions available in the literature. Furthermore, we"/>
   <result pre="strategies. Our review identified 12 English language articles on atypical" exact="croup" post="in the pediatric population. In our search the term"/>
   <result pre="in the pediatric population. In our search the term atypical" exact="croup" post="was used in the literature in a variety of"/>
   <result pre="in the literature in a variety of contexts. Recurrent episodes," exact="croup" post="in a child who lies outside the age range"/>
   <result pre="range of typical viral croup, prolonged or severe episodes, or" exact="croup" post="occurring due to uncommon etiology were all observed. Typical"/>
   <result pre="occurring due to uncommon etiology were all observed. Typical viral" exact="croup" post="is most commonly associated with the parainfluenza viruses, but"/>
   <result pre="but is also associated with adenovirus, RSV, rhinovirus and the" exact="influenza" post="viruses [ 4]. Our search revealed several infectious etiologies"/>
   <result pre="of corticosteroid administration due to treatment of an initial typical" exact="croup" post="presentation [ 13, 15, 16, 20]. In one immunosuppressed"/>
   <result pre="This suggests that immune modulation plays a role in determining" exact="croup" post="presentation and severity. Bacterial causes such as Staphylococcus and"/>
   <result pre="Chlamydiae species were also reported although distinctions made between bacterial" exact="tracheitis" post="and atypical croup were unclear in those studies ["/>
   <result pre="also reported although distinctions made between bacterial tracheitis and atypical" exact="croup" post="were unclear in those studies [ 15, 19]. Moreover,"/>
   <result pre="was a defining factor in assigning the definition of atypical" exact="croup" post="in several reports reviewed. Two studies outlined a time"/>
   <result pre="lower boundary. In the literature, the peak incidence of typical" exact="croup" post="is cited between the ages of 6 months to"/>
   <result pre="ages of 6 months to 3 years, however presentations of" exact="croup" post="up to 6 years of age were not uncommon."/>
   <result pre="6 years of age were not uncommon. The incidence of" exact="croup" post="by age reported by Denny et al. (1983) for"/>
   <result pre="age [ 23]. Based on the incidence found in typical" exact="croup" post="literature, the upper bound of 3 years of age"/>
   <result pre="upper bound of 3 years of age proposed for atypical" exact="croup" post="appears too low. Overall, our search suggests that atypical"/>
   <result pre="croup appears too low. Overall, our search suggests that atypical" exact="croup" post="is not a unique clinical entity. Rather, it is"/>
   <result pre="broader definition of atypical croup. We therefore propose that atypical" exact="croup" post="may be defined as a child who presents with"/>
   <result pre="croup may be defined as a child who presents with" exact="croup" post="that is either: a) severe, necessitating definitive airway management,"/>
   <result pre="lesions was as high as 40% in patients with recurrent" exact="croup" post="[ 11]. The question of who needs endoscopic evaluation"/>
   <result pre="Farmer and Wohl (2001) who proposed endoscopy be undertaken if" exact="croup" post="is severe, persists despite treatment, in cases of abnormal"/>
   <result pre="17]. The rate of intubation in other forms of atypical" exact="croup" post="was not well studied. Furthermore, specific characteristics associated with"/>
   <result pre="is warranted to clarify this issue. The atypical presentation of" exact="croup" post="is a common problem faced by emergency physicians, pediatricians"/>
   <result pre="Canadian Pediatric Society Position Statement on the &quot;Acute management of" exact="croup" post="in the emergency department&quot;, the Seattle Children's Hospital Croup"/>
   <result pre="Croup&quot; [ [24], [25], [26]]. We then adapted our institutional" exact="croup" post="pathway, and integrated recommendations from the practice guidelines listed"/>
   <result pre="listed and the conclusions from our literature review on atypical" exact="croup" post="to formulate a pathway for atypical croup ( Fig."/>
   <result pre="review on atypical croup to formulate a pathway for atypical" exact="croup" post="( Fig. 2 ). Fig. 2 Croup diagnosis and"/>
   <result pre="This case offers insight into the diagnostic pathway of atypical" exact="croup" post="and highlights the role of surgical airway management in"/>
   <result pre="without agreement on the frequency, duration, or severity. Moreover, atypical" exact="croup" post="was used in multiple contexts including airway lesions, bacterial"/>
   <result pre="exists a gap in knowledge of the incidence of atypical" exact="croup" post="and factors that result in definitive airway management. We"/>
   <result pre="definitive airway management. We propose a broad definition of atypical" exact="croup" post="and propose a pathway for healthcare providers faced with"/>
   <result pre="this paradigm within our own centre has not only reduced" exact="croup" post="consultations, but provided emergency physicians, hospital pediatricians and intensivists"/>
   <result pre="common basis from which to approach seemingly unusual or atypical" exact="croup" post="presentations. Declarations of competing interests Raphael Hanna: none. Francisco"/>
   <result pre="Gelder C.M. Kotecha S. Doull I.J.M. The viral aetiology of" exact="croup" post="and recurrent croup Arch. Dis. Child. 94 2009 359"/>
   <result pre="S. Doull I.J.M. The viral aetiology of croup and recurrent" exact="croup" post="Arch. Dis. Child. 94 2009 359 360 18801765 5"/>
   <result pre="827 834 8 Narayanan S. Funkhouser E. Inpatient hospitalizations for" exact="croup" post="Hosp. Pediatr. 4 2014 88 92 24584978 9 Gelbart"/>
   <result pre="epidemiology of life-threatening upper airway infections: the reemergence of bacterial" exact="tracheitis" post="Pediatrics 118 2006 1418 1421 17015531 11 Cooper T."/>
   <result pre="W.M. Gower V.C. The incidence of gastroesophageal reflux in recurrent" exact="croup" post="Int. J. Pediatr. Otorhinolaryngol. 32 1995 223 232 7665269"/>
   <result pre="13 Chauhan N. Robinson J.L. Guillemaud J. El-Hakim H. Acute" exact="herpes simplex" post="laryngotracheitis: report of two pediatric cases and review of"/>
   <result pre="15 Hatherill M. Severe upper airway obstruction caused by ulcerative" exact="laryngitis" post="Arch. Dis. Child. 85 2001 326 329 11567944 16"/>
   <result pre="A.F. Herpes simplex virus infection. A rare cause of prolonged" exact="croup" post="Arch. Otolaryngol. Head Neck Surg. 119 1993 551 552"/>
   <result pre="R.H. Conley S.F. Ulcerative lesions as a rare cause of" exact="laryngotracheitis" post="in the pediatric population Am. J. Otolaryngol. 34 2013"/>
   <result pre="Fungal laryngotracheobronchitis in an immunocompromised child: a case of atypical" exact="croup" post="Int. J. Pediatr. Otorhinolaryngol. Extra 7 2012 141 143"/>
   <result pre="B.R. Arthur J.D. Parry W.H. Perez T.R. Mosman P.L. Atypical" exact="croup" post="and Chlamydia trachomatis Lancet 1 1982 1022 20 Krause"/>
   <result pre="I. Schonfeld T. Ben-Ari J. Offer I. Garty B.Z. Prolonged" exact="croup" post="due to herpes simplex virus infection Eur. J. Pediatr."/>
   <result pre="Ben-Ari J. Offer I. Garty B.Z. Prolonged croup due to" exact="herpes simplex" post="virus infection Eur. J. Pediatr. 157 1998 567 569"/>
   <result pre="Subglottic cysts in a critically Ill pediatric patient with refractory" exact="croup" post="symptoms Crit. Care Med. 44 1999 575 2016 22"/>
   <result pre="Harris J.B. Lusk R. Wagener J.S. Andersen R.D. Acute viral" exact="laryngotracheitis" post="complicated by herpes simplex virus infection Otolaryngol. Head Neck"/>
   <result pre="R. Wagener J.S. Andersen R.D. Acute viral laryngotracheitis complicated by" exact="herpes simplex" post="virus infection Otolaryngol. Head Neck Surg. 96 1987 190"/>
   <result pre="A, Croup Pathway, ((n.d.)). 26 Ortiz-Alvarez O. Acute management of" exact="croup" post="in the emergency department Paediatr. Child Health 22 2017"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7113380/results/search/disease/results.xml">
   <result pre="surpassed infections caused by two other major coronavirus to date," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)."/>
   <result pre="process to help readers understand the natural history of an" exact="infectious disease." post="The incubation period \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy}"/>
   <result pre="control. Discussion Obtaining timely understanding of the transmission of emerging" exact="infectious disease" post="is crucial for evaluating the damage and size from"/>
   <result pre="CA Fraser C Riley S et al. The epidemiology of" exact="severe acute respiratory syndrome" post="in the 2003 Hong Kong epidemic: an analysis of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7115519/results/search/disease/results.xml">
   <result pre="investigate the impacts of infectious diseases, including Avian Flu and" exact="severe acute respiratory syndrome," post="on international tourist arrivals in Asia. The empirical results"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7115773/results/search/disease/results.xml">
   <result pre="cystic carcinoma Osteochondroplastic tracheobronchopathia Endobronchial metastases Papillomatosis Benign Lesions Tracheal" exact="leiomyoma" post="Lipoma Pleomorphic adenoma Granular cell tumors Normal Anatomy of"/>
   <result pre="tracheobronchopathia Endobronchial metastases Papillomatosis Benign Lesions Tracheal leiomyoma Lipoma Pleomorphic" exact="adenoma" post="Granular cell tumors Normal Anatomy of the Trachea The"/>
   <result pre="up less than 0.4% of all tumors, producing 0.1% of" exact="cancer" post="deaths worldwide. Primary malignant tumors typically arise from surface"/>
   <result pre="Carcinoma Squamous cell carcinoma (SCC) is the most common primary" exact="tracheal tumor," post="with higher male prevalence, and is highly associated with"/>
   <result pre="Carcinoma Adenoid cystic carcinoma (ACC) is the second most common" exact="tracheal tumor," post="with similar incidence among males and females, and with"/>
   <result pre="mass was found to be a cardinoid. Endotracheobronchial Lymphoma Endobronchial" exact="lymphoma" post="is a rare manifestation of Hodgkin's and Non-Hodgkin's lymphoma,"/>
   <result pre="of 44 years (4-81 years). 24, 25 Bronchus-associated lymphoid tissue" exact="lymphoma" post="is a rare low-grade subtype of marginal zone lymphoma"/>
   <result pre="tissue lymphoma is a rare low-grade subtype of marginal zone" exact="lymphoma" post="which mostly occurs in distal bronchi. Conditions such as"/>
   <result pre="development. Some of the entities associated with bronchus-associated lymphoid tissue" exact="lymphoma" post="include AIDS, Sjogren's syndrome, amyloid deposition, and dysgammaglobulinemia. 26,"/>
   <result pre="27, 28 There is no specific radiologic finding to suggest" exact="lymphoma" post="and diagnosis is based on biopsy. However CT is"/>
   <result pre="compromise/obstruction ( Fig 6 ). Fig. 6 (a, b) Endobronchial" exact="lymphoma" post="is manifesting as a large intraluminal mass expanding the"/>
   <result pre="common sources of local invasion. Tumors producing tracheal metastases include" exact="renal cell carcinoma," post="breast, colon, hepatocellular carcinoma, and melanoma. Metastases can present"/>
   <result pre="Tumors producing tracheal metastases include renal cell carcinoma, breast, colon," exact="hepatocellular carcinoma," post="and melanoma. Metastases can present as solitary or multiple"/>
   <result pre="setting of childhood infections, such as with parainfluenza types 1–3," exact="influenza" post="A and B viruses; adenoviruses; coronavirus NL63; and respiratory"/>
   <result pre="33, 34, 35 Overall, most of the cases of viral" exact="tracheitis" post="stem from parainfluenza or respiratory syncytial virus infection, which"/>
   <result pre="subglottic or laryngeal narrowing. Tuberculosis Around 10%-40% of patients with" exact="tuberculosis" post="exhibit features of endobronchial involvement with the thickened and"/>
   <result pre="with the thickened and irregular wall with active disease. Tuberculosis" exact="tracheitis" post="is considered one of the most communicable patterns of"/>
   <result pre="Wegner Granulomatosis) Granulomatosis with polyangiitis is a systemic necrotizing granulomatous" exact="vasculitis" post="mainly affecting the respiratory system, in which 90% of"/>
   <result pre="positive Antineutrophil cytoplasmic antibodies (ANCA), and there is often concurrent" exact="glomerulonephritis" post="as a part of the pulmonary-renal syndrome. CT scanning"/>
   <result pre="wall and presents with dyspnea, wheeze, cough, hemoptysis, and recurrent" exact="pneumonia" post="39 ( Fig 11 ). Fig. 11 (a) Multiple"/>
   <result pre="thickening is sparing the posterior wall in a patient with" exact="relapsing polychondritis." post="Respiratory Papillomatosis Infection leading to respiratory papillomatosis is associated"/>
   <result pre="restored (panel C). The patient developed a subsegmental area of" exact="aspiration pneumonia" post="(image 2), which subsequently resolved on follow-up imaging (Image"/>
   <result pre="(panel C). The patient developed a subsegmental area of aspiration" exact="pneumonia" post="(image 2), which subsequently resolved on follow-up imaging (Image"/>
   <result pre="1169 1763640 11 Licht P.B. Friis S. Pettersson G. Tracheal" exact="cancer" post="in Denmark: a nationwide study Eur J Cardiothorac Surg"/>
   <result pre="Lopez A.E. Anzalone M.L. Postmortem findings in eight cases of" exact="influenza" post="A/H1N1 Modern Pathol 23 2010 1449 33 Ben‐Izhak O."/>
   <result pre="33 Ben‐Izhak O. Ben‐Arieh Y. Necrotizing squamous metaplasia in herpetic" exact="tracheitis" post="following prolonged intubation: a lesion similar to necrotizing sialometaplasia"/>
   <result pre="in herpetic tracheitis following prolonged intubation: a lesion similar to" exact="necrotizing sialometaplasia" post="Histopathology 22 1993 265 270 8388361 34 Baras L."/>
   <result pre="Baras L. Farber C. Van Vooren J.-P. Herpes simplex virus" exact="tracheitis" post="in a patient with the acquired immunodeficiency syndrome Eur"/>
   <result pre="11 2007 R119 17996032 36 Riley E.C. Amundson D.E. Laryngeal" exact="tuberculosis" post="revisited Am Fam Phys 46 1992 759 762 37"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7117081/results/search/disease/results.xml">
   <result pre="Europe PMC, consistent with existing copyright protections. Abstract Acute disseminated" exact="encephalomyelitis" post="(ADEM) is a common yet clinically heterogenous syndrome characterized"/>
   <result pre="distinctive review of the spectrum of MOG antibodies. Keywords ADEM" exact="acute disseminated encephalomyelitis" post="diagnosis treatment MOG antibody Introduction Acute disseminated encephalomyelitis (ADEM)"/>
   <result pre="of the spectrum of MOG antibodies. Keywords ADEM acute disseminated" exact="encephalomyelitis" post="diagnosis treatment MOG antibody Introduction Acute disseminated encephalomyelitis (ADEM)"/>
   <result pre="acute disseminated encephalomyelitis diagnosis treatment MOG antibody Introduction Acute disseminated" exact="encephalomyelitis" post="(ADEM) is an immune-mediated disorder of the central nervous"/>
   <result pre="brain is abnormal during the acute (3-mo) phase Abbreviations: ADEM," exact="acute disseminated encephalomyelitis;" post="MRI, magnetic resonance imaging. The clinical diagnosis of ADEM"/>
   <result pre="is required for the diagnosis. In children, the degree of" exact="encephalopathy" post="varies and patients may have more than depressed mental"/>
   <result pre="and other active behavioral changes. 3 Additional neurologic features include" exact="cerebellar ataxia," post="cranial neuropathy, hemiparesis/weakness, optic neuritis (ON) (which can include"/>
   <result pre="3 Additional neurologic features include cerebellar ataxia, cranial neuropathy, hemiparesis/weakness," exact="optic neuritis" post="(ON) (which can include vision loss, pain with eye"/>
   <result pre="which may or may not be consistent with a transverse" exact="myelitis" post="(TM). 1 2 3 5 Disturbances of language function,"/>
   <result pre="very rare and may indicate an alternative diagnosis such as" exact="neuromyelitis optica" post="spectrum disorders (NMOSDs). As with other neuroimmunologic disorders, up"/>
   <result pre="infections have included mycoplasma, Epstein–Bar's virus, coronavirus, coxsackie virus, hepatitis," exact="herpes simplex" post="virus, human immunodeficiency virus, human herpesvirus, parainfluenza virus, influenzas"/>
   <result pre="influenzas A and B, as well as measles, mumps, and" exact="rubella" post="viruses. 3 5 8 9 10 11 A minority"/>
   <result pre="(5%) are associated with vaccination, including but not limited to:" exact="hepatitis" post="B, influenza, diphtheria/pertussis/tetanus, measles/mumps/rubella, pneumococcus, and polio. 5 These"/>
   <result pre="in a child who presents with polyfocal neurologic abnormalities and" exact="encephalopathy" post="is broad. Viral and bacterial meningitis/encephalitis must be ruled"/>
   <result pre="12 While data are limited, there has been report of" exact="meningoencephalitis" post="associated with MOG antibodies which can complicate even the"/>
   <result pre="on MRI of the brain, other inflammatory demyelinating disorders include" exact="multiple sclerosis" post="(MS), MOG antibody-associated demyelination, antibody-associated limbic encephalitis, primary angiitis"/>
   <result pre="on the differential diagnosis in any clinical presentation with subacute" exact="encephalopathy" post="or behavioral dysregulation. Over the past two decades, considerable"/>
   <result pre="cortical ribboning, and white matter lesions. For patients presenting with" exact="status epilepticus" post="at presentation, antibodies against thyroid peroxidase and thyroglobulin may"/>
   <result pre="presentation, antibodies against thyroid peroxidase and thyroglobulin may indicate Hashimoto's" exact="encephalopathy" post="(also known as steroid responsive encephalopathy associated with autoimmune"/>
   <result pre="thyroglobulin may indicate Hashimoto's encephalopathy (also known as steroid responsive" exact="encephalopathy" post="associated with autoimmune thyroiditis) is warranted. Neuroimaging in ADEM"/>
   <result pre="increasingly nuanced. Other neuroradiologic mimics of ADEM include hypotensive encephalopathy," exact="hemophagocytic lymphohistiocytosis," post="primary CNS lymphoma, systemic rheumatologic disorders (systemic lupus erythematosus,"/>
   <result pre="encephalopathy, hemophagocytic lymphohistiocytosis, primary CNS lymphoma, systemic rheumatologic disorders (systemic" exact="lupus erythematosus," post="Behcet's disease, Sjogren's disease, Wegner's disease, and CNS vasculitis),"/>
   <result pre="in MS Absence of oligoclonal bands in CSF Abbreviations: ADEM," exact="acute disseminated encephalomyelitis;" post="CSF, cerebrospinal fluid; MS, multiple sclerosis. Fig. 1 Axial"/>
   <result pre="CSF Abbreviations: ADEM, acute disseminated encephalomyelitis; CSF, cerebrospinal fluid; MS," exact="multiple sclerosis." post="Fig. 1 Axial flair sequence demonstrating multiple, bilateral, T2"/>
   <result pre="tracks in a 5-year-old boy with myelin oligodendrocyte glycoprotein antibody-negative" exact="acute disseminated encephalomyelitis." post="Fig. 2 Coronal T2 sequence demonstrating multiple, patchy, cortical,"/>
   <result pre="lesions in a 4-year-old girl with myelin oligodendrocyte glycoprotein antibody-positive" exact="acute disseminated encephalomyelitis." post="Fig. 3 Axial flair sequence demonstrating poorly circumscribed, patchy,"/>
   <result pre="matter in a 6-year-old boy with myelin oligodendrocyte glycoprotein antibody-positive" exact="acute disseminated encephalomyelitis." post="As mentioned previously, the concept of &quot;relapsing&quot; ADEM has"/>
   <result pre="of both seizure at presentation and long-term risk of post-ADEM" exact="epilepsy" post="which is another distinguishing characteristic when compared with other"/>
   <result pre="31 32 Interestingly, as additional attacks occur (and age increases)," exact="encephalopathy" post="is less frequently appreciated, although new neurologic signs and"/>
   <result pre="followed by ON, and NMO-SD. Additionally, the potential for post-ADEM" exact="epilepsy" post="also seems to be higher in this group, although"/>
   <result pre="A Albani S Kao A S et al. Acute disseminated" exact="encephalomyelitis" post="in childhood: epidemiologic, clinical and laboratory features Pediatr Infect"/>
   <result pre="J S ; International Pediatric MS Study Group. Acute disseminated" exact="encephalomyelitis" post="Neurology 2007 68 16 02 S23 S36 17438235 4"/>
   <result pre="Raju S et al. Temporal trends of pediatric hospitalizations with" exact="acute disseminated encephalomyelitis" post="in the United States: an analysis from 2006 to"/>
   <result pre="et al. Temporal trends of pediatric hospitalizations with acute disseminated" exact="encephalomyelitis" post="in the United States: an analysis from 2006 to"/>
   <result pre="532 543 16773356 7 Sospedra M Martin R Immunology of" exact="multiple sclerosis" post="Annu Rev Immunol 2005 23 683 747 15771584 8"/>
   <result pre="al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric" exact="multiple sclerosis" post="and immune-mediated central nervous system demyelinating disorders: revisions to"/>
   <result pre="A S Kean M J Clinical and neuroradiologic features of" exact="acute disseminated encephalomyelitis" post="in children Neurology 2001 56 10 1308 1312 11376179"/>
   <result pre="Kean M J Clinical and neuroradiologic features of acute disseminated" exact="encephalomyelitis" post="in children Neurology 2001 56 10 1308 1312 11376179"/>
   <result pre="Harding B Neville B G Acute disseminated encephalomyelitis, multiphasic disseminated" exact="encephalomyelitis" post="and multiple sclerosis in children Brain 2000 123(Pt 12):"/>
   <result pre="Neville B G Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and" exact="multiple sclerosis" post="in children Brain 2000 123(Pt 12): 2407 2422 11099444"/>
   <result pre="M et al. A case of anti-MOG antibody-positive unilaterally dominant" exact="meningoencephalitis" post="followed by longitudinally extensive transverse myelitis Mult Scler Relat"/>
   <result pre="anti-MOG antibody-positive unilaterally dominant meningoencephalitis followed by longitudinally extensive transverse" exact="myelitis" post="Mult Scler Relat Disord 2018 25 128 130 30071506"/>
   <result pre="R et al. A clinical approach to diagnosis of autoimmune" exact="encephalitis" post="Lancet Neurol 2016 15 04 391 404 26906964 20"/>
   <result pre="et al. Clinical and neuroradiological differences of paediatric acute disseminating" exact="encephalomyelitis" post="with and without antibodies to the myelin oligodendrocyte glycoprotein"/>
   <result pre="Clinical outcome of children presenting with a severe manifestation of" exact="acute disseminated encephalomyelitis" post="Neuropediatrics 2009 40 05 211 217 20221956 22 Callen"/>
   <result pre="of children presenting with a severe manifestation of acute disseminated" exact="encephalomyelitis" post="Neuropediatrics 2009 40 05 211 217 20221956 22 Callen"/>
   <result pre="to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating" exact="central nervous system disease" post="Ann Neurol 2009 66 06 833 842 20033986 24"/>
   <result pre="native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central" exact="nervous system disease" post="Ann Neurol 2009 66 06 833 842 20033986 24"/>
   <result pre="B cell autoimmunity to a myelin surface antigen in pediatric" exact="multiple sclerosis" post="J Immunol 2009 183 06 4067 4076 19687098 25"/>
   <result pre="T Benetou C Wright S et al. Early predictors of" exact="epilepsy" post="and subsequent relapse in childrenwith acute disseminated encephalomyelitis Mult"/>
   <result pre="al. Early predictors of epilepsy and subsequent relapse in childrenwith" exact="acute disseminated encephalomyelitis" post="Mult Scler 2019. doi:1352458518823486 31 Baumann M Hennes E"/>
   <result pre="predictors of epilepsy and subsequent relapse in childrenwith acute disseminated" exact="encephalomyelitis" post="Mult Scler 2019. doi:1352458518823486 31 Baumann M Hennes E"/>
   <result pre="E M Schanda K et al. Children with multiphasic disseminated" exact="encephalomyelitis" post="and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending"/>
   <result pre="Huppke P Rostasy K Karenfort M et al. Acute disseminated" exact="encephalomyelitis" post="followed by recurrent or monophasic optic neuritis in pediatric"/>
   <result pre="et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic" exact="optic neuritis" post="in pediatric patients Mult Scler 2013 19 07 941"/>
   <result pre="R et al. Antibodies to MOG are transient in childhood" exact="acute disseminated encephalomyelitis" post="Neurology 2011 77 06 580 588 21795651 35 Spadaro"/>
   <result pre="al. Antibodies to MOG are transient in childhood acute disseminated" exact="encephalomyelitis" post="Neurology 2011 77 06 580 588 21795651 35 Spadaro"/>
   <result pre="al. Autoantibodies to MOG in a distinct subgroup of adult" exact="multiple sclerosis" post="Neurol Neuroimmunol Neuroinflamm 2016 3 05 e257 27458601 36"/>
   <result pre="J et al. Association of MOG-IgG serostatus with relapse after" exact="acute disseminated encephalomyelitis" post="and proposed diagnostic criteria for MOG-IgG-associated disorders JAMA Neurol"/>
   <result pre="al. Association of MOG-IgG serostatus with relapse after acute disseminated" exact="encephalomyelitis" post="and proposed diagnostic criteria for MOG-IgG-associated disorders JAMA Neurol"/>
   <result pre="of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral" exact="encephalitis" post="PLoS One 2016 11 08 e0161656 27575749 40 Pohl"/>
   <result pre="08 e0161656 27575749 40 Pohl D Tenembaum S Treatment of" exact="acute disseminated encephalomyelitis" post="Curr Treat Options Neurol 2012 14 03 264 275"/>
   <result pre="27575749 40 Pohl D Tenembaum S Treatment of acute disseminated" exact="encephalomyelitis" post="Curr Treat Options Neurol 2012 14 03 264 275"/>
   <result pre="immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent" exact="acute disseminated encephalomyelitis" post="J Neurol 2002 249 01 100 104 11954856 42"/>
   <result pre="in adult patients with steroid-resistant monophasic or recurrent acute disseminated" exact="encephalomyelitis" post="J Neurol 2002 249 01 100 104 11954856 42"/>
   <result pre="E Ravid S Long-term motor, cognitive and behavioral outcome of" exact="acute disseminated encephalomyelitis" post="Eur J Paediatr Neurol 2016 20 03 361 367"/>
   <result pre="S Long-term motor, cognitive and behavioral outcome of acute disseminated" exact="encephalomyelitis" post="Eur J Paediatr Neurol 2016 20 03 361 367"/>
   <result pre="long term motor, behavioral, and scholastic outcome in children with" exact="acute disseminated encephalomyelitis" post="Pediatr Neurol 2018 89 49 57 30409457 45 Weier"/>
   <result pre="motor, behavioral, and scholastic outcome in children with acute disseminated" exact="encephalomyelitis" post="Pediatr Neurol 2018 89 49 57 30409457 45 Weier"/>
   <result pre="A MomayyezSiahkal P et al. White matter changes in paediatric" exact="multiple sclerosis" post="and monophasic demyelinating disorders Brain 2017 140 05 1300"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7117180/results/search/disease/results.xml">
   <result pre="pmcid: 7117180 S0378-1135(19)30048-3 doi: 10.1016/j.vetmic.2019.03.017 : Article Novel insights into" exact="pasteurellosis" post="in captive pinnipeds Crawford Rebecca L. a 1 Blyde"/>
   <result pre="occurred at Sea World, Australia during December 2017. A fibrinosuppurative" exact="bronchopneumonia" post="in a Subantarctic fur seal ( Arctocephalus tropicalis) resulted"/>
   <result pre="within 24 h of nonspecific signs of illness, whereas a septic" exact="peritonitis" post="in a New Zealand fur seal ( Arctocephalus forsteri)"/>
   <result pre="cholera in avian species, haemorrhagic septicaemia in bovine species, atrophic" exact="rhinitis" post="in swine, and snuffles in lagomorphs ( Harper et"/>
   <result pre="in captivity ( Hansen et al., 2012). In marine mammals," exact="pasteurellosis" post="has been reported as an acute or peracute septicemia,"/>
   <result pre="hemorrhage in cetaceans ( Dunn et al., 2001). In pinnipeds," exact="pasteurellosis" post="has been reported as causing disease in different species"/>
   <result pre="in captive fur seals at Sea World Australia. A fibrinosuppurative" exact="bronchopneumonia" post="in a Subantarctic fur seal ( Arctocephalus tropicalis) resulted"/>
   <result pre="within 24 h of nonspecific signs of illness, whereas a septic" exact="peritonitis" post="in a New Zealand fur seal ( Arctocephalus forsteri)"/>
   <result pre="biochemistry, complete blood count, PCR for the detection of Mycobacterium" exact="tuberculosis" post="complex and serology for phocine morbillivirus were performed (the"/>
   <result pre="minor wound management. Two negative intradermal skin tests for Mycobacterium" exact="tuberculosis" post="complex were obtained during the quarantine period. The seal"/>
   <result pre="of several lung sections revealed a severe, acute diffuse fibrinosuppurative" exact="bronchopneumonia" post="with pleuritis and numerous small Gram-negative bacilli. In the"/>
   <result pre="and GCA_002859465) randomly picked from a study on naturally occurring" exact="respiratory disease" post="in a herd that consisted of multisourced feedlot cattle,"/>
   <result pre="multocida has been isolated from cases of septicaemia, mortality and" exact="pneumonia" post="in pinnipeds as well as cetaceans ( Dunn et"/>
   <result pre="Hansen et al., 2012; Nielsen et al., 2013). Fatal septicaemic" exact="pasteurellosis" post="has been reported in cetaceans and pinnipeds, where the"/>
   <result pre="cetaceans and pinnipeds, where the most common origin of generalized" exact="pasteurellosis" post="in captive and wild pinnipeds is bite wounds inflicted"/>
   <result pre="Dunn et al., 2001). Typical necropsy findings include pneumonia, enteritis," exact="myocarditis" post="with epicardial/pericardial petechiation, hemorrhage, hepatitis, nephritis, splenitis, necrotic peritonitis,"/>
   <result pre="( Dunn et al., 2001). However, the per-acute nature of" exact="pasteurellosis" post="might result in few gross lesions. In the seal"/>
   <result pre="in Case 1, in-house tests and necropsy findings such as" exact="lymphadenopathy" post="and cardiac changes suggested a severe inflammatory response and"/>
   <result pre="and/or protein-losing enteropathy. A severe effusive, exudative, hemorrhagic and septic" exact="peritonitis" post="was observed upon necropsy in the fur seal in"/>
   <result pre="sudden death, a severe bacteraemic sepsis as a sequelae to" exact="peritonitis" post="was suspected. Isolation of P. multocida mostly as pure"/>
   <result pre="or any other genotyping method. The clinical presentation of septic" exact="pasteurellosis" post="is suspected to appear most probably after the levels"/>
   <result pre="2000). In addition to that, an association between prevalence of" exact="pasteurellosis" post="in seals in an aquarium in the USA with"/>
   <result pre="the same genetic lineage, thus confirming that an outbreak of" exact="pasteurellosis" post="had indeed occurred. This is beyond what routine MLST"/>
   <result pre="1, suggesting a common source. Given the peracute nature of" exact="pasteurellosis" post="in these two cases, it is very unlikely to"/>
   <result pre="aureus ( Didelot et al., 2016) and Psuedomonas aeruginosa in" exact="cystic fibrosis" post="patients ( Sherrard et al., 2017). Mixed colonization by"/>
   <result pre="has not previously reported in P. multocida. Future investigations into" exact="pasteurellosis" post="outbreaks would help in providing more insight if multiple"/>
   <result pre="with nasal secretions is an important route of transmission of" exact="pasteurellosis" post="( DiGiacomo et al., 1987). Given the two seals"/>
   <result pre="gamithromycin in pulmonary epithelial lining fluid in naturally occurring bovine" exact="respiratory disease" post="in multisource commingled feedlot cattle J. Vet. Pharmacol. Ther."/>
   <result pre="analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in" exact="cystic fibrosis" post="PLoS One 12 2017e0172179 Stamatakis A. RAxML version 8:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7118492/results/search/disease/results.xml">
   <result pre="Abstract Background Kawasaki disease (KD) is a self-limiting acute systemic" exact="vasculitis" post="occur mainly in infants and young children under 5"/>
   <result pre="Kawasaki, 2002), KD was identified as an acute pediatric systemic" exact="vasculitis" post="with clinical symptoms such as sustained fever, oral mucosal"/>
   <result pre="KD, is gradually replacing rheumatism as the most common acquired" exact="heart disease" post="of childhood in developed countries ( Dimitriades et al.,"/>
   <result pre="conjunctival hyperemia. 3) Lip and oral changes: dry lips, redness," exact="cleft palate," post="tongue nipple bulge, diffuse oral and pharyngeal mucosa. 4)"/>
   <result pre="echocardiogram or coronary angiography which can confirm the diagnosis of" exact="coronary aneurysm" post="or coronary artery dilatation (with 4 major symptoms being"/>
   <result pre="and when a patient has confirmed with the development of" exact="coronary aneurysm" post="or coronary artery dilatation. 2005 1) The diagnostic criteria"/>
   <result pre="et al., 2004 2017 1) For the first time the" exact="coronary artery anomaly" post="was evaluated by the Z-value, i.e. the body surface"/>
   <result pre="fever and irritability (ii) Long-term fever in infants with unexplained" exact="aseptic meningitis" post="(iii) Infants or children with prolonged fever and unexplained"/>
   <result pre="and irritability (ii) Long-term fever in infants with unexplained aseptic" exact="meningitis" post="(iii) Infants or children with prolonged fever and unexplained"/>
   <result pre="shock. (iv) Infants or children with prolonged fever and cervical" exact="lymphadenitis" post="but no response after antibiotic treatment (v) Long-term fever"/>
   <result pre="Long-term fever in infants or children after antibiotic treatment towards" exact="cellulitis" post="in pharynx. 5) It is proposed that elevated N-terminal"/>
   <result pre="incomplete KD, such as by evaluating the presence of anterior" exact="uveitis" post="symptoms ( Lee et al., 2016), are needed to"/>
   <result pre="et al., 2015), therefore, KD is also suggested as an" exact="infectious disease." post="However, there is still no definite test to differentiate"/>
   <result pre="definite test to differentiate KD from other diseases such as" exact="scarlet fever," post="juvenile rheumatoid arthritis, toxic shock syndrome or measles that"/>
   <result pre="differentiate KD from other diseases such as scarlet fever, juvenile" exact="rheumatoid arthritis," post="toxic shock syndrome or measles that cause similar symptoms"/>
   <result pre="from other diseases such as scarlet fever, juvenile rheumatoid arthritis," exact="toxic shock syndrome" post="or measles that cause similar symptoms ( Maconochie, 2004;"/>
   <result pre="as scarlet fever, juvenile rheumatoid arthritis, toxic shock syndrome or" exact="measles" post="that cause similar symptoms ( Maconochie, 2004; Pilania and"/>
   <result pre="retrovirus, measles, chickenpox, human herpesvirus 6, cytomegalovirus, group A streptococcus," exact="dengue fever" post="virus, epstein-barr virus, coronavirus, parvovirus B19, bacillus cereus, human"/>
   <result pre="of KD which may be associated with the pathogens of" exact="acute pyelonephritis" post="and exanthem subitum ( Jung-Woo et al., 2019). Furthermore,"/>
   <result pre="KD which may be associated with the pathogens of acute" exact="pyelonephritis" post="and exanthem subitum ( Jung-Woo et al., 2019). Furthermore,"/>
   <result pre="may be associated with the pathogens of acute pyelonephritis and" exact="exanthem" post="subitum ( Jung-Woo et al., 2019). Furthermore, Jordan et"/>
   <result pre="high-dose AAS, and with a higher risk of developing coronary" exact="heart disease" post="complications ( Singer et al., 2008). Some reports have"/>
   <result pre="AAS, and is usually preceded by a viral infection, especially" exact="influenza" post="and chickenpox, in children and teenagers, leading to possible"/>
   <result pre="teenagers, leading to possible lethal side effects such as toxic" exact="encephalopathy" post="or liver dysfunction ( Chornomydz et al., 2017). The"/>
   <result pre="X.P. Cryptotanshinone inhibits prostaglandin E2 production and COX-2 expression via" exact="suppression" post="of TLR4/NF-kappa B signaling pathway in LPS-stimulated Caco-2 cells"/>
   <result pre="C.N. Yu H.R. Wang L. Wang C.L. The relationship of" exact="eosinophilia" post="to intravenous immunoglobulin treatment failure in Kawasaki disease Pediatr."/>
   <result pre="J.H. Lee S.J. Lee K.Y. Han J.W. Usefulness of anterior" exact="uveitis" post="as an additional tool for diagnosing incomplete Kawasaki disease"/>
   <result pre="– a statement for health professionals from the committee on" exact="rheumatic fever," post="endocarditis and Kawasaki disease, council on cardiovascular disease in"/>
   <result pre="statement for health professionals from the committee on rheumatic fever," exact="endocarditis" post="and Kawasaki disease, council on cardiovascular disease in the"/>
   <result pre="committee on rheumatic fever, endocarditis and Kawasaki disease, council on" exact="cardiovascular disease" post="in the young Am. Heart Assoc. Circul. 110 2004"/>
   <result pre="Kobayashi H. Ishii M. Transcriptional regulation by infliximab therapy in" exact="kawasaki disease" post="patients with immunoglobulin resistance Pediatr. Res. 76 2014 287"/>
   <result pre="Saguil A. Fargo M. Grogan S. Diagnosis and management of" exact="kawasaki disease" post="Am. Fam. Phys. 91 2015 365 371 Sato S."/>
   <result pre="H.M. Fu J.R. Liu Q. Liu D.X. Emodin-mediated protection from" exact="acute myocardial infarction" post="via inhibition of inflammation and apoptosis in local ischemic"/>
   <result pre="Xiongshao Capsule on anti-inflammatory function of high-density lipoprotein in an" exact="atherosclerosis" post="rabbit model Chin. J. Integr. Med. 23 2017 357"/>
   <result pre="of dendritic cells via JAK/STAT/SOCS signal in mice with experimental" exact="colitis" post="Front. Pharmacol. 7 2016 Acknowledgments This work was supported"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7118597/results/search/disease/results.xml">
   <result pre="Introduction In December of 2019, a mysterious virus that causes" exact="pneumonia" post="and produces pneumonia-like symptoms; i.e., dry cough and fever"/>
   <result pre="known as Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2 and coronavirus" exact="infectious disease" post="2019 (COVID-19) respectively [ [1], [2], [3], [4]]. SARS-CoV-2"/>
   <result pre="viruses have been studied using PONDR® VLXT including equine infectious" exact="anemia" post="virus (EIAV), human immunodeficiency virus (HIV), herpes simplex virus"/>
   <result pre="including equine infectious anemia virus (EIAV), human immunodeficiency virus (HIV)," exact="herpes simplex" post="virus (HSV), smallpox virus, polio virus, Nipah and Ebola"/>
   <result pre="virus (EIAV), human immunodeficiency virus (HIV), herpes simplex virus (HSV)," exact="smallpox" post="virus, polio virus, Nipah and Ebola viruses, SARS-CoV, MERS-CoV,"/>
   <result pre="smallpox virus, polio virus, Nipah and Ebola viruses, SARS-CoV, MERS-CoV," exact="influenza" post="virus, hepatitis C virus (HCV), hepatitis A virus (HAV),"/>
   <result pre="polio virus, Nipah and Ebola viruses, SARS-CoV, MERS-CoV, influenza virus," exact="hepatitis" post="C virus (HCV), hepatitis A virus (HAV), yellow fever"/>
   <result pre="Ebola viruses, SARS-CoV, MERS-CoV, influenza virus, hepatitis C virus (HCV)," exact="hepatitis" post="A virus (HAV), yellow fever virus (YFV), and Zika"/>
   <result pre="influenza virus, hepatitis C virus (HCV), hepatitis A virus (HAV)," exact="yellow fever" post="virus (YFV), and Zika virus [ 2, [5], [6],"/>
   <result pre="in the environment for a long time such, as the" exact="smallpox" post="virus, have low outer shell PIDs. 4.5 Lessons from"/>
   <result pre="This is especially so in the case of TGEV (transmissible" exact="gastroenteritis" post="virus) and PEDV (porcine epidemic diarrhea virus). TGEV could"/>
   <result pre="case of TGEV (transmissible gastroenteritis virus) and PEDV (porcine epidemic" exact="diarrhea" post="virus). TGEV could move rapidly among farm pigs to"/>
   <result pre="which has similar characteristics as TGEV [ 29]. Like TGEV," exact="diarrhea" post="and vomiting are main symptoms of PEDV infection. While"/>
   <result pre="X.L. Wang X.G. Hu B. Zhang L. Zhang W. A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="Goh G.K. Dunker A.K. Uversky V.N. Protein intrinsic disorder and" exact="influenza" post="virulence: the 1918 H1N1 and H5N1 viruses Virol. J."/>
   <result pre="A.N. Oeselli M.A. Saif L. Antigenic relationships among procine epidemic" exact="diarrhea" post="virus and transmissible gastroenteritis virus strains J. Virol. 89"/>
   <result pre="L. Antigenic relationships among procine epidemic diarrhea virus and transmissible" exact="gastroenteritis" post="virus strains J. Virol. 89 2015 3332 3342 25589635"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7118644/results/search/disease/results.xml">
   <result pre="maintained a relatively innocuous reputation as a cause of the" exact="common cold" post="[ 2]. However, public perception and awareness of HCoVs"/>
   <result pre="interest in potential therapeutic options for HCoV-related illnesses. In 2002–2003," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) infected more than 8000 people, reaching 26"/>
   <result pre="have been underestimated [ 5]. Most recently, the emergence of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) in December 2019 in Wuhan and"/>
   <result pre="displayed antiviral activity against SARS-CoV, Marburg virus, and feline infectious" exact="peritonitis" post="virus, among others [ 9, [14], [15], [16]]. A"/>
   <result pre="30]. Unsurprisingly, Agostini et al. reported that a mutant murine" exact="hepatitis" post="virus (MHV) devoid of proofreading ability was more sensitive"/>
   <result pre="as reported by each respective study. † MHV = murine" exact="hepatitis" post="virus. ‡ PDCoV = porcine deltacoronavirus. ¥ FIPV ="/>
   <result pre="‡ PDCoV = porcine deltacoronavirus. ¥ FIPV = feline infectious" exact="peritonitis" post="virus. In studies of SARS-CoV and MERS-CoV in human"/>
   <result pre="that only infects wild and domestic cats, the feline infectious" exact="peritonitis" post="(FIP) virus (EC 50 = 0.78 μM; Table 1)"/>
   <result pre="with intravenous remdesivir under the compassionate use clause after developing" exact="pneumonia" post="in January 2020 [ 37]. This 35-year-old male had"/>
   <result pre="A. A rare Case of human coronavirus 229E associated with" exact="acute respiratory distress syndrome" post="in a healthy adult Case Rep. Infect. Dis. 2018"/>
   <result pre="C.I. Marston H.D. Fauci A.S. Coronavirus infections-more than just the" exact="common cold" post="JAMA 2020 3 World Health Organization SARS (Severe Acute"/>
   <result pre="Eckstrand C. The nucleoside analog GS-441524 strongly inhibits feline infectious" exact="peritonitis" post="(FIP) virus in tissue culture and experimental cat infection"/>
   <result pre="GS-441524 for treatment of cats with naturally occurring feline infectious" exact="peritonitis" post="J. Feline Med. Surg. 21 4 2019 271 281"/>
   <result pre="Liu H. Leutenegger C. Murphy B. Levels of feline infectious" exact="peritonitis" post="virus in blood, effusions, and various tissues and the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7124368/results/search/disease/results.xml">
   <result pre="future implications of the current coronavirus pandemic. Figure 1 Emerging" exact="infectious disease" post="(EID) events (defined as the temporal origin of an"/>
   <result pre="and (d) transmission mode. Figure 2 Global number of human" exact="infectious disease" post="outbreaks and richness of causal diseases 1980–2010. Outbreak records"/>
   <result pre="human coronaviruses (HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1) and cause the" exact="common cold." post="Severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East"/>
   <result pre="(MERS-CoV) are zoonotic. In 2002–2003, SARS-CoV caused an outbreak of" exact="pneumonia" post="in 8000 affected cases, distributed over 30 countries and"/>
   <result pre="from bats, with dromedary camels as the intermediate host, causes" exact="pneumonia" post="in humans and has a mortality rate of over"/>
   <result pre="6], and causes mild to severe disease with fatal bilateral" exact="viral pneumonia" post="described in humans [ 7, 8]. It is referred"/>
   <result pre="and causes mild to severe disease with fatal bilateral viral" exact="pneumonia" post="described in humans [ 7, 8]. It is referred"/>
   <result pre="food is just as important, and zoonotic diseases such as" exact="avian influenza" post="(including the 2006 H5N1 epidemic) and swine influenza (including"/>
   <result pre="is just as important, and zoonotic diseases such as avian" exact="influenza" post="(including the 2006 H5N1 epidemic) and swine influenza (including"/>
   <result pre="as avian influenza (including the 2006 H5N1 epidemic) and swine" exact="influenza" post="(including the 2009 H1N1 pandemic) are often associated with"/>
   <result pre="from wild animals of similar species. In the case of" exact="avian influenza," post="the virus, which circulates naturally in wild bird populations,"/>
   <result pre="often treated with vaccines and antibiotics. Both avian and swine" exact="influenza" post="continue to be managed through regular vaccination of livestock"/>
   <result pre="stable oil) in Malaysia has led to the upsurge of" exact="malaria" post="in the region. Currently, the world's highest rate of"/>
   <result pre="of palm oil plantations [ [24], [25], [26]]. The zoonotic" exact="malaria" post="species Plasmodium knowlesi has recently become the principal cause"/>
   <result pre="Plasmodium knowlesi has recently become the principal cause of human" exact="malaria" post="in Borneo, and this has been linked directly to"/>
   <result pre="the worst epidemics and pandemics (including human immunodeficiency virus, SARS-CoV," exact="avian influenza," post="swine influenza, Ebola virus and Zika virus) of the"/>
   <result pre="health emergency. Health systems are varied. A small outbreak of" exact="influenza" post="in a high-resource country with a robust health system"/>
   <result pre="not yet available, SARS-CoV-2 may be less deadly than the" exact="influenza" post="virus that hospitals deal with on an annual basis,"/>
   <result pre="not give information on how fast it will spread. Seasonal" exact="influenza" post="has an R 0 of approximately 1.3, but circulates"/>
   <result pre="a highly variable reproductive rate [ 56]. Still, SARS-CoV-2 causes" exact="pneumonia" post="in healthy people [ 57], even if most of"/>
   <result pre="for Disease Control and Prevention Rapid risk assessment: outbreak of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2): increased transmission beyond China – fourth"/>
   <result pre="Carlson L. Chen J. Chen C. Global rise in human" exact="infectious disease" post="outbreaks J R Soc Interface 11 2014 20140950 25401184"/>
   <result pre="R.A.M. Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N Engl J Med 367 2012"/>
   <result pre="Yang B. Song J. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019 N Engl J Med 382 2020"/>
   <result pre="31551053 18 collab: Centers for Disease Control and Prevention Avian" exact="influenza" post="in birds 2018 CDC Atlanta, GA Available at: https://www.cdc.gov/flu/avianflu/avian-in-birds.htm"/>
   <result pre="[last accessed January 2020] 19 Spickler A.R. Influenza: flu, grippe," exact="avian influenza," post="grippe aviaire, fowl plague, swine influenza, hog flu, pig"/>
   <result pre="G.F. MERS, SARS, and Ebola: the role of super-spreaders in" exact="infectious disease" post="Cell Host Microbe 18 2015 398 401 26468744 35"/>
   <result pre="Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected" exact="pneumonia" post="N Engl J Med 2020 10.1056/NEJMoa2001316 50 Gralinski L.E."/>
   <result pre="e428 28757186 55 Coburn B.J. Wagner B.G. Blower S. Modeling" exact="influenza" post="epidemics and pandemics: insights into the future of swine"/>
   <result pre="against droplets and contact in prevention of nosocomial transmission of" exact="severe acute respiratory syndrome" post="(SARS) Lancet 361 2003 1519 1520 12737864 62 World"/>
   <result pre="62 World Health Organization Consensus document on the epidemiology of" exact="severe acute respiratory syndrome" post="(SARS) 2003 WHO Geneva 63 Donnelly C.A. Ghani A.C."/>
   <result pre="Riley S. Epidemiological determinants of spread of causal agent of" exact="severe acute respiratory syndrome" post="in Hong Kong Lancet 361 2003 1761 1766 12781533"/>
   <result pre="H. Kamigaki T. Suzuki A. Major issues and challenges of" exact="influenza" post="pandemic preparedness in developing countries Emerg Infect Dis 14"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7125732/results/search/disease/results.xml">
   <result pre="the first new episode, she had a left-gaze deviation and" exact="encephalopathy" post="for a few minutes, without postictal state (PS). In"/>
   <result pre="on serum were all normal, except for the presence of" exact="leukopenia" post="(3580 cells/microL) and a mild elevation in both aspartate"/>
   <result pre="onset. Viral serologies were performed and results were negative for" exact="influenza" post="A and B, adenovirus, coronavirus, parainfluenza virus, enterovirus, human"/>
   <result pre="herpes 6). In addition, antibody results for lupus, Sjogren's syndrome," exact="antiphospholipid syndrome," post="celiac disease, neuromyelielitis optica (aquaporin-4 antibody) as well as"/>
   <result pre="febrile syndrome and inflammatory changes, they are called to have" exact="encephalitis" post="( Zhu et al., 2016). Two classifications of acute"/>
   <result pre="encephalitis ( Zhu et al., 2016). Two classifications of acute" exact="encephalopathy" post="were reported ( Hoshino et al., 2012). The first"/>
   <result pre="based on clinical, laboratory, MRI scan and pathological findings of" exact="encephalopathy" post="( Hoshino et al., 2012; Zhu et al., 2016)."/>
   <result pre="D.S. Barnett Y. The corpus callosum in the diagnosis of" exact="multiple sclerosis" post="and other CNS demyelinating and inflammatory diseases Journal of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7125844/results/search/disease/results.xml">
   <result pre="long as the COVID-19 resource centre remains active. Abstract Cutaneous" exact="leishmaniasis" post="is a neglected tropical disease caused by the parasite"/>
   <result pre="biopharmaceutical characterization analytical biochemistry biotechnology vaccine(s) protein(s) Abbreviations used CL," exact="cutaneous leishmaniasis" post="PpSP15, 15 kDa sandfly ( P. papatasi) salivary protein"/>
   <result pre="characterization analytical biochemistry biotechnology vaccine(s) protein(s) Abbreviations used CL, cutaneous" exact="leishmaniasis" post="PpSP15, 15 kDa sandfly ( P. papatasi) salivary protein"/>
   <result pre="homogenate or sandfly bites has been shown the cause delayed-type" exact="hypersensitivity" post="to salivary components, which has been shown to impede"/>
   <result pre="vector’s salivary proteins also were shown to be protected against" exact="encephalitis" post="virus, 17 Mycobacterium ulcerans infection, 18 and dengue virus."/>
   <result pre="this protection was due to the development of a delayed-type" exact="hypersensitivity" post="response to PpSP15. 20 , 23 In addition, as"/>
   <result pre="University of the Health Sciences, we are now developing a" exact="leishmaniasis" post="vaccine consisting of the sandfly antigen, PpSP15, and a"/>
   <result pre="In conclusion, the production process for recombinant PpSP15 as a" exact="leishmaniasis" post="vaccine antigen candidate has been developed. The upstream production"/>
   <result pre="Alencar C.H. Heukelbach J. Mortality and case fatality due to" exact="visceral leishmaniasis" post="in Brazil: a nationwide analysis of epidemiology, trends and"/>
   <result pre="C.H. Heukelbach J. Mortality and case fatality due to visceral" exact="leishmaniasis" post="in Brazil: a nationwide analysis of epidemiology, trends and"/>
   <result pre="J.C. Louzir H. Pirmez C. Alexander B. Brooker S. Cutaneous" exact="leishmaniasis" post="Lancet Infect Dis 7 9 2007 581 596 17714672"/>
   <result pre="2007 581 596 17714672 4 Hotez P.J. The rise of" exact="leishmaniasis" post="in the twenty-first century Trans R Soc Trop Med"/>
   <result pre="Sahibi H. Boelaert M. Psychosocial impact of scars due to" exact="cutaneous leishmaniasis" post="on high school students in Errachidia Province, Morocco Infect"/>
   <result pre="H. Boelaert M. Psychosocial impact of scars due to cutaneous" exact="leishmaniasis" post="on high school students in Errachidia Province, Morocco Infect"/>
   <result pre="e0005739 28796782 7 Bailey F. Mondragon-Shem K. Haines L.R. Cutaneous" exact="leishmaniasis" post="and co-morbid major depressive disorder: a systematic review with"/>
   <result pre="D. Gontijo N.F. Leon I.R. Antibodies from dogs with canine" exact="visceral leishmaniasis" post="recognise two proteins from the saliva of Lutzomyia longipalpis"/>
   <result pre="Gontijo N.F. Leon I.R. Antibodies from dogs with canine visceral" exact="leishmaniasis" post="recognise two proteins from the saliva of Lutzomyia longipalpis"/>
   <result pre="longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type" exact="hypersensitivity" post="J Infect Dis 186 10 2002 1530 1534 12404176"/>
   <result pre="Belkaid Y. Modi G. Rowton E. Sacks D. Protection against" exact="cutaneous leishmaniasis" post="resulting from bites of uninfected sand flies Science 290"/>
   <result pre="Y. Modi G. Rowton E. Sacks D. Protection against cutaneous" exact="leishmaniasis" post="resulting from bites of uninfected sand flies Science 290"/>
   <result pre="McDowell M.A. Uninfected mosquito bites confer protection against infection with" exact="malaria" post="parasites Infect Immun 75 5 2007 2523 2530 17339356"/>
   <result pre="nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing" exact="cutaneous leishmaniasis" post="Protein Expr Purif 130 2017 129 136 27773761 26"/>
   <result pre="hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous" exact="leishmaniasis" post="Protein Expr Purif 130 2017 129 136 27773761 26"/>
   <result pre="A sand fly salivary protein vaccine shows efficacy against vector-transmitted" exact="cutaneous leishmaniasis" post="in nonhuman primates Sci Transl Med 7 290 2015"/>
   <result pre="sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous" exact="leishmaniasis" post="in nonhuman primates Sci Transl Med 7 290 2015"/>
   <result pre="Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human" exact="intestinal schistosomiasis" post="Hum Vaccin Immunother 9 11 2013 2342 2350 23899507"/>
   <result pre="mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal" exact="schistosomiasis" post="Hum Vaccin Immunother 9 11 2013 2342 2350 23899507"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7126206/results/search/disease/results.xml">
   <result pre="herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with" exact="herpes simplex" post="viruses type 2 Duan Qianni 540740962@qq.com a Liu Tong"/>
   <result pre="has preventive and therapeutic effects on Trichomonas vaginitis, Candida albicans" exact="vaginitis" post="and GH in vitro and in vivo experiments. Aim"/>
   <result pre="2018). HSV-2 infection during early pregnancy can also cause neonatal" exact="encephalitis" post="through placental transmission, resulting in high morbidity and mortality"/>
   <result pre="a vital role in the treatment of epidemic infection of" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) and influenza A virus H1N1 ( Ge"/>
   <result pre="epidemic infection of severe acute respiratory syndrome coronavirus (SARS-CoV) and" exact="influenza" post="A virus H1N1 ( Ge et al., 2010; Lin"/>
   <result pre="has a remarkable clinical effect on pelvic inflammation, cervicitis, and" exact="vaginitis" post="according to clinical study ( LI et al., 2017;"/>
   <result pre="treatment that it can cure syphilitic poisoned sores, morbid leucorrhea," exact="carbuncle" post="toxin, limb hypertonicity, strangury due to heat, eczema pruritus,"/>
   <result pre="It can also be used to treat digestive diseases like" exact="acute pancreatitis," post="ulcerative colitis, and cholecystitis ( WU et al., 2019)."/>
   <result pre="also be used to treat digestive diseases like acute pancreatitis," exact="ulcerative colitis," post="and cholecystitis ( WU et al., 2019). S. glabra"/>
   <result pre="to treat digestive diseases like acute pancreatitis, ulcerative colitis, and" exact="cholecystitis" post="( WU et al., 2019). S. glabra Roxb., D."/>
   <result pre="Yao F. Development of a glycoprotein D-expressing dominant-negative and replication-defective" exact="herpes simplex" post="virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection"/>
   <result pre="Investigation on prevention effects of Jieze NO.2 on candida albicans" exact="vaginitis" post="Chinese. Matern. Child Health Care China vol. 24 2009"/>
   <result pre="Huang G.-Y. The experimental study of Jieze No2 on trichomonas" exact="vaginitis" post="Chinese. Matern. Child Health Care China vol. 24 2009"/>
   <result pre="Huang G.-Y. The effect of Jieze NO.2 jel on trichomonas" exact="vaginitis" post="in rats Chinese. Matern. Child Health Care China vol."/>
   <result pre="Ducke show strong antiviral activity against the sexually transmitted pathogen" exact="herpes simplex" post="virus type 2 J. Ethnopharmacol. 210 2018 192 197"/>
   <result pre="Stanberry L.R. Knipe D.M. Construction and characterization of a replication-defective" exact="herpes simplex" post="virus 2 ICP8 mutant strain and its use in"/>
   <result pre="D. Su W. Jiang C. Antiviral effects of ABMA against" exact="herpes simplex" post="virus type 2 in vitro and in vivo Viruses"/>
   <result pre="Oakes J.E. Taylor J.A. Effect of treatment with 5-ethyl-2’-deoxyuridine on" exact="herpes simplex" post="virus encephalitis in normal and immunosuppressed mice Antimicrob. Agents"/>
   <result pre="J.A. Effect of treatment with 5-ethyl-2’-deoxyuridine on herpes simplex virus" exact="encephalitis" post="in normal and immunosuppressed mice Antimicrob. Agents Chemother. 14"/>
   <result pre="or VP16 expressed from adenovirus vectors induces reactivation of latent" exact="herpes simplex" post="virus type 1 in primary cultures of latently infected"/>
   <result pre="Ping X.U. Yong-gui M.A. Li-jun X.U. Effect of jieze No.1(洁泽Ⅰ号)on" exact="cervicitis" post="caused by ureaplasma urealyticum and on ureaplasma urealyticum in"/>
   <result pre="A.M. Shukla D. Host enzymes heparanase and cathepsin L promote" exact="herpes simplex" post="virus 2 release from cells J. Virol. 92 2018"/>
   <result pre="González P.A. Experimental dissection of the lytic replication cycles of" exact="herpes simplex" post="viruses in vitro Front. Microbiol. 9 2018 2406 30386309"/>
   <result pre="Nishiyama Y. Synthesis, subcellular localization and VP16 interaction of the" exact="herpes simplex" post="virus type 2 UL46 gene product Arch. Virol. 145"/>
   <result pre="A. Bavand A. Mirzapour P. Ramezani A. No role of" exact="herpes simplex" post="virus type 2 (HSV-2) infection on HIV progression in"/>
   <result pre="K. Kawaguchi Y. Nishiyama Y. Formation of aggresome-like structures in" exact="herpes simplex" post="virus type 2-infected cells and a potential role in"/>
   <result pre="Binding of ICP4, TATA-binding protein, and RNA polymerase II to" exact="herpes simplex" post="virus type 1 immediate-early, early, and late promoters in"/>
   <result pre="149 179 27518199 Smith C.A. Schaffer P.A. Mutants defective in" exact="herpes simplex" post="virus type 2 ICP4: isolation and preliminary characterization J."/>
   <result pre="anthraquinone derivative extracted from the roots of Rheum tanguticum, against" exact="herpes simplex" post="virus in vitro and in vivo J. Ethnopharmacol. 133"/>
   <result pre="Muz M. Antiviral activity of hatay propolis against replication of" exact="herpes simplex" post="virus type 1 and type 2 Med. Sci. Monit."/>
   <result pre="Han Z.Q. Xu Y.M. Recombinant cell lines expressing shRNA targeting" exact="herpes simplex" post="virus 2 VP16 inhibit virus replication Intervirology 55 2012"/>
   <result pre="the preventive effect of patrinia scabiosaefolia fisch on multipathogen induced" exact="pelvic inflammatory disease" post="in rats Evid. Based Complement. Alternat. Med. 2015 2015"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7126469/results/search/disease/results.xml">
   <result pre="a good thing because though fibrin generation is desirable during" exact="cellulitis" post="intravascular blood coagulation is not. For the cascade’s exponential"/>
   <result pre="annexin V may be effective there. Coronavirus SARS and severe" exact="influenza" post="infections are other lethal conditions to consider for annexin"/>
   <result pre="to consider for annexin V therapy. In them their lethal" exact="respiratory failure" post="may be the result of the inflammation and blood"/>
   <result pre="further macrophage and dendritic cell infection. In non-critical SARS and" exact="influenza" post="infections monitoring the levels of PS+ cells could be"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7126544/results/search/disease/results.xml">
   <result pre="Coronavirus are associated with about 15% of cases of the" exact="common cold," post="the SARS-CoV-2 may present with varying degrees of severity,"/>
   <result pre="Coronavirus are associated with about 15% of cases of the" exact="common cold," post="the SARS-CoV-2 is far more deadly, with a mortality"/>
   <result pre="[ 6]. Other significant causes of upper respiratory infections include" exact="influenza" post="virus, rhinovirus, parainfluenza virus, Group A Streptococci, EBV and"/>
   <result pre="respiratory syncytial virus (RSV). The three other strains of HCoVs," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and"/>
   <result pre="syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2), have a different pathogenicity and lead"/>
   <result pre="was isolated from a male patient who died from acute" exact="pneumonia" post="and renal failure in Saudi Arabia in 2012 ["/>
   <result pre="circulating in human populations causing only mild illnesses like the" exact="common cold" post="[ 3, 25]. However, SARS, MERS and SARS-CoV-2 present"/>
   <result pre="a spectrum of disease severity ranging from flu-like symptoms to" exact="acute respiratory distress syndrome" post="[ 25, 26]. Early on, these patients are usually"/>
   <result pre="an atypical and virulent form of a coronavirus. For comparison," exact="influenza" post="has an estimated mortality rate of 0.07%–0.2%. A high"/>
   <result pre="of SARS patients had acute renal impairment and 84.6% had" exact="proteinuria" post="[ 34]. Hematological abnormalities such as thrombocytopenia and lymphopenia"/>
   <result pre="and 84.6% had proteinuria [ 34]. Hematological abnormalities such as" exact="thrombocytopenia" post="and lymphopenia were frequently observed in SARS [ 35,"/>
   <result pre="in SARS [ 35, 36]. Complications encountered for SARS-CoV-2 include" exact="acute respiratory distress syndrome" post="(29%,12/41), anemia (15%, 6/41), acute cardiac injury (12%, 5/41)"/>
   <result pre="Complications encountered for SARS-CoV-2 include acute respiratory distress syndrome (29%,12/41)," exact="anemia" post="(15%, 6/41), acute cardiac injury (12%, 5/41) and secondary"/>
   <result pre="contained It has been 17 years since the outbreak of" exact="severe acute respiratory syndrome" post="(SARS) caused by the SARS coronavirus (SARS-CoV) [ 43]."/>
   <result pre="the SARS coronavirus (SARS-CoV) [ 43]. This highly contagious atypical" exact="pneumonia" post="first appeared in Guangdong Province, China, in November 2002."/>
   <result pre="5.1 The origin of SARS-CoV-2 A cluster of cases of" exact="viral pneumonia" post="of unknown etiology, now known as SARS-CoV-2 pneumonia, occurred"/>
   <result pre="The origin of SARS-CoV-2 A cluster of cases of viral" exact="pneumonia" post="of unknown etiology, now known as SARS-CoV-2 pneumonia, occurred"/>
   <result pre="epidemiological developments Currently, person to person transmission from patients with" exact="pneumonia" post="or even asymptomatic patients during the incubation period are"/>
   <result pre="22, 2020, a member of the national expert panel on" exact="pneumonia" post="reported that he was infected by SARS-CoV-2 during an"/>
   <result pre="infection caused by vertical transmission in women who develop COVID-19" exact="pneumonia" post="in late pregnancy [ 76]. No cases of newborns"/>
   <result pre="accounted for 0.9% and 1.2% respectively. Hypertension (12.8%), diabetes (5.3%)," exact="cardiovascular disease" post="(4.2%) were the most common underlying diseases. A total"/>
   <result pre="published guidelines for the diagnosis and clinical management of SARS-CoV-2" exact="pneumonia" post="[ 81, 82]. 6 Clinical presentation 6.1 Clinical manifestations"/>
   <result pre="no pneumonia. In severe cases, the infection can cause pneumonia," exact="shortness" post="of breath and breathing difficulties occurring more than one"/>
   <result pre="one week after infection. Critical patients may progress rapidly to" exact="acute respiratory distress syndrome" post="(ARDS), septic shock, metabolic acidosis, coagulation dysfunction, and even"/>
   <result pre="progress rapidly to acute respiratory distress syndrome (ARDS), septic shock," exact="metabolic acidosis," post="coagulation dysfunction, and even death. It is worth noting"/>
   <result pre="of symptoms to first hospital admission was 7.0 days, to" exact="shortness" post="of breath was 8.0 days, and to ARDS was"/>
   <result pre="patients died. Chen et al. reported 99 patients with SARS-CoV-2" exact="pneumonia" post="admitted to the Jinyintan Hospital in Wuhan [ 37]."/>
   <result pre="diseases. Patients had clinical manifestations of fever (83%), cough (82%)," exact="shortness" post="of breath (31%), muscle aches (11%), confusion (9%), headache"/>
   <result pre="(8%), sore throat (5%), rhinorrhea (4%), chest pain (2%), and" exact="diarrhea" post="(2%). Eighty-nine (90%) patients had more than one symptom."/>
   <result pre="most common symptoms including fever (87.9%) and cough (67.7%), whereas" exact="diarrhea" post="(3.7%) and vomiting (5.0%) were rare. They also pointed"/>
   <result pre="more common in severe cases. The most common complication was" exact="pneumonia" post="(79.1%), ARDS (3.4%) and shock (1.0%). Of the 1099"/>
   <result pre="of 41, 99 and 138 (total 278) cases of SARS-CoV" exact="pneumonia" post="admitted in the 3 regional hospitals closest to the"/>
   <result pre="were tested for nine respiratory pathogens and nucleic acids of" exact="influenza" post="viruses A and B, as well as bacteria and"/>
   <result pre="studies In Huang's study [ 26], all 41 patients had" exact="pneumonia" post="with abnormal findings on chest computed tomography (CT) and"/>
   <result pre="with or without a recorded temperature 2. Radiographic evidence of" exact="pneumonia" post="3. Low or normal leukocyte count or low lymphocyte"/>
   <result pre="and/or respiratory symptoms 2) with the above-mentioned imaging characteristics of" exact="pneumonia" post="3) the total number of leukocytes in the early"/>
   <result pre="needs to be distinguished from other known viral pneumonias including" exact="influenza" post="virus, parainfluenza virus, adenovirus, respiratory syncytial virus, rhinovirus, human"/>
   <result pre="organizing pneumonia. It should be noted that often patients with" exact="viral pneumonia" post="may test positive to multiple viruses, and the potential"/>
   <result pre="pneumonia. It should be noted that often patients with viral" exact="pneumonia" post="may test positive to multiple viruses, and the potential"/>
   <result pre="there were six CoVs that could infect humans and cause" exact="respiratory disease." post="HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 are sometimes attributed to"/>
   <result pre="tract infections HCoV-OC43 beta mild respiratory tract infections HCoV-HKU1 beta" exact="pneumonia" post="SARS-CoV beta severe acute respiratory syndrome, 11% mortality rate"/>
   <result pre="beta mild respiratory tract infections HCoV-HKU1 beta pneumonia SARS-CoV beta" exact="severe acute respiratory syndrome," post="11% mortality rate MERS-CoV beta severe acute respiratory syndrome,"/>
   <result pre="beta severe acute respiratory syndrome, 11% mortality rate MERS-CoV beta" exact="severe acute respiratory syndrome," post="34% mortality rate SARS-CoV-2 beta severe acute respiratory syndrome,"/>
   <result pre="beta severe acute respiratory syndrome, 34% mortality rate SARS-CoV-2 beta" exact="severe acute respiratory syndrome," post="2.6% mortality rate The term &quot;cell pyroptosis&quot; was first"/>
   <result pre="the spread of disease In response to the outbreak of" exact="pneumonia" post="caused by the SARS-CoV-2, China has activated Level I"/>
   <result pre="also formulated a community prevention and control program for SARS-CoV-2" exact="pneumonia" post="to strengthen community-level epidemic prevention measures to control the"/>
   <result pre="diagnosis, and early treatment. The treatment and management of SARS-CoV-2" exact="pneumonia" post="mainly include the following aspects ( Fig. 8 )"/>
   <result pre="symptoms and without underlying chronic diseases (such as lung or" exact="heart disease," post="renal failure, or immunodeficiency) may be cared for in"/>
   <result pre="for COVID-19. The previous experience of treating SARS-CoV, MERS-CoV or" exact="influenza" post="infections guides the selection of antiviral agents for COVID-19."/>
   <result pre="is lower than that of SARS. From 2017 to 2018," exact="influenza" post="ravaged the world, affecting up to 45 million people"/>
   <result pre="about 0.2%. Every year millions of people are infected by" exact="influenza" post="despite the existence of a yearly vaccine. According to"/>
   <result pre="of childhood deaths in the United States so far from" exact="influenza" post="during this flu season alone is 105. Compared with"/>
   <result pre="27012512 4 Zhu N. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019 2020 N Engl J Med 5"/>
   <result pre="A.M. Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N. Engl. J. Med. 367 19"/>
   <result pre="Weiss S.R. Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen" exact="severe acute respiratory syndrome" post="coronavirus Microbiol. Mol. Biol. Rev. 69 4 2005 635"/>
   <result pre="16195424 17 Lu H. Stratton C.W. Tang Y.W. Outbreak of" exact="pneumonia" post="of unknown etiology in wuhan China: the mystery and"/>
   <result pre="433 440 31967321 19 Chan J.F. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="Wunderink R.G. MERS, SARS and other coronaviruses as causes of" exact="pneumonia" post="Respirology 23 2 2018 130 137 29052924 26 Huang"/>
   <result pre="Virol. 2020 34 Chu K.H. Acute renal impairment in coronavirus-associated" exact="severe acute respiratory syndrome" post="Kidney Int. 67 2 2005 698 705 15673319 35"/>
   <result pre="Lancet 43 Peiris J.S. Coronavirus as a possible cause of" exact="severe acute respiratory syndrome" post="Lancet 361 9366 2003 1319 1325 12711465 44 NS"/>
   <result pre="12711465 44 NS Z. GQ Z. Our strategies for fighting" exact="severe acute respiratory syndrome" post="(SARS) Am. J. Respir. Crit. Care Med. 168 1"/>
   <result pre="46 Pang X. Evaluation of control measures implemented in the" exact="severe acute respiratory syndrome" post="outbreak in Beijing JAMA, 2003 290 24 2003 3215"/>
   <result pre="Role of China in the quest to define and control" exact="severe acute respiratory syndrome" post="Emerg. Infect. Dis. 9 9 2003 1037 1041 14519236"/>
   <result pre="Z. GQ Z. Pandemic planning in China: applying lessons from" exact="severe acute respiratory syndrome" post="Respirology 2008 S33 S35 18366527 54 AS A. Lessons"/>
   <result pre="2008 S33 S35 18366527 54 AS A. Lessons from the" exact="severe acute respiratory syndrome" post="outbreak in Hong Kong Emerg. Infect. Dis. 9 9"/>
   <result pre="58 Pang X. Evaluation of control measures implemented in the" exact="severe acute respiratory syndrome" post="outbreak in Beijing JAMA, 2003 290 24 2003 3215"/>
   <result pre="T. A novel coronavirus genome identified in a cluster of" exact="pneumonia" post="cases — wuhan, China 2019−2020 China CDC Weekly 2"/>
   <result pre="Q. Early transmission dynamics in wuhan, China, of novel coronavirus-infected" exact="pneumonia" post="N. Engl. J. Med. 2020 66 Paules C.I. Marston"/>
   <result pre="C.I. Marston H.D. Fauci A.S. Coronavirus infections-more than just the" exact="common cold" post="J. Am. Med. Assoc. 2020 67 Novel Coronavirus Pneumonia"/>
   <result pre="Lancet 77 Commission C.N.H. Notice on prevention and control of" exact="pneumonia" post="in children and pregnant women with new coronavirus infection"/>
   <result pre="M.e.g.o.T.h.a.t.T.M.C.o.H.U.o.S.a. A rapid guideline for the diagnosis and treatment of" exact="pneumonia" post="with new coronavirus infection (Third edition). . Herald of"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in wuhan, China J. Am. Med. Assoc. 2020 84"/>
   <result pre="32007145 93 Wu F. A new coronavirus associated with human" exact="respiratory disease" post="in China Nature 2020 Feb 3 [Epub ahead of"/>
   <result pre="Feb 3 [Epub ahead of print] 94 Zhou P. A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="B.J. Bartelink W. Rottier P.J.M. Cathepsin L functionally cleaves the" exact="severe acute respiratory syndrome" post="coronavirus class I fusion protein upstream of rather than"/>
   <result pre="5876 19321428 101 Glowacka I. Evidence that TMPRSS2 activates the" exact="severe acute respiratory syndrome" post="coronavirus spike protein for membrane fusion and reduces viral"/>
   <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan Emerg. Microb. Infect. 9 1 2020"/>
   <result pre="spike protein Cell. Mol. Immunol. 2020 106 DeDiego M.L. A" exact="severe acute respiratory syndrome" post="coronavirus that lacks the E gene is attenuated in"/>
   <result pre="5871 5876 19321428 113 Matsuyama S. Efficient activation of the" exact="severe acute respiratory syndrome" post="coronavirus spike protein by the transmembrane protease TMPRSS2 J."/>
   <result pre="12664 20926566 114 Bertram S. Cleavage and activation of the" exact="severe acute respiratory syndrome" post="coronavirus spike protein by human airway trypsin-like protease J."/>
   <result pre="134 Richardson P. Baricitinib as potential treatment for 2019-nCoV acute" exact="respiratory disease" post="Lancet 395 10223 2020 Feb 15 e30 e31 Epub"/>
   <result pre="synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in" exact="influenza" post="A viral-induced acute exacerbation of chronic obstructive pulmonary disease"/>
   <result pre="Capsule and oseltamivir in influenza A viral-induced acute exacerbation of" exact="chronic obstructive pulmonary disease" post="Biomed. Pharmacotherapy = Biomed. Pharmacotherapie 121 2020 109652-109652 139"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7127252/results/search/disease/results.xml">
   <result pre="10.1016/j.jfma.2020.02.007 : Article First case of Coronavirus Disease 2019 (COVID-19)" exact="pneumonia" post="in Taiwan Cheng Shao-Chung a 1 Chang Yuan-Chia b"/>
   <result pre="Herein, we reported the first confirmed case of novel coronavirus" exact="pneumonia" post="(NCP) imported from China in Taiwan. This case report"/>
   <result pre="Wuhan, specimens including oropharyngeal swab and sputum were collected for" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR) in accordance with"/>
   <result pre="for Disease Control (TCDC) guidance. Apart from a history of" exact="hypothyroidism" post="with regular medical follow-up, she had no other underlying"/>
   <result pre="295 U/L) ( Fig. 1). A rapid screening test for" exact="influenza" post="A and B showed negative. The chest X-ray revealed"/>
   <result pre="a subsequent chest computed tomography (CT) indicated the tenacious COVID-19" exact="pneumonia" post="and sequelae ( Fig. 3 ). Antitussive agent, O"/>
   <result pre="Discussion We reported the first confirmed case of novel coronavirus" exact="pneumonia" post="(NCP) in Taiwan. In accordance with the first report"/>
   <result pre="day 5 of illness, dyspnea with mild hypoxemia and radiographical" exact="pneumonia" post="on day 9 of illness. 3 Furthermore, reports from"/>
   <result pre="3 Furthermore, reports from China showed all patients had bilateral" exact="pneumonia" post="on high resolution CT with different severity even in"/>
   <result pre="since admission (illness day 10), even without antiviral treatment. Despite" exact="pneumonia" post="on chest X-rays worsen in the following seven days,"/>
   <result pre="pneumonia on chest X-rays worsen in the following seven days," exact="respiratory failure" post="did not occur eventually. Even though ceftriaxone was used,"/>
   <result pre="antibiotic treatment were not compatible with the clinical picture of" exact="bacterial pneumonia." post="The effective medical treatment against COVID-19 remains unknown. In"/>
   <result pre="elevated CRP, LDH, ALT and AST, were also observed in" exact="influenza" post="virus pandemic. 6 Lymphopenia has been considered as a"/>
   <result pre="been considered as a poor prognostic factor for severe hospitalized" exact="influenza" post="(H1N1) pandemic 2009, 7 as well as severe acute"/>
   <result pre="severe hospitalized influenza (H1N1) pandemic 2009, 7 as well as" exact="severe acute respiratory syndrome" post="(SARS). 8 These findings may explain common biomarker presentation"/>
   <result pre="(SARS). 8 These findings may explain common biomarker presentation in" exact="viral pneumonia," post="including COVID-19. The quarantine period for potentially COVID-19 infected"/>
   <result pre="and turned negative on day 17 of illness. Similar to" exact="viral pneumonia" post="due to other etiologies, ground-glass opacities (GGOs) are the"/>
   <result pre="turned negative on day 17 of illness. Similar to viral" exact="pneumonia" post="due to other etiologies, ground-glass opacities (GGOs) are the"/>
   <result pre="NCP without progression to ARDS. The worst status of her" exact="pneumonia" post="was on illness day 17 ( Fig. 2c) and"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China J Am Med Assoc 2020 E1"/>
   <result pre="Kim Y.K. Clinical, laboratory and radiologic characteristics of 2009 pandemic" exact="influenza" post="A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia"/>
   <result pre="and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary" exact="influenza" post="pneumonia versus concomitant/secondary bacterial pneumonia Influenza Other Respir Viruses"/>
   <result pre="radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza" exact="pneumonia" post="versus concomitant/secondary bacterial pneumonia Influenza Other Respir Viruses 5"/>
   <result pre="2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary" exact="bacterial pneumonia" post="Influenza Other Respir Viruses 5 2011 e535 e543 21682848"/>
   <result pre="pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial" exact="pneumonia" post="Influenza Other Respir Viruses 5 2011 e535 e543 21682848"/>
   <result pre="Cao B. Risk factors for nosocomial infection among hospitalised severe" exact="influenza" post="A(H1N1) pandemic 2009 patients Respir Med 134 2018 86"/>
   <result pre="L.M. Chau P. Wong I.O. Thach T.Q. The epidemiology of" exact="severe acute respiratory syndrome" post="in the 2003 Hong Kong epidemic: an analysis of"/>
   <result pre="F. Zhang Z. Shen J. Lu H. Emerging coronavirus 2019-nCoV" exact="pneumonia" post="Radiology 2020 200274 https://doi: 10.1148/radiol.2020200274 10 Chung M. Bernheim"/>
   <result pre="Qi X. CT Imaging of the 2019 novel coronavirus (2019-nCoV)" exact="pneumonia" post="Radiology 2020 200236 https://doi: 10.1148/radiol.2020200236 12 Liu P. Tan"/>
   <result pre="10.1148/radiol.2020200236 12 Liu P. Tan X.Z. 2019 novel coronavirus (2019-nCoV)" exact="pneumonia" post="Radiology 2020 200257 https://doi: 10.1148/radiol.2020200257 13 Fang Y. Zhang"/>
   <result pre="CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV)" exact="pneumonia" post="Radiology 2020 200280 https://doi: 10.1148/radiol.2020200280 14 Chang Y.C. Yu"/>
   <result pre="manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV)" exact="pneumonia" post="in Wuhan, China Radiology 2020 200269 https://doi: 10.1148/radiol.2020200269 Acknowledgments"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7127293/results/search/disease/results.xml">
   <result pre="Introduction Middle East respiratory syndrome (MERS) is an acute viral" exact="respiratory disease," post="caused by a novel virus called MERS coronavirus (MERS-CoV)"/>
   <result pre="we were to describe the serial radiographic characteristics of MERS-CoV" exact="pneumonia" post="by analyzing radiographic scores. Second, we tried to identify"/>
   <result pre="care unit of our institution. One patient with underlying stage-four" exact="lymphoma" post="was not included in this study, as this condition"/>
   <result pre="25 patients with abnormality on CXR were classified as MERS" exact="pneumonia" post="cases. Among the 25 patients with MERS pneumonia (15"/>
   <result pre="as MERS pneumonia cases. Among the 25 patients with MERS" exact="pneumonia" post="(15 men, 10 women; median age, 55 years), 18"/>
   <result pre="had an underlying disease, whereas seven patients (28%) with MERS" exact="pneumonia" post="had underlying co-morbidities, such as diabetes mellitus (n = 1), chronic"/>
   <result pre="patients (28%) with MERS pneumonia had underlying co-morbidities, such as" exact="diabetes mellitus" post="(n = 1), chronic renal disease (n = 1), myelodysplastic syndrome (n = 1), ovarian"/>
   <result pre="co-morbidities, such as diabetes mellitus (n = 1), chronic renal disease (n = 1)," exact="myelodysplastic syndrome" post="(n = 1), ovarian cancer (n = 1), and colonic fistula (n = 1), or"/>
   <result pre="diabetes mellitus (n = 1), chronic renal disease (n = 1), myelodysplastic syndrome (n = 1)," exact="ovarian cancer" post="(n = 1), and colonic fistula (n = 1), or were older than"/>
   <result pre="mellitus (n = 1), chronic renal disease (n = 1), myelodysplastic syndrome (n = 1), ovarian" exact="cancer" post="(n = 1), and colonic fistula (n = 1), or were older than"/>
   <result pre="dyspnea (n = 14), gastrointestinal (GI) symptoms such as nausea, vomiting, and" exact="diarrhea" post="(n = 3). The average time to symptom commencement from the"/>
   <result pre="of patients’ demographics and clinical characteristics among patients with MERS" exact="pneumonia" post="( p &amp;gt; 0.05), except for symptom presentation. Presence"/>
   <result pre="virus exposure to radiographic abnormality in 25 patients with MERS" exact="pneumonia" post="was 9.2 days (SD, ±2.8; range 5–15 days). In"/>
   <result pre="Further, pleural effusion was noted in 14 patients (56%) and" exact="pneumothorax" post="in one (4%). Comparison of radiographic findings between intubation"/>
   <result pre="findings between intubation and non-intubation groups in patients of MERS" exact="pneumonia" post="is summarized in Table 2 . Peak radiographic score"/>
   <result pre="of myalgia on initial presentation also showed significant correlation with" exact="respiratory failure" post="( P = 0.047 and = 0.047, respectively). Variables with p &amp;lt; "/>
   <result pre="10 on day 10 had the largest predictive power for" exact="respiratory failure," post="though not statistically significant (OR, 9.98; 95% CI, 0.875–196.35;"/>
   <result pre="time point and cutoff radiographic scores in patients with MERS" exact="pneumonia" post="which could be used as an indicator of respiratory"/>
   <result pre="et al., specified the presence of radiographic abnormality, indicating MERS" exact="pneumonia" post="in all three patients suspected of super spreading the"/>
   <result pre="infection [ 18]. Therefore, careful evaluation of CXR for detecting" exact="pneumonia" post="is critical in the control of MERS outbreak. Additionally,"/>
   <result pre="critical in the control of MERS outbreak. Additionally, prediction of" exact="respiratory failure" post="is also important to avoid urgent intubation or tracheostomy,"/>
   <result pre="follow-up CXR. Ajlan et al. [ 1] described the organizing" exact="pneumonia" post="pattern of MERS pneumonia, with predominance of airspace opacities"/>
   <result pre="Kim et al. recently reported a case of treated organizing" exact="pneumonia" post="in patient with MERS-CoV infection [ 20]. We can"/>
   <result pre="10 on day 10 had the largest predictive power for" exact="respiratory failure," post="it was not found to be statistically significant on"/>
   <result pre="R.A. Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N. Engl. J. Med. 367 19"/>
   <result pre="M. Association of radiologic findings with mortality in patients with" exact="avian influenza" post="H7N9 pneumonia PLoS One 9 4 2014e93885 13 Wong"/>
   <result pre="Association of radiologic findings with mortality in patients with avian" exact="influenza" post="H7N9 pneumonia PLoS One 9 4 2014e93885 13 Wong"/>
   <result pre="radiologic findings with mortality in patients with avian influenza H7N9" exact="pneumonia" post="PLoS One 9 4 2014e93885 13 Wong K.T. Antonio"/>
   <result pre="18 Ko J.H. Park G.E. Lee J.Y. Predictive factors for" exact="pneumonia" post="development and progression to respiratory failure in MERS-CoV infected"/>
   <result pre="Lee J.Y. Predictive factors for pneumonia development and progression to" exact="respiratory failure" post="in MERS-CoV infected patients J. Infect. 73 5 2016"/>
   <result pre="S. Lee K. Mok J.H. Successful treatment of suspected organizing" exact="pneumonia" post="in a patient with Middle East respiratory syndrome coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7127367/results/search/disease/results.xml">
   <result pre="less than a decade ago. FeMV has been associated with" exact="chronic kidney disease" post="of cats characterized by tubulointerstitial nephritis (TIN), although this"/>
   <result pre="associated with chronic kidney disease of cats characterized by tubulointerstitial" exact="nephritis" post="(TIN), although this aspect is still controversial and not"/>
   <result pre="role of FeMV in co-infection processes. Keywords Feline morbillivirus Tubulointerstitial" exact="nephritis" post="Genetic heterogeneity Epidemiology Virus histochemistry 1 Introduction Morbilliviruses belong"/>
   <result pre="F protein by tissue-specific proteases leading to cellular infection. Tubulo-interstitial" exact="nephritis" post="(TIN) is the most frequent histopathological finding in feline"/>
   <result pre="nephritis (TIN) is the most frequent histopathological finding in feline" exact="chronic kidney disease" post="(CKD) ( Jepson, 2016) and CKD is one of"/>
   <result pre="potential factors that may include toxic insults, hypoxia, chronic glomerulonephritis," exact="chronic pyelonephritis," post="upper urinary tract obstructions, viral infections, that lead to"/>
   <result pre="( Elliott and Barber, 1998). Idiopathic CKD such as pyelonephritis," exact="glomerulonephritis" post="and TIN due to unknown causes has been reported"/>
   <result pre="2009 ( Woo et al., 2012) and associated with tubulo-interstitial" exact="nephritis" post="(TIN). Following the first report in Hong Kong, FeMV"/>
   <result pre="Italy. A 15-years old domestic stray cat diagnosed with severe" exact="nephropathy" post="was hospitalized and found positive for FeMV RNA in"/>
   <result pre="resulted qPCR FeMV positive were further tested for feline infectious" exact="peritonitis" post="virus (FIPV, Dual IPC‑TaqVetTM, LSI, Lissieu, France), feline immunodeficiency"/>
   <result pre="(FIV, gag protein gene‑genesig® Advanced Kit, Rownhams, UK) and feline" exact="leukemia" post="virus (FeLV, U3 region LTR‑ genesig® Advanced Kit, Rownhams,"/>
   <result pre="(cerebrum and cerebellum), lung and kidney. Published protocols established for" exact="influenza" post="viruses ( Eriksson et al., 2018; van Riel et"/>
   <result pre="were observed in 4/7 cats ( Fig. 5 a). Oxalate" exact="nephropathy" post="with intratubular crystal deposits, microlithiasis, glomerular hyalinosis, glomerulo-nephrosis and"/>
   <result pre="Fig. 5 Histological and immunoistochemical investigations, cat, kidney. (a) Tubulointerstitial" exact="nephritis" post="with aggregates of lympho-plasmacytic cells around tubules of the"/>
   <result pre="(&quot;Batuffolo 9216/2016&quot;, see table S2 for further details). (b) Oxalate" exact="nephropathy" post="with intratubular crystalline deposits, (&quot;Monck9257/2016&quot;, see table S2 for"/>
   <result pre="and tubular lipidosis were detected; in one cat, nodular renal" exact="lymphoma" post="was also observed. 10/16 cats showed multifocal lympho-plasmacytic interstitial"/>
   <result pre="renal lymphoma was also observed. 10/16 cats showed multifocal lympho-plasmacytic" exact="interstitial nephritis." post="No lesions were observed in 12 cats, which tested"/>
   <result pre="S. Syme H.M. Brown C.A. Elliott J. Histomorphometry of feline" exact="chronic kidney disease" post="and correlation with markers of renal dysfunction Vet. Pathol."/>
   <result pre="Lundkvist A. Olsen B. Jourdain E. Ellstrom P. Characterization of" exact="avian influenza" post="virus attachment patterns to human and pig tissues Sci."/>
   <result pre="A. Olsen B. Jourdain E. Ellstrom P. Characterization of avian" exact="influenza" post="virus attachment patterns to human and pig tissues Sci."/>
   <result pre="23929233 Jepson R.E. Current understanding of the pathogenesis of progressive" exact="chronic kidney disease" post="in cats Vet. Clin. North Am. Small Anim. Pract."/>
   <result pre="Vaden S.L. Gruen M.E. Marks S.L. Prevalence and classification of" exact="chronic kidney disease" post="in cats randomly selected from four age groups and"/>
   <result pre="R.E. Erb H.N. Urinary tract infections in cats with hyperthyroidism," exact="diabetes mellitus" post="and chronic kidney disease J. Feline Med. Surg. 9"/>
   <result pre="Urinary tract infections in cats with hyperthyroidism, diabetes mellitus and" exact="chronic kidney disease" post="J. Feline Med. Surg. 9 2007 124 132 17088093"/>
   <result pre="paramyxoviruses in geriatric cats with and without evidence of azotemic" exact="chronic kidney disease" post="J. Vet. Intern. Med. 32 2018 1100 1108 29572949"/>
   <result pre="T.W. Discovery of new feline paramyxoviruses in domestic cats with" exact="chronic kidney disease" post="Virus Genes 51 2015 294 297 26265247 Sieg M."/>
   <result pre="Rimmelzwaan G.F. Fouchier R.A. Osterhaus A.D. Kuiken T. Human and" exact="avian influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="G.F. Fouchier R.A. Osterhaus A.D. Kuiken T. Human and avian" exact="influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="K.Y. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial" exact="nephritis" post="in domestic cats Proc Natl Acad Sci U S"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7127374/results/search/disease/results.xml">
   <result pre="Health (WFBH), an 850-bed tertiary care center with a large" exact="cancer" post="center and transplant services, our ASP has been active"/>
   <result pre="Encourage no testing or use the rapid flu test if" exact="influenza" post="is suspected GIP Community-acquired diarrhea of ≥7 d duration,"/>
   <result pre="the rapid flu test if influenza is suspected GIP Community-acquired" exact="diarrhea" post="of ≥7 d duration, travel-related diarrhea, severe presentation (bloody"/>
   <result pre="clinical presentation Abbreviations: CSF, cerebrospinal fluid; GIP, gastrointestinal panel; HSV," exact="herpes simplex" post="virus; MEP, meningitis/encephalitis panel; RVP, respiratory viral panel; WBC,"/>
   <result pre="test for respiratory infections. Testing for respiratory viruses other than" exact="influenza" post="is controversial because many argue that detecting viruses for"/>
   <result pre="implemented in 2009 around the time of the 2009 H1N1" exact="influenza" post="A pandemic. Initially it was mostly used for the"/>
   <result pre="increased, with the maximum volume observed during the months of" exact="influenza" post="activity. The high cost of the test and escalating"/>
   <result pre="days of antibiotic therapy. a Viruses detected by RVP include" exact="influenza" post="(38%), respiratory syncytial virus (20%), metapneumovirus (20%), rhino/enterovirus (18%),"/>
   <result pre="metapneumovirus (20%), rhino/enterovirus (18%), and coronavirus (4%). Gastrointestinal panels Infectious" exact="diarrhea" post="is caused by bacterial, viral, and parasitic pathogens and"/>
   <result pre="detect the most important bacterial, parasitic, and viral pathogens causing" exact="diarrhea" post="in the United States. Because the results are available"/>
   <result pre="panel varies considerably. For this reason, at WFBH when suspecting" exact="herpes simplex" post="virus (HSV) infection, particularly in neonates, we recommend ordering"/>
   <result pre="with less than 50 WBC/dL unless approved by a consulting" exact="infectious disease" post="or AS team member. All positive results for bacterial"/>
   <result pre="using PCR alone. The evaluation also identified common reasons for" exact="diarrhea" post="that led to unnecessary CDI testing, many of which"/>
   <result pre="cause of diarrhea. If symptoms and signs are consistent with" exact="colitis" post="and risk factors are present for C difficile (eg,"/>
   <result pre="susceptible to ceftriaxone and meropenem even if β-lactamase positive. H" exact="influenza" post="and Haemophilus parainfluenza from respiratory specimens H influenzae may"/>
   <result pre="data to develop institution-specific guidelines for the treatment of hospital-acquired" exact="pneumonia" post="Chest 130 3 2006 787 793 16963676 12 Theel"/>
   <result pre="Messacar K. Parker S.K. Todd J.K. Implementation of rapid molecular" exact="infectious disease" post="diagnostics: the role of diagnostic and antimicrobial stewardship J"/>
   <result pre="time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with" exact="pneumonia" post="and/or bacteremia Diagn Microbiol Infect Dis 84 1 2016"/>
   <result pre="3115 25762770 33 Farthing M. Salam M.A. Lindberg G. Acute" exact="diarrhea" post="in adults and children: a global perspective J Clin"/>
   <result pre="Gomez C.A. Pinsky B.A. Liu A. Delayed diagnosis of tuberculous" exact="meningitis" post="misdiagnosed as herpes simplex virus-1 encephalitis with the FilmArray"/>
   <result pre="B.A. Liu A. Delayed diagnosis of tuberculous meningitis misdiagnosed as" exact="herpes simplex" post="virus-1 encephalitis with the FilmArray syndromic polymerase chain reaction"/>
   <result pre="Delayed diagnosis of tuberculous meningitis misdiagnosed as herpes simplex virus-1" exact="encephalitis" post="with the FilmArray syndromic polymerase chain reaction panel Open"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7127679/results/search/disease/results.xml">
   <result pre="and other acute pulmonary disorders of acute lung injury and" exact="acute respiratory distress syndrome" post="regarding the involvement of complement. We conclude that, even"/>
   <result pre="1]. TRALI is characterized by the acute onset of noncardiogenic" exact="pulmonary edema" post="[ 1]. It is one of the leading causes"/>
   <result pre="RBCs that are formed following RBC transfusion or present in" exact="autoimmune hemolytic anemia" post="[ 22, 23]. In addition, mutations resulting in altered"/>
   <result pre="that are formed following RBC transfusion or present in autoimmune" exact="hemolytic anemia" post="[ 22, 23]. In addition, mutations resulting in altered"/>
   <result pre="are formed following RBC transfusion or present in autoimmune hemolytic" exact="anemia" post="[ 22, 23]. In addition, mutations resulting in altered"/>
   <result pre="the AP as seen in atypical hemolytic uremic syndrome and" exact="paroxysmal nocturnal hemoglobinuria" post="[ 24, 25]. In contrast to the CP and"/>
   <result pre="as seen in atypical hemolytic uremic syndrome and paroxysmal nocturnal" exact="hemoglobinuria" post="[ 24, 25]. In contrast to the CP and"/>
   <result pre="its inactive form, iC3b, releasing the C3f fragment. CR1 also" exact="aids" post="FI to cleave iC3b into C3dg. Other plasma proteases"/>
   <result pre="TRALI patient died 2 hours after initial clinical signs of" exact="pulmonary edema." post="Studies using animal models of TRALI have also assessed"/>
   <result pre="immune complex– mediated ROS production in a setting of autoimmune" exact="arthritis" post="[ 57]. Next to activation via immune complexes, ROS"/>
   <result pre="mediates PMN activation and ROS formation in anti-neutrophil cytoplasmic autoantibody–induced" exact="glomerulonephritis" post="[ 59]. Importantly, it has been shown that production"/>
   <result pre="51, 68]. For instance, using the K/BxN mouse serum transfer-induced" exact="arthritis" post="mouse model expressing human Fc γRIIa on PMNs but"/>
   <result pre="that cross talk between PMN-Fc γRIIa and PMN-C5aR promoted inflammatory" exact="arthritis" post="in mice [ 68]. Taken together, the complement system"/>
   <result pre="drawn with other forms of acute lung injury (ALI) and" exact="acute respiratory distress syndrome" post="(ARDS). Activation of the complement system plays an important"/>
   <result pre="role in ALI caused by highly pathogenic viruses such as" exact="influenza" post="virus A (H5N1 and H7N9) and severe acute respiratory"/>
   <result pre="viruses such as influenza virus A (H5N1 and H7N9) and" exact="severe acute respiratory syndrome" post="[ 69]. It has been shown that infection of"/>
   <result pre="of the human host with highly pathogenic viruses such as" exact="influenza" post="A results in complement activation and formation of C5a"/>
   <result pre="Semple JW Kapur R The pathogenic involvement of neutrophils in" exact="acute respiratory distress syndrome" post="and transfusion-related acute lung injury Transfus Med Hemother 45"/>
   <result pre="Immunol 2012 2012307093 23 Berentsen S Role of complement in" exact="autoimmune hemolytic anemia" post="Transfus Med Hemother 42 2015 303 310 26696798 24"/>
   <result pre="2012 2012307093 23 Berentsen S Role of complement in autoimmune" exact="hemolytic anemia" post="Transfus Med Hemother 42 2015 303 310 26696798 24"/>
   <result pre="2012307093 23 Berentsen S Role of complement in autoimmune hemolytic" exact="anemia" post="Transfus Med Hemother 42 2015 303 310 26696798 24"/>
   <result pre="25 DeZern AE Brodsky RA Paroxysmal nocturnal hemoglobinuria: a complement-mediated" exact="hemolytic anemia" post="Hematol Oncol Clin North Am 29 2015 479 494"/>
   <result pre="DeZern AE Brodsky RA Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic" exact="anemia" post="Hematol Oncol Clin North Am 29 2015 479 494"/>
   <result pre="Fc receptor-mediated neutrophil functions and the effector phase of autoimmune" exact="arthritis" post="J Exp Med 206 2009 577 593 19273622 58"/>
   <result pre="leukocyte recruitment in a murine model of monosodium urate crystal-induced" exact="peritonitis" post="Front Pharmacol 8 2017 10 28167912 59 Schreiber A"/>
   <result pre="FC Kettritz R C5a receptor mediates neutrophil activation and ANCA-induced" exact="glomerulonephritis" post="J Am Soc Nephrol 20 2009 289 298 19073822"/>
   <result pre="IgA Complexes in plasma and synovial fluid of patients with" exact="rheumatoid arthritis" post="induce neutrophil extracellular traps via FcalphaRI J Immunol 197"/>
   <result pre="Complexes in plasma and synovial fluid of patients with rheumatoid" exact="arthritis" post="induce neutrophil extracellular traps via FcalphaRI J Immunol 197"/>
   <result pre="human neutrophil Fcgamma receptor IIa by C5a receptor promotes inflammatory" exact="arthritis" post="in mice Arthritis Rheum 63 2011 467 478 21280001"/>
   <result pre="complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1" exact="influenza" post="Microbiol Immunol 55 2011 191 198 21244468 72 Garcia"/>
   <result pre="Tavares LP Rachid MA Alves-Filho JC Complement C5 activation during" exact="influenza" post="A infection in mice contributes to neutrophil recruitment and"/>
   <result pre="complement activation alleviates acute lung injury induced by highly pathogenic" exact="avian influenza" post="H5N1 virus infection Am J Respir Cell Mol Biol"/>
   <result pre="activation alleviates acute lung injury induced by highly pathogenic avian" exact="influenza" post="H5N1 virus infection Am J Respir Cell Mol Biol"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitis Am J Pathol 179 2011 199 210 21703402"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7127836/results/search/disease/results.xml">
   <result pre="which was significantly lower than the level in patients with" exact="acute myocardial infarction" post="(MI), 89.6 (4.3–214.6) pg/mL. The cut-off value was set"/>
   <result pre="impaired resolution leading to chronic inflammatory disorders, autoimmune diseases like" exact="rheumatoid arthritis," post="and Crohn’s disease, as well as it contributing to"/>
   <result pre="vaccination effects and induction of immunogenic cell death (ICD) in" exact="cancer" post="cells, sought to instigate a potent antitumor immune response."/>
   <result pre="to boost short- and long-term innate resistance against pathogens and" exact="cancer" post="cells. For a long time, adjuvants have been used"/>
   <result pre="76], a conceptual revolution in oncology has emerged in that" exact="cancer" post="is considered to be entities that can be detected"/>
   <result pre="NK cell counts after radiotherapy - Potential markers for predicting" exact="breast cancer" post="recurrence? Radiat Oncol. BioMed Central Ltd.; 2019; p 14."/>
   <result pre="cell counts after radiotherapy - Potential markers for predicting breast" exact="cancer" post="recurrence? Radiat Oncol. BioMed Central Ltd.; 2019; p 14."/>
   <result pre="specialized pro-resolving lipid mediators for the treatment of inflammation in" exact="cystic fibrosis" post="Front Pharmacol. 2019 10 252 10.3389/fphar.2019.00252 31001110 23. Kooij"/>
   <result pre="mediators are differentially altered in peripheral blood of patients with" exact="multiple sclerosis" post="and attenuate monocyte and blood-brain barrier dysfunction. Haematologica. 2019;haematol.2019.219519."/>
   <result pre="RNA sensing in mammalian cells: role in stress response and" exact="cancer" post="therapies Int Rev Cell Mol Biol. 2019 2019 31"/>
   <result pre="Liu D Chen WJ et al. Arf1-mediated lipid metabolism sustains" exact="cancer" post="cells and its ablation induces anti-tumor immune responses in"/>
   <result pre="Serum S100A4 levels as a novel biomarker for detection of" exact="acute myocardial infarction." post="Eur Rev Med Pharmacol Sci. 2015;19:2221–5. https://www.ncbi.nlm.nih.gov/pubmed/26166646 47. Meddeb"/>
   <result pre="L, et al. Plasma nuclear and mitochondrial DNA levels in" exact="acute myocardial infarction" post="patients. Coron Artery Dis. 2015;26:296–300. https://www.ncbi.nlm.nih.gov/pubmed/25714070 49. Dalli J,"/>
   <result pre="adjuvants parallelly enhance protective type-2 and type-1 immune responses to" exact="influenza" post="split vaccination. Front Immunol. 2018;9:2619. https://www.ncbi.nlm.nih.gov/pubmed/30515151 73. Land WG"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7128449/results/search/disease/results.xml">
   <result pre="active. In late December, 2019, a cluster of cases of" exact="viral pneumonia" post="was linked to a seafood market in Wuhan (Hubei,"/>
   <result pre="In late December, 2019, a cluster of cases of viral" exact="pneumonia" post="was linked to a seafood market in Wuhan (Hubei,"/>
   <result pre="was later determined to be caused by a novel coronavirus," exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV). 1 The"/>
   <result pre="two other coronaviruses responsible for large-scale outbreaks in the past:" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV; about 79% sequence identity) and Middle East"/>
   <result pre="(COVID-19) pneumonia, and reports on the radiological appearances of COVID-19" exact="pneumonia" post="are emerging. In The Lancet Infectious Diseases, Heshui Shi"/>
   <result pre="3 discuss the CT findings and temporal changes of COVID-19" exact="pneumonia" post="with reference to the time of onset of symptoms,"/>
   <result pre="findings. 8 Nevertheless, this small number of individuals with COVID-19" exact="pneumonia" post="poses a diagnostic dilemma given the varied manifestations. The"/>
   <result pre="in the province. As the predominant pattern seen in COVID-19" exact="pneumonia" post="is ground-glass opacification, detecting COVID-19 with use of chest"/>
   <result pre="literature is partly skewed by the geographical distribution of COVID-19" exact="pneumonia" post="and the preferential use of CT over chest radiograph"/>
   <result pre="There is more to be learnt about this novel contagious" exact="viral pneumonia;" post="more research is needed into the correlation of CT"/>
   <result pre="X Jiang N Radiological findings from 81 patients with COVID-19" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet Infect Dis"/>
   <result pre="5 Song F Shi N Shan F Emerging coronavirus 2019-nCoV" exact="pneumonia" post="Radiology 2020 published online Feb 6. 10.1148/radiol.2020200274 6 Ng"/>
   <result pre="Chan JF Yuan S Kok KH A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="on chest CT during recovery from 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="Radiology 2020 published online Feb 13. 10.1148/radiol.2020200370 10 Ooi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7128598/results/search/disease/results.xml">
   <result pre="as the COVID-19 resource centre remains active. Large outbreaks of" exact="severe acute respiratory syndrome," post="Middle East respiratory syndrome, pandemic influenza, Ebola virus, and"/>
   <result pre="as well as several millions from other diseases such as" exact="influenza" post="and tuberculosis). The conception for the fund was that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7128863/results/search/disease/results.xml">
   <result pre="Other combined vaccines 3 Other (vaccines against dengue, travellers' diarrhea," exact="malaria" post="and filovirus) 6    III Pre-travel Assessment/Consultation 431 (31.32%)"/>
   <result pre="Chemoprophylaxis 62 Malaria 47 Travellers' Diarrhea 11 Other (HIV PrEP," exact="rabies" post="post-exposure prophylaxis, SARS) 4 Personal Protective Measures 6 Self-treatment"/>
   <result pre="topics most frequently reflected in the analysed articles related to" exact="malaria" post="(83 articles), chemoprophylaxis (62 articles), mass gatherings (57 articles),"/>
   <result pre="(32 articles). The most frequently recorded travel vaccine topics discussed" exact="rabies" post="(13 articles) and yellow fever (10 articles) vaccines. This"/>
   <result pre="frequently recorded travel vaccine topics discussed rabies (13 articles) and" exact="yellow fever" post="(10 articles) vaccines. This bibliometric analysis of travel medicine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7128973/results/search/disease/results.xml">
   <result pre="31, 2019, Chinese authorities in Wuhan announced a cluster of" exact="pneumonia" post="cases of unknown etiology, most of which included patients"/>
   <result pre="the new coronavirus, COVID-19, and the new virus was named" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). Genomic analyses indicated that SARS-CoV-2 shares"/>
   <result pre="RA Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N Engl J Med 367 19"/>
   <result pre="Synthesis and characterization of a native, oligomeric form of recombinant" exact="severe acute respiratory syndrome" post="coronavirus spike glycoprotein J Virol 78 19 2004 10328"/>
   <result pre="e30839 22363498 21 Song L Xiong D Kang X An" exact="avian influenza" post="A (H7N9) virus vaccine candidate based on the fusion"/>
   <result pre="22363498 21 Song L Xiong D Kang X An avian" exact="influenza" post="A (H7N9) virus vaccine candidate based on the fusion"/>
   <result pre="Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated" exact="influenza" post="vaccine Vaccine 28 24 2010 4103 4112 19654062 24"/>
   <result pre="DG Del Pilar Martin M Dissolving polymer microneedle patches for" exact="influenza" post="vaccination Nat Med 16 8 2010 915 920 20639891"/>
   <result pre="MR Kang S-M Dose sparing enabled by skin immunization with" exact="influenza" post="virus-like particle vaccine using microneedles J Controll Rel 147"/>
   <result pre="AS Prausnitz MR Development of a thermostable microneedle patch for" exact="influenza" post="vaccination J Pharmaceut Sci 140 2 2015 740 749"/>
   <result pre="34 Mistilis MJ Joyce JC Esser ES Long-term stability of" exact="influenza" post="vaccine in a dissolving microneedle patch Drug Delivery Transl"/>
   <result pre="Jayashi Flores CM Safety, tolerability, acceptability and immunogenicity of an" exact="influenza" post="vaccine delivered to human skin by a novel high-density"/>
   <result pre="M Mosley R The safety, immunogenicity, and acceptability of inactivated" exact="influenza" post="vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised,"/>
   <result pre="Prausnitz MR Microneedle patches: Usability and acceptability for self-vaccination against" exact="influenza" post="Vaccine 32 16 2014 1856 1862 24530146 38 Boopathy"/>
   <result pre="Lu X Protection of mice and poultry from lethal H5N1" exact="avian influenza" post="virus through adenovirus-based immunization J Virol 80 4 2006"/>
   <result pre="X Protection of mice and poultry from lethal H5N1 avian" exact="influenza" post="virus through adenovirus-based immunization J Virol 80 4 2006"/>
   <result pre="Steitz J Barlow PG Hossain J A candidate H1N1 pandemic" exact="influenza" post="vaccine elicits protective immunity in mice PloS One 5"/>
   <result pre="immune responses with neutralizing activity: Implication for developing novel mucosal" exact="influenza" post="vaccines Human Vaccines Immunotherapeut 11 12 2015 2831 2838"/>
   <result pre="Compans RW Yang C Prausnitz MR Enhanced stability of inactivated" exact="influenza" post="vaccine encapsulated in dissolving microneedle patches Pharmaceut Res 33"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7131249/results/search/disease/results.xml">
   <result pre="10.1016/j.msard.2020.102097 102097 : Article Immunosuppression during the COVID-19 pandemic in" exact="neuromyelitis optica" post="spectrum disorders patients: A new challenge Carnero Contentti Edgar"/>
   <result pre="Organization, 2020). COVID-19 morbidity and mortality has been associated with" exact="respiratory failure" post="due to acute respiratory distress syndrome (ARDS) ( World"/>
   <result pre="and mortality has been associated with respiratory failure due to" exact="acute respiratory distress syndrome" post="(ARDS) ( World Health Organization, 2020; Chen et al.,"/>
   <result pre="related to elderly age and comorbidities such as heart diseases," exact="diabetes mellitus," post="cancer, smoking habit and lung disease such as asthma"/>
   <result pre="such as heart diseases, diabetes mellitus, cancer, smoking habit and" exact="lung disease" post="such as asthma or chronic obstructive pulmonary disease, among"/>
   <result pre="diabetes mellitus, cancer, smoking habit and lung disease such as" exact="asthma" post="or chronic obstructive pulmonary disease, among others ( World"/>
   <result pre="cancer, smoking habit and lung disease such as asthma or" exact="chronic obstructive pulmonary disease," post="among others ( World Health Organization, 2020). In this"/>
   <result pre="It was recently reported that increased interleukin (IL)−6 levels and" exact="pneumonia" post="were risk factors for mortality in a Chinese cohort"/>
   <result pre="an astrocytopathy often characterized by devastating neurological sequelae, including persistent" exact="paraplegia" post="and blindness ( Palace et al., 2019). Does NMOSD"/>
   <result pre="standard of care in hospitalized adult patients with severe COVID-19" exact="pneumonia" post="(ClinicalTrials.gov, Identifier: NCT04317092), and 2) eculizumab in confirmed COVID-19"/>
   <result pre="NCT04288713). Are any prophylactic or therapeutic measures recommended? Immunizations, particularly" exact="influenza" post="vaccine, pneumococcal vaccine and varicella zoster virus vaccine included"/>
   <result pre="and safety of tocilizumab in the treatment of new coronavirus" exact="pneumonia" post="(COVID-19) Lancet Respir 2020 http://www.chictr.org.cn/showprojen.aspx?proj=49409 Collongues N. Ayme-Dietrich E."/>
   <result pre="N. Ayme-Dietrich E. Monassier L. de Seze J Pharmacotherapy for" exact="neuromyelitis optica" post="spectrum disorders: current management and future options Drugs 79"/>
   <result pre="Kim H.J. N-MOmentum study investigators. Inebilizumab for the treatment of" exact="neuromyelitis optica" post="spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3"/>
   <result pre="Lin D.Y. Zeng D. Outcome prediction models in AQP4-IGG positive" exact="neuromyelitis optica" post="spectrum disorders Brain 142 2019 1310 1323 30938427 Pittock"/>
   <result pre="A. Fujita K.P. Armstrong R. Wingerchuk D.M Eculizumab in aquaporin-4-positive" exact="neuromyelitis optica" post="spectrum disorder N. Engl. J. Med. 381 7 2019"/>
   <result pre="Oeda T. Okada K. Safety and efficacy of rituximab in" exact="neuromyelitis optica" post="spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled"/>
   <result pre="Shi L. Wang Y. Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome" post="Lancet Respir. Med. 2020 Feb 18pii: S2213-2600(20)30076-X[Epub ahead of"/>
   <result pre="Yamamura T. Kleiter I. Fujihara K. Trial of satralizumab in" exact="neuromyelitis optica" post="spectrum disorder N Engl J Med. 381 22 2019"/>
   <result pre="Zhang M. Qiu W. Tocilizumab versus azathioprine in highly relapsing" exact="neuromyelitis optica" post="spectrum disorders (TANGO): a head-to-head comparative study Multiple Scler."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7132475/results/search/disease/results.xml">
   <result pre="been a renewed focus on the disaster literature, following other" exact="infectious disease" post="outbreak situations, and the H1N1 outbreak in 2009 in"/>
   <result pre="Development of a triage protocol for critical care during an" exact="influenza" post="pandemic CMAJ 175 11 2006 1377 1381 17116904 Colville"/>
   <result pre="T. Fowler R. Preparing intensive care for the next pandemic" exact="influenza" post="Crit. Care 23 2019 337 31665057 Kentish-Barnes N. Chaize"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7132485/results/search/disease/results.xml">
   <result pre="long as the COVID-19 resource centre remains active. Canine infectious" exact="respiratory disease" post="complex (CIRDC) refers to a syndrome of diseases that"/>
   <result pre="viral pathogens can result in clinical signs of canine infectious" exact="respiratory disease" post="complex (CIRDC), with coinfection by multiple pathogens commonly identified."/>
   <result pre="• Antimicrobial treatment is warranted in dogs suspected to have" exact="bacterial pneumonia" post="and optimally should be directed based on bacterial culture"/>
   <result pre="Antimicrobial treatment is warranted in dogs suspected to have bacterial" exact="pneumonia" post="and optimally should be directed based on bacterial culture"/>
   <result pre="based on bacterial culture and susceptibility results. The development of" exact="pneumonia" post="should raise concern for underlying canine distemper virus infection"/>
   <result pre="prevention strategies are necessary, especially in group-housing situations. Canine infectious" exact="respiratory disease" post="complex (CIRDC), commonly referred to as &quot;kennel cough,&quot; refers"/>
   <result pre="refers to a syndrome characterized by acute onset of contagious" exact="respiratory disease" post="in dogs that can be caused by a wide"/>
   <result pre="outbreaks of novel pathogens, including canine herpesvirus-1 (CHV-1) and canine" exact="influenza" post="virus (CIV), have been reported, and advances in molecular"/>
   <result pre="1 Summary of the primary pathogens associated with canine infectious" exact="respiratory disease" post="complex Organism Incubation Period (d) Clinical Presentation Vaccination B"/>
   <result pre="Variable ranging from commensal to mild upper-respiratory signs to severe" exact="bronchopneumonia" post="Parenteral inactivated; attenuated live intranasal, mucosal vaccine Mycoplasma cynos"/>
   <result pre="completely described. Isolated as a single agent from dogs with" exact="pneumonia" post="None available Streptococcus equi subsp zooepidemicus Probably days Although"/>
   <result pre="days Although has been associated with severe, rapidly progressing hemorrhagic" exact="pneumonia" post="in overcrowded environments, can also cause mild upper-respiratory signs"/>
   <result pre="severe ocular changes; severe disease in neonates None available Canine" exact="influenza" post="virus 2–4 Variable, ranging from subclinical to severe clinical"/>
   <result pre="dogs that have coinfections with multiple CIRDC pathogens or secondary" exact="bacterial pneumonia." post="14, 15, 16, 17 Here, potential pathogens involved in"/>
   <result pre="diagnostics, and treatment options. Bacterial organisms associated with canine infectious" exact="respiratory disease" post="complex Bordetella bronchiseptica B bronchiseptica is a worldwide cause"/>
   <result pre="complex Bordetella bronchiseptica B bronchiseptica is a worldwide cause of" exact="respiratory disease" post="in dogs and also causes disease in other species,"/>
   <result pre="of the respiratory tract, and their role in canine infectious" exact="respiratory disease" post="is not clear. Mycoplasma spp are fastidious organisms that"/>
   <result pre="M cynos is the only Mycoplasma spp significantly associated with" exact="respiratory disease" post="in dogs, 35 most commonly pneumonia. 36 , 37"/>
   <result pre=", 35 and without 35 , 36 other identifiable infectious" exact="respiratory disease." post="Recently it was associated with lethal bronchopneumonia in a"/>
   <result pre="identifiable infectious respiratory disease. Recently it was associated with lethal" exact="bronchopneumonia" post="in a litter of golden retriever puppies 38 and"/>
   <result pre="C streptococcus, has emerged as a cause of acute, severe" exact="bronchopneumonia" post="in dogs. It is a commensal organism of the"/>
   <result pre="but also can cause opportunistic infections, such as abscesses, and" exact="endometritis" post="and can result in abortion. 41 Outbreaks of severe"/>
   <result pre="and can result in abortion. 41 Outbreaks of severe hemorrhagic" exact="pneumonia" post="have been described in several populations of group-housed dogs"/>
   <result pre="disease in dogs is similar to that of streptococcal exotoxin-induced" exact="toxic shock syndrome" post="in people, in which an overzealous host immune response"/>
   <result pre="as opposed to primary pathogens. Viruses associated with canine infectious" exact="respiratory disease" post="complex Canine Adenovirus 2 Canine adenovirus-2, genus Mastadenovirus of"/>
   <result pre="double-stranded DNA virus that is a worldwide cause of infectious" exact="respiratory disease" post="in dogs. 50 CAV-2 infects the nonciliated bronchiolar epithelial"/>
   <result pre="been isolated from lung and tracheal specimens from dogs with" exact="rhinitis" post="and pharyngitis, and a high seroprevalence has been noted"/>
   <result pre="CHV-1 can lead to rhinitis, tracheobronchitis, and ocular signs, including" exact="keratitis" post="and conjunctivitis. 63 CHV-1 infects the epithelial cells of"/>
   <result pre="a single host. CIV is caused by 2 subtypes of" exact="influenza" post="that have adapted to spread throughout the dog population."/>
   <result pre="Florida in 2004. The virus is closely related to equine" exact="influenza" post="virus subtype H3N8. 64 , 65 Serosurveys of greyhounds"/>
   <result pre="CIV was noted in Chicago, Illinois caused by an H3N2" exact="influenza" post="subtype that is genetically similar to a strain previously"/>
   <result pre="East Asia, suspected to be the result of a mutated" exact="avian influenza" post="virus that has now adapted to the dog. 66"/>
   <result pre="Asia, suspected to be the result of a mutated avian" exact="influenza" post="virus that has now adapted to the dog. 66"/>
   <result pre="infections. After experimental infection, H3N8 CIV induced necrotizing and hyperplastic" exact="tracheitis" post="and bronchitis in all dogs, and mild bronchiolitis and"/>
   <result pre="and hyperplastic tracheitis and bronchitis in all dogs, and mild" exact="bronchiolitis" post="and pneumonia in some dogs. 8 Many dogs also"/>
   <result pre="tracheitis and bronchitis in all dogs, and mild bronchiolitis and" exact="pneumonia" post="in some dogs. 8 Many dogs also developed secondary"/>
   <result pre="pneumonia in some dogs. 8 Many dogs also developed secondary" exact="bacterial pneumonia." post="8 Viral shedding decreases dramatically 1 week after infection;"/>
   <result pre="virus 5 . CPIV is a highly contagious cause of" exact="respiratory disease" post="in dogs worldwide. Before introduction of vaccines, CPIV could"/>
   <result pre="could be isolated from up to 50% of dogs with" exact="respiratory disease" post="in a kennel situation. 68 CPIV is spread via"/>
   <result pre="severe when coinfections occur. In experimental infections, clinical signs of" exact="respiratory disease" post="are absent or very mild. 69 Histologic examination shows"/>
   <result pre="disease are absent or very mild. 69 Histologic examination shows" exact="rhinitis" post="with mixed inflammatory cell infiltration, tracheobronchitis, and bronchiolitis with"/>
   <result pre="examination shows rhinitis with mixed inflammatory cell infiltration, tracheobronchitis, and" exact="bronchiolitis" post="with loss of ciliated respiratory cells, and epithelial hyperplasia."/>
   <result pre="was first described in a group of shelter dogs with" exact="respiratory disease" post="in 2003 in the United Kingdom and has now"/>
   <result pre="be found in dogs with and without clinical signs of" exact="respiratory disease." post="Infection with CRCoV is associated with mild clinical signs,"/>
   <result pre="sneezing. 70 Experimental CRCoV infection of dogs resulted in mild" exact="respiratory disease," post="with virus infecting most respiratory tissue and respiratory associated"/>
   <result pre="the stool or intestines of dogs that presented with primary" exact="respiratory disease" post="in the absence of GI signs and in 2"/>
   <result pre="isolated from a group of dogs in Italy with severe" exact="respiratory disease." post="This strain of pantropic CCoV has been associated with"/>
   <result pre="from 2 animal shelters in the United States that had" exact="respiratory disease" post="with no other causative agents discovered. 73 Other viruses"/>
   <result pre="73 Other viruses that have been identified in dogs with" exact="respiratory disease" post="include canine reovirus, canine bocavirus, and canine hepacivirus. 13"/>
   <result pre="13 The role of these viruses in the induction of" exact="respiratory disease" post="is unclear, and further investigation is warranted to elucidate"/>
   <result pre="CIRDC and no published recommendations for administration of commercially available" exact="influenza" post="antivirals used in human medicine; therefore, antiviral therapy is"/>
   <result pre="clinical signs persisting beyond 1 week or any signs of" exact="bacterial pneumonia," post="such as pyrexia, lethargy, decreased appetite, or an alveolar"/>
   <result pre="neck lead and removing barking triggers. Prevention of canine infectious" exact="respiratory disease" post="Vaccines are available for many common CIRDC pathogens (see"/>
   <result pre="population. If an outbreak does occur, facilities should have an" exact="infectious disease" post="protocol in place to limit exposure to other dogs"/>
   <result pre="targeted prevention and treatment protocols can be instituted. Summary Contagious" exact="respiratory disease" post="is a pervasive problem in group-housed dogs and pets"/>
   <result pre="H. European surveillance of emerging pathogens associated with canine infectious" exact="respiratory disease" post="Vet Microbiol 212 2017 31 38 29173585 3 Anderson"/>
   <result pre="H.L. Torres-Henderson C. Seroprevalence and risk factors for canine H3N8" exact="influenza" post="virus exposure in household dogs in Colorado J Vet"/>
   <result pre="62 2004 89 99 15156996 6 Ford R.B. Canine infectious" exact="respiratory disease" post="Greene C.E. Infectious diseases of the dog and cat"/>
   <result pre="16704791 8 Castleman W. Powe J. Crawford P. Canine H3N8" exact="influenza" post="virus infection in dogs and mice Vet Pathol 47"/>
   <result pre="2008 221 234 18635322 10 Dubovi E.J. Njaa B.L. Canine" exact="influenza" post="Vet Clin North Am Small Anim Pract 38 2008"/>
   <result pre="of a group 2 coronavirus in dogs with canine infectious" exact="respiratory disease" post="Virology 310 2003 216 223 12781709 13 Priestnall S.L."/>
   <result pre="J.A. Walker C.A. New and emerging pathogens in canine infectious" exact="respiratory disease" post="Vet Pathol 51 2014 492 504 24232191 14 Damián"/>
   <result pre="of distemper, adenovirus and parainfluenza viruses in domestic dogs with" exact="pneumonia" post="J Comp Pathol 133 2005 289 293 16202422 15"/>
   <result pre="Brooks H.W. Longitudinal study of viruses associated with canine infectious" exact="respiratory disease" post="J Clin Microbiol 42 2004 4524 4529 15472304 16"/>
   <result pre="Larson L.J. Henningson J. Sharp P. Efficacy of the canine" exact="influenza" post="virus H3N8 vaccine to decrease severity of clinical disease"/>
   <result pre="to decrease severity of clinical disease after cochallenge with canine" exact="influenza" post="virus and Streptococcus equi subsp. zooepidemicus Clin Vaccine Immunol"/>
   <result pre="surveillance of traditional and emerging pathogens associated with canine infectious" exact="respiratory disease" post="Vet Microbiol 192 2016 21 25 27527760 23 Schulz"/>
   <result pre="V.J. Owen W.M. Paterson C. Mycoplasmas associated with canine infectious" exact="respiratory disease" post="Microbiology 150 2004 3491 3497 15470126 36 Chandler J.C."/>
   <result pre="37 Rosendal S. Mycoplasmas as a possible cause of enzootic" exact="pneumonia" post="in dogs Acta Vet Scand 13 1972 137 5063299"/>
   <result pre="137 5063299 38 Zeugswetter F. Weissenbock H. Shibly S. Lethal" exact="bronchopneumonia" post="caused by Mycoplasma cynos in a litter of golden"/>
   <result pre="Molecular identification of Mycoplasma cynos from laboratory beagle dogs with" exact="respiratory disease" post="Lab Anim Res 28 2012 61 66 22474476 40"/>
   <result pre="61 66 22474476 40 Rosendal S. Vinther O. Experimental mycoplasmal" exact="pneumonia" post="in dogs: electron microscopy of infected tissue Acta Pathol"/>
   <result pre="The association of Streptococcus equi subsp. zooepidemicus with canine infectious" exact="respiratory disease" post="Vet Microbiol 95 2003 149 156 12860084 43 Kim"/>
   <result pre="M.K. Jee H. Shin S.W. Outbreak and control of haemorrhagic" exact="pneumonia" post="due to Streptococcus equi subspecies zooepidemicus in dogs Vet"/>
   <result pre="K.F. Bannasch M.J. A clonal outbreak of acute fatal hemorrhagic" exact="pneumonia" post="in intensively housed (shelter) dogs caused by Streptococcus equi"/>
   <result pre="20643889 46 Priestnall S.L. Erles K. Brooks H.W. Characterization of" exact="pneumonia" post="due to Streptococcus equi subsp. zooepidemicus in dogs Clin"/>
   <result pre="20713629 48 Radhakrishnan A. Drobatz K.J. Culp W.T. Community-acquired infectious" exact="pneumonia" post="in puppies: 65 cases (1993–2002) J Am Vet Med"/>
   <result pre="of a canine adenovirus (Toronto A26/61) with an outbreak of" exact="laryngotracheitis" post="(kennel cough). A preliminary report Can Vet J 3"/>
   <result pre="P.C. Kouo T.S. Influenza A virus (H3N8) in dogs with" exact="respiratory disease," post="Florida Emerg Infect Dis 14 2008 902 908 18507900"/>
   <result pre="P. Perry I.A. Jang Y. Evolution of canine and equine" exact="influenza" post="(H3N8) viruses co-circulating between 2005 and 2008 Virology 408"/>
   <result pre="66 Voorhees I.E.H. Glaser A.L. Toohey-Kurth K. Spread of canine" exact="influenza" post="A(H3N2) virus, United States Emerg Infect Dis 23 2017"/>
   <result pre="K.P. Prolonged intermittent virus shedding during an outbreak of canine" exact="influenza" post="A H3N2 virus infection in dogs in three Chicago"/>
   <result pre="Canine respiratory coronavirus: an emerging pathogen in the canine infectious" exact="respiratory disease" post="complex Vet Clin North Am Small Anim Pract 38"/>
   <result pre="R.W. Zylich N.C. Laverack M.A. Pneumovirus in dogs with acute" exact="respiratory disease" post="Emerg Infect Dis 16 2010 993 995 20507755 74"/>
   <result pre="Jeoung H.-Y. Song D.-S. Jeong W. Simultaneous detection of canine" exact="respiratory disease" post="associated viruses by a multiplex reverse transcription-polymerase chain reaction"/>
   <result pre="S. Chaisingh A. Single step multiplex real-time RT-PCR for H5N1" exact="influenza" post="A virus detection J Virol Methods 131 2006 143"/>
   <result pre="82 Rodriguez L. Nogales A. Murcia P.R. A bivalent live-attenuated" exact="influenza" post="vaccine for the control and prevention of H3N8 and"/>
   <result pre="for the control and prevention of H3N8 and H3N2 canine" exact="influenza" post="viruses Vaccine 35 2017 4374 4381 28709557 83 Rodriguez"/>
   <result pre="28709557 83 Rodriguez L. Nogales A. Reilly E.C. A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virus Virology 504 2017"/>
   <result pre="A. Reilly E.C. A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virus Virology 504 2017 96 106 28167384 Disclosure Dr"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7136941/results/search/disease/results.xml">
   <result pre="that you will engage in a conversation about the recent" exact="infectious disease" post="that has traveled globally. The Coronavirus is well known"/>
   <result pre="infected. Of course this is not the first major global" exact="infectious disease" post="of concern, but the scope of the infection rates"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7138188/results/search/disease/results.xml">
   <result pre="has been investigated in patients with primary central nervous system" exact="lymphoma" post="(PCNSL) and non-Hodgkin lymphoma (NHL) with CNS involvement and"/>
   <result pre="patients with primary central nervous system lymphoma (PCNSL) and non-Hodgkin" exact="lymphoma" post="(NHL) with CNS involvement and has shown promising results."/>
   <result pre="(thiotepa, busulfan, cyclophosphamide) conditioning for PCNSL (27 patients), secondary CNS" exact="lymphoma" post="(SCNSL) (8 patients), or relapsed disease with CNS involvement"/>
   <result pre="CI, 58.6%-98.6%), respectively. The most common side effects were febrile" exact="neutropenia" post="(89.6%; of which 66.7% had an infectious etiology identified),"/>
   <result pre="of which 66.7% had an infectious etiology identified), nausea/vomiting (85.4%)," exact="diarrhea" post="(93.8%), mucositis (89.6%), and electrolyte abnormalities (89.6%). Four patients"/>
   <result pre="analyzed the data from 48 patients with central nervous system" exact="lymphoma" post="who had received high-dose chemotherapy and autologous stem cell"/>
   <result pre="primary or secondary central nervous system lymphoma. Keywords ASCT Non-Hodgkin" exact="lymphoma" post="PCNSL Relapse SCNL Introduction Both primary central nervous system"/>
   <result pre="PCNSL Relapse SCNL Introduction Both primary central nervous system (CNS)" exact="lymphoma" post="(PCNSL) and non-Hodgkin lymphoma (NHL) with CNS involvement have"/>
   <result pre="Both primary central nervous system (CNS) lymphoma (PCNSL) and non-Hodgkin" exact="lymphoma" post="(NHL) with CNS involvement have historically carried poor prognoses."/>
   <result pre="institution retrospective analysis of consecutive patients with PCNSL, secondary CNS" exact="lymphoma" post="(SCNSL), or relapsed CNS lymphoma who had undergone consolidative"/>
   <result pre="patients with PCNSL, secondary CNS lymphoma (SCNSL), or relapsed CNS" exact="lymphoma" post="who had undergone consolidative ASCT with TBC conditioning based"/>
   <result pre="groups of patients were included: those with PCNSL, defined as" exact="lymphoma" post="confined to the CNS, including intraocular lymphoma; those with"/>
   <result pre="the CNS, including intraocular lymphoma; those with SCNSL, defined as" exact="lymphoma" post="with systemic disease and CNS involvement; and those with"/>
   <result pre="and CNS relapse were grouped together as patients with systemic" exact="lymphoma" post="with CNS involvement, whether found at the initial diagnosis"/>
   <result pre="have infection. Bacterial infection was present in 58.3% and included" exact="pneumonia" post="(18.8%), colitis (16.7%; 10.4% with Clostridium difficile), bacteremia (10.4%;"/>
   <result pre="Bacterial infection was present in 58.3% and included pneumonia (18.8%)," exact="colitis" post="(16.7%; 10.4% with Clostridium difficile), bacteremia (10.4%; with organisms"/>
   <result pre="organisms that included Escherichia coli, Staphylococcus epidermidis, and coagulase-negative staphylococcus)," exact="urinary tract infection" post="(6.3%; with organisms that included coagulase-negative staphylococcus and E."/>
   <result pre="with organisms that included coagulase-negative staphylococcus and E. coli), and" exact="sinusitis" post="(2.1%). Viral infection was present in 45.8% of patients,"/>
   <result pre="infection was present in 45.8% of patients, including 33.3% with" exact="herpes simplex" post="virus mucositis, 2.1% with herpes simplex virus vaginitis, 2.1%"/>
   <result pre="patients, including 33.3% with herpes simplex virus mucositis, 2.1% with" exact="herpes simplex" post="virus vaginitis, 2.1% with coronavirus, 2.1% with rhinovirus, 2.1%"/>
   <result pre="parainfluenza, 2.1% with human herpesvirus 6 bacteremia, and 2.1% with" exact="viral pneumonia." post="Fungal infection was present in 8.3% of patients, including"/>
   <result pre="present in 8.3% of patients, including 6.3% with Candida glabrata" exact="urinary tract infection" post="and 2.1% with Candida dubliniensis bacteremia. Almost all patients"/>
   <result pre="bacteremia. Almost all patients developed nausea and vomiting (85.4%) and" exact="diarrhea" post="(93.8%). Mucositis was present in 89.6% of patients; 35.4%"/>
   <result pre="patients, with 4.2% developing seizure. Four patients (8.3%) developed hemorrhagic" exact="cystitis" post="as a result of cyclophosphamide. Renal injury occurred in"/>
   <result pre="Cardiac toxicity developed in 16.7% of patients, including 2.1% with" exact="cardiomyopathy" post="presumed secondary to cyclophosphamide and 14.6% with arrhythmia that"/>
   <result pre="cyclophosphamide and 14.6% with arrhythmia that included supraventricular tachycardia and" exact="atrial fibrillation" post="with a rapid ventricular response. Liver function abnormalities occurred"/>
   <result pre="Median 15.0 15.0 14.0 IQR 12.5-19.5 14.0-21.0 11.0-16.0 Toxicity Febrile" exact="neutropenia" post="43 (89.6) 25 (52.1) 18 (37.5) Infection 32 (66.7)"/>
   <result pre="3 (6.3) Seizure 2 (4.2) 1 (2.1) 1 (2.1) Hemorrhagic" exact="cystitis" post="4 (8.3) 2 (4.2) 2 (4.2) Renal injury 8"/>
   <result pre="result in poorer outcomes than those for patients with CNS" exact="lymphoma" post="in remission. 38 , 41 All the patients with"/>
   <result pre="instead contribute to increased toxicity. Four patients (8.3%) developed hemorrhagic" exact="cystitis" post="in our study. One study by Montemurro et al,"/>
   <result pre="= .008). • The most common side effects were febrile" exact="neutropenia" post="and infection, nausea/vomiting, diarrhea, mucositis, and electrolyte abnormalities, with"/>
   <result pre="Reni M. Gatta G. Ferreri A.J.M. Primary central nervous system" exact="lymphoma" post="Crit Rev Oncol Hematol 113 2017 97 110 28427529"/>
   <result pre="methotrexate with or without whole brain radiotherapy for primary CNS" exact="lymphoma" post="(G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial Lancet Oncol"/>
   <result pre="Randomized phase III study of whole-brain radiotherapy for primary CNS" exact="lymphoma" post="Neurology 84 2015 1242 1248 25716362 5 Abrey L.E."/>
   <result pre="autologous stem cell transplantation as first-line therapy for primary CNS" exact="lymphoma" post="in patients younger than 60 years: a multicenter phase"/>
   <result pre="stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary" exact="lymphoma" post="of the central nervous system Haematologica 93 2008 147"/>
   <result pre="rescue in 22 patients with refractory or recurrent primary CNS" exact="lymphoma" post="or intraocular lymphoma J Clin Oncol 19 2001 742"/>
   <result pre="patients with refractory or recurrent primary CNS lymphoma or intraocular" exact="lymphoma" post="J Clin Oncol 19 2001 742 749 11157026 10"/>
   <result pre="Damaj G. First-line autologous stem cell transplantation in primary CNS" exact="lymphoma" post="Eur J Haematol 75 2005 288 292 16146534 11"/>
   <result pre="Montemurro M. Kiefer T. Schuler F. Primary central nervous system" exact="lymphoma" post="treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation"/>
   <result pre="and ASCT without whole-brain radiotherapy for poor prognosis primary CNS" exact="lymphoma" post="Bone Marrow Transplant 31 2003 679 685 12692608 14"/>
   <result pre="TBC and autologous stem-cell transplant for newly diagnosed primary CNS" exact="lymphoma" post="Blood 125 2015 1403 1410 25568347 15 Chen Y.-B."/>
   <result pre="transplantation in patients with central nervous system involvement by non-Hodgkin" exact="lymphoma" post="Cancer 121 2015 226 233 25204639 16 Houillier C."/>
   <result pre="cell rescue (IC + HCR) for primary central nervous system" exact="lymphoma" post="(PCNSL) in young patients: an Intergroup Anocef-Goelams randomized phase"/>
   <result pre="stem cell transplantation for patients with primary central nervous system" exact="lymphoma" post="in first complete remission Cancer 123 2017 3073 28369839"/>
   <result pre="comprehensive assessment of toxicities in patients with central nervous system" exact="lymphoma" post="undergoing autologous stem cell transplantation using thiotepa, busulfan, and"/>
   <result pre="cell rescue in relapsed or refractory primary central nervous system" exact="lymphoma" post="and intraocular lymphoma: a retrospective study of 79 cases"/>
   <result pre="transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS" exact="lymphoma" post="J Clin Oncol 24 2006 3865 3870 16864853 22"/>
   <result pre="Atta J. Prognosis of patients with primary central nervous system" exact="lymphoma" post="after high-dose chemotherapy followed by autologous stem cell transplantation"/>
   <result pre="of autologous stem cell transplantation in primary central nervous system" exact="lymphoma" post="Blood 127 2016 1642 1649 26834241 26 Illerhaus G."/>
   <result pre="cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin" exact="lymphoma" post="Biol Blood Marrow Transplant 18 2012 76 83 21749848"/>
   <result pre="in recurrent or refractory primary or secondary central nervous system" exact="lymphoma" post="using thiotepa, busulfan and cyclophosphamide Leuk Lymphoma 56 2015"/>
   <result pre="K. Rubenstein J.L. New approaches in primary central nervous system" exact="lymphoma" post="Chin Clin Oncol 4 2015 11 25841718 32 Wiebe"/>
   <result pre="Acaba L. Treatment of patients with relapsed and resistant non-Hodgkin’s" exact="lymphoma" post="using total body irradiation, etoposide, and cyclophosphamide and autologous"/>
   <result pre="autologous stem cell transplantation as upfront consolidation for systemic non-Hodgkin" exact="lymphoma" post="with synchronous central nervous system involvement Clin Lymph Myeloma"/>
   <result pre="Clinical features, treatment, and survival of secondary central nervous system" exact="lymphoma" post="Blood 124 2014 5389 38 Maziarz R.T. Wang Z."/>
   <result pre="Wang Z. Zhang M.-J. Autologous haematopoietic cell transplantation for non-Hodgkin" exact="lymphoma" post="with secondary CNS involvement Br J Haematol 162 2013"/>
   <result pre="transplantation for patients with central nervous system involvement by non-Hodgkin’s" exact="lymphoma" post="Biol Blood Marrow Transplant 6 2000 352 358 10905773"/>
   <result pre="Goldstone A.H. Autologous bone marrow transplantation for patients with non-Hodgkin’s" exact="lymphoma" post="and CNS involvement: those transplanted with active CNS disease"/>
   <result pre="and outcome of elderly patients with primary central nervous system" exact="lymphoma" post="(PCNSL)—a systematic review and individual patient data meta-analysis Ann"/>
   <result pre="L.S. Panageas K.S. Delayed neurotoxicity in primary central nervous system" exact="lymphoma" post="Arch Neurol 62 2005 1595 1600 16216945 47 Ferreri"/>
   <result pre="high-dose methotrexate-based chemoimmunotherapy in patients with newly diagnosed primary CNS" exact="lymphoma" post="(PCNSL): results of the second randomization of the IELSG32"/>
   <result pre="Dureau S. Radiotherapy or autologous stem-cell transplantation for primary CNS" exact="lymphoma" post="in patients 60 years of age and younger: results"/>
   <result pre="Introduction of novel agents in the treatment of primary CNS" exact="lymphoma" post="Neuro Oncol 21 2019 306 313 30423172 51 Mendez"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7138407/results/search/disease/results.xml">
   <result pre="care system. Extreme measures, including continued social distancing and coordinated" exact="suppression" post="efforts, may be required to reduce catastrophic mortality ("/>
   <result pre="&quot;directly observed therapy&quot; by using approaches first developed for treating" exact="tuberculosis" post="that provide a video record of medication ingestion at"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7140248/results/search/disease/results.xml">
   <result pre="signifiquen unaamenaza para él. Por su frecuencia y gravedad la" exact="malaria" post="debe ser descartada, sin olvidar las otras causashabituales de"/>
   <result pre="is the second reason for consultation 2 after diarrhoea. Globally," exact="malaria" post="was the most frequent cause of fever (29%), followed"/>
   <result pre="was the most frequent cause of fever (29%), followed by" exact="dengue fever" post="(15%), with the incidence varying according to the region"/>
   <result pre="causes of fever to be highlighted in this study are" exact="typhoid fever," post="Chikungunya, rickettsiosis, viral hepatitis and HIV primary infection, with"/>
   <result pre="be highlighted in this study are typhoid fever, Chikungunya, rickettsiosis," exact="viral hepatitis" post="and HIV primary infection, with no significant difference to"/>
   <result pre="highlighted in this study are typhoid fever, Chikungunya, rickettsiosis, viral" exact="hepatitis" post="and HIV primary infection, with no significant difference to"/>
   <result pre="or ruling out diseases with high morbidity and mortality (malaria," exact="typhoid fever," post="meningitis) and those that pose a public health danger"/>
   <result pre="contact with land (walking barefoot) Ancylostomiasis, strongyloidiasis, cutaneous larva migrans," exact="tungiasis" post="Contact with animals Rabies, tularemia, Q-fever, anthrax, viral haemorrhagic"/>
   <result pre="with animals Rabies, tularemia, Q-fever, anthrax, viral haemorrhagic fevers, plague," exact="brucellosis" post="Dairy consumption Brucellosis, tuberculosis, shigellosis Untreated water consumption Amebiasis,"/>
   <result pre="anthrax, viral haemorrhagic fevers, plague, brucellosis Dairy consumption Brucellosis, tuberculosis," exact="shigellosis" post="Untreated water consumption Amebiasis, ulcer, hepatitis A and E,"/>
   <result pre="Dairy consumption Brucellosis, tuberculosis, shigellosis Untreated water consumption Amebiasis, ulcer," exact="hepatitis" post="A and E, typhoid fever, shigellosis, cryptosporidiasis, cyclosporiasis, giardiasis"/>
   <result pre="shigellosis Untreated water consumption Amebiasis, ulcer, hepatitis A and E," exact="typhoid fever," post="shigellosis, cryptosporidiasis, cyclosporiasis, giardiasis Consumption of raw or undercooked"/>
   <result pre="ulcer, hepatitis A and E, typhoid fever, shigellosis, cryptosporidiasis, cyclosporiasis," exact="giardiasis" post="Consumption of raw or undercooked foods Hepatitis A, bacterial"/>
   <result pre="trichinosis, amebiasis, toxoplasmosis, cestodiasis, hepatic dystomatosis High-risk sexual contact HIV," exact="hepatitis" post="A, B and C, herpes, gonorrhoea, syphilis, Epstein-Barr virus,"/>
   <result pre="and C, herpes, gonorrhoea, syphilis, Epstein-Barr virus, cytomegalovirus Caves Histoplasmosis," exact="rabies" post="Contact with ill-patients Tuberculosis, meningitis, influenza, MERS-CoV, HF (Ebola,"/>
   <result pre="HF (Ebola, Crimean-Congo, Lassa) Exposure to arthropods Mosquitoes Malaria, dengue," exact="yellow fever," post="other arboviriasis, filariasis Ticks Rickettsiosis, borreliosis, Q-fever, tularemia, encephalitis,"/>
   <result pre="Exposure to arthropods Mosquitoes Malaria, dengue, yellow fever, other arboviriasis," exact="filariasis" post="Ticks Rickettsiosis, borreliosis, Q-fever, tularemia, encephalitis, Crimean-Congo haemorrhagic fever"/>
   <result pre="tularemia, encephalitis, Crimean-Congo haemorrhagic fever Flies African trypanosomiasis, leishmaniasis, onchocerciasis," exact="bartonellosis" post="Fleas Murine typhus, plague Lice Exanthematic typhus, relapsing fever"/>
   <result pre="fever Flies African trypanosomiasis, leishmaniasis, onchocerciasis, bartonellosis Fleas Murine typhus," exact="plague" post="Lice Exanthematic typhus, relapsing fever Mites Shrub typhus Table"/>
   <result pre="leishmaniasis, onchocerciasis, bartonellosis Fleas Murine typhus, plague Lice Exanthematic typhus," exact="relapsing fever" post="Mites Shrub typhus Table 2 Incubation periods. [alt-text] Table"/>
   <result pre="Murine typhus, plague Lice Exanthematic typhus, relapsing fever Mites Shrub" exact="typhus" post="Table 2 Incubation periods. [alt-text] Table 2 Disease Incubation"/>
   <result pre="Peninsula Yellow fever 3–8 days Africa, South America West Nile" exact="encephalitis" post="3–6 days Africa, Asia and Europe Japanese encephalitis 3–14"/>
   <result pre="West Nile encephalitis 3–6 days Africa, Asia and Europe Japanese" exact="encephalitis" post="3–14 days Southeast Asia from Japan to India Central"/>
   <result pre="3–14 days Southeast Asia from Japan to India Central European" exact="encephalitis" post="2–4 weeks Central Europe, the Alps, Balkan countries and"/>
   <result pre="and all of Russia Typhoid fever 6–30 days Cosmopolitan Epidemic" exact="typhus" post="7–14 Cosmopolitan, epidemics Leptospirosis 2–39 Cosmopolitan (Asia and South"/>
   <result pre="or the region where the traveller has been, was a" exact="malaria" post="area or if there is an outbreak of any"/>
   <result pre="in that country. The CDC has updated on-line information regarding" exact="malaria" post="( https://www.cdc.gov/malaria/travelers/country_table/e.html), and the International Society for Infectious Diseases"/>
   <result pre="and aetiological possibility. [alt-text] Table 3 Neurological disorder Meningitis, malaria," exact="typhoid fever," post="leptospirosis, rickettsia, viral encephalitis (Japanese, tick-borne, West Nile) Jaundice"/>
   <result pre="3 Neurological disorder Meningitis, malaria, typhoid fever, leptospirosis, rickettsia, viral" exact="encephalitis" post="(Japanese, tick-borne, West Nile) Jaundice Viral hepatitis (A, B,"/>
   <result pre="leptospirosis, rickettsia, viral encephalitis (Japanese, tick-borne, West Nile) Jaundice Viral" exact="hepatitis" post="(A, B, C, E), malaria, leptospirosis, yellow fever and"/>
   <result pre="Nile) Jaundice Viral hepatitis (A, B, C, E), malaria, leptospirosis," exact="yellow fever" post="and other viral hemorrhagic fevers Localised adenopathies Pyodermitis, Bartonella,"/>
   <result pre="viral hemorrhagic fevers Localised adenopathies Pyodermitis, Bartonella, TB, Toxoplasmosis, tularemia," exact="trypanosomiasis" post="Conjunctivitis Leptospirosis, Zika Haemorrhagic manifestations (petechiae and ecchymoses) Meningococcaemia,"/>
   <result pre="trypanosomiasis Conjunctivitis Leptospirosis, Zika Haemorrhagic manifestations (petechiae and ecchymoses) Meningococcaemia," exact="dengue fever," post="viral hemorrhagic fever, leptospirosis Splenomegaly/hepatomegaly Malaria, leishmaniasis, mononucleosis, dengue,"/>
   <result pre="manifestations (petechiae and ecchymoses) Meningococcaemia, dengue fever, viral hemorrhagic fever," exact="leptospirosis" post="Splenomegaly/hepatomegaly Malaria, leishmaniasis, mononucleosis, dengue, schistosome, amoebic abscess, viral"/>
   <result pre="fever, leptospirosis Splenomegaly/hepatomegaly Malaria, leishmaniasis, mononucleosis, dengue, schistosome, amoebic abscess," exact="viral hepatitis" post="Rash Dengue, Zika, Chikungunya, measles and other viruses, rickettsia,"/>
   <result pre="leptospirosis Splenomegaly/hepatomegaly Malaria, leishmaniasis, mononucleosis, dengue, schistosome, amoebic abscess, viral" exact="hepatitis" post="Rash Dengue, Zika, Chikungunya, measles and other viruses, rickettsia,"/>
   <result pre="dengue, schistosome, amoebic abscess, viral hepatitis Rash Dengue, Zika, Chikungunya," exact="measles" post="and other viruses, rickettsia, typhoid fever, HIV, Katayama fever"/>
   <result pre="hepatitis Rash Dengue, Zika, Chikungunya, measles and other viruses, rickettsia," exact="typhoid fever," post="HIV, Katayama fever Despite all of this, in up"/>
   <result pre="any fever from an endemic area should be considered as" exact="malaria" post="13 until proven otherwise. It must be ruled out."/>
   <result pre="reported that in 2016 there were 216 million cases of" exact="malaria" post="in the world and 445,000 deaths, with cases being"/>
   <result pre="is the most aggressive species, producing more severe cases, and" exact="cerebral malaria." post="The clinical presentation occurs after an incubation period of"/>
   <result pre="10 years later. 16 The clinical condition produced by uncomplicated" exact="malaria" post="consists of high fever, accompanied by malaise and musculoskeletal"/>
   <result pre="fever, accompanied by malaise and musculoskeletal pain. In the laboratory," exact="thrombocytopenia" post="(80–85%, i.e. the most frequent disorder), anaemia (30%) and"/>
   <result pre="thrombocytopenia (80–85%, i.e. the most frequent disorder), anaemia (30%) and" exact="leukopenia" post="(20%) can be observed. LDH and bilirubin may be"/>
   <result pre="can be observed. LDH and bilirubin may be increased; and" exact="metabolic acidosis" post="and hypoglycaemia may appear in severe forms. 17 According"/>
   <result pre="forms. 17 According to WHO, it is considered as severe" exact="malaria" post="if it meets at least one of the criteria"/>
   <result pre="Seizures, more than two seizures in 24 h Dyspnoea with acute" exact="respiratory failure" post="Shock Jaundice (&amp;gt;3 mg/dl) Spontaneous bleeding from the gums, nose,"/>
   <result pre="the species). 18 If there is a high suspicion of" exact="malaria" post="but the thick film is negative, it should be"/>
   <result pre="conditions and do not usually present complications. The treatment of" exact="malaria" post="should be carried out according to the species and"/>
   <result pre="as a way to consider the possible pharmacological resistance. Uncomplicated" exact="malaria" post="can be treated orally with drugs if there is"/>
   <result pre="drugs if there is no digestive intolerance. Cases of complicated" exact="malaria" post="should be treated in ICUs. IV artesunate has been"/>
   <result pre="quinine + clindamycin. Table 5 Treatment of malaria. [alt-text] Table 5 Severe" exact="malaria" post="or oral intolerance First line Intravenous artesunate 2.4 mg/kg at"/>
   <result pre="complete the cycle with a complete oral regimen for uncomplicated" exact="malaria" post="(oral artemisinins or atovaquone-proguanil) Second line Quinine gluconate a:"/>
   <result pre="maintenance dose of 10 mg/kg/8 h (infusing each dose in 4 h) Uncomplicated" exact="malaria" post="Plasmodium falciparum First line Atovaquone/proguanil 250 mg/100 mg: 4 tablets/day orally"/>
   <result pre="practically the same geographical location. Zika usually produces a pruritic" exact="rash" post="and conjunctivitis more frequently, and Chikungunya produces more painful"/>
   <result pre="same geographical location. Zika usually produces a pruritic rash and" exact="conjunctivitis" post="more frequently, and Chikungunya produces more painful arthralgias. Only"/>
   <result pre="and polymyalgias begin shortly after the onset of fever, and" exact="arthritis" post="and joint oedema may occur, predominantly in the distal"/>
   <result pre="50% of patients present a chronic condition of arthralgia, arthritis," exact="tenosynovitis" post="and even symptoms similar to rheumatoid arthritis with joint"/>
   <result pre="condition of arthralgia, arthritis, tenosynovitis and even symptoms similar to" exact="rheumatoid arthritis" post="with joint erosion, 29 predominantly distal, which can last"/>
   <result pre="of arthralgia, arthritis, tenosynovitis and even symptoms similar to rheumatoid" exact="arthritis" post="with joint erosion, 29 predominantly distal, which can last"/>
   <result pre="are also severe and infrequent complications, such as encephalitis, hepatitis," exact="myocarditis" post="and multiorgan failure. The treatment used is antipyretics and"/>
   <result pre="30 There, the association between the disease and cases of" exact="microcephaly" post="and other brain malformations in the foetuses of mothers"/>
   <result pre="at least one criterion of the following: profuse haemorrhagic manifestations," exact="thrombocytopenia" post="(&amp;lt;100,000 platelets/mm 3 ), prolonged prothrombin time. Leukopenia (&amp;lt;4000"/>
   <result pre="day haemorrhagic fever symptoms appear, with the presence of jaundice," exact="kidney failure" post="and haemorrhagic diathesis (petechiae, gingivorrhagia, melenas, epistaxis), leading to"/>
   <result pre="in neighbouring countries (Liberia, Sierra Leone and Guinea). Meningitis and" exact="encephalitis" post="- The Japanese encephalitis virus usually produces asymptomatic or"/>
   <result pre="Sierra Leone and Guinea). Meningitis and encephalitis - The Japanese" exact="encephalitis" post="virus usually produces asymptomatic or paucisymptomatic infections (fever and"/>
   <result pre="there is a vaccine to prevent it. - The Tick-borne" exact="encephalitis" post="virus is transmitted by the bite of ticks of"/>
   <result pre="The other third of patients develop the neurological manifestations of" exact="encephalitis" post="later in the week. 45 It leaves sequelae in"/>
   <result pre="There is no specific treatment or vaccine. With respect to" exact="bacterial meningitis," post="meningococcal meningitis in Europe and North America is mainly"/>
   <result pre="specific treatment or vaccine. With respect to bacterial meningitis, meningococcal" exact="meningitis" post="in Europe and North America is mainly due to"/>
   <result pre="observed. It presents in the form of fever, cough, headache," exact="constipation" post="or diarrhoea and abdominal pain. Its classic description is"/>
   <result pre="Possible complications may appear in the form of endocarditis, osteomyelitis," exact="arthritis" post="and meningitis. The diagnosis is made by culture (50–70%"/>
   <result pre="period is usually between 5 and 14 days. Rocky Mountain" exact="spotted fever," post="Mediterranean spotted fever, scrub typhus, and epidemic typhus produce"/>
   <result pre="between 5 and 14 days. Rocky Mountain spotted fever, Mediterranean" exact="spotted fever," post="scrub typhus, and epidemic typhus produce very severe conditions,"/>
   <result pre="and 14 days. Rocky Mountain spotted fever, Mediterranean spotted fever," exact="scrub typhus," post="and epidemic typhus produce very severe conditions, with an"/>
   <result pre="Rocky Mountain spotted fever, Mediterranean spotted fever, scrub typhus, and" exact="epidemic typhus" post="produce very severe conditions, with an estimated mortality of"/>
   <result pre="Mountain spotted fever, Mediterranean spotted fever, scrub typhus, and epidemic" exact="typhus" post="produce very severe conditions, with an estimated mortality of"/>
   <result pre="case series as the second cause of traveller's fever after" exact="malaria" post="in Africa. 54 The most frequent conditions are described"/>
   <result pre="asymptomatic cases to febrile symptoms with cough and respiratory distress," exact="pneumonia" post="and respiratory distress. It can also be accompanied by"/>
   <result pre="pass into the blood stream. In some cases, a localised" exact="dermatitis" post="(swimmer's itch) is produced. 59 In the blood, they"/>
   <result pre="symptoms such as cough, and urticaria, and frequently a skin" exact="rash" post="and eosinophilia in 50% of cases. There are 5"/>
   <result pre="as cough, and urticaria, and frequently a skin rash and" exact="eosinophilia" post="in 50% of cases. There are 5 species of"/>
   <result pre="Chen L.H. Wilson M.E. Schlagenhauf P. Controversies and misconceptions in" exact="malaria" post="chemoprophylaxis for travelers JAMA 297 2007 2251 2263 17519415"/>
   <result pre="2263 17519415 12 Behrens R.H. Neave P.E. Jones C.O.H. Imported" exact="malaria" post="among people who travel to visit friends and relatives:"/>
   <result pre="152 161 14 World Health Organization, Global Malaria Programme. World" exact="malaria" post="report 2017 [Internet]. [accessed 31 Aug] Available from: https://www.who.int/malaria/publications/world-malaria-report-2017/en/."/>
   <result pre="Lozano-Serrano A.B. Pérez-Moyano R. Porrino-Herrera C. Cabezas-Fernández M.T. Symptomatic falciparum" exact="malaria" post="after living in a nonendemic area for 10 years:"/>
   <result pre="Treviño B. Perez Arellano J.L. Diagnóstico y tratamiento de la" exact="malaria" post="importada en España: recomendaciones del Grupo de Trabajo de"/>
   <result pre="rapid diagnostic test performance: results of WHO product testing of" exact="malaria" post="RDTs: 4 (2012). [Internet]. Geneva, Switzerland: World Health Organization"/>
   <result pre="P. Suon S. Spread of artemisinin resistance in Plasmodium falciparum" exact="malaria" post="N Engl J Med 371 5 2014 411 423"/>
   <result pre="and Prevention Travelers’ Health. Infectious diseases related to travel. Tickborne" exact="encephalitis" post="[Internet]. [accessed 5 Sep 2018] https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/tickborne-encephalitis 2018 Available from:"/>
   <result pre="https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/tickborne-encephalitis 2018 Available from: 45 Lindquist L. Vapalahti O. Tick-borne" exact="encephalitis" post="Lancet Lond Engl 371 2008 1861 1871 46 Petersen"/>
   <result pre="Travelers’ Health. Infec-tious diseases related to travel. Rickettsial (spotted &amp;amp;" exact="typhus" post="fevers) &amp;amp; related infections, including anaplasmosis &amp;amp; ehrlichiosis [Internet]."/>
   <result pre="(spotted &amp;amp; typhus fevers) &amp;amp; related infections, including anaplasmosis &amp;amp;" exact="ehrlichiosis" post="[Internet]. [accessed 3 Sep 2018]. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/rickettsial-spotted-and-typhus-fevers-and-related-infections-including-anaplasmosis-and-ehrlichiosis. 54"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7141248/results/search/disease/results.xml">
   <result pre="including provision of psychological support. clinical research COVID-19 pandemic outbreak" exact="infectious disease" post="public health ethics Introduction As the medical landscape changes"/>
   <result pre="the public think about participation in medical research during an" exact="influenza" post="pandemic: an international cross-sectional survey Public Health 2019 12"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7142687/results/search/disease/results.xml">
   <result pre="unprecedented healthcare crisis caused by a pandemic novel beta coronavirus," exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). The pathogen is spread by human-to-human"/>
   <result pre="symptoms in the majority of cases, but critical illness, bilateral" exact="viral pneumonia," post="and acute respiratory distress syndrome (ARDS) in a minority."/>
   <result pre="majority of cases, but critical illness, bilateral viral pneumonia, and" exact="acute respiratory distress syndrome" post="(ARDS) in a minority. Currently, controlling infection to prevent"/>
   <result pre="• SARS-CoV-2 is a highly infectious virus that causes a" exact="severe acute respiratory syndrome" post="in humans known as COVID-19. • The virus is"/>
   <result pre="critical care, obstetrics, and paediatrics to minimise transmission. After the" exact="severe acute respiratory syndrome" post="(SARS) outbreak of 2002–3, and subsequently the H1N1 pandemic"/>
   <result pre="to SARS-CoV 3 (which causes SARS), and has been named" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19). The"/>
   <result pre="of infection. 22 These patterns appear similar to patients with" exact="influenza" post="23 and imply value in early case detection to"/>
   <result pre="3.3, 43, 44, 45 which is higher than for recent" exact="influenza" post="epidemics 28 and SARS. 45 Individual quarantine alongside contact"/>
   <result pre="showed that there were no statistically significant differences in preventing" exact="influenza" post="or respiratory viral infections using N95 respirators and surgical"/>
   <result pre="HFNO should be used for selected adult patients with hypoxaemic" exact="respiratory failure" post="56 and that HFNO can reduce the need for"/>
   <result pre="during tracheal intubation and to reduce intubation rates in acute" exact="respiratory failure." post="In China it has been used in patients with"/>
   <result pre="prevent the delivery system becoming contaminated with the virus. Although" exact="thrombocytopenia" post="appears to be more common in COVID-19 infected patients,"/>
   <result pre="critical care. 83 The use of policies, protocols, and cognitive" exact="aids" post="such as checklists, helps with decreasing cognitive load when"/>
   <result pre="Zhang D. Wang W. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019 N Engl J Med 382 2020"/>
   <result pre="Wilson S. Sarwal S. Investigation of a nosocomial outbreak of" exact="severe acute respiratory syndrome" post="(SARS) in Toronto, Canada CMAJ 169 2003 285 292"/>
   <result pre="2012e35797 13 De Albuquerque N. Baig E. Ma X. Murine" exact="hepatitis" post="virus strain 1 produces a clinically relevant model of"/>
   <result pre="hepatitis virus strain 1 produces a clinically relevant model of" exact="severe acute respiratory syndrome" post="in A/J mice J Virol 80 2006 10382 10394"/>
   <result pre="P.Y. Air, surface, environmental, and personal protective equipment contamination by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) from a symptomatic patient JAMA. Advance"/>
   <result pre="2020, doi:10.1101/2020.03.05.20031088 46 Coburn B.J. Wagner B.G. Blower S. Modeling" exact="influenza" post="epidemics and pandemics: insights into the future of swine"/>
   <result pre="epidemiological and clinical features of the emerging 2019 novel coronavirus" exact="pneumonia" post="(COVID-19) implicate special control measures J Med Virol Advance"/>
   <result pre="2020 48 Fowler R. Guest C.B. Lapinsky S.E. Transmission of" exact="severe acute respiratory syndrome" post="during intubation and mechanical ventilation Am J Resp Crit"/>
   <result pre="M.W. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute" exact="respiratory failure" post="Eur Respir J 50 2017 1602426 28860265 58 Kotoda"/>
   <result pre="Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study Lancet"/>
   <result pre="oxygen face mask for environmental bacterial contamination in critically ill" exact="pneumonia" post="patients: a randomized controlled crossover trial J Hosp Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7144273/results/search/disease/results.xml">
   <result pre="have demonstrated safety and possible efficacy in patients with the" exact="acute respiratory distress syndrome" post="(ARDS), although not as yet well studied in respiratory"/>
   <result pre="mostly commonly characterised by fever (82%) and cough (81%). Severe" exact="pneumonia" post="and acute respiratory distress syndrome (ARDS) have been described"/>
   <result pre="characterised by fever (82%) and cough (81%). Severe pneumonia and" exact="acute respiratory distress syndrome" post="(ARDS) have been described in 14% of the reported"/>
   <result pre="other cell types, have been initiated in China for COVID-19" exact="respiratory disease." post="As these encompass a wide range of approaches and"/>
   <result pre="to inhibit the cytotoxicity of specific T cells against H1N1" exact="influenza" post="virus in vitro [ 18], leading perhaps to prolonged"/>
   <result pre="ameliorate SARS-CoV-2 lung damage based on limited pre-clinical data in" exact="influenza" post="infection models (lower right). Figure adapted from Laffey and"/>
   <result pre="cultured cells by many viruses, including dengue virus, Ebola virus," exact="influenza" post="A virus and SARS coronavirus [ 22]. Silencing of"/>
   <result pre="expressed ISGs in MSCs (p21/CDKN1A), specifically increased their susceptibility to" exact="chikungunya" post="virus (CHIKV), whereas knockdown of IFITM3 rendered MSC susceptible"/>
   <result pre="contrast, some literature demonstrates that human BM-MSCs are permissive to" exact="avian influenza" post="A (H5N1) infection, losing viability and immunoregulatory activities ["/>
   <result pre="some literature demonstrates that human BM-MSCs are permissive to avian" exact="influenza" post="A (H5N1) infection, losing viability and immunoregulatory activities ["/>
   <result pre="virus replication and lung inflammation [ 24– 27]. BM-MSCs express" exact="influenza" post="virus alpha-2,3 and alpha-2,6 sialic acid receptors on their"/>
   <result pre="and can support replication of both avian H1N1 and H9N5" exact="influenza" post="strains [ 24, 25]. Influenza-infected MSCs undergo cell lysis"/>
   <result pre="of respiratory virus infections. These have further been limited to" exact="influenza" post="viruses, have produced conflicting results, and have not as"/>
   <result pre="two earlier studies found MSCs not to be protective against" exact="influenza" post="respiratory infections in mice. Darwish and colleagues assessed the"/>
   <result pre="No BM-MSC-derived EVs: Decreased virus shedding in nasal swabs, Reduced" exact="influenza" post="virus replication in the lungs, Prevent virus-induced production of"/>
   <result pre="of systemic MSC administration in rodent and pig models of" exact="influenza" post="respiratory infections. Chan and colleagues found in in vitro"/>
   <result pre="fluid clearance and protein permeability induced by H5N1 and H7N9" exact="influenza" post="viruses, in part by releasing soluble mediators that up-regulated"/>
   <result pre="dealing with more clinically relevant sequelae of epithelial infection. Avian" exact="influenza" post="virus infection can trigger a very intense pro-inflammatory response"/>
   <result pre="can trigger a very intense pro-inflammatory response compared to other" exact="influenza" post="viruses; thus, authors speculated that the beneficial effects might"/>
   <result pre="MSCs was safe and reduced virus shedding in nasal swabs," exact="influenza" post="replication in the lungs, BALF pro-inflammatory cytokines and chemokines,"/>
   <result pre="infected with SARS-CoV-2 demonstrated virus replication in lung and interstitial" exact="pneumonia" post="with lymphocyte and monocytes infiltration into the alveolar interstitium"/>
   <result pre="of the administered MSCs by the viruses, particularly the Avian" exact="influenza" post="viruses, might explain the lack of effectiveness observed in"/>
   <result pre="of potential efficacy of MSC administration in pre-clinical models of" exact="influenza" post="respiratory viral lung infections, there are limited published clinical"/>
   <result pre="in Beijing administered BM-derived MSCs to seven patients with COVID-19" exact="pneumonia" post="with differing degrees of severity including one patient with"/>
   <result pre="recently published study evaluated MSC administration in patients with H7N9" exact="influenza" post="virus respiratory infections during the 2013–2014 outbreak in China"/>
   <result pre="cell infusion in the treatment of patients with severe 2019-nCoV" exact="pneumonia" post="(novel coronavirus pneumonia, NCP) MSCs Experimental group: Ruxolitinib combined"/>
   <result pre="cells (hucMSCs) in the treatment of high risk novel coronavirus" exact="pneumonia" post="(COVID-19) patients UC- MSCs Experimental group: MSCs Control group:"/>
   <result pre="study of mesenchymal stem cells in treating severe novel coronavirus" exact="pneumonia" post="(COVID- 19) MSCs Experimental group 1: critical group Intervention,"/>
   <result pre="cord mesenchymal stem cells for the treatment of novel coronavirus" exact="pneumonia" post="(COVID-19) and clinical application demonstration UC- MSCs Experimental group:"/>
   <result pre="human umbilical cord mesenchymal stem cells in the treatment of" exact="acute respiratory distress syndrome" post="of severe novel coronavirus pneumonia (COVID-19) UC- MSCs Experimental"/>
   <result pre="treatment of acute respiratory distress syndrome of severe novel coronavirus" exact="pneumonia" post="(COVID-19) UC- MSCs Experimental group: Different stem cell doses"/>
   <result pre="mesenchymal stem cells in the treatment of severe novel coronavirus" exact="pneumonia" post="(COVID- 19) UC-Whartons Jellys MSCs Experimental group: Iv injection"/>
   <result pre="research related to mesenchymal stem cells to treat novel coronavirus" exact="pneumonia" post="(COVID- 19) MSCs Experimental group: Case series: MSCs therapy"/>
   <result pre="cells for the treatment of pneumonitis caused by novel coronavirus" exact="pneumonia" post="(COVID- 19) MSCs Experimental group: MSCs Control group: Saline"/>
   <result pre="medium in the treatment of severe and critically novel coronavirus" exact="pneumonia" post="(COVID-19): a randomized controlled trial UC- MSCs CM Experimental"/>
   <result pre="stem cells exosomes atomization in the treatment of novel coronavirus" exact="pneumonia" post="(COVID-19) MSCs Exo Experimental group: Aerosol inhalation of exosomes"/>
   <result pre="cells in the treatment of severe and critically novel coronavirus" exact="pneumonia" post="(COVID-19): a randomized controlled clinical trial UCBMC Experimental group:"/>
   <result pre="treatment of mild and general patients infected with novel coronavirus" exact="pneumonia" post="(COVID- 19) CIK and NK Experimental group: CIK group:"/>
   <result pre="infections Activities of health care providers and researchers during an" exact="infectious disease" post="outbreak, including clinical trials, are aimed towards finding rapid"/>
   <result pre="currently recognised risk factors such as increased age, diabetes and/or" exact="cardiovascular disease" post="at potentially higher risk for clinical deterioration. In this"/>
   <result pre="data. The limited available data regarding MSC administration in pre-clinical" exact="respiratory disease" post="injury models and current understanding of potential mechanisms of"/>
   <result pre="Cells for Cells, a University spin-off developing therapies for Osteoarthritis," exact="pulpitis" post="and cardiac failure, and Regenero, a consortium for Chilean"/>
   <result pre="Cells for Cells, a University spin-off developing therapies for Osteoarthritis," exact="pulpitis" post="and cardiac failure, and Regenero, a consortium for Chilean"/>
   <result pre="W , et al. Mesenchymal stromal cell treatment prevents H9N2" exact="avian influenza" post="virus-induced acute lung injury in mice . Stem Cell"/>
   <result pre=", et al. Mesenchymal stromal cell treatment prevents H9N2 avian" exact="influenza" post="virus-induced acute lung injury in mice . Stem Cell"/>
   <result pre="of chicken lung mesenchymal stromal cells and their susceptibility to" exact="avian influenza" post="virus . Dev Comp Immunol 2010; 34: 474– 479."/>
   <result pre="chicken lung mesenchymal stromal cells and their susceptibility to avian" exact="influenza" post="virus . Dev Comp Immunol 2010; 34: 474– 479."/>
   <result pre="Kanrai P , Wiboon-ut S , et al. Tropism of" exact="avian influenza" post="a (H5N1) virus to mesenchymal stem cells and CD34+"/>
   <result pre="P , Wiboon-ut S , et al. Tropism of avian" exact="influenza" post="a (H5N1) virus to mesenchymal stem cells and CD34+"/>
   <result pre=", Rocco PRM Prospects and progress in cell therapy for" exact="acute respiratory distress syndrome." post="Expert Opin Biol Ther 2016; 16: 1353– 1360. doi:"/>
   <result pre="(stem) cell therapy fails to improve outcomes in experimental severe" exact="influenza" post=". PLoS One 2013; 8: e71761. doi: 10.1371/journal.pone.0071761 23967240"/>
   <result pre="Leung CYH , et al. Human mesenchymal stromal cells reduce" exact="influenza" post="A H5N1-associated acute lung injury in vitro and in"/>
   <result pre="LA , Meulia T Mesenchymal stem cell-derived extracellular vesicles attenuate" exact="influenza" post="virus-induced acute lung injury in a pig model ."/>
   <result pre="2019 — Article Clinical study of mesenchymal stem cell treating" exact="acute respiratory distress syndrome" post="induced by epidemic Influenza A (H7N9) infection, a hint"/>
   <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version) . Mil Med Res 2020. 50 Matthay"/>
   <result pre="Treatment with allogeneic mesenchymal stromal cells for moderate to severe" exact="acute respiratory distress syndrome" post="(START study): a randomised phase 2a safety trial ."/>
   <result pre="30455077 51 Organisation WH Guidance for managing ethical issues in" exact="infectious disease" post="outbreaks. World Heal Organ 2016; 62. 52 Athersys Provides"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7144807/results/search/disease/results.xml">
   <result pre="of the article for non-commercial scholarly purposes. COVID-19, an infectious" exact="respiratory disease" post="caused by a novel coronavirus SARS-CoV-2, has quickly evolved"/>
   <result pre="is crucial for monitoring and containing the spread of all" exact="infectious disease." post="Current virus tests are typically accomplished by first collecting"/>
   <result pre="She conducts basic and clinical research on severe pneumonia, including" exact="viral pneumonia." post="At the early stage of COVID-19 outbreak in Wuhan,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7145770/results/search/disease/results.xml">
   <result pre="cocaine, heroin, tobacco) and have a much higher incidence of" exact="chronic obstructive pulmonary disease" post="(COPD) than the general population [ 4]. Drug-related deaths"/>
   <result pre="susceptible to SSTI and related complications, such as septicaemia and" exact="endocarditis" post="[ 10]. This increased risk among the unstably housed"/>
   <result pre="benefit hand washing can have against viral infections such as" exact="influenza" post="and COVID-19. Water is required to prepare street drugs"/>
   <result pre="of Drugs Act. In response to the increased evidence of" exact="hepatitis" post="C (HCV) risk from sharing injecting paraphernalia (i.e. injecting"/>
   <result pre="resistant spores of anaerobic bacteria including Clostridium species that cause" exact="tetanus" post="and botulism [ 43] and Pseudomonas species, associated with"/>
   <result pre="of anaerobic bacteria including Clostridium species that cause tetanus and" exact="botulism" post="[ 43] and Pseudomonas species, associated with multidrug resistance"/>
   <result pre="their needles were more likely to have an abscess or" exact="cellulitis" post="than those who did not. A study of 40"/>
   <result pre="the European Union 4. Mehta S et al. COPD and" exact="asthma" post="in patients with opioid dependency: a cross-sectional study in"/>
   <result pre="Edition. London; 2019. 25. Doerrbecker J et al. Transmission of" exact="hepatitis" post="C virus among people who inject drugs: viral stability"/>
   <result pre="26. Pouget ER Hagan H Des Jarlais DC Meta-analysis of" exact="hepatitis" post="C seroconversion in relation to shared syringes and drug"/>
   <result pre="rationale for investigating skin and soft tissue infections and AA" exact="amyloidosis" post="among people who inject drugs in London Harm Reduct"/>
   <result pre="44. Binswanger IA et al. High prevalence of abscesses and" exact="cellulitis" post="among community-recruited injection drug users in San Francisco Clin"/>
   <result pre="79 10.1016/S0147-9571(03)00052-3 14690717 47. Raucher B et al. Occult polymicrobial" exact="endocarditis" post="with haemophilus parainfluenzae in intravenous drug abusers Am J"/>
   <result pre="Oh S Havlen PR Hussain N A case of polymicrobial" exact="endocarditis" post="caused by anaerobic organisms in an injection drug user"/>
   <result pre="C1 C2 10.1007/s11606-005-0236-8 16191149 49. Mah MW Shafran SD Polymicrobial" exact="endocarditis" post="with eight pathogens in an intravenous drug abuser Scand"/>
   <result pre="10.1016/S0955-3959(00)00069-4 11099923 56. Heimer R et al. Recovery of infectious" exact="hepatitis" post="C virus from injection paraphernalia: implications for prevention programs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7146681/results/search/disease/results.xml">
   <result pre="Condition Recommended surgeries Rationale Average length of stay Oncology Bladder" exact="cancer" post="• Cystectomy for MIBC, regardless of receipt of neoadjuvant"/>
   <result pre="significant risk of missed MIBC [8] • Outpatient procedure Testicular" exact="cancer" post="• Orchiectomy for suspected testicular tumors • Limited data"/>
   <result pre="when clinically appropriate • 1–3 d (minimally invasive) [12] Kidney" exact="cancer" post="• Nephrectomy for cT3+ tumors, including all patients with"/>
   <result pre="1–2 d (minimally invasive) • 2–4 d (open) [16] Prostate" exact="cancer" post="• Most prostatectomies should be delayed • Surgery for"/>
   <result pre="even for high risk disease, may not alter operative outcomes," exact="cancer" post="specific mortality, or other outcomes). • 0–2 d [20]"/>
   <result pre="• Selected high-risk patients and those with intermediate- or low-risk" exact="cancer" post="should be delayed UTUC • Nephroureterectomy for high-grade and/or"/>
   <result pre="survival. Delay may decrease resectability and affect survival [24] Urethral/penile" exact="cancer" post="• Clinically invasive or obstructing cancers • Data for"/>
   <result pre="• TURP: 1–2 d [28] Female urology/incontinence Stress urinary incontinence," exact="interstitial cystitis," post="overactive bladder, neurogenic bladder • Delay all procedures Nerve"/>
   <result pre="[28] Female urology/incontinence Stress urinary incontinence, interstitial cystitis, overactive bladder," exact="neurogenic bladder" post="• Delay all procedures Nerve stimulator in place •"/>
   <result pre="incision is urgent in those with impending or complete lower" exact="urinary tract obstruction" post="• Outpatient procedure Prosthetic surgery Erectile dysfunction • Infected"/>
   <result pre="scrotal abscesses, Fournier’s gangrene • Variable Ischemia • Shunting for" exact="priapism" post="• 1–3 d • Testicular detorsion/orchidopexy Hemorrhage • Clot"/>
   <result pre="• Outpatient procedure Infertility • Delay all procedures ACC =" exact="adrenocortical carcinoma;" post="BPH = benign prostatic hyperplasia; CIS = carcinoma in"/>
   <result pre="= adrenocortical carcinoma; BPH = benign prostatic hyperplasia; CIS =" exact="carcinoma in situ;" post="CSS = cancer-specific survival; GU = genitourinary; HoLEP ="/>
   <result pre="the prostate; IVC = inferior vena cava; MIBC = muscle-invasive" exact="bladder cancer;" post="NCCN = National Comprehensive Cancer Network; OS = overall"/>
   <result pre="Frank I. Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive" exact="bladder cancer" post="is associated with adverse survival outcomes Eur Urol Oncol"/>
   <result pre="I. Delaying radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder" exact="cancer" post="is associated with adverse survival outcomes Eur Urol Oncol"/>
   <result pre="G.N. Timing and outcomes for radical cystectomy in nonmuscle invasive" exact="bladder cancer" post="Curr Opin Urol 23 2013 423 428 23880740 9"/>
   <result pre="Timing and outcomes for radical cystectomy in nonmuscle invasive bladder" exact="cancer" post="Curr Opin Urol 23 2013 423 428 23880740 9"/>
   <result pre="length of hospital stay after retroperitoneal lymph node dissection for" exact="testicular cancer" post="J Clin Urol 12 2019 122 128 30854207 12"/>
   <result pre="of hospital stay after retroperitoneal lymph node dissection for testicular" exact="cancer" post="J Clin Urol 12 2019 122 128 30854207 12"/>
   <result pre="The role of robotic retroperitoneal lymph node dissection for testis" exact="cancer" post="Urol Clin North Am 46 2019 409 417 31277735"/>
   <result pre="Rossi M.S. Cucchiara V. Evaluating the effect of time from" exact="prostate cancer" post="diagnosis to radical prostatectomy on cancer control: can surgery"/>
   <result pre="M.S. Cucchiara V. Evaluating the effect of time from prostate" exact="cancer" post="diagnosis to radical prostatectomy on cancer control: can surgery"/>
   <result pre="of time from prostate cancer diagnosis to radical prostatectomy on" exact="cancer" post="control: can surgery be postponed safely? Urol Oncol 35"/>
   <result pre="relevant literature relating to delay of care for each urologic" exact="cancer" post="type."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7146687/results/search/disease/results.xml">
   <result pre="pregnancies, unsafe abortions, sexually transmitted infections (STIs), pregnancy complications, miscarriage," exact="post-traumatic stress disorder," post="depression, suicide, intimate partner violence, and maternal and infant"/>
   <result pre="prevention, as well as trauma-informed care for managing gender-based violence," exact="post-traumatic stress disorder," post="depression, and suicide. 16, 17 Sex-disaggregated mortality and morbidity"/>
   <result pre="Viboud C Natality decline and miscarriages associated with the 1918" exact="influenza" post="pandemic: the Scandinavian and United States experiences J Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7148425/results/search/disease/results.xml">
   <result pre="shared viral antigen, as is sometimes the case for seasonal" exact="influenza" post="strains. As SARS-CoV-2 is almost certainly completely novel for"/>
   <result pre="old populations as evidenced by the low efficacy of seasonal" exact="influenza" post="vaccine in such populations. Alternatively, adoptive immunotherapy with neutralising"/>
   <result pre="populations. Alternatively, adoptive immunotherapy with neutralising monoclonal antibody, as in" exact="cancer" post="treatment, may be a possibility, and several companies are"/>
   <result pre="have to rely mostly on the large literature on seasonal" exact="influenza" post="vaccination. However, the problem here is that everyone has"/>
   <result pre="that everyone has already been exposed to some strains of" exact="influenza" post="and even newly-emerging strains such as the avian H7N1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7151292/results/search/disease/results.xml">
   <result pre="of psychiatric syndromes and this has long been demonstrated in" exact="schizophrenia" post="( Kneeland and Fatemi, 2013). Experience of quarantine, self-isolation,"/>
   <result pre="(in Press) Kneeland R.E. Fatemi S.H. Viral infection, inflammation and" exact="schizophrenia" post="Prog. Neuropsychopharmacol. Biol. Psychiatry 42 2013 35 48 22349576"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7151480/results/search/disease/results.xml">
   <result pre="by the World Health Organization. The infection is caused by" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). COVID-19 infected patients can be asymptomatic"/>
   <result pre="after the onset of the disease, and rapidly deteriorate to" exact="acute respiratory distress syndrome" post="(ARDS), septic shock, metabolic acidosis, and coagulation abnormalities. 5"/>
   <result pre="rapidly deteriorate to acute respiratory distress syndrome (ARDS), septic shock," exact="metabolic acidosis," post="and coagulation abnormalities. 5 Cheng et al found that"/>
   <result pre="no statistical difference in clinical features in patients with COVID-19" exact="pneumonia" post="and those with non-COVID-19 infection except for leukocyte and"/>
   <result pre="subpleural curvilinear consolidation. The patient subsequently succumbed to respiratory and" exact="cardiac arrest." post="FIG 1 (A) CXR with nonspecific peripheral and bilateral"/>
   <result pre="fever, sore throat and dry cough, runny nose, and mild" exact="shortness" post="of breath (SOB). Initial CXR showed patchy peripheral airspace"/>
   <result pre="(arrows). Three days later (B) the CXR shows worsening of" exact="lung disease" post="(arrows). Day 5 CXR (C) shows progression of opacities"/>
   <result pre="ARDS (arrows). Improving opacities day 10 of treatment (D). ARDS," exact="acute respiratory distress syndrome;" post="CXR, Chest radiograph. Case 3 Fifty-six-year-old male health care"/>
   <result pre="to the ED with 3 days of increasing cough, fever," exact="shortness" post="of breath, and an episode of hemoptysis. Recently traveled"/>
   <result pre="without any known COVID-19 positive contact. Comorbidities include type II" exact="diabetes mellitus" post="(DM) and emphysema. Worsening hypoxia in the ED prompted"/>
   <result pre="made. Patient developed acute renal failure and a left-sided tension" exact="pneumothorax" post="while in ICU ( Fig 4E), treated with chest"/>
   <result pre="cavitation. Follow-up CXR (E) day 6 shows a left-sided tension" exact="pneumothorax" post="(arrows). CXR, Chest radiograph. Case 5 Forty-five-year-old male with"/>
   <result pre="male with known history of hypothyroidism, hypertension, hereditary hemochromatosis, and" exact="obstructive sleep apnea" post="presented to the ED with worsening fever, cough, SOB,"/>
   <result pre="with known history of hypothyroidism, hypertension, hereditary hemochromatosis, and obstructive" exact="sleep apnea" post="presented to the ED with worsening fever, cough, SOB,"/>
   <result pre="9 of treatment with improvement in lung opacities (F). ARDS," exact="acute respiratory distress syndrome;" post="CXR, Chest radiograph; GGO, ground glass opacities. Case 6"/>
   <result pre="Case 6 Forty-three-year-old man with history of uncontrolled type 2" exact="diabetes mellitus" post="presented to ED with fever, sore throat, dry cough,"/>
   <result pre="admitted to the ICU for cardiac monitoring and for worsening" exact="shortness" post="of breath, where he tested positive for COVID-19. The"/>
   <result pre="arrows). Nine days later (B) the CXR shows worsening of" exact="lung disease" post="(white arrows) in the mid and lower lung zones"/>
   <result pre="(arrow in D) evident in the right upper lobe. ARDS," exact="acute respiratory distress syndrome;" post="CXR, Chest radiograph; GGO, ground glass opacities. Case 7"/>
   <result pre="to the ED with worsening cough. She complained of mild" exact="shortness" post="of breath while coughing, mid-sternal chest pain, and absent"/>
   <result pre="basal segments of both lower lobes. These findings of organizing" exact="pneumonia" post="pattern are nonspecific and may be seen with atypical"/>
   <result pre="nonspecific and may be seen with atypical infection such as" exact="viral pneumonia" post="among other etiologies. Note the right apical mass and"/>
   <result pre="and may be seen with atypical infection such as viral" exact="pneumonia" post="among other etiologies. Note the right apical mass and"/>
   <result pre="with the zoonoses middle east respiratory syndrome coronavirus (MERS-CoV) and" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV). 1 The COVID-19 outbreak has resulted in"/>
   <result pre="pattern, and air bronchograms are common. Pleural effusion and mediastinal" exact="lymphadenopathy" post="are rarely seen and most likely favor alternative etiologies."/>
   <result pre="mimic those of other viral pneumonias, particularly influenza, and organizing" exact="pneumonia" post="due to other causes such as bacterial infection, drug"/>
   <result pre="2 (25%) TABLE 2 Imaging findings in patients with COVID" exact="pneumonia" post="[alt-text] TABLEable 2 Patient Location of abnormality on initial"/>
   <result pre="to be familiar with the varying radiographic features of coronavirus" exact="lung disease" post="to assist in difficult clinical decisions and manage the"/>
   <result pre="Zhang D. Wang W. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019 N Engl J Med 382 8"/>
   <result pre="lung lesions on radiographs and clinical findings in patients with" exact="severe acute respiratory syndrome" post="Korean J Radiol 8 6 2007 466 474 10.3348/kjr.2007.8.6.466"/>
   <result pre="correlation of common and uncommon computed tomographic patterns of organizing" exact="pneumonia" post="Hum Pathol 71 2018 30 40 10.1016/j.humpath.2017.10.028 29122655 17"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7151489/results/search/disease/results.xml">
   <result pre="severe and critical diseases 2 ; notably, they may exhibit" exact="acute respiratory distress syndrome" post="(ARDS), which is an important cause of COVID-2019-associated death."/>
   <result pre="patients exhibited underlying disease, including four with hypertension, three with" exact="diabetes mellitus," post="two with cerebral infarction, one with rheumatic disease, one"/>
   <result pre="including four with hypertension, three with diabetes mellitus, two with" exact="cerebral infarction," post="one with rheumatic disease, one with chronic renal insufficiency,"/>
   <result pre="57 47 47 65 40 91 56 Complication Hypertension, multiple" exact="cerebral infarction," post="chronic renal insufficiency, gastrointestinal bleeding Type 2 diabetes Type"/>
   <result pre="bleeding Type 2 diabetes Type 2 diabetes Hypertension Type 2" exact="diabetes mellitus," post="rheumatoid arthritis, Sjogren's syndrome No Hypertension, sequelae of cerebral"/>
   <result pre="2 diabetes Type 2 diabetes Hypertension Type 2 diabetes mellitus," exact="rheumatoid arthritis," post="Sjogren's syndrome No Hypertension, sequelae of cerebral infarction Hypertension"/>
   <result pre="diabetes mellitus, rheumatoid arthritis, Sjogren's syndrome No Hypertension, sequelae of" exact="cerebral infarction" post="Hypertension PSI 5 4 2 3 4 2 5"/>
   <result pre="60 50 40 60 Note: M, male; F, female; PSI," exact="pneumonia" post="severity index; HFNC, high-flow nasal cannula; SPO 2, oxygen"/>
   <result pre="259.88±58.15 mmHg; six patients had developed ARDS, with a mean" exact="pneumonia" post="severity index of 3.62±1.19. The initial oxygen concentration was"/>
   <result pre="has a robust effect on mild to moderate type I" exact="respiratory failure" post="4 ; it can also provide adequately warmed and"/>
   <result pre="intubation rate and improve clinical prognosis in patients with acute" exact="respiratory failure." post="6 During treatment of the eight patients in this"/>
   <result pre="Does high-flow nasal cannula oxygen improve outcome in acute hypoxemic" exact="respiratory failure?" post="A systematic review and meta-analysis Respiratory Medicine 131 2017"/>
   <result pre="collab: China National Health Commission Diagnosis and treatment of 2019-nCoV" exact="pneumonia" post="in China In Chinese 2020 Published March 3 http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7152874/results/search/disease/results.xml">
   <result pre="from the 18 th and 19 th centuries suggest that" exact="influenza" post="pandemics in particular have been marked by increased incidences"/>
   <result pre="suicidality, and delirium ( Honigsbaum, 2013, Menninger, 1926). For instance," exact="encephalitis" post="lethargica (EL) is an inflammatory disorder of the CNS"/>
   <result pre="incidence of which increased around the time of the &quot;Spanish&quot;" exact="influenza" post="pandemic of the early 20 th century ( Von"/>
   <result pre="century ( Von Economo, 1932). During the more recent 2009" exact="influenza" post="(H1N1) pandemic and other coronavirus infections (SARS-CoV-1 epidemic in"/>
   <result pre="describing significantly reduced blood lymphocyte counts in CoV-positive children with" exact="encephalitis" post="(CoV-CNS) compared to those with acute respiratory CoV-associated infection"/>
   <result pre="2019). Although studies on post-viral olfactory disorders (PVOD) exist for" exact="influenza" post="and other viruses, only a single case report describes"/>
   <result pre="seen over the next several months to years. Following past" exact="influenza" post="pandemics and CoV outbreaks, such complications have been described"/>
   <result pre="after in-utero exposure to viral infection in the case of" exact="schizophrenia" post="onset ( Kępińska et al., 2020, Kim et al.,"/>
   <result pre="human CoV strain (HCoV-NL63) has been associated with history of" exact="mood disorder," post="although not with its polarity (i.e. unipolar versus bipolar"/>
   <result pre="of SARS-CoV-1 were clinically diagnosed with PTSD (54.5%), depression (39%)," exact="pain disorder" post="(36.4%), panic disorder (32.5%), and obsessive compulsive disorder (15.6%)"/>
   <result pre="clinically diagnosed with PTSD (54.5%), depression (39%), pain disorder (36.4%)," exact="panic disorder" post="(32.5%), and obsessive compulsive disorder (15.6%) at 31 to"/>
   <result pre="adulthood have each been associated with increased risk of developing" exact="schizophrenia" post="( Brown and Derkits, 2010, Khandaker et al., 2012,"/>
   <result pre="Menninger, 1926). While most studies have focused on history of" exact="influenza" post="infection and psychosis risk, two studies have evaluated presence"/>
   <result pre="between seropositivity for HCoV-NL63 and history of psychotic symptoms in" exact="mood disorder" post="patients in one study ( Okusaga et al., 2011)."/>
   <result pre="been described following both SARS-CoV-1 and MERS-CoV infection, such as" exact="peripheral neuropathy," post="myopathy, Bickerstaff brainstem encephalitis (BBE), and Guillain-Barre syndrome (GBS),"/>
   <result pre="and MERS-CoV infection, such as peripheral neuropathy, myopathy, Bickerstaff brainstem" exact="encephalitis" post="(BBE), and Guillain-Barre syndrome (GBS), and these symptoms were"/>
   <result pre="Hosking, 2010). In humans, postmortem analysis of brain tissue from" exact="multiple sclerosis" post="(MS) patients and controls indicated that HCoV RNA was"/>
   <result pre="surveillance. 3.4 Neurodegenerative disorders Parkinsonism is a late feature of" exact="encephalitis" post="lethargica, which was first described following the influenza pandemic"/>
   <result pre="feature of encephalitis lethargica, which was first described following the" exact="influenza" post="pandemic of 1918 ( Cheyette and Cummings, 1995). While"/>
   <result pre="nucleus, nucleus ambiguus), may partially mediate the high incidence of" exact="respiratory failure" post="currently seen in COVID-19 (Y. C. Li et al.,"/>
   <result pre="and electroencephalogram (EEG) findings, may be difficult to distinguish from" exact="encephalopathy" post="arising from systemic (but not CNS) infection. At present,"/>
   <result pre="K.-H. Wong C.-W. Ng Y.-K. Psychiatric complications in patients with" exact="severe acute respiratory syndrome" post="(SARS) during the acute treatment phase: a series of"/>
   <result pre="Rose N.R. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced" exact="myocarditis" post="Rev. Med. Virol. 15 2005 17 27 15386590 Fazzini"/>
   <result pre="M. The art of medicine: &quot;an inexpressible dread&quot;: Psychoses of" exact="influenza" post="at fin-de-siècle Lancet 381 2013 988 989 23668571 Huang"/>
   <result pre="Med. Virol. 75 2005 185 194 15602737 Hwang C.S. Olfactory" exact="neuropathy" post="in severe acute respiratory syndrome: Report of a case"/>
   <result pre="Mushynski W.E. Talbot P.J. Human coronavirus OC43 infection induces chronic" exact="encephalitis" post="leading to disabilities in BALB/C mice Virology 349 2006"/>
   <result pre="of SARS-CoV2 may be at least partially responsible for the" exact="respiratory failure" post="of COVID-19 patients J. Med. Virol. 24–27 2020 Li"/>
   <result pre="Chang J. Chan C.H. Yang D.Y. The psychological effect of" exact="severe acute respiratory syndrome" post="on emergency department staff Emerg. Med. J. 24 2007"/>
   <result pre="Wang, F., Zhang, Y., 2020. Clinical characteristics of refractory COVID-19" exact="pneumonia" post="in Wuhan, China. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa270 Montemurro N."/>
   <result pre="Cabassa J.A. Balis T. Postolache T.T. Association of seropositivity for" exact="influenza" post="and coronaviruses with history of mood disorders and suicide"/>
   <result pre="Y.C. Lin Y.H. Chang S.C. Chang Y.C. Neuromuscular disorders in" exact="severe acute respiratory syndrome" post="Arch. Neurol. 61 2004 1669 1673 15534177 Vaira L.A."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7153046/results/search/disease/results.xml">
   <result pre="in the brain vasculature. 4 Translating the known about the" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), it has been shown that full interaction"/>
   <result pre="A non-peer-reviewed report claims there was a case of symptomatic" exact="encephalitis" post="with detected SARS-CoV-2 in cerebrospinal fluid. 14 2 Host–Virus"/>
   <result pre="salient molecule implicated in cytokine storm. The aforementioned case of" exact="encephalitis" post="may corroborate such a notion. 14 Additionally, systemic inflammation"/>
   <result pre="possibly be implicated in the pathogenesis of Parkinson’s disease, 26" exact="acute disseminated encephalomyelitis," post="27 or multiple sclerosis. 23, 28 In already established"/>
   <result pre="pathogenesis of Parkinson’s disease, 26 acute disseminated encephalomyelitis, 27 or" exact="multiple sclerosis." post="23, 28 In already established neurologic patients and even"/>
   <result pre="; Liu J. ; et al. ( 2005) Detection of" exact="severe acute respiratory syndrome" post="coronavirus in the brain: potential role of the chemokine"/>
   <result pre="of SARS-CoV2 may be at least partially responsible for the" exact="respiratory failure" post="of COVID-19 patients . J. Med. Virol. 10.1002/jmv.25728 ."/>
   <result pre="30224810 Savarin C. ; Bergmann C. C. ( 2017) Viral-induced" exact="suppression" post="of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination"/>
   <result pre="coronavirus in the central nervous system of a child with" exact="acute disseminated encephalomyelitis" post=". Pediatrics 113 ( 1), e73– 6. 10.1542/peds.113.1.e73 ."/>
   <result pre="the central nervous system of a child with acute disseminated" exact="encephalomyelitis" post=". Pediatrics 113 ( 1), e73– 6. 10.1542/peds.113.1.e73 ."/>
   <result pre="L. ( 2001) Coronaviruses in brain tissue from patients with" exact="multiple sclerosis" post=". Acta Neuropathol. 101 ( 6), 601– 604. 10.1007/s004010000331"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7153689/results/search/disease/results.xml">
   <result pre="become infected ( 4). For comparison, the R 0 for" exact="severe acute respiratory syndrome" post="(SARS) was estimated at 3.0 and Middle East respiratory"/>
   <result pre="areas and dilemmas exist without clear consensus, including guidelines for" exact="cancer" post="patients on chemotherapy or those needing early surgical treatments."/>
   <result pre="al. Early transmission dynamics in Wuhan, China of novel coronavirus–infected" exact="pneumonia" post="N Engl J Med 2020 382 13 1199 1207"/>
   <result pre="J et al. Radiological findings from 81 patients with COVID-19" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet Infect Dis"/>
   <result pre="at: http://www.acadmed.org.my/index.cfm?&amp;amp;menuid=46 10 Li T Diagnosis and clinical management of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking"/>
   <result pre="10.1038/d41586-020-00740-y 17 Wong LP Sam IC Behavioral responses to the" exact="influenza" post="A (H1N1) outbreak in Malaysia J Behav Med 2011"/>
   <result pre="IC Temporal changes in psychobehavioral responses during the 2009 H1N1" exact="influenza" post="pandemic J Prev Med 2010 51 1 92 93"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7155909/results/search/disease/results.xml">
   <result pre="COVID-19 can progress from asymptomatic or mild illness to hypoxemic" exact="respiratory failure" post="or multisystem organ failure, necessitating intubation and intensive care"/>
   <result pre="and potential therapeutics, with a focus on management of COVID-19–associated" exact="respiratory failure." post="The authors draw on literature from other viral epidemics,"/>
   <result pre="authors draw on literature from other viral epidemics, treatment of" exact="acute respiratory distress syndrome," post="and recent publications on COVID-19, as well as guidelines"/>
   <result pre="perioperative settings, based on current understanding of coronavirus biology and" exact="acute respiratory distress syndrome" post="pathophysiology. In December 2019, a novel pneumonia syndrome was"/>
   <result pre="acute respiratory distress syndrome pathophysiology. In December 2019, a novel" exact="pneumonia" post="syndrome was identified in patients clustered around the Huanan"/>
   <result pre="that cause lower respiratory tract infection is smaller, but includes" exact="influenza" post="and parainfluenza, respiratory syncytial virus, cytomegalovirus, and hantavirus. These"/>
   <result pre="but can cause severe viral pneumonias in immunocompromised patients. While" exact="influenza" post="is one of the best-known causes of pneumonia in"/>
   <result pre="patients. While influenza is one of the best-known causes of" exact="pneumonia" post="in the intensive care unit (ICU), this presentation is"/>
   <result pre="as with Staphylococcus aureus. 4 Some of the rarity of" exact="viral pneumonia" post="can be attributed to the types of cells that"/>
   <result pre="with Staphylococcus aureus. 4 Some of the rarity of viral" exact="pneumonia" post="can be attributed to the types of cells that"/>
   <result pre="viruses can infect, termed tropism. Thus, while the more common" exact="influenza" post="strains (like H1N1) target cells in the trachea and"/>
   <result pre="strains (like H1N1) target cells in the trachea and bronchi," exact="influenza" post="pneumonia is particularly linked to avian strains (like H5N1)"/>
   <result pre="(like H1N1) target cells in the trachea and bronchi, influenza" exact="pneumonia" post="is particularly linked to avian strains (like H5N1) that"/>
   <result pre="SARS-CoV-2 is a beta-coronavirus, a family that includes the original" exact="severe acute respiratory syndrome" post="(SARS) virus, as well as Middle East respiratory syndrome-related"/>
   <result pre="The most commonly reported hematologic laboratory abnormalities with COVID-19 are" exact="leukopenia" post="and lymphopenia. 17, 22– 24 21 22 23 The"/>
   <result pre="17, 22– 24 21 22 23 The cause of this" exact="leukopenia" post="is not well understood but could relate to bone"/>
   <result pre="good prognosis, up to 15% of patients will develop pneumonia," exact="acute respiratory distress syndrome" post="(ARDS), cardiac injury, renal injury, or multiorgan failure from"/>
   <result pre="the pathologic findings are similar to those seen with coronavirus-associated" exact="severe acute respiratory syndrome" post="caused by SARS-CoV and Middle East respiratory syndrome–related coronavirus,"/>
   <result pre="thick secretions likely causes decreased alveolar gas exchange predisposing to" exact="respiratory failure," post="suggesting a potential role for airway clearance and bronchial"/>
   <result pre="on random sampling identified individuals with greater symptom burden in" exact="influenza" post="37 and greater mortality in adenoviral pneumonia. 38 At"/>
   <result pre="early reported cases of COVID-19 are old age and underlying" exact="respiratory disease." post="24 Again, the reasons for these age associations are"/>
   <result pre="outcomes in the setting of influenza, respiratory syncytial virus, and" exact="herpes zoster" post="infections, 41 and have been demonstrated in mouse models"/>
   <result pre="is one biologic mechanism of aging, which primarily manifests as" exact="pulmonary fibrosis" post="but can also restrict leukocyte proliferation. It is conceivable"/>
   <result pre="be linked to short telomeres, as has been reported with" exact="pulmonary fibrosis," post="ARDS, and sepsis. 42, 43 It is also possible"/>
   <result pre="age and immunosenescence. If fecal–oral transmission resulted in a milder" exact="gastroenteritis" post="presentation of SARS-CoV-2, it is also conceivable that children"/>
   <result pre="a relatively mild disease course, a subset will develop hypoxemic" exact="respiratory failure" post="with imaging patterns consistent with diffuse viral pneumonitis, organizing"/>
   <result pre="additional safety measure. 50, 51 In select patients with COVID-19–associated" exact="respiratory failure" post="presenting with hypoxemia that is not adequately treated with"/>
   <result pre="and reduces the work of breathing in patients with acute" exact="respiratory failure." post="55, 56 High flow nasal cannula has been used"/>
   <result pre="from other outbreaks to guide its use in COVID-19 associated" exact="respiratory failure." post="49, 57 In one study of 310 patients with"/>
   <result pre="cannula as an initial strategy for the treatment of COVID-19–associated" exact="respiratory failure" post="appears reasonable when patients are closely monitored for worsening"/>
   <result pre="of noninvasive positive pressure ventilation in the management of acute" exact="respiratory failure" post="due to cardiogenic pulmonary edema and in patients with"/>
   <result pre="in the management of acute respiratory failure due to cardiogenic" exact="pulmonary edema" post="and in patients with chronic obstructive pulmonary disease (COPD)"/>
   <result pre="failure due to cardiogenic pulmonary edema and in patients with" exact="chronic obstructive pulmonary disease" post="(COPD) exacerbation leading to respiratory acidosis, no recommendations have"/>
   <result pre="is not widely available. 63 Experience from the 2009 H1N1" exact="influenza" post="epidemic and the Middle East respiratory syndrome–related coronavirus epidemic"/>
   <result pre="the choice of initial oxygen therapy for patients with COVID-19–associated" exact="respiratory failure," post="these patients should be closely monitored for deterioration and"/>
   <result pre="as compared with usual oxygen therapy in patients with hypoxemic" exact="respiratory failure." post="76 However, high flow nasal cannula may be of"/>
   <result pre="Caring for Patients with COVID-19 After intubation, management of COVID-19–associated" exact="respiratory failure" post="is the same as in ARDS from other causes."/>
   <result pre="manage such complex patients. 49, 50 If patients with COVID-19–associated" exact="respiratory failure" post="develop superimposed septic shock, adherence to standard sepsis treatment"/>
   <result pre="advised. 49 Additional, nonevidence-based recommendations for the management of COVID-19–associated" exact="respiratory failure" post="have been promulgated by a variety of guidelines and"/>
   <result pre="steroid administration has been suggested to prevent progression to hypoxemic" exact="respiratory failure" post="in case series. 97 At the same time, the"/>
   <result pre="steroids has been shown to be less relevant for organizing" exact="pneumonia" post="with an identified cause, as in COVID-19. 97 Compared"/>
   <result pre="with steroids, patients treated with macrolides for mild cryptogenic organizing" exact="pneumonia" post="also demonstrated symptom resolution, albeit with higher relapse rates."/>
   <result pre="in a subset of patients, such as those with organizing" exact="pneumonia" post="patterns. Conclusions In the face of this rapidly emerging"/>
   <result pre="Coronavirus I, Research T: A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med 2020; 382:"/>
   <result pre="Rimmelzwaan GF Fouchier RA Osterhaus AD Kuiken T Human and" exact="avian influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="GF Fouchier RA Osterhaus AD Kuiken T Human and avian" exact="influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="Protective and pathologic roles of the immune response to mouse" exact="hepatitis" post="virus type 1: Implications for severe acute respiratory syndrome."/>
   <result pre="immune response to mouse hepatitis virus type 1: Implications for" exact="severe acute respiratory syndrome." post="J Virol 2009; 83: 9258– 72 19570864 20. Li"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: A descriptive study. Lancet 2020; 395:"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China. JAMA 2020 DOI: 10.1001/jama.2020.1585 25. Chen"/>
   <result pre="cell adhesion molecules and leukocyte apoptosis in the lymphopenia and" exact="thrombocytopenia" post="of patients with severe acute respiratory syndrome (SARS). Microbes"/>
   <result pre="leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with" exact="severe acute respiratory syndrome" post="(SARS). Microbes Infect 2006; 8: 122– 7 16182592 26."/>
   <result pre="Zhao J Wang FS Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome." post="Lancet Respir Med 2020 DOI: 10.1016/S2213-2600(20)30076-X 32. Tian S"/>
   <result pre="SY Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="in two patients with lung cancer. J Thorac Oncol"/>
   <result pre="phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with" exact="lung cancer." post="J Thorac Oncol 2020 DOI: 10.1016/j.jtho.2020.02.010 33. Xiang Y-T"/>
   <result pre="Frimpong-Boateng K Letvin NL Kinetics of recombinant adenovirus type 5," exact="vaccinia virus," post="modified vaccinia ankara virus, and DNA antigen expression in"/>
   <result pre="JA Dallas RH Gu Z Hayden RT Clinical correlation of" exact="influenza" post="and respiratory syncytial virus load measured by digital PCR."/>
   <result pre="WH Yuen KY Peiris JS Serological responses in patients with" exact="severe acute respiratory syndrome" post="coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43,"/>
   <result pre="Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: A single-centered, retrospective, observational study. Lancet"/>
   <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version). Mil Med Res 2020; 7: 4 DOI:"/>
   <result pre="A Physiologic effects of high-flow nasal cannula in acute hypoxemic" exact="respiratory failure." post="Am J Respir Crit Care Med 2017; 195: 1207–"/>
   <result pre="REVA Network: High-flow oxygen through nasal cannula in acute hypoxemic" exact="respiratory failure." post="N Engl J Med 2015; 372: 2185– 96 25981908"/>
   <result pre="S Official ERS/ATS clinical practice guidelines: Noninvasive ventilation for acute" exact="respiratory failure." post="Eur Respir J 2017; 50 DOI: 10.1183/13993003.02426-2016 61. Bellani"/>
   <result pre="SAFE Investigators; ESICM Trials Group: Noninvasive ventilation of patients with" exact="acute respiratory distress syndrome." post="Insights from the LUNG SAFE Study. Am J Respir"/>
   <result pre="Thille AW Predictors of intubation in patients with acute hypoxemic" exact="respiratory failure" post="treated with a noninvasive oxygenation strategy. Crit Care Med"/>
   <result pre="for noninvasive ventilation failure in critically ill subjects with confirmed" exact="influenza" post="infection. Respir Care 2017; 62: 1307– 15 28698265 65."/>
   <result pre="Medicine Clinical Practice Guideline: Mechanical ventilation in adult patients with" exact="acute respiratory distress syndrome." post="Am J Respir Crit Care Med 2017; 195: 1253–"/>
   <result pre="N Wise MP Baudouin SV Guidelines on the management of" exact="acute respiratory distress syndrome." post="BMJ Open Respir Res 2019; 6: e000420 79. Griffiths"/>
   <result pre="Institute PETAL Clinical Trials Network: Early neuromuscular blockade in the" exact="acute respiratory distress syndrome." post="N Engl J Med 2019; 380: 1997– 2008. DOI:"/>
   <result pre="Trial Group, REVA, and ECMONet: Extracorporeal membrane oxygenation for severe" exact="acute respiratory distress syndrome." post="N Engl J Med 2018; 378: 1965– 75 29791822"/>
   <result pre="D Slutsky AS Combes A Extracorporeal membrane oxygenation for severe" exact="acute respiratory distress syndrome" post="and posterior probability of mortality benefit in a post"/>
   <result pre="The application of lopinavir/ritonavir for the treatment of COVID-19 infected" exact="pneumonia" post="monitored by quantitative RT-PCR. J Korean Med Sci 2020;"/>
   <result pre="MW Thomas CM Smith AF Pharmacological agents for adults with" exact="acute respiratory distress syndrome." post="Cochrane Database Syst Rev 2019; 7: CD004477 31334568 96."/>
   <result pre="Bai C Zheng J Song Y Risk factors associated with" exact="acute respiratory distress syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
   <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China. JAMA Intern Med 2020: e200994 DOI:"/>
   <result pre="B Wang JW Identification of a novel coronavirus causing severe" exact="pneumonia" post="in human: A descriptive study. Chin Med J (Engl)"/>
   <result pre="AB Brenneman F Elective and emergency surgery in patients with" exact="severe acute respiratory syndrome" post="(SARS). Can J Surg 2005; 48: 71– 4 15757044"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7156148/results/search/disease/results.xml">
   <result pre="in the risk of skin damage and malignant melanoma, a" exact="cancer" post="of melanocytes. Besides, the abnormal production of melanin leads"/>
   <result pre="to the Web version of this article.) Drugs repositioning for" exact="cancer" post="therapy. As cancer is one of the leading cause"/>
   <result pre="version of this article.) Drugs repositioning for cancer therapy. As" exact="cancer" post="is one of the leading cause of death worldwide"/>
   <result pre="anti-cancer drugs. The drug discovery and development process for the" exact="cancer" post="treatment takes an average of 13 years at a cost of"/>
   <result pre="drug repurposing approach (see Fig. 3 for drugs repurposing in" exact="cancer" post="therapy). Fig. 3 Chemical structures of drugs repurposed for"/>
   <result pre="cancer therapy). Fig. 3 Chemical structures of drugs repurposed for" exact="cancer" post="therapy. Aspirin ( 20), also known as acetylsalicylic acid,"/>
   <result pre="used as an analgesic and an antipyretic to prevent the" exact="heart attack" post="and stroke. For the first time, Gasic and co-workers"/>
   <result pre="Gasic and co-workers reported the possible role of aspirin in" exact="cancer" post="therapy. They discovered that the antiplatelet activity of 20"/>
   <result pre="significant beneficial effect against gastrointestinal, esophageal, pancreatic, brain, prostate, and" exact="lung cancer" post="[ 41]. The mode of action aspirin is reported"/>
   <result pre="beneficial effect against gastrointestinal, esophageal, pancreatic, brain, prostate, and lung" exact="cancer" post="[ 41]. The mode of action aspirin is reported"/>
   <result pre="compound 20 not only inhibited proliferations and promoted apoptosis of" exact="cancer" post="cells, but also delayed and overcame acquired resistance to"/>
   <result pre="targeted therapy. The underlying mechanism could be attributed to enhanced" exact="cancer" post="stemness and activated NF-kB signaling in acquired resistant tumors"/>
   <result pre="than parental, sensitive cells in terms of proliferation, apoptosis and" exact="cancer" post="stemness. On the contrary, aspirin has no effects on"/>
   <result pre="mammary epithelial cell proliferation at concentrations used on lung and" exact="breast cancer" post="cells. Hence, aspirin could be a potential candidate for"/>
   <result pre="epithelial cell proliferation at concentrations used on lung and breast" exact="cancer" post="cells. Hence, aspirin could be a potential candidate for"/>
   <result pre="for population-wide use. On the other hand, as a primary" exact="cancer" post="prevention tool, many reports revealed using 20 would have"/>
   <result pre="20 for patients above 40 years with increased risk of" exact="cardiovascular disease" post="and colorectal cancer. Celecoxib ( 21) belongs to the"/>
   <result pre="above 40 years with increased risk of cardiovascular disease and" exact="colorectal cancer." post="Celecoxib ( 21) belongs to the family of NSAID,"/>
   <result pre="has been used to treat pain and inflammation associated with" exact="rheumatoid arthritis" post="(RA) and osteoarthritis (OA) [ 46]. In 1999, the"/>
   <result pre="been used to treat pain and inflammation associated with rheumatoid" exact="arthritis" post="(RA) and osteoarthritis (OA) [ 46]. In 1999, the"/>
   <result pre="treat pain and inflammation associated with rheumatoid arthritis (RA) and" exact="osteoarthritis" post="(OA) [ 46]. In 1999, the FDA approved celecoxib,"/>
   <result pre="a highly selective reversible inhibitor of COX-2, a well-known inflammatory" exact="cancer" post="target. Because of its COX-2 inhibitory activity, the antitumor"/>
   <result pre="extensively studied and shown to have chemopreventive activities against various" exact="cancer" post="types. Other than COX-2, celecoxib targets glycogen synthase kinase"/>
   <result pre="NF-κB, AKT8 virus oncogene cellular homolog (AKT), and B cell" exact="lymphoma" post="(Bcl)-2 families [ 47]. In people with familial adenomatous"/>
   <result pre="B cell lymphoma (Bcl)-2 families [ 47]. In people with" exact="familial adenomatous polyposis" post="(FAP), a daily dosage of drug 21 (400 mg) significantly"/>
   <result pre="compound to reduce colon and rectal polyps in people with" exact="familial adenomatous polyposis" post="[ 48]. However, it was associated with some drawbacks"/>
   <result pre="of COX. The drug was marketed for the treatment of" exact="rheumatoid arthritis" post="in the United Kingdom (1969), and in the United"/>
   <result pre="COX. The drug was marketed for the treatment of rheumatoid" exact="arthritis" post="in the United Kingdom (1969), and in the United"/>
   <result pre="anticancer activity of drug 22 has been investigated in various" exact="cancer" post="cell types. Ibuprofen has been shown to inhibit the"/>
   <result pre="types. Ibuprofen has been shown to inhibit the growth of" exact="prostate cancer" post="cells [ 49]. In adenocarcinoma gastric cells, drug 22"/>
   <result pre="Ibuprofen has been shown to inhibit the growth of prostate" exact="cancer" post="cells [ 49]. In adenocarcinoma gastric cells, drug 22"/>
   <result pre="decreasing the levels of heat shock protein 70s (Hsp70s) in" exact="lung cancer" post="cells. Hsp70s are an important part of the cell's"/>
   <result pre="the levels of heat shock protein 70s (Hsp70s) in lung" exact="cancer" post="cells. Hsp70s are an important part of the cell's"/>
   <result pre="successful clinical evaluations, FDA approved the drug 23 for treating" exact="multiple myeloma." post="Additionally, molecule 23 also showed efficacy against several malignancies,"/>
   <result pre="Additionally, molecule 23 also showed efficacy against several malignancies, including" exact="acute myeloid leukemia" post="[ 53], myelodysplasia [ 54], and myelodysplastic syndrome ["/>
   <result pre="molecule 23 also showed efficacy against several malignancies, including acute" exact="myeloid leukemia" post="[ 53], myelodysplasia [ 54], and myelodysplastic syndrome ["/>
   <result pre="23 also showed efficacy against several malignancies, including acute myeloid" exact="leukemia" post="[ 53], myelodysplasia [ 54], and myelodysplastic syndrome ["/>
   <result pre="including acute myeloid leukemia [ 53], myelodysplasia [ 54], and" exact="myelodysplastic syndrome" post="[ 55]. Mechanistically, thalidomide binds to cereblon, which forms"/>
   <result pre="(mTOR), a gene that is involved in the survival of" exact="cancer" post="cells is negatively regulated by AMPK. Metformin is also"/>
   <result pre="In general, diabetic patients have an increased risk of several" exact="cancer" post="types; especially diabetic women have a 20% risk of"/>
   <result pre="types; especially diabetic women have a 20% risk of developing" exact="breast cancer." post="Several studies suggested the anticancer property of drug 24."/>
   <result pre="of 250–500 mg/day has been shown to reduce the risk of" exact="cancer" post="as well as its daily dose reduces the incidence"/>
   <result pre="well as its daily dose reduces the incidence of gastrological" exact="cancer" post="in patients with diabetes [ 59, 60]. Several reviews"/>
   <result pre="taking drug 24 was associated with reduced risk of all" exact="cancer" post="mortality in patients with diabetes [ 61]. In a"/>
   <result pre="patients using drug 24 had an overall reduced risk of" exact="cancer" post="and decreased mortality rate by 14 and 30%, respectively."/>
   <result pre="use of insulin was associated with an increased risk of" exact="cancer" post="and mortality. The recent phase 3 clinical trial studies"/>
   <result pre="using the occurrence of colorectal adenomas as a biomarker for" exact="cancer" post="as a primary endpoint at 1 year after intervention"/>
   <result pre="approved this compound in 1988 for the treatment of osteosarcoma," exact="breast cancer," post="acute lymphoblastic leukemia, and Hodgkin lymphoma. Several reports suggest"/>
   <result pre="compound in 1988 for the treatment of osteosarcoma, breast cancer," exact="acute lymphoblastic leukemia," post="and Hodgkin lymphoma. Several reports suggest that the antitumor"/>
   <result pre="in 1988 for the treatment of osteosarcoma, breast cancer, acute" exact="lymphoblastic leukemia," post="and Hodgkin lymphoma. Several reports suggest that the antitumor"/>
   <result pre="to suppress the NF-κB through the release of adenosine in" exact="cancer" post="cells [ 63]. Rapamycin ( 26), also known as"/>
   <result pre="drug 26 was reported to reduce the colony formation of" exact="leukemia" post="progenitor cells in patients with acute myeloid leukemia ["/>
   <result pre="the colony formation of leukemia progenitor cells in patients with" exact="acute myeloid leukemia" post="[ 64]. In addition to that, drug 26 also"/>
   <result pre="colony formation of leukemia progenitor cells in patients with acute" exact="myeloid leukemia" post="[ 64]. In addition to that, drug 26 also"/>
   <result pre="formation of leukemia progenitor cells in patients with acute myeloid" exact="leukemia" post="[ 64]. In addition to that, drug 26 also"/>
   <result pre="26 also showed efficacious in patients with imatinib-resistant chronic myelogenous" exact="leukemia" post="through the suppression of vascular endothelial growth factor (VEGF)"/>
   <result pre="efficacious in patients with imatinib-resistant chronic myelogenous leukemia through the" exact="suppression" post="of vascular endothelial growth factor (VEGF) mRNA levels in"/>
   <result pre="suppression of vascular endothelial growth factor (VEGF) mRNA levels in" exact="leukemia" post="cells with mild side effects [ 65]. Diclofenac ("/>
   <result pre="anticancer activity of drug 27 has been reported in several" exact="cancer" post="types including hepatoma, colon, and fibrosarcoma, pancreatic, and ovarian"/>
   <result pre="several cancer types including hepatoma, colon, and fibrosarcoma, pancreatic, and" exact="ovarian cancer." post="In rat models of fibrosarcoma and hepatoma, the drug"/>
   <result pre="and fibrosarcoma, pancreatic, and ovarian cancer. In rat models of" exact="fibrosarcoma" post="and hepatoma, the drug 27 significantly reduced the growth"/>
   <result pre="27 was found to have an anti-proliferative effect on human" exact="colon cancer" post="cell lines [ 67]. The tumor inhibitory activity of"/>
   <result pre="was found to have an anti-proliferative effect on human colon" exact="cancer" post="cell lines [ 67]. The tumor inhibitory activity of"/>
   <result pre="tumor inhibitory activity of drug 27 was also proved in" exact="ovarian cancer" post="[ 68]. At the molecular level, diclofenac induces apoptosis"/>
   <result pre="inhibitory activity of drug 27 was also proved in ovarian" exact="cancer" post="[ 68]. At the molecular level, diclofenac induces apoptosis"/>
   <result pre="been used to treat pain and inflammatory diseases such as" exact="rheumatoid arthritis," post="and fever. This drug works by non-selectively inhibiting both"/>
   <result pre="inhibit cell proliferation, induce apoptosis, and suppress metastasis in various" exact="cancer" post="cell types. In vitro studies of drug 28 in"/>
   <result pre="types. In vitro studies of drug 28 in human urinary" exact="bladder cancer" post="cell lines showed that it induces cell-cycle arrest and"/>
   <result pre="In vitro studies of drug 28 in human urinary bladder" exact="cancer" post="cell lines showed that it induces cell-cycle arrest and"/>
   <result pre="it has been investigated in combination with calcitriol for recurrent" exact="prostate cancer." post="The results showed that the combination was well tolerated."/>
   <result pre="reduce cholesterol synthesis in patients with a high risk of" exact="cardiovascular disease." post="In addition to that, statins inhibit the mevalonate pathway"/>
   <result pre="and cell proliferation, and therefore statins represent promising candidates in" exact="cancer" post="therapeutics. In chronic myeloid leukemia cells, simvastatin ( 29)"/>
   <result pre="and therefore statins represent promising candidates in cancer therapeutics. In" exact="chronic myeloid leukemia" post="cells, simvastatin ( 29) [ 74]. and other natural"/>
   <result pre="therefore statins represent promising candidates in cancer therapeutics. In chronic" exact="myeloid leukemia" post="cells, simvastatin ( 29) [ 74]. and other natural"/>
   <result pre="statins represent promising candidates in cancer therapeutics. In chronic myeloid" exact="leukemia" post="cells, simvastatin ( 29) [ 74]. and other natural"/>
   <result pre="use of statins reduced the risk of patients with gastric" exact="cancer" post="[ 77]. as well as esophageal [ 78], and"/>
   <result pre="[ 77]. as well as esophageal [ 78], and hepatocarcinoma" exact="cancer" post="types [ 79]. In a case-control study, drug 29"/>
   <result pre="of 40 mg/day for 2–5 years significantly reduced the incidence of" exact="colorectal cancer" post="[ 80]. Depakine ( 33) or valproic acid (VPA)"/>
   <result pre="40 mg/day for 2–5 years significantly reduced the incidence of colorectal" exact="cancer" post="[ 80]. Depakine ( 33) or valproic acid (VPA)"/>
   <result pre="brain. Anti-cancer activity of drug 33 was first established in" exact="leukemia" post="cells, in which the drug 33 was shown to"/>
   <result pre="of cytokine and to modulate inflammatory signaling cascade. In human" exact="leukemia" post="and human glioma cells, drug 33 was able to"/>
   <result pre="to modulate inflammatory signaling cascade. In human leukemia and human" exact="glioma" post="cells, drug 33 was able to suppress the production"/>
   <result pre="suppress the production of IL-6 and TNF-α [ 82]. In" exact="prostate cancer" post="cells, drug 33 suppressed the IL-6 through inhibition of"/>
   <result pre="the production of IL-6 and TNF-α [ 82]. In prostate" exact="cancer" post="cells, drug 33 suppressed the IL-6 through inhibition of"/>
   <result pre="for sarcomas, thyroid cancers, acute myelogenous leukemia, B cell lymphoma," exact="breast cancer," post="melanoma, non-small, and small-cell lung cancers, prostate cancer, recurrent"/>
   <result pre="cell lymphoma, breast cancer, melanoma, non-small, and small-cell lung cancers," exact="prostate cancer," post="recurrent glioblastoma, and relapsed/refractory leukemia ( www.clinicaltrials.gov.) Recently, Abdullah"/>
   <result pre="and small-cell lung cancers, prostate cancer, recurrent glioblastoma, and relapsed/refractory" exact="leukemia" post="( www.clinicaltrials.gov.) Recently, Abdullah et al. [ 84] has"/>
   <result pre="has shown that pitavastatin ( 34) has potential to treat" exact="ovarian cancer" post="if dietary geranylgeraniol is controlled. However, relatively high doses"/>
   <result pre="shown that pitavastatin ( 34) has potential to treat ovarian" exact="cancer" post="if dietary geranylgeraniol is controlled. However, relatively high doses"/>
   <result pre="high doses of statins are required to induce apoptosis in" exact="cancer" post="cells, increasing the risk of myopathy, the most common"/>
   <result pre="several assays measuring the growth, survival or apoptosis in several" exact="ovarian cancer" post="cells lines. Prednisolone, alone or in some cases in"/>
   <result pre="assays measuring the growth, survival or apoptosis in several ovarian" exact="cancer" post="cells lines. Prednisolone, alone or in some cases in"/>
   <result pre="Therefore, clinical trials of prednisolone with pitavastatin in patients with" exact="ovarian cancer" post="may be highly warranted. In case of triple-negative breast"/>
   <result pre="clinical trials of prednisolone with pitavastatin in patients with ovarian" exact="cancer" post="may be highly warranted. In case of triple-negative breast"/>
   <result pre="ovarian cancer may be highly warranted. In case of triple-negative" exact="breast cancer" post="(TNBC) and several other cancers, Wnt signaling is overactivated"/>
   <result pre="cancer may be highly warranted. In case of triple-negative breast" exact="cancer" post="(TNBC) and several other cancers, Wnt signaling is overactivated"/>
   <result pre="several other cancers, Wnt signaling is overactivated and hence, its" exact="suppression" post="emerges as an effective anticancer treatment. However, no drugs"/>
   <result pre="myeloma (MM, also known as plasma cell myeloma, is a" exact="cancer" post="of plasma cells) is an incurable hematological malignancy driven"/>
   <result pre="thereby antagonizing the PRC2 catalytic activity [ 86]. Treatment for" exact="acute myeloid leukemia" post="(AML) has not significantly changed in the last decades"/>
   <result pre="antagonizing the PRC2 catalytic activity [ 86]. Treatment for acute" exact="myeloid leukemia" post="(AML) has not significantly changed in the last decades"/>
   <result pre="the PRC2 catalytic activity [ 86]. Treatment for acute myeloid" exact="leukemia" post="(AML) has not significantly changed in the last decades"/>
   <result pre="Parkinson's disease, acromegaly, hyperprolactinemia and galactorrhoea, and recently repositioned for" exact="diabetes mellitus" post="[ 88, 89]. Repurposing strategy handled by Lara-Castillo, María"/>
   <result pre="shown bromocriptine as a potent anti-leukemia drug that mainly targets" exact="leukemia" post="stem cells [ 90]. Treatment with 38 reduced cell"/>
   <result pre="was previously reported as an effective anti-viral agent against flavivirus," exact="influenza" post="virus, HIV [ 99], Ebola virus [ 100], and"/>
   <result pre="is the first antipsychotic drug developed for the treatment of" exact="schizophrenia" post="[ 102], and mechanistically it inhibited the clathrin-mediated endocytosis."/>
   <result pre="hepatic C virus (HCV) [ 103], alphavirus [ 104], mouse" exact="hepatitis" post="virus (MHV-2) [ 105], and another coronavirus SARS-CoV ["/>
   <result pre="50 2.4 μM) and HCoV-229E (EC 50 5.1 μM) and feline infectious" exact="peritonitis" post="(FIPV, EC 50 7.0 μM) within a not-toxic range of"/>
   <result pre="stages of MERS-CoV life cycle in Huh-7 cells through a possible" exact="suppression" post="of SFK signaling pathways. Interestingly, co-treatment of the drug"/>
   <result pre="Among the many approaches applied to identify novel drugs for" exact="dengue fever," post="drug repurposing gained much attention to the scientific community."/>
   <result pre="58), an anthracenedione antineoplastic agent used for the treatment of" exact="leukemia" post="[ 122]. Quinine sulfate ( 59) is a natural"/>
   <result pre="ability to reduce the viral replication was also demonstrated against" exact="herpes simplex" post="virus (HSV) [ 124], and influenza virus [ 125]."/>
   <result pre="also demonstrated against herpes simplex virus (HSV) [ 124], and" exact="influenza" post="virus [ 125]. Among these four drugs investigated, the"/>
   <result pre="126]. Huge efforts have been taken to prevent or cure" exact="malaria" post="over the decades, and as a result, the mortality"/>
   <result pre="drug-resistant strains of Plasmodium falciparum makes it more challenging in" exact="malaria" post="treatment. Therefore, the discovery and development of new antimalarial"/>
   <result pre="use in the year 1967 to prevent hay fever and" exact="allergy" post="symptoms. Loperamide ( 41) is a medication used to"/>
   <result pre="esomeprazole are used in the treatment of gastroesophageal reflux disease," exact="peptic ulcer," post="and Zollinger-Ellison syndrome. They were tested against liver-stage P.berghei"/>
   <result pre="resistance mechanisms. Salirasib ( 72, Fig. 6) is a promising" exact="cancer" post="drug candidate inhibits isoprenylcysteine carboxyl methyltransferase (ICMT), a validated"/>
   <result pre="candidate inhibits isoprenylcysteine carboxyl methyltransferase (ICMT), a validated target for" exact="cancer" post="drug development. Recently, Salirasib and its analogs with 1,2,3-triazole"/>
   <result pre="Drug repurposed on Neurodegenerative diseases. In general, neurodegenerative diseases including" exact="amyotrophic lateral sclerosis," post="Parkinson's disease (PD), Alzheimer's disease (AD), and Huntington's disease"/>
   <result pre="were approximately 29.8 million people worldwide with AD of which" exact="dementia" post="resulted in about 1.9 million deaths. It is estimated"/>
   <result pre="that there will be more than 115 million people with" exact="dementia" post="worldwide by 2050. Therefore, AD represents a major and"/>
   <result pre="152]. Overall, there was significant reduction in the incidence of" exact="dementia" post="in patients taking ARBs compared to those taking the"/>
   <result pre="shown to have a neuroprotective effect against Aβ-induced apoptosis in" exact="neuroblastoma" post="MG65 cell lines. A protective effect in a Drosophila melanogaster"/>
   <result pre="as the lack of operational diagnostic criteria for AD or" exact="vascular dementia." post="Tetracycline antibiotics are widely used to treat bacterial infections"/>
   <result pre="treatment of high blood pressure to reduce the risk of" exact="heart attack" post="and stroke. This drug 88 came into medical use"/>
   <result pre="and peroxynitrite scavenging property with potential benefits to patients with" exact="multiple sclerosis." post="Many studies suggest that individuals with increased levels of"/>
   <result pre="of urate in serum have the risk of hypertension, coronary" exact="heart disease," post="and stroke over the long term. These side effects"/>
   <result pre="serum have the risk of hypertension, coronary heart disease, and" exact="stroke" post="over the long term. These side effects are potentially"/>
   <result pre="kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous" exact="leukemia" post="(CML). Accumulating evidence suggests that c-Abl activation has been"/>
   <result pre="was also reported that activation of c-Abl in mice induces" exact="neurodegeneration" post="in the hippocampal and striatal brain areas [ 195]."/>
   <result pre="safety and tolerability of nilotinib in 12 patients with PD" exact="dementia" post="or dementia with Lewy bodies followed-up for 24 weeks,"/>
   <result pre="tolerability of nilotinib in 12 patients with PD dementia or" exact="dementia" post="with Lewy bodies followed-up for 24 weeks, followed by"/>
   <result pre="are already used in clinic for treatment of menopause symptoms," exact="cancer" post="and use for contraception; thus they could be repositioned"/>
   <result pre="very high. For medicinal chemists, the repurposing of drugs on" exact="cancer" post="is a rewarding job for the global healthcare system"/>
   <result pre="to get cheaper and safer medicines rather than afford for" exact="cancer" post="therapy. However, time and minimum investment have to be"/>
   <result pre="use(s) Repurposed use(s) Ethionamide ( 2) Treatment of multi-drug resistant" exact="tuberculosis" post="Anti-melanogenesis (Tyrosinase inhibitor) Prothionamide ( 3) Antituberculosis Anti-melanogenesis (Tyrosinase"/>
   <result pre="inhibitor) Isoniazid ( 8) Antibiotic used for the treatment of" exact="tuberculosis" post="Anti-melanogenesis (Tyrosinase inhibitor) Thioacetazone ( 9) Antibiotic used for"/>
   <result pre="inhibitor) Thioacetazone ( 9) Antibiotic used for the treatment of" exact="tuberculosis" post="Anti-melanogenesis (Tyrosinase inhibitor) Ambazone ( 10) Antiseptic Anti-melanogenesis (Tyrosinase"/>
   <result pre="diseases Anti-melanogenesis (Tyrosinase inhibitor) Azathioprine ( 18) Immunosuppressive agent for" exact="rheumatoid arthritis," post="Crohn's disease, ulcerative colitis and in kidney transplants to"/>
   <result pre="Azathioprine ( 18) Immunosuppressive agent for rheumatoid arthritis, Crohn's disease," exact="ulcerative colitis" post="and in kidney transplants to prevent rejection Anti-melanogenesis (Tyrosinase"/>
   <result pre="( 18) Immunosuppressive agent for rheumatoid arthritis, Crohn's disease, ulcerative" exact="colitis" post="and in kidney transplants to prevent rejection Anti-melanogenesis (Tyrosinase"/>
   <result pre="Anticancer (Activator of AMP-induced protein kinase) Methotrexate ( 23) Osteosarcoma," exact="breast cancer," post="acute lymphoblastic leukemia and Hodgkin lymphoma Anticancer (inhibitor of"/>
   <result pre="of AMP-induced protein kinase) Methotrexate ( 23) Osteosarcoma, breast cancer," exact="acute lymphoblastic leukemia" post="and Hodgkin lymphoma Anticancer (inhibitor of dihydrofolate reductase) Rapamycin"/>
   <result pre="AMP-induced protein kinase) Methotrexate ( 23) Osteosarcoma, breast cancer, acute" exact="lymphoblastic leukemia" post="and Hodgkin lymphoma Anticancer (inhibitor of dihydrofolate reductase) Rapamycin"/>
   <result pre="protein kinase) Methotrexate ( 23) Osteosarcoma, breast cancer, acute lymphoblastic" exact="leukemia" post="and Hodgkin lymphoma Anticancer (inhibitor of dihydrofolate reductase) Rapamycin"/>
   <result pre="( 23) Osteosarcoma, breast cancer, acute lymphoblastic leukemia and Hodgkin" exact="lymphoma" post="Anticancer (inhibitor of dihydrofolate reductase) Rapamycin ( 24) Anti-fungal"/>
   <result pre="B cells) Celecoxib ( 25) Pain and inflammation associated with" exact="rheumatoid arthritis" post="(RA) and osteoarthritis Anticancer (inhibitor of COX-2) Ibuprofen ("/>
   <result pre="cells) Celecoxib ( 25) Pain and inflammation associated with rheumatoid" exact="arthritis" post="(RA) and osteoarthritis Anticancer (inhibitor of COX-2) Ibuprofen ("/>
   <result pre="25) Pain and inflammation associated with rheumatoid arthritis (RA) and" exact="osteoarthritis" post="Anticancer (inhibitor of COX-2) Ibuprofen ( 26) Treatment of"/>
   <result pre="COX) Diclofenac ( 27) Pain and inflammatory diseases such as" exact="gout" post="Anticancer (inhibitor of COX-1 and 2) Naproxen ( 28)"/>
   <result pre="2) Naproxen ( 28) Pain and inflammatory diseases such as" exact="rheumatoid arthritis" post="and fever Anticancer (inhibitor of COX-1 and 2) Statins"/>
   <result pre="Naproxen ( 28) Pain and inflammatory diseases such as rheumatoid" exact="arthritis" post="and fever Anticancer (inhibitor of COX-1 and 2) Statins"/>
   <result pre="and mortality in those who are at high risk of" exact="cardiovascular disease" post="Anticancer, Schistosomiasis (Inhibition of adult and immature S. mansoniworms),"/>
   <result pre="virus infection and Parkinson's disease Depakine ( 33) Epilepsy and" exact="bipolar disorder" post="as well as migraines Anticancer (suppress the production of"/>
   <result pre="inhibition) Loperamide ( 41) Diarrhea, gastroenteritis, inflammatory bowel disease and" exact="short bowel syndrome" post="Anti-infective (SARS-and MERS-CoV inhibition), Anti-malarial ( P. falciparum inhibition)"/>
   <result pre="( 54) Parasite infestation (head lice, scabies, river blindness, strongyloidiasis," exact="trichuriasis" post="and lymphatic filariasis) Dengue virus infection Ketotifen ( 55)"/>
   <result pre="Skin diseaes also used in photodynamic detection and surgery of" exact="cancer" post="Dengue virus infection Azelaic acid ( 57) Skin diseaes"/>
   <result pre="virus infection Mitoxantrone hydrochloride ( 58) Anthracenedione antineoplastic agent (metastatic" exact="breast cancer," post="acute myeloid leukemia and non-Hodgkin's lymphoma) Dengue virus infection"/>
   <result pre="Mitoxantrone hydrochloride ( 58) Anthracenedione antineoplastic agent (metastatic breast cancer," exact="acute myeloid leukemia" post="and non-Hodgkin's lymphoma) Dengue virus infection Quinine sulfate ("/>
   <result pre="hydrochloride ( 58) Anthracenedione antineoplastic agent (metastatic breast cancer, acute" exact="myeloid leukemia" post="and non-Hodgkin's lymphoma) Dengue virus infection Quinine sulfate ("/>
   <result pre="( 58) Anthracenedione antineoplastic agent (metastatic breast cancer, acute myeloid" exact="leukemia" post="and non-Hodgkin's lymphoma) Dengue virus infection Quinine sulfate ("/>
   <result pre="Dengue virus infection Clemastine fumarate ( 60) Hay fever and" exact="allergy" post="symptoms (Antihistamine with anticholinergic properties and sedative side effects)"/>
   <result pre="falciparum inhibitor) Raloxifene hydrochloride ( 63) Prevention and treatment of" exact="osteoporosis" post="in postmenopausal women and those on glucocorticoids Anti-malaria ("/>
   <result pre="P. falciparum inhibitor) cyclosporin A ( 68) Immunosuppressant agent for" exact="rheumatoid arthritis," post="psoriasis, Crohn's disease, nephrotic syndrome and in organ transplants"/>
   <result pre="( 68) Immunosuppressant agent for rheumatoid arthritis, psoriasis, Crohn's disease," exact="nephrotic syndrome" post="and in organ transplants to prevent rejection Anti-malaria ("/>
   <result pre="( 88) Calcium channel blocker to reduce the risk of" exact="stroke" post="and heart attack Alzheimer's disease and Parkinson's disease Nimodipine"/>
   <result pre="Calcium channel blocker to reduce the risk of stroke and" exact="heart attack" post="Alzheimer's disease and Parkinson's disease Nimodipine ( 89) Calcium"/>
   <result pre="used to treat a number of bacterial infections such as" exact="pneumonia" post="Alzheimer's disease Bexarotene ( 92) Anticancer (treatment for cutaneous"/>
   <result pre="lymphoma) Alzheimer's disease Acitretin ( 93) Treatment of severe resistant" exact="psoriasis" post="Alzheimer's disease Drug repurposing also offers the possibility to"/>
   <result pre="Inorg. Chem. 53 2014 12848 12858 25415587 38 United States" exact="cancer" post="statistics Incidence and mortality web based report. Atlanta, US:"/>
   <result pre="review update of observational studies further supports aspirin role in" exact="cancer" post="treatment: time to share evidence and decision-making with patients?"/>
   <result pre="A.M. Duthie G.G. Mur L.A.J. Morgan G. Aspirin, salicylates, and" exact="cancer" post="Lancet 373 2009 1301 1309 19328542 43 Simmons D.L."/>
   <result pre="Retrieved 47 Jendrossek V. Targeting apoptosis pathways by celecoxib in" exact="cancer" post="Canc. Lett. 332 2011 313 324 48 Lynch P.M."/>
   <result pre="trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with" exact="familial adenomatous polyposis" post="Gut 65 2016 286 295 25792707 49 Costea T."/>
   <result pre="J. Mocanu M.M. Molecular mechanisms and bioavailability of polyphenols in" exact="prostate cancer" post="Int. J. Mol. Sci. 20 2019 1 39 50"/>
   <result pre="Mocanu M.M. Molecular mechanisms and bioavailability of polyphenols in prostate" exact="cancer" post="Int. J. Mol. Sci. 20 2019 1 39 50"/>
   <result pre="effect of ibuprofen on tumor survival and angiogenesis in gastric" exact="cancer" post="cell Tumour Biol 36 2015 3237 3243 25542229 51"/>
   <result pre="Kido H. Ibuprofen enhances the anticancer activity of cisplatin in" exact="lung cancer" post="cells by inhibiting the heat shock protein 70 Cell"/>
   <result pre="H. Ibuprofen enhances the anticancer activity of cisplatin in lung" exact="cancer" post="cells by inhibiting the heat shock protein 70 Cell"/>
   <result pre="Vij R. Blum W. Single-agent lenalidomide induces complete remission of" exact="acute myeloid leukemia" post="in patients with isolated trisomy13 Blood 113 2009 1002"/>
   <result pre="R. Blum W. Single-agent lenalidomide induces complete remission of acute" exact="myeloid leukemia" post="in patients with isolated trisomy13 Blood 113 2009 1002"/>
   <result pre="Blum W. Single-agent lenalidomide induces complete remission of acute myeloid" exact="leukemia" post="in patients with isolated trisomy13 Blood 113 2009 1002"/>
   <result pre="Ashizuka S. Ohki T. Thalidomide potentiates etoposide-induced apoptosis in murine" exact="neuroblastoma" post="through suppression of NF-κB activation Pediatr. Surg. Int. 34"/>
   <result pre="Ohki T. Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through" exact="suppression" post="of NF-κB activation Pediatr. Surg. Int. 34 2018 443"/>
   <result pre="719 22277680 56 Stewart A.K. Medicine. How thalidomide works against" exact="cancer" post="Science 343 2014 256 257 24436409 57 Mazzurana L."/>
   <result pre="Type 2 diabetes increases and metformin reducestotal, colorectal, liver and" exact="pancreatic cancer" post="incidences in taiwanese: a representative population prospective cohort study"/>
   <result pre="2 diabetes increases and metformin reducestotal, colorectal, liver and pancreatic" exact="cancer" post="incidences in taiwanese: a representative population prospective cohort study"/>
   <result pre="signaling axis in HCT 116 more efficiently compared to SW480" exact="colon cancer" post="cells Mol. Biol. Rep. 45 2018 2175 2184 30406888"/>
   <result pre="axis in HCT 116 more efficiently compared to SW480 colon" exact="cancer" post="cells Mol. Biol. Rep. 45 2018 2175 2184 30406888"/>
   <result pre="Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cellgrowth in" exact="ovarian cancer" post="cells PLoS One 8 2013e61836 69 Cecere F. Iuliano"/>
   <result pre="anti-inflammatory drugs decrease E2F1 expression and inhibit cellgrowth in ovarian" exact="cancer" post="cells PLoS One 8 2013e61836 69 Cecere F. Iuliano"/>
   <result pre="Zappelli C. Castellano I. Grimaldi P. Diclofenac-induced apoptosis in the" exact="neuroblastoma" post="cell line SH-SY5Y: possible involvement of the mitochondrial superoxide"/>
   <result pre="Matteo S. Romanelli M. The relapse rate in patients with" exact="actinic keratosis" post="treated with diclofenac sodium 3% gel Int. J. Med."/>
   <result pre="Naproxen induces cell cycle arrest and apoptosis in human urinary" exact="bladder cancer" post="cell lines and chemically induced cancers by targeting PI3K"/>
   <result pre="induces cell cycle arrest and apoptosis in human urinary bladder" exact="cancer" post="cell lines and chemically induced cancers by targeting PI3K"/>
   <result pre="Khan M.A. Sethi G. Role of reactive oxygen species in" exact="cancer" post="progression: molecular mechanisms and recent advancements Biomolecules 9 2019"/>
   <result pre="Y. Chen H. Sun L. Statin uses and mortality in" exact="colorectal cancer" post="patients: an updated systematic review and meta-analysis Cancer Med"/>
   <result pre="Chen H. Sun L. Statin uses and mortality in colorectal" exact="cancer" post="patients: an updated systematic review and meta-analysis Cancer Med"/>
   <result pre="Morros R. Moreno V. Statin use and the risk of" exact="colorectal cancer" post="in a population-based electronic health records study Sci. Rep"/>
   <result pre="R. Moreno V. Statin use and the risk of colorectal" exact="cancer" post="in a population-based electronic health records study Sci. Rep"/>
   <result pre="B. The role of statins for primary prevention in non-elderly" exact="colorectal cancer" post="patients Anticancer Res. 34 2014 5043 5050 25202089 80"/>
   <result pre="The role of statins for primary prevention in non-elderly colorectal" exact="cancer" post="patients Anticancer Res. 34 2014 5043 5050 25202089 80"/>
   <result pre="approved drugs reveals that prednisolone synergizes with pitavastatin to induce" exact="ovarian cancer" post="cell death Sci. Rep. 9 2019 1 10 30626917"/>
   <result pre="drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian" exact="cancer" post="cell death Sci. Rep. 9 2019 1 10 30626917"/>
   <result pre="Esteve J. Risueño R.M. Repositioning of bromocriptine for treatment of" exact="acute myeloid leukemia" post="J. Transl. Med. 14 2016 261 27604463 91 Marra"/>
   <result pre="J. Risueño R.M. Repositioning of bromocriptine for treatment of acute" exact="myeloid leukemia" post="J. Transl. Med. 14 2016 261 27604463 91 Marra"/>
   <result pre="Risueño R.M. Repositioning of bromocriptine for treatment of acute myeloid" exact="leukemia" post="J. Transl. Med. 14 2016 261 27604463 91 Marra"/>
   <result pre="L. López-Cabrera M. Gastaminza P. Majano P.L. Clathrin mediates infectious" exact="hepatitis" post="C virus particle egress J. Virol. 89 2015 4180"/>
   <result pre="PLoS One 6 2011e28923 105 Pu Y. Zhang X. Mouse" exact="hepatitis" post="virus type 2 enters cells through a clathrin-mediated endocytic"/>
   <result pre="K. Zhuang M. Hattori T. Sugamura K. Clathrin-dependent entry of" exact="severe acute respiratory syndrome" post="coronavirus into target cells expressing ACE2 with the cytoplasmic"/>
   <result pre="J.M. Chen S.T. Liang P.H. Wong C.H. Small molecules targeting" exact="severe acute respiratory syndrome" post="human coronavirus Proc. Natl. Acad. Sci. U. S. A"/>
   <result pre="N.M. Fernandes P.A. Ramos M.J. Gemcitabine: a critical nucleoside for" exact="cancer" post="therapy Curr. Med. Chem. 19 2012 1076 1087 22257063"/>
   <result pre="Vasudevan S.G. Efficacy and safety of celgosivir in patients with" exact="dengue fever" post="(CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial"/>
   <result pre="study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk" exact="acute myeloid leukemia" post="Blood Adv. 4 2020 599 606 32074275 123 Achan"/>
   <result pre="of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute" exact="myeloid leukemia" post="Blood Adv. 4 2020 599 606 32074275 123 Achan"/>
   <result pre="azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid" exact="leukemia" post="Blood Adv. 4 2020 599 606 32074275 123 Achan"/>
   <result pre="drug in a modern world: role in the treatment of" exact="malaria" post="Malar. J. 10 2011 144 156 21609473 124 Baroni"/>
   <result pre="Meunier I. Weingartl H.M. Cantin A.M. Richter M.V. Inhibition of" exact="influenza" post="virus replication by targeting broad host cell pathways PLoS"/>
   <result pre="130 Derbyshire E.R. Prudêncio M. Mota M.M. Clardy J. Liver-stage" exact="malaria" post="parasites vulnerable to diverse chemical scaffolds Proc. Natl. Acad."/>
   <result pre="Chhibber-Goel J. Sharma A. New leads for drug repurposing against" exact="malaria" post="Drug Discov. Today 24 2019 263 271 30099124 132"/>
   <result pre="T. Park H.-W. Pizarro J.C. Repurposing drugs to target the" exact="malaria" post="parasite unfolding protein response Sci. Rep. 8 2018 10333"/>
   <result pre="Wolozin B. Use of angiotensin receptor blockers and risk of" exact="dementia" post="in a predominantly male population: prospective cohort analysis Br."/>
   <result pre="Lopez-Arrieta J.M. Birks J. Nimodipine for primary degenerative, mixed and" exact="vascular dementia" post="Cochrane Database Syst. Rev. 2002 CD000147 12137606 161 Fan"/>
   <result pre="J.M. Birks J. Nimodipine for primary degenerative, mixed and vascular" exact="dementia" post="Cochrane Database Syst. Rev. 2002 CD000147 12137606 161 Fan"/>
   <result pre="Bacskai B.J. Matrix metalloproteinase inhibition reduces oxidative stress associated with" exact="cerebral amyloid angiopathy" post="in vivo in transgenic mice J. Neurochem . 109"/>
   <result pre="Increases in β-amyloid protein in the hippocampus caused by diabetic" exact="metabolic disorder" post="are blocked by minocycline through inhibition of NF-κB pathway"/>
   <result pre="insulin degrading enzyme and of a related endoprotease in human" exact="neuroblastoma" post="cell lines Cell Growth Differ. 7 1996 787 796"/>
   <result pre="IL interleukin VEGF vascular endothelial growth factor Bcl B cell" exact="lymphoma" post="FDA food and drug administration SOD superoxide dismutase PSADT"/>
   <result pre="C virus AD Alzheimer's disease PD Parkinson's disease MHV mouse" exact="hepatitis" post="virus FIPV feline infectious peritonitis HSV herpes simplex virus"/>
   <result pre="PD Parkinson's disease MHV mouse hepatitis virus FIPV feline infectious" exact="peritonitis" post="HSV herpes simplex virus DNDi drugs for neglected disease"/>
   <result pre="disease MHV mouse hepatitis virus FIPV feline infectious peritonitis HSV" exact="herpes simplex" post="virus DNDi drugs for neglected disease initiative; ROS reactive"/>
   <result pre="3-Hydroxy-3-methyl-glutaryl-coenzyme A Abl-TKs Abelson tyrosine kinases AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML" exact="acute myeloid leukemia" post="ALL acute lymphocytic leukemia CML chronic myeloid leukemia GVBD"/>
   <result pre="A Abl-TKs Abelson tyrosine kinases AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML acute" exact="myeloid leukemia" post="ALL acute lymphocytic leukemia CML chronic myeloid leukemia GVBD"/>
   <result pre="Abl-TKs Abelson tyrosine kinases AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML acute myeloid" exact="leukemia" post="ALL acute lymphocytic leukemia CML chronic myeloid leukemia GVBD"/>
   <result pre="AMPA amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AML acute myeloid leukemia ALL acute lymphocytic" exact="leukemia" post="CML chronic myeloid leukemia GVBD assay competitive germinal vesicle"/>
   <result pre="acid AML acute myeloid leukemia ALL acute lymphocytic leukemia CML" exact="chronic myeloid leukemia" post="GVBD assay competitive germinal vesicle breakdown assay HAT human"/>
   <result pre="AML acute myeloid leukemia ALL acute lymphocytic leukemia CML chronic" exact="myeloid leukemia" post="GVBD assay competitive germinal vesicle breakdown assay HAT human"/>
   <result pre="acute myeloid leukemia ALL acute lymphocytic leukemia CML chronic myeloid" exact="leukemia" post="GVBD assay competitive germinal vesicle breakdown assay HAT human"/>
   <result pre="GVBD assay competitive germinal vesicle breakdown assay HAT human African" exact="trypanosomiasis" post="VL visceral leishmaniosis PUVA psoralen and ultraviolet A IBD"/>
   <result pre="PUVA psoralen and ultraviolet A IBD inflammatory bowel disease UC" exact="ulcerative colitis" post="MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA 6-hydroxydopamine. Acknowledgments M.M thank PSG Management"/>
   <result pre="psoralen and ultraviolet A IBD inflammatory bowel disease UC ulcerative" exact="colitis" post="MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA 6-hydroxydopamine. Acknowledgments M.M thank PSG Management"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7156231/results/search/disease/results.xml">
   <result pre="at least one underlying disease, including immunocompromised status (chronic lymphocytic" exact="leukemia" post="and renal transplantation) or other conditions (cirrhosis, hypertension, and"/>
   <result pre="counts, with significant rise toward the end, and all had" exact="lymphocytopenia" post="except for the patient with leukemia. Histologically, the main"/>
   <result pre="examinations show advanced diffuse alveolar damage, as well as superimposed" exact="bacterial pneumonia" post="in some patients. Changes in the liver and heart"/>
   <result pre="show advanced diffuse alveolar damage, as well as superimposed bacterial" exact="pneumonia" post="in some patients. Changes in the liver and heart"/>
   <result pre="Duration of the clinical course 1 78 F Chronic lymphocytic" exact="leukemia" post="37.8 Bilateral pneumonia 1730 67.2 657 5.7 33.9 14.6"/>
   <result pre="clinical course 1 78 F Chronic lymphocytic leukemia 37.8 Bilateral" exact="pneumonia" post="1730 67.2 657 5.7 33.9 14.6 2.3 85.4 23.9"/>
   <result pre="22 2 74 M Cirrhosis, variceal rupture bleeding 38.7 Bilateral" exact="pneumonia" post="321 26.5 527 3.8 32.8 11 3.0 96 12.3"/>
   <result pre="12.3 14.3 15 3 81 M Diabetes, hypertension 37.4 Bilateral" exact="pneumonia" post="NA 44.4 513 2 30 25.5 1.2 100.3 54.5"/>
   <result pre="M Status post renal transplantation for 3 months 38.9 Bilateral" exact="pneumonia" post="3140 310.1 502 2.8 48.8 13.7 3.6 271.4 70.1"/>
   <result pre="the elevated lymphocyte count is consistent with her history of" exact="chronic lymphocytic leukemia" post="(CLL). Marked lymphocytopenia is seen in Cases 2, 3,"/>
   <result pre="lymphocyte count is consistent with her history of chronic lymphocytic" exact="leukemia" post="(CLL). Marked lymphocytopenia is seen in Cases 2, 3,"/>
   <result pre="consistent with her history of chronic lymphocytic leukemia (CLL). Marked" exact="lymphocytopenia" post="is seen in Cases 2, 3, and 4 ("/>
   <result pre="They each had at least one underlying disease, such as" exact="chronic lymphocytic leukemia" post="(CLL), cirrhosis, hypertension, diabetes, and renal transplantation. Although they"/>
   <result pre="had at least one underlying disease, such as chronic lymphocytic" exact="leukemia" post="(CLL), cirrhosis, hypertension, diabetes, and renal transplantation. Although they"/>
   <result pre="unique profile, with the most prominent abnormality being the marked" exact="lymphocytopenia" post="in Cases 2, 3, and 4. Case 1 had"/>
   <result pre="images are shown in Fig. 2. All patients had bilateral" exact="pneumonia" post="with ground-glass opacity (GGO), with or without initial consolidations."/>
   <result pre="evidence of consolidation by abundant intra-alveolar neutrophilic infiltration, consistent with" exact="bronchopneumonia" post="of a superimposed bacterial infection (Fig. 3f). Fig. 3"/>
   <result pre="background (inset: fibrinoid vascular necrosis, arrow heads). f Changes of" exact="bronchopneumonia" post="with prominent neutrophilic infiltration filling up alveolar spaces. The"/>
   <result pre="nodules and thick fibrous bands, consistent with his history of" exact="cirrhosis" post="(Fig. 4b). In addition to mild zone 3 sinusoidal"/>
   <result pre="findings from the lungs of these fatal cases of COVID-19" exact="pneumonia" post="include hyaline membrane formation, fibrin exudates, epithelial damage, and"/>
   <result pre="A common feature of the chest radiological findings of COVID-19" exact="pneumonia" post="is GGO, which may represent an early exudative phase"/>
   <result pre="caused by massive intra-alveolar neutrophilic infiltration, likely due to superimposed" exact="bacterial pneumonia." post="These were identified in Case 4, who had a"/>
   <result pre="[ 13]. These evidently represent an early phase of COVID-19" exact="pneumonia" post="and are consistent with GGO in chest CT scans."/>
   <result pre="studied. Excluding the patient with underlying CLL, there is uniform" exact="lymphocytopenia" post="in these cases. Some investigators suggested that this might"/>
   <result pre="to account for the lymphocytopenia. Another possibility may be virus-related" exact="suppression" post="of bone marrow, as described in SARS-COV [ 8,"/>
   <result pre="bone marrow tissue has been studied so far. Pathologically, COVID-19" exact="pneumonia" post="shows overlapping features with SARS. Both exhibit fluid exudation,"/>
   <result pre="days, interstitial and alveolar fibroblast proliferation, septal thickening, and organizing" exact="pneumonia" post="are seen. Reported pathologic changes for SARS come mostly"/>
   <result pre="changes. Our previous study of early pathologic changes of COVID-19" exact="pneumonia" post="in two patients showed relatively simple, early exudative phase"/>
   <result pre="we have found that the pathologic basis for the COVID-19" exact="pneumonia" post="are advanced DAD and superimposed bacterial pneumonia in some"/>
   <result pre="basis for the COVID-19 pneumonia are advanced DAD and superimposed" exact="bacterial pneumonia" post="in some patients. Early organization is noted but without"/>
   <result pre="for the COVID-19 pneumonia are advanced DAD and superimposed bacterial" exact="pneumonia" post="in some patients. Early organization is noted but without"/>
   <result pre="Chu H Yang J et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="Song J et al. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019 N Engl J Med 2020 382"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet. 2020 395"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China JAMA 2020 323 1061 9 10.1001/jama.2020.1585"/>
   <result pre="Zhang C et al. Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome" post="Lancet Respir Med 2020 8 420 2 10.1016/S2213-2600(20)30076-X 32085846"/>
   <result pre="Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="in two patients with lung cancer. J Thorac Oncol."/>
   <result pre="early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with" exact="lung cancer." post="J Thorac Oncol. 10.1016/j.jtho.2020.02.010. (in press) 14. Chai X,"/>
   <result pre="JR Lourens RM Reid AH et al. Lung pathology of" exact="severe acute respiratory syndrome" post="(SARS): a study of 8 autopsy cases from Singapore"/>
   <result pre="SM Low DE Asa SL Butany J Pulmonary pathology of" exact="severe acute respiratory syndrome" post="in Toronto Mod Pathol. 2005 18 1 10 10.1038/modpathol.3800247"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7156246/results/search/disease/results.xml">
   <result pre="viral infection. These range from hearth injury until hepatic and" exact="kidney failure," post="hindering a clear depiction of the pathogenetic mechanisms of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7156252/results/search/disease/results.xml">
   <result pre="patients was admitted to hospitals with an initial diagnosis of" exact="pneumonia" post="of unknown etiology 1 . Initially, the outbreak of"/>
   <result pre="asymptomatic infection, mild infections of the upper respiratory tract, severe" exact="viral pneumonia," post="respiratory failure, multiple organ failure and death 3 ."/>
   <result pre="mild infections of the upper respiratory tract, severe viral pneumonia," exact="respiratory failure," post="multiple organ failure and death 3 . Some studies"/>
   <result pre="fatal cases (2.3%) being higher than that observed for seasonal" exact="influenza" post="5 . Most deaths involved older adults, many of"/>
   <result pre="therefore recommended for the treatment of autoimmune diseases, such as" exact="systemic lupus erythematosus" post="and rheumatoid arthritis, in which patients are exposed to"/>
   <result pre="recommended for the treatment of autoimmune diseases, such as systemic" exact="lupus erythematosus" post="and rheumatoid arthritis, in which patients are exposed to"/>
   <result pre="treatment of autoimmune diseases, such as systemic lupus erythematosus and" exact="rheumatoid arthritis," post="in which patients are exposed to the drug for"/>
   <result pre="Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study Lancet"/>
   <result pre="Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against" exact="malaria" post="caused by plasmodium vivax Antimicrob Agents Chemother 2009 53"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7158769/results/search/disease/results.xml">
   <result pre="with a collapsed vascular bed, as is the case with" exact="cardiac arrest" post="or hypovolemic shock. For our analysis, we reviewed the"/>
   <result pre="time dependent association of adrenaline administration and survival from out-of-hospital" exact="cardiac arrest" post="Resuscitation. 96 2015 180 185 26307453 3 Castle N."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7158880/results/search/disease/results.xml">
   <result pre="that can spread from animals to humans. The novel CoVs" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) emerged in 2002 and Middle East respiratory"/>
   <result pre="cause respiratory and gastrointestinal symptoms. Clinical manifestations range from a" exact="common cold" post="to more severe disease such as bronchitis, pneumonia, severe"/>
   <result pre="cold to more severe disease such as bronchitis, pneumonia, severe" exact="acute respiratory distress syndrome," post="multi-organ failure and even death. SARS-CoV, MERS-CoV and SARS-CoV-2"/>
   <result pre="infections in humans with a focus on infections in children." exact="severe acute respiratory syndrome" post="coronavirus Middle East respiratory syndrome coronavirus severe acute respiratory"/>
   <result pre="severe acute respiratory syndrome coronavirus Middle East respiratory syndrome coronavirus" exact="severe acute respiratory syndrome" post="coronavirus 2 epidemiology symptoms laboratory imaging treatment vaccines prevention"/>
   <result pre="CoVs mostly cause respiratory and gastrointestinal symptoms ranging from the" exact="common cold" post="to more severe disease such as bronchitis, pneumonia, severe"/>
   <result pre="cold to more severe disease such as bronchitis, pneumonia, severe" exact="acute respiratory distress syndrome" post="(ARDS), coagulopathy, multi-organ failure and death. 4– 8 Human"/>
   <result pre="Human coronaviruses (HCoVs) have also been associated with exacerbations of" exact="chronic obstructive pulmonary disease," post="9 cystic fibrosis 10 and asthma. 11, 12 FIGURE"/>
   <result pre="been associated with exacerbations of chronic obstructive pulmonary disease, 9" exact="cystic fibrosis" post="10 and asthma. 11, 12 FIGURE 1. Summary of"/>
   <result pre="This occurred in China in 2002 when the novel CoV" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) emerged, thought to have been transmitted from"/>
   <result pre="of Hubei province first announced a cluster of adults with" exact="pneumonia" post="of unexplained etiology on December 31, 2019. A local"/>
   <result pre="Children under the age of 3 years and children with" exact="heart disease" post="are the most frequently affected. 4, 15, 35, 36"/>
   <result pre="with other respiratory viruses such as adeno-, boca-, rhino-, RSV," exact="influenza" post="or parainfluenza virus. 5, 15, 16, 31– 33, 36,"/>
   <result pre="SYMPTOMS Common HCoVs In children, common circulating HCoVs can cause" exact="common cold" post="symptoms such as fever, 5, 11, 32 rhinitis, 5,"/>
   <result pre="11, 32 rhinitis, 5, 11 otitis, 5 pharyngitis, 5, 11" exact="laryngitis" post="5 and headache, 5, 16, 81 but also bronchitis,"/>
   <result pre="has been associated with conjunctivitis, 78 croup, 11, 79, 80" exact="asthma" post="exacerbations, 11, 12 febrile seizures 11 and HCoV-HKU1 with"/>
   <result pre="of HCoV in cerebrospinal fluid in a child presenting with" exact="acute disseminated encephalomyelitis" post="83 or in cerebrospinal fluid of adults with multiple"/>
   <result pre="in cerebrospinal fluid in a child presenting with acute disseminated" exact="encephalomyelitis" post="83 or in cerebrospinal fluid of adults with multiple"/>
   <result pre="to have fever (91%–100%), 57– 59 myalgia (10%–40%), 57, 58" exact="rhinitis" post="(33%–60%), 57– 59 sore throat (5%–30%), 57– 59 cough"/>
   <result pre="less commonly, vomiting (20%), 57, 59 abdominal pain (10%), 57" exact="diarrhea" post="(10%) 58, 59 and febrile seizures (10%). 57 In"/>
   <result pre="7 children, 57% suffered from fever, 28% from vomiting and" exact="diarrhea" post="and 14% from cough and shortness of breath. 76"/>
   <result pre="28% from vomiting and diarrhea and 14% from cough and" exact="shortness" post="of breath. 76 Two children required oxygen supplementation and"/>
   <result pre="low to moderate or no fever, rhinitis, cough, fatigue, headache," exact="diarrhea" post="and, in more severe cases, with dyspnea, cyanosis and"/>
   <result pre="children, the white blood cell count was normal in 83%," exact="neutropenia" post="and lymphopenia were each found in 1 case (3%)."/>
   <result pre="to be ineffective or even harmful because it can cause" exact="hemolytic anemia" post="or liver dysfunction. 152 In adults, interferon-alpha alone or"/>
   <result pre="be ineffective or even harmful because it can cause hemolytic" exact="anemia" post="or liver dysfunction. 152 In adults, interferon-alpha alone or"/>
   <result pre="selection bias. 152 Chloroquine Chloroquine, which is commonly used against" exact="malaria" post="and autoimmune diseases, increases the endosomal pH thereby inhibiting"/>
   <result pre="are based on recombinant parainfluenza virus, 229, 230 live-attenuated recombinant" exact="measles" post="virus, 231 attenuated rabies virus 232 and attenuated Salmonella."/>
   <result pre="parainfluenza virus, 229, 230 live-attenuated recombinant measles virus, 231 attenuated" exact="rabies" post="virus 232 and attenuated Salmonella. 233 DNA Vaccines Vaccines"/>
   <result pre="LJ Animal coronaviruses: what can they teach us about the" exact="severe acute respiratory syndrome?" post="Rev Sci Tech. 2004; 23: 643– 660. 15702725 4."/>
   <result pre="Human coronavirus and acute respiratory illness in older adults with" exact="chronic obstructive pulmonary disease." post="J Infect Dis. 2009; 199: 847– 857. 19239338 10."/>
   <result pre="differential clinical impact of human coronavirus species in children with" exact="cystic fibrosis." post="J Infect Dis. 2012; 206: 384– 388. 22459737 11."/>
   <result pre="infection and other coronavirus infections in children hospitalized with acute" exact="respiratory disease" post="in Hong Kong, China. Clin Infect Dis. 2005; 40:"/>
   <result pre="S Oppong S Drexler JF et al. Distant relatives of" exact="severe acute respiratory syndrome" post="coronavirus and close relatives of human coronavirus 229E in"/>
   <result pre="et al. Identification of a novel coronavirus in patients with" exact="severe acute respiratory syndrome." post="N Engl J Med. 2003; 348: 1967– 1976. 12690091"/>
   <result pre="Yuan S Kok KH et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="Wang W et al. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med. 2020; 382:"/>
   <result pre="20. 42. Wallinga J Teunis P Different epidemic curves for" exact="severe acute respiratory syndrome" post="reveal similar impacts of control measures. Am J Epidemiol."/>
   <result pre="T Cooper B et al. Transmission dynamics and control of" exact="severe acute respiratory syndrome." post="Science. 2003; 300: 1966– 1970. 12766207 46. Kucharski AJ"/>
   <result pre="Zheng BJ Li YM et al. Epidemiology and cause of" exact="severe acute respiratory syndrome" post="(SARS) in Guangdong, People’s Republic of China, in February,"/>
   <result pre="CW Cheng WT et al. Clinical presentations and outcome of" exact="severe acute respiratory syndrome" post="in children. Lancet. 2003; 361: 1701– 1703. 12767737 58."/>
   <result pre="GM Hedley AJ Ho LM et al. The epidemiology of" exact="severe acute respiratory syndrome" post="in the 2003 Hong Kong epidemic: an analysis of"/>
   <result pre="coronavirus in the central nervous system of a child with" exact="acute disseminated encephalomyelitis." post="Pediatrics. 2004; 113( 1 pt 1): e73– e76. 14702500"/>
   <result pre="al. Viral shedding patterns of coronavirus in patients with probable" exact="severe acute respiratory syndrome." post="Lancet. 2004; 363: 1699– 1700. 15158632 92. Chim SS"/>
   <result pre="[Serological analysis of SARS coronavirus in children diagnosed clinically as" exact="severe acute respiratory syndrome" post="cases during SARS epidemic in Beijing]. Zhonghua Er Ke"/>
   <result pre="NL-63 infection in a Brazilian patient suspected of H1N1 2009" exact="influenza" post="infection: description of a fatal case. J Clin Virol."/>
   <result pre="et al. Molecular epidemiology of the novel coronavirus that causes" exact="severe acute respiratory syndrome." post="Lancet. 2004; 363: 99– 104. 14726162 126. Tsang KW"/>
   <result pre="PL Ooi GC et al. A cluster of cases of" exact="severe acute respiratory syndrome" post="in Hong Kong. N Engl J Med. 2003; 348:"/>
   <result pre="al. Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from" exact="multiple sclerosis" post="patients. New Microbiol. 1997; 20: 105– 114. 9208420 130."/>
   <result pre="JL Coronaviruses in spinal fluid of patients with acute monosymptomatic" exact="optic neuritis." post="Acta Neurol Scand. 1999; 100: 88– 91. 10442448 131."/>
   <result pre="PC Fung GP et al. Infants born to mothers with" exact="severe acute respiratory syndrome." post="Pediatrics. 2003; 112: e254. 14523207 138. Wong SF Chow"/>
   <result pre="TN et al. Pregnancy and perinatal outcomes of women with" exact="severe acute respiratory syndrome." post="Am J Obstet Gynecol. 2004; 191: 292– 297. 15295381"/>
   <result pre="Chan KS Lai ST Chu CM et al. Treatment of" exact="severe acute respiratory syndrome" post="with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong"/>
   <result pre="Li AM et al. Inflammatory cytokine profile in children with" exact="severe acute respiratory syndrome." post="Pediatrics. 2004; 113( 1 pt 1): e7– e14. 14702488"/>
   <result pre="bronchial epithelial cells with serine and cysteine protease inhibitors prevents" exact="severe acute respiratory syndrome" post="coronavirus entry. J Virol. 2012; 86: 6537– 6545. 22496216"/>
   <result pre="et al. Evaluation of SSYA10-001 as a replication inhibitor of" exact="severe acute respiratory syndrome," post="mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob"/>
   <result pre="M Weingartl H Czub S et al. Evaluation of modified" exact="vaccinia virus" post="Ankara based recombinant SARS vaccine in ferrets. Vaccine. 2005;"/>
   <result pre="198. DeDiego ML Alvarez E Almazán F et al. A" exact="severe acute respiratory syndrome" post="coronavirus that lacks the E gene is attenuated in"/>
   <result pre="EW DeDiego ML Roberts A et al. A live attenuated" exact="severe acute respiratory syndrome" post="coronavirus is immunogenic and efficacious in golden Syrian hamsters."/>
   <result pre="Safety and immunogenicity from a phase I trial of inactivated" exact="severe acute respiratory syndrome" post="coronavirus vaccine. Antivir Ther. 2007; 12: 1107– 1113. 18018769"/>
   <result pre="Zakhartchouk AN Petric M et al. Comparative evaluation of two" exact="severe acute respiratory syndrome" post="(SARS) vaccine candidates in mice challenged with SARS coronavirus."/>
   <result pre="Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated" exact="vaccinia virus" post="protectively immunizes mice. Proc Natl Acad Sci U S"/>
   <result pre="Yang L et al. Contributions of the structural proteins of" exact="severe acute respiratory syndrome" post="coronavirus to protective immunity. Proc Natl Acad Sci U"/>
   <result pre="antibodies and cellular immune responses against SARS coronavirus by recombinant" exact="measles" post="viruses. Vaccine. 2008; 26: 2164– 2174. 18346823 232. Faber"/>
   <result pre="et al. A single immunization with a rhabdovirus-based vector expressing" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) S protein results in the production of"/>
   <result pre="S et al. Transmission of SARS and MERS coronaviruses and" exact="influenza" post="virus in healthcare settings: the possible role of dry"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7159165/results/search/disease/results.xml">
   <result pre="of the HAdV‐positive samples. The most common clinical diagnosis was" exact="pneumonia" post="and the most common symptoms were fever and cough."/>
   <result pre="infected with HAdV‐7 alone had an increased frequency of severe" exact="pneumonia" post="involvement (11.6% vs 32.4%; P = 0.031), higher intensive care unit"/>
   <result pre="of HAdV respiratory infections include fever, cough, sore throat, and" exact="tonsillitis" post="and are accompanied by gastrointestinal symptoms, such as vomiting"/>
   <result pre="Pulmonary sequelae occur in 14% to 60% of patients with" exact="pneumonia" post="caused by HAdV infection. 5, 6, 7 To date,"/>
   <result pre="screened for human respiratory syncytial virus (HRSV), human metapneumovirus (HMPV)," exact="influenza" post="viruses A and B (IFVA and IFVB), parainfluenza virus"/>
   <result pre="dyspnea (21.8%), and decreased breath sounds (5.0%). Extrapulmonary manifestations included" exact="diarrhea" post="(12.2%), vomiting (9.7%), neurological symptoms (7.2%), and rash (9.0%)."/>
   <result pre="manifestations included diarrhea (12.2%), vomiting (9.7%), neurological symptoms (7.2%), and" exact="rash" post="(9.0%). Table 1 Demographic data and clinical characteristics of"/>
   <result pre="12 (12.4) 28 (31.1) 0 3 (12.0) 44 (15.8) Severe" exact="pneumonia" post="3 (9.1) 1 (4.2) 11 (11.3) 30 (33.3) 0"/>
   <result pre="duration of fever, cough, wheezing, rales, tachypnea, rash, vomiting, and" exact="diarrhea" post="(Table 3). However, infection with HAdV‐7 alone was associated"/>
   <result pre="(12.3) 31 (17.9) 0.208 6 (14.0) 9 (26.5) 0.168 Severe" exact="pneumonia" post="12 (11.3) 35 (20.2) 0.054 5 (11.6) 11 (32.4)"/>
   <result pre="HBoV, human bocavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; IFVA," exact="influenza" post="virus; PIV1, parainfluenza virus type 1; RSV, respiratory syncytial"/>
   <result pre="mainland China, such as Hangzhou 30 and Jiangsu, 35 most" exact="respiratory disease" post="outbreaks were associated with HAdV‐3 infection. From 2012 to"/>
   <result pre="high frequency of infection of HAdV‐7 and HAdV‐3 in pediatric" exact="pneumonia" post="in Chongqing and Beijing, and HAdV‐7 infection was associated"/>
   <result pre="Chongqing (China), 3089 samples were collected from hospitalized children with" exact="pneumonia" post="from June 2009 to May 2014, of which 208"/>
   <result pre="is much needed. The most common clinical ALRTI diagnosis was" exact="pneumonia" post="(85.0%), followed by bronchitis and bronchiolitis. Most patients showed"/>
   <result pre="by adenovirus in children: Clinical features and risk factors for" exact="bronchiolitis" post="obliterans and mortality . Pediatr Pulmonol. 2009; 44( 5):"/>
   <result pre="virus of the species human adenovirus d associated with acute" exact="gastroenteritis" post=". Genome Announc. 2013; 1( 1): e00068. 23405334 12"/>
   <result pre="et al. Epidemical features of HAdV‐3 and HAdV‐7 in pediatric" exact="pneumonia" post="in Chongqing, China. Arch Virol. 2015; 160( 3): 633‐"/>
   <result pre="of adenovirus types 3 and 7 isolated from children with" exact="pneumonia" post="in Beijing . J Med Virol. 1996; 49( 3):"/>
   <result pre="respiratory infections in childhood in Beijing: An etiological study of" exact="pneumonia" post="and bronchiolitis . Chin Med J. 1986; 99( 9):"/>
   <result pre="in childhood in Beijing: An etiological study of pneumonia and" exact="bronchiolitis" post=". Chin Med J. 1986; 99( 9): 695‐ 702."/>
   <result pre="23. 21241515 20 Zhao JMWZ . Adenovirus analysis in pediatric" exact="pneumonia" post="of Beijing area during the year of 1964‐1967 and"/>
   <result pre=", Su X , et al. An outbreak of acute" exact="respiratory disease" post="in China caused by human adenovirus type B55 in"/>
   <result pre="et al. Two adenovirus serotype 3 outbreaks associated with febrile" exact="respiratory disease" post="and pharyngoconjunctival fever in children under 15 years of"/>
   <result pre="is not associated with increased disease severity in children with" exact="bronchiolitis" post=". Pediatr Pulmonol. 2012; 47: 393‐ 400. 21901859 46"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7159870/results/search/disease/results.xml">
   <result pre="Article The UK Coronavirus Cancer Monitoring Project: protecting patients with" exact="cancer" post="in the era of COVID-19 collab: The UK Coronavirus"/>
   <result pre="analyse, and disseminate in real time data from the UK" exact="cancer" post="centres about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"/>
   <result pre="in real time data from the UK cancer centres about" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection rates in patients with cancer,"/>
   <result pre="COVID-19 varies from no or minor symptoms akin to the" exact="common cold," post="to severe acute respiratory distress syndrome, resulting in severely"/>
   <result pre="or minor symptoms akin to the common cold, to severe" exact="acute respiratory distress syndrome," post="resulting in severely impaired respiratory function. 1 SARS-CoV-2 is"/>
   <result pre="2·5 million individuals live with, or have a history of," exact="cancer" post="in the UK, with 1000 new diagnoses each day."/>
   <result pre="or are recovering from surgery and complex treatments. Patients with" exact="cancer" post="potentially have increased susceptibility to SARS-CoV-2 infection and have"/>
   <result pre="more serious sequelae, resulting from impaired immune function due to" exact="cancer" post="itself, cancer treatment, or both. 5, 6 Wenhua Liang"/>
   <result pre="sequelae, resulting from impaired immune function due to cancer itself," exact="cancer" post="treatment, or both. 5, 6 Wenhua Liang and colleagues"/>
   <result pre="and colleagues 6 reported their identification of 18 patients with" exact="cancer" post="in a cohort of 1590 patients with COVID-19 in"/>
   <result pre="China, indicating an increased incidence of COVID-19 in patients with" exact="cancer" post="compared with the general Chinese population (1·13% vs 0·29%)."/>
   <result pre="and colleagues 7 who investigated SARS-CoV-2 infection in patients with" exact="cancer" post="at a tertiary care hospital in Wuhan. The incidence"/>
   <result pre="hospital in Wuhan. The incidence of COVID-19 in patients with" exact="cancer" post="(12 [0·79%] of 1524 patients) was higher than in"/>
   <result pre="the general Wuhan population (0·37%). Patients with specific types of" exact="cancer" post="might be at an increased risk of COVID-19, with"/>
   <result pre="both these reports highlighting the high proportion of patients with" exact="lung cancer" post="with confirmed diagnoses of COVID-19 (five of 18 patients"/>
   <result pre="these reports highlighting the high proportion of patients with lung" exact="cancer" post="with confirmed diagnoses of COVID-19 (five of 18 patients"/>
   <result pre="seven of 12 in Yu et al 7 ). Specific" exact="cancer" post="treatments might also differentially contribute to risk of COVID-19."/>
   <result pre="populations, potentially rendering patients more susceptible to infection. Conversely, many" exact="cancer" post="treatments for solid tumours have little effect on lymphocyte"/>
   <result pre="SARS-CoV-2 infection is highly unlikely to affect all patients with" exact="cancer" post="equally. The European Society of Medical Oncology has published"/>
   <result pre="effect of COVID-19 on patients with cancer, by prioritisation of" exact="cancer" post="treatment in patients expected to derive a substantial absolute"/>
   <result pre="stretched health-care resources. However, substantial reallocation of resources away from" exact="cancer" post="care services could potentially have unintended cancer-related implications, including"/>
   <result pre="Therefore, real-time collection, analysis, and dissemination of data from our" exact="cancer" post="centres about SARS-CoV-2 infection rates in patients with cancer,"/>
   <result pre="18, 2020, and aiming to involve over 90% of UK" exact="cancer" post="centres, will achieve this goal. A Local Emergency Response"/>
   <result pre="Emergency Response Reporting Group has been created at each UK" exact="cancer" post="centre to ensure continued updating of the UKCCMP live"/>
   <result pre="dissemination system. The project will collect data on patients with" exact="cancer" post="who are positive for SARS-CoV-2 infection, including tumour type"/>
   <result pre="SARS-CoV-2 infection, including tumour type and stage, patient age, present" exact="cancer" post="treatment, and clinical outcomes, with the aim to enable"/>
   <result pre="Cloud. 10 UKCCMP delivers meaningful real-time data to all UK" exact="cancer" post="centres and clinicians to allow more personalised approaches to"/>
   <result pre="care and inform clinical decision making. This initiative will improve" exact="cancer" post="care in the UK and beyond at this time"/>
   <result pre="W Chua MLK Xie C SARS-CoV-2 transmission in patients with" exact="cancer" post="at a tertiary care hospital in Wuhan, China JAMA"/>
   <result pre="Wu C Chen X Cai Y Risk factors associated with" exact="acute respiratory distress syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
   <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China JAMA Intern Med 2020 published online"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7160911/results/search/disease/results.xml">
   <result pre="true for SARS-CoV-2. It is known for other viruses, e.g.," exact="rabies" post="virus, that they can hijack existing vesicular axonal transport"/>
   <result pre="because of many reports of neurological impairments such as stroke," exact="epilepsy" post=",and encephalitis. The ACE2 expression in glia and in"/>
   <result pre="syndrome coronavirus infection causes neuronal death in the absence of" exact="encephalitis" post="in mice transgenic for human ACE2 . J. Virol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7161346/results/search/disease/results.xml">
   <result pre="timely and useful picture of the evolution of a national" exact="influenza" post="outbreak in the United Kingdom (UK).[ 43] The high"/>
   <result pre="the United Kingdom (UK).[ 43] The high burden of seasonal" exact="influenza" post="outbreaks prompted the implementation of innovative TMS-based solutions as"/>
   <result pre="Fortunately, infection rates appear to be lower than the 2002–2003" exact="severe acute respiratory syndrome" post="(SARS) outbreak where 30% of infections occurred in health-care"/>
   <result pre="has been considered as an adjunct in the treatment of" exact="infectious disease" post="outbreak, but growing concerns over the emergence of a"/>
   <result pre="of mortality are somewhat variable, with multiple organ failure and" exact="myocarditis" post="featuring prominently on the list. Moreover, the left ventricular"/>
   <result pre="testing will become an important asset, allowing early differentiation between" exact="influenza" post="and coronavirus infections and facilitating targeted therapeutic approaches while"/>
   <result pre="and core measures for prevention and control of novel coronavirus" exact="pneumonia" post="in China Zhonghua Yu Fang Yi Xue Za Zhi"/>
   <result pre="Stockpile of personal protective equipment in hospital settings: Preparedness for" exact="influenza" post="pandemics Am J Infect Control 2009 37 703 7"/>
   <result pre="M Large S Groenewegen PP Tracking the spatial diffusion of" exact="influenza" post="and norovirus using telehealth data: A spatiotemporal analysis of"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: A descriptive study Lancet 2020 395"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7161491/results/search/disease/results.xml">
   <result pre="2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by" exact="severe acute respiratory syndrome" post="coronavirus-2 (SARS-CoV-2) occurred in Wuhan, Hubei Province, China. 1"/>
   <result pre="was considered a zoonotic disease with limited human-to-human transmission. Initially," exact="pneumonia" post="cases were linked to the Huanan Seafood Wholesale Market."/>
   <result pre="than 6 months, have higher mortality rates due to seasonal" exact="influenza" post="infection than individuals in other age groups. 4 During"/>
   <result pre="tract infection signs; 2) Moderate type: The above manifestations with" exact="pneumonia" post="in imaging study; 3) Severe type: Disease progression with"/>
   <result pre="The pooled data were further compared with those for laboratory-confirmed" exact="severe acute respiratory syndrome" post="(SARS) children reported in previous studies. Categorical data were"/>
   <result pre="as critical in one report, 26 presented with vomiting and" exact="diarrhea" post="for 6 days. There was no obvious cough or"/>
   <result pre="deteriorated quickly after admission. Shock developed and soon progressed to" exact="acute respiratory distress syndrome" post="(ARDS), so he received mechanical ventilation. Acute kidney injury"/>
   <result pre="lung injury. 28 In one study about the pathophysiology of" exact="acute respiratory distress syndrome" post="(ARDS), increasing age led to an imbalance of the"/>
   <result pre="fact is that children rarely have underlying diseases, such as" exact="diabetes mellitus," post="chronic obstructive pulmonary disease or cardiovascular diseases, as adults"/>
   <result pre="that children rarely have underlying diseases, such as diabetes mellitus," exact="chronic obstructive pulmonary disease" post="or cardiovascular diseases, as adults do. These underlying diseases"/>
   <result pre="Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected" exact="pneumonia" post="N Engl J Med 382 13 2020 1199 1207"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study Lancet 395 10223"/>
   <result pre="Clinical analysis of 10 neonates born to mothers with 2019-nCoV" exact="pneumonia" post="Transl Pediatr 9 1 2020 51 60 32154135 20"/>
   <result pre="F.Y. Wu Y.C. Su I.J. Chiu N.C. Chen K.T. Childhood" exact="severe acute respiratory syndrome" post="in Taiwan and how to differentiate it from childhood"/>
   <result pre="syndrome in Taiwan and how to differentiate it from childhood" exact="influenza" post="infection Arch Pediatr Adolesc Med 158 11 2004 1037"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, China JAMA 2020 Feb 7 10.1001/jama.2020.1585 [published"/>
   <result pre="Y. Cheng X.F. Frist case of severe childhood novel coronavirus" exact="pneumonia" post="in China Zhonghua Er Ke Za Zhi 58 3"/>
   <result pre="M.O. Differential downregulation of ACE2 by the spike proteins of" exact="severe acute respiratory syndrome" post="coronavirus and human coronavirus NL63 J Virol 84 2"/>
   <result pre="To K.K. Chu H. Yang J. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7161532/results/search/disease/results.xml">
   <result pre="immunity against viral infection. • Patients with malnutrition, diabetes and" exact="obesity" post="require personalized nutrition advices to improve their health during"/>
   <result pre="supplementation have increased the humeral immunity of paediatric patients following" exact="influenza" post="vaccination [ 2]. A high dose Zinc supplementation has"/>
   <result pre="Similarly, Selenium supplementation has shown a positive response after an" exact="influenza" post="vaccination challenge [ 4]. In addition to micronutrients, several"/>
   <result pre="gummy placebo, on days 0 and 28 Both groups received" exact="influenza" post="vaccine Study benefit of vitamin A&amp;amp;D supplements on humoral"/>
   <result pre="of vitamin A&amp;amp;D supplements on humoral immune responses following paediatric" exact="influenza" post="vaccination Clinical: NA Immunological: Higher antibody responses among children"/>
   <result pre="Israel Vitamin D R, C; 48 weeks; 1 point Chronic" exact="hepatitis" post="C (HCV) patients; 36/36; 39/33; 18–65 IG: Vitamin D"/>
   <result pre="CG: Placebo (6 doses, 1 vial/15 days) Both groups received" exact="influenza" post="vaccine Study whether Vitamin D supplementation in deficient elderly"/>
   <result pre="whether Vitamin D supplementation in deficient elderly persons could improve" exact="influenza" post="sero-protection and immune response. Clinical: NA Immunological: IG had"/>
   <result pre="IG had a higher TGFβ plasma level in response to" exact="influenza" post="vaccination without improved antibody response. Vitamin D seems to"/>
   <result pre="improved viral response and predicted treatment outcome in patients with" exact="hepatitis" post="C virus (HCV) genotype 2–3. Clinical: NA Immunological: Ninety-five"/>
   <result pre="Italy Vitamin E R, C; 3 months; 2 points Chronic" exact="hepatitis" post="B, (HBV) patients; 15/17; NM; I: 37 ± 15 C: 42 ± 14"/>
   <result pre="of vitamin E for the treatment of paediatric HBeAg-positive chronic" exact="hepatitis" post="B Clinical: NA Immunological: Significantly more patients in IG"/>
   <result pre="β-ca CG: Placebo Examine the effects of vita-min E and" exact="pneumonia" post="risk in males who initiated smoking at an early"/>
   <result pre="Vitamin E supplementation had no effect on the risk of" exact="pneumonia" post="in participants with body weight in a range from"/>
   <result pre="from 70 to 89 kg. Vitamin E increased the risk of" exact="pneumonia" post="in participants with body weight &amp;lt;60 kg and in participants"/>
   <result pre="effect was noted on upper respiratory tract infections, particularly the" exact="common cold." post="Immunological: NA Girodon et al. [ 33] 1999; France"/>
   <result pre="which there was no effect of any treatment on delayed-type" exact="hypersensitivity" post="skin response. Number of patients without respiratory tract infections"/>
   <result pre="in groups that received trace elements. Immunological: Antibody titers after" exact="influenza" post="vaccine were higher in groups that received trace elements"/>
   <result pre="the potential to improve antibody response after some vaccines, including" exact="measles" post="[ 15] and anti-rabies vaccination (2.1 times) [ 16]."/>
   <result pre="times) [ 16]. In addition an enhanced immune response to" exact="influenza" post="virus vaccination has also been observed in children (2–8"/>
   <result pre="recent RCT on the impact of vitamin D supplementation on" exact="influenza" post="vaccine response in deficient elderly person, showed that it"/>
   <result pre="E supplementation might cause harmful effects on the incidence of" exact="infectious disease." post="A study among 50–69 years old adult smokers showed"/>
   <result pre="smokers showed that vitamin E supplementation increases the risk of" exact="pneumonia" post="[ 27]. Similarly, supplementation of vitamin E (200 IU/day)"/>
   <result pre="vitamin E have been observed in the treatment of chronic" exact="hepatitis" post="B in a small pilot RCT, where a significantly"/>
   <result pre="an essential factor for the antiviral immune responses against the" exact="influenza" post="A virus (H3N2) through the increased production of interferon-α/β,"/>
   <result pre="the role of vitamin C for preventing and treating the" exact="common cold," post="did not find any conclusive evidence to indicate that"/>
   <result pre="mega-dose prophylaxis in the community to reduce the incidence of" exact="common cold," post="which is most often caused by viral infections ["/>
   <result pre="response. A RCT including 725 institutionalized elderly patients, studying delayed-type" exact="hypersensitivity" post="skin response, humoral response to influenza vaccine, and infectious"/>
   <result pre="elderly patients, studying delayed-type hypersensitivity skin response, humoral response to" exact="influenza" post="vaccine, and infectious morbidity and mortality showed that low-dose"/>
   <result pre="comparison to the control group [ 33]. Antibody titers after" exact="influenza" post="vaccine were higher in groups that received trace elements"/>
   <result pre="days; 1.5 points Patients undergoing autologous stem cell transplantation for" exact="multiple myeloma;" post="9/9; 12/6; 47-72; IG: Zinc sulphate 600 mg/day (150 mg of"/>
   <result pre="20 mg) Evaluate immunomodulatory effect of zinc supplementation in children with" exact="pneumonia" post="younger than 5 years old. Clinical: Higher improvement in"/>
   <result pre="(400 mg/day) with Arginine (4 g/day) CG: No placebo All groups received" exact="influenza" post="vaccine Evaluate whether oral supplementation with zinc or zinc/arginine"/>
   <result pre="supplementation with zinc or zinc/arginine increases the antibody response to" exact="influenza" post="vaccine or modulates lymphocyte phenotype in elderly subjects. Clinical:"/>
   <result pre="age-related impairment in zinc concentrations. Immunological: The antibody titre against" exact="influenza" post="viral antigens was not increased in both IGs in"/>
   <result pre="Levels of SEPS1 mRNA increased significantly 7 days after the" exact="influenza" post="vaccine challenge, the magnitude of the increase in SEPS1"/>
   <result pre="Consumption of the low-selenium yeast induced anergy in delayed type" exact="hypersensitivity" post="(DTH) skin responses and increased counts of Natural killer"/>
   <result pre="by copper supplementation. Antibody titre for the Beijing strain of" exact="influenza" post="virus was significantly lower in IG after immunization than"/>
   <result pre="Acevedo-Murillo et al. among 103 children (1 month–5 years) with" exact="pneumonia" post="showed a statically significant clinical improvement (duration of illness,"/>
   <result pre="response or number of CD3, CD4 or CD8 lymphocytes after" exact="influenza" post="vaccination [ 38]. 3.2.2 Selenium Selenium is another trace"/>
   <result pre="supplementation significantly improves selenoprotein W (SEPW1) mRNA, while after an" exact="influenza" post="vaccination, a dose dependent increase in selenoprotein S (SEPS1)"/>
   <result pre="selenium supplementation has also demonstrated effects on the delayed type" exact="hypersensitivity" post="(DTH) skin response [ 42]. In this study low-selenium"/>
   <result pre="antiviral properties. For example, thujaplicin-copper chelates inhibit replication of human" exact="influenza" post="viruses [ 44], while intracellular copper has been shown"/>
   <result pre="44], while intracellular copper has been shown to regulate the" exact="influenza" post="virus life cycle [ 45]. Turnlund et al. conducted"/>
   <result pre="IL-2R and the antibody titer against the Beijing strain of" exact="influenza" post="[ 46]. 3.2.4 Magnesium Magnesium plays an important role"/>
   <result pre="relief to people infected with encapsulated RNA viruses, such as" exact="influenza" post="and coronavirus by boosting immune responses [ 6]. Our"/>
   <result pre="athletes to protect cells in culture from killing by vesicular" exact="stomatitis" post="virus following strenuous exercise. Serum of subjects who ingested"/>
   <result pre="whether plant stanol esters effect on the immune response in" exact="asthma" post="patient Clinical: NA Immunological: IG showed higher antibody titres"/>
   <result pre="patient Clinical: NA Immunological: IG showed higher antibody titres against" exact="hepatitis" post="A virus post-vaccination. Substantial reductions in plasma IgE, IL-1ß,"/>
   <result pre="in serum proteins, albumin, immunoglobulins, and secretory IgA. Antibodies against" exact="influenza" post="B increased significantly from weeks 0–8, with no significant"/>
   <result pre="weeks 0–8, with no significant differences between groups. Antibodies against" exact="influenza" post="A did not increase. No effects of prebiotics on"/>
   <result pre="group granzyme B levels appeared to be negatively associated with" exact="influenza" post="RNA levels in nasal lavage fluid cells. Nabeshima et"/>
   <result pre="of Maoto with neuraminidase inhibitors in the treatment of seasonal" exact="influenza" post="Clinical: No significant between-group differences were found in total"/>
   <result pre="with lunch and taken daily Study immune response to seasonal" exact="influenza" post="vaccination after supplementation of Fucoidan from seaweed Clinical: NA"/>
   <result pre="antibody titres against all 3 strains contained in the seasonal" exact="influenza" post="virus vaccine than the placebo group. In the IG,"/>
   <result pre="a new echinacea formulation with oseltamivir, in the treatment of" exact="influenza" post="Clinical: Recovery from illness was comparable in both groups"/>
   <result pre="oseltamivir in early treatment of clinically diagnosed and virologically confirmed" exact="influenza" post="virus infections. Immunological: NA Roman et al. [ 63]"/>
   <result pre="3 g/day C:G No placebo used To study immune response to" exact="influenza" post="vaccine with AHCC supplementation. Clinical: NA Immunological: Flow cytometric"/>
   <result pre="revealed that AHCC supplementation significantly improved protective antibody titres to" exact="influenza" post="B, while the improvement was not significant in the"/>
   <result pre="platensis (cynobacterium) R, DB, C; 6 months; 5 points Chronic" exact="hepatitis" post="C patients; 30/29; Both genders; 18–70 IG: Spirulina 500 mg"/>
   <result pre="of Spirulina platensis versus silymarin in the treatment of chronic" exact="hepatitis" post="C virus infection. Clinical: NA Immunological: In Spirulina group"/>
   <result pre="IL – Interleukin; INF – Interferon; LAIV – Live attenuated" exact="influenza" post="virus; MF – Mekabu fucoidan; NA – Not applicable;"/>
   <result pre="et al. implied that probiotics have a modest effect in" exact="common cold" post="reduction [ 7]. Our review found 4 studies on"/>
   <result pre="did not significantly affect hemagglutination inhibition titres in response to" exact="influenza" post="vaccine. NK cell activity decreased significantly in CG but"/>
   <result pre="Investigate whether consumption of probiotic lactobacilli could affect naturally acquired" exact="common cold" post="infections in healthy subjects. Clinical: Incidence of acquiring one"/>
   <result pre="in healthy subjects. Clinical: Incidence of acquiring one or more" exact="common cold" post="episode, number of days with common cold symptoms and"/>
   <result pre="one or more common cold episode, number of days with" exact="common cold" post="symptoms and total symptom score was reduced significantly in"/>
   <result pre="consumption of probiotic drink Actimel® on specific antibody responses to" exact="influenza" post="vaccination in healthy elderly. Clinical: NA Immunological: Titres against"/>
   <result pre="vaccination in healthy elderly. Clinical: NA Immunological: Titres against the" exact="influenza" post="B strain increased significantly more in the IG. Significant"/>
   <result pre="Clinical: Intake of probiotic had no effect on incidence of" exact="common cold" post="infections, but significantly shortened duration of episodes by almost"/>
   <result pre="Similarly, evidence does not support supplementation of vitamin E in" exact="cardiovascular disease" post="and cancer prevention. In fact, high-dosage of vitamin E"/>
   <result pre="not support supplementation of vitamin E in cardiovascular disease and" exact="cancer" post="prevention. In fact, high-dosage of vitamin E supplementation may"/>
   <result pre="to obtain the relevant beneficial effect. In addition to micronutrients," exact="obesity" post="has long been associated with higher risks of chronic"/>
   <result pre="vitamins, trace elements and nutraceuticals against several viral diseases including" exact="influenza" post="virus [ 87, 88]. However, it is difficult to"/>
   <result pre="12 weeks to improve their immunity [ 92]. Patients with" exact="diabetes mellitus" post="require a varied and balanced diet to maintain blood"/>
   <result pre="to be inefficient to enhance immunity except vitamin E for" exact="viral hepatitis" post="[ 32, 34]. Nearly 1/5 of the world's population"/>
   <result pre="be inefficient to enhance immunity except vitamin E for viral" exact="hepatitis" post="[ 32, 34]. Nearly 1/5 of the world's population"/>
   <result pre="in general and Lactobacillus varieties can be recommended to prevent" exact="influenza" post="like viral infections [ 70, 71]. Every patient who"/>
   <result pre="with respect to COVID-19 [ 103]. 5 Conclusion For a" exact="viral disease" post="like COVID-19, where no pharmacological strategies for prevention or"/>
   <result pre="oral vitamin A&amp;amp;D supplements to humoral immune responses following pediatric" exact="influenza" post="vaccination Viruses 11 10 2019 3 Iovino L. High-dose"/>
   <result pre="Selenium supplementation has beneficial and detrimental effects on immunity to" exact="influenza" post="vaccine in older adults Clin Nutr 36 2 2017"/>
   <result pre="Mousa H.A. Prevention and treatment of influenza, influenza-like illness, and" exact="common cold" post="by herbal, complementary, and natural therapies J Evid Based"/>
   <result pre="boosting the type 1 interferon response to RNA viruses including" exact="influenza" post="and coronavirus Prog Cardiovasc Dis 2020 7 Kang E.-J."/>
   <result pre="28719693 22 Goncalves-Mendes N. Impact of vitamin D supplementation on" exact="influenza" post="vaccine response and immune functions in deficient elderly persons:"/>
   <result pre="S. Vitamin D supplementation improves sustained virologic response in chronic" exact="hepatitis" post="C (genotype 1)-naive patients World J Gastroenterol 17 47"/>
   <result pre="Nimer A. Mouch A. Vitamin D improves viral response in" exact="hepatitis" post="C genotype 2-3 naïve patients World J Gastroenterol 18"/>
   <result pre="10714244 27 Hemila H. Kaprio J. Vitamin E supplementation and" exact="pneumonia" post="risk in males who initiated smoking at an early"/>
   <result pre="15315997 29 Andreone P. Vitamin E as treatment for chronic" exact="hepatitis" post="B: results of a randomized controlled pilot trial Antivir"/>
   <result pre="Fiorino S. Vitamin E for the treatment of children with" exact="hepatitis" post="B e antigen-positive chronic hepatitis: a systematic review and"/>
   <result pre="through the production of interferon-α/β at the initial stage of" exact="influenza" post="A virus (H3N2) infection Immune network 13 2 2013"/>
   <result pre="H. Chalker E. Vitamin C for preventing and treating the" exact="common cold" post="Cochrane Database Syst Rev 1 2013 CD000980 23440782 33"/>
   <result pre="and improves clinical symptoms in fewer hours in children with" exact="pneumonia" post="younger than 5 Years old. A randomized controlled clinical"/>
   <result pre="plus arginine supplementation on antibody titre and lymphocyte subsets after" exact="influenza" post="vaccination in elderly subjects: a randomized controlled trial Age"/>
   <result pre="of selenium supplementation on selenoprotein gene expression and response to" exact="influenza" post="vaccine challenge: a randomised controlled trial PloS One 6"/>
   <result pre="175 44 Miyamoto D. Thujaplicin-copper chelates inhibit replication of human" exact="influenza" post="viruses Antivir Res 39 2 1998 89 100 9806486"/>
   <result pre="Host cell copper transporters CTR1 and ATP7A are important for" exact="influenza" post="A virus replication Virol J 14 1 2017 11"/>
   <result pre="affects the cytokine secretion of CD4(+) T lymphocytes in acute" exact="asthma" post="J Asthma 49 10 2012 1012 1015 23134345 48"/>
   <result pre="F. Dietary plant stanol ester consumption improves immune function in" exact="asthma" post="patients: results of a randomized, double-blind clinical trial1 Am"/>
   <result pre="57 Müller L. Effect of broccoli sprouts and live attenuated" exact="influenza" post="virus on peripheral blood natural killer cells: a randomized,"/>
   <result pre="herbal medicine and neuraminidase inhibitors in the treatment of seasonal" exact="influenza" post="J Infect Chemother 18 4 2012 534 543 22350323"/>
   <result pre="women with fucoidan from seaweed increases immune responses to seasonal" exact="influenza" post="vaccination J Nutr 143 11 2013 1794 1798 24005608"/>
   <result pre="K. Effect of an echinacea-based hot drink versus oseltamivir in" exact="influenza" post="treatment: a randomized, double-blind, double-dummy, multicenter, noninferiority clinical trial"/>
   <result pre="with active hexose correlated compound improves the antibody response to" exact="influenza" post="B vaccine Nutr Res 33 1 2013 12 17"/>
   <result pre="A. Spirulina platensis versus silymarin in the treatment of chronic" exact="hepatitis" post="C virus infection. A pilot randomized, comparative clinical trial"/>
   <result pre="T. A probiotic fermented dairy drink improves antibody response to" exact="influenza" post="vaccination in the elderly in two randomised controlled trials"/>
   <result pre="bacteria reduced duration and severity but not the incidence of" exact="common cold" post="episodes in a double blind, randomized, controlled trial Vaccine"/>
   <result pre="1487 1499 25709784 78 Chen Y.-H. Well-tolerated Spirulina extract inhibits" exact="influenza" post="virus replication and reduces virus-induced mortality Sci Rep 6"/>
   <result pre="1079 19114073 81 Milner J.J. Beck M.A. The impact of" exact="obesity" post="on the immune response to infection Proc Nutr Soc"/>
   <result pre="W.D. Beck M.A. Obesity impairs the adaptive immune response to" exact="influenza" post="virus Annals of the American Thoracic Society 14 Supplement_5"/>
   <result pre="17 26086030 87 Bouvier N.M. Lowen A.C. Animal models for" exact="influenza" post="virus pathogenesis and transmission Viruses 2 8 2010 1530"/>
   <result pre="immunological significance of a human monoclonal antibody directed to the" exact="influenza" post="a virus nucleoprotein Clin Vaccine Immunol : CVI 20"/>
   <result pre="COVID-19 Coronavirus disease 2019 DHA Docosahexaenoic acid DTH Delayed type" exact="hypersensitivity" post="HBeAg Hepatitis B e-antigen HBV Hepatitis B virus HCV"/>
   <result pre="IL Interleukin IL-2R Interleukin-2 receptor INF Interferon LAIV Live attenuated" exact="influenza" post="virus MF Mekabu fucoidan NK Natural killer cells NRS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7162742/results/search/disease/results.xml">
   <result pre="PCR tests 24 hours apart and take direction from our" exact="infectious disease" post="physicians about the feasibility of de-isolating the patient if"/>
   <result pre="of Langerhans cell Histiocytosis who was in the ICU with" exact="pneumonia" post="and recent travel history to COVID-19 endemic country. He"/>
   <result pre="5 Matthay MA, Aldrich JM, Gotts JE. Treatment for severe" exact="acute respiratory distress syndrome" post="from COVID-19 Lancer Respir Med 2020 10.1016/S2213-2600(20)30127-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7162760/results/search/disease/results.xml">
   <result pre="chronic health conditions who are more likely to develop severe" exact="pneumonia" post="and death. Those with pulmonary arterial hypertension represent such"/>
   <result pre="hypertension represent such a high-risk group. Severe COVID-19 presents with" exact="respiratory failure" post="secondary to immuno-pathologic injury likely due to a combination"/>
   <result pre="P Galvin JR Lourens RM Reid AH Lung pathology of" exact="severe acute respiratory syndrome" post="(SARS): a study of 8 autopsy cases from Singapore"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7162794/results/search/disease/results.xml">
   <result pre="may well change. Keywords anticoagulant deep venous thrombosis venous thromboembolism" exact="pulmonary embolism" post="duplex ultrasound Introduction The diagnosis of venous thromboembolism (VTE)"/>
   <result pre="deep venous thrombosis (DVT) or with computed tomography (CT-PE) for" exact="pulmonary embolism." post="1 This common diagnosis and its work up are"/>
   <result pre="events and utility of empiric low dose anticoagulation with H1N1" exact="viral pneumonia" post="were reviewed, as well as emerging evidence regarding VTE"/>
   <result pre="and utility of empiric low dose anticoagulation with H1N1 viral" exact="pneumonia" post="were reviewed, as well as emerging evidence regarding VTE"/>
   <result pre="(2) the results will change management (3) clinical suspicion of" exact="pulmonary embolism" post="is high and CT PE is unobtainable or clinical"/>
   <result pre="across different patient populations, with the highest case reports of" exact="pulmonary embolism" post="(PE) in up to 40% of patients with elevated"/>
   <result pre="Algorithm for stable patient with suspected DVT. Note PE =" exact="pulmonary embolism;" post="VTE = venous thromboembolism; AC = anticoagulation; LE ="/>
   <result pre="for critically ill patient with suspected DVT. Note PE =" exact="pulmonary embolism;" post="VTE = venous thromboembolism; AC = anticoagulation; ACS ="/>
   <result pre="of Lower Extremity Deep Venous Thrombosis Clinical Characteristic Score Active" exact="cancer" post="(patient receiving treatment for cancer within the previous 6"/>
   <result pre="Thrombosis Clinical Characteristic Score Active cancer (patient receiving treatment for" exact="cancer" post="within the previous 6 months or currently receiving palliative"/>
   <result pre="than prophylactic dose in those patients with severe ARDS: Viral" exact="pneumonia" post="associated venous thrombotic events resulting in significant mortality were"/>
   <result pre="an empiric low dose anticoagulation protocol: P/F ratio &amp;lt; 200;" exact="viral pneumonia" post="suspected or confirmed; no absolute contraindications to anticoagulation. In"/>
   <result pre="empiric low dose anticoagulation protocol: P/F ratio &amp;lt; 200; viral" exact="pneumonia" post="suspected or confirmed; no absolute contraindications to anticoagulation. In"/>
   <result pre="data regarding risk-benefit ratio of empiric anticoagulation strategies. Patients with" exact="thrombocytopenia" post="(platelets &amp;lt; 30) should not be anticoagulated due to"/>
   <result pre="the inpatient setting and performance in the setting of pandemic" exact="pneumonia" post="is untested, yet no reasonable alternative exists. 12, 13,"/>
   <result pre="from OSH study. Table 6 VTE-BLEED Score Factor Score Active" exact="cancer" post="a 2 Male with uncontrolled arterial hypertension b 1"/>
   <result pre="BCC or SCC of the skin), recently recurrent or progressive" exact="cancer" post="or any cancer that required anti-cancer Tx within 6"/>
   <result pre="of the skin), recently recurrent or progressive cancer or any" exact="cancer" post="that required anti-cancer Tx within 6 mos. before VTE"/>
   <result pre="Algorithm for stable patient with suspected PE. Note PE =" exact="pulmonary embolism;" post="VTE = venous thromboembolism; AC = anticoagulation; LE ="/>
   <result pre="for critically ill patient with suspected PE. Note PE =" exact="pulmonary embolism;" post="VTE = venous thromboembolism; AC = anticoagulation; ACS ="/>
   <result pre="additional risk factors that increase bleeding risk such as thrombocytopenia," exact="cirrhosis" post="and other anti-thrombotic use that should be taken into"/>
   <result pre="of lower extremity venous duplex examination in the diagnosis of" exact="pulmonary embolism" post="J Vasc Surg 17 1993 934 938 ; discussion"/>
   <result pre="anticoagulation is associated with decreased venous thromboembolism in critically ill" exact="influenza" post="A H1N1 acute respiratory distress syndrome patients J Vasc"/>
   <result pre="with decreased venous thromboembolism in critically ill influenza A H1N1" exact="acute respiratory distress syndrome" post="patients J Vasc Surg Venous Lymphat Disord 7 2019"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7164393/results/search/disease/results.xml">
   <result pre="human CoV have emerged in the past 20 years with" exact="severe acute respiratory syndrome" post="CoV (SARS-CoV) in 2002, Middle East respiratory syndrome CoV"/>
   <result pre="25,000 deaths in 199 countries. Like SARS- and MERS-CoV, the" exact="respiratory disease" post="caused by SARS-CoV-2 can progress to acute lung injury"/>
   <result pre="can progress to acute lung injury (ALI), an end stage" exact="lung disease" post="with limited treatment options and very poor prognoses( 3"/>
   <result pre="to humans. A novel group 1 CoV called swine acute" exact="diarrhea" post="syndrome CoV (SADS-CoV) recently emerged from bats causing the"/>
   <result pre="unrelated RNA viruses including influenza, Ebola, CoV, and Venezuelan equine" exact="encephalitis" post="virus (VEEV)( 13 - 16 ). For VEEV, the"/>
   <result pre="RdRp residues F480L and V557L in a model coronavirus mouse" exact="hepatitis" post="virus (MHV) and in SARS-CoV, resulting in a 5-fold"/>
   <result pre="have demonstrated a high genetic barrier to NHC for VEEV," exact="influenza" post="and CoV ( 14 - 16 ), the lack"/>
   <result pre="depicts percent amino acid identity (% A.A. similarity) against mouse" exact="hepatitis" post="virus (MHV), SARS-CoV, or MERS-CoV. (B) The variation encompassed"/>
   <result pre="RNA of RSV ( 24 ), VEEV ( 14 )," exact="influenza" post="( 24 ), and our previous study used RNA"/>
   <result pre="is broadly active against multiple genetically distinct viruses including VEE," exact="influenza" post="A and B, Ebola, and Chikungunya viruses ( 13"/>
   <result pre="is compressed (e.g., 24-48 hours). As with oseltamivir treatment for" exact="influenza" post="which fails to provide a protective effect if administered"/>
   <result pre="to U, U to C) consistent with those reported after" exact="influenza" post="and VEE infections ( 14 , 15 ). Under"/>
   <result pre=", Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia . N. Engl. J. Med. 367,"/>
   <result pre="R. , Plemper R. K. , Characterization of orally efficacious" exact="influenza" post="drug with high resistance barrier in ferrets and human"/>
   <result pre="Baric R. S. , A mouse model for MERS coronavirus-induced" exact="acute respiratory distress syndrome" post=". Nat. Microbiol. 2, 16226 ( 2016). 10.1038/nmicrobiol.2016.226 27892925"/>
   <result pre="Y. , Risk factors for severe illness with 2009 pandemic" exact="influenza" post="A (H1N1) virus infection in China . Clin. Infect."/>
   <result pre="Shi, Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin. bioRxiv,"/>
   <result pre="vaccination strategies that protect aged mice from lethal challenge from" exact="influenza" post="virus and heterologous severe acute respiratory syndrome coronavirus ."/>
   <result pre="aged mice from lethal challenge from influenza virus and heterologous" exact="severe acute respiratory syndrome" post="coronavirus . J. Virol. 85, 217– 230 ( 2011)."/>
   <result pre="influences the infectious dose of MERS-CoV necessary to achieve severe" exact="respiratory disease" post=". Virology 517, 98– 107 ( 2018). 10.1016/j.virol.2017.12.006 29277291"/>
   <result pre=", Systematic assembly of a full-length infectious cDNA of mouse" exact="hepatitis" post="virus strain A59 . J. Virol. 76, 11065– 11078"/>
   <result pre="Serial histopathological examination of the lungs of mice infected with" exact="influenza" post="A virus PR8 strain . PLOS ONE 6, e21207"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7165113/results/search/disease/results.xml">
   <result pre="Introduction First reported in December 2019 as a cluster of" exact="pneumonia" post="cases in Wuhan (China), the novel coronavirus (SARS-CoV-2) has"/>
   <result pre="the most common symptoms of COVID-19 are fever, cough, and" exact="shortness" post="of breath, we present a case in which a"/>
   <result pre="prescribed. He subsequently developed diarrhea, was diagnosed with Clostridium difficile" exact="colitis" post="2 days ago, and started on treatment that resulted"/>
   <result pre="electively placed on mechanical ventilator support for concerns of impending" exact="respiratory failure" post="and transferred to our facility. On arrival to our"/>
   <result pre="exam findings, history of recent infection, negative MRI results, and" exact="respiratory failure" post="without obvious parenchymal pathology to explain the same, a"/>
   <result pre="novel virus [ 4]. Most immediate causes of death involve" exact="acute respiratory distress syndrome" post="(ARDS) and its sequelae along with overwhelming shock from"/>
   <result pre="model with infection by a coronavirus variant to model human" exact="multiple sclerosis," post="another known demyelinating disease [ 8, 9]. Evidence has"/>
   <result pre="of the MERS-CoV outbreak, one patient was diagnosed with Bickerstaff’s" exact="encephalitis" post="with overlapping GBS during his treatment course [ 11]."/>
   <result pre="subsequently. Her laboratory work up had already revealed lymphopenia and" exact="thrombocytopenia" post="on admission though. Hence, there was suggestion of infection,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7165846/results/search/disease/results.xml">
   <result pre="prices rise Increased rates of infectious diseases Higher rates of" exact="respiratory disease" post="because of air pollution Increased traumatic injury and subsequent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7166760/results/search/disease/results.xml">
   <result pre="2020. Together with the other two highly pathogenic coronaviruses, the" exact="severe acute respiratory syndrome" post="coronavirus (SARS‐CoV) and Middle East respiratory syndrome coronavirus (MERS‐CoV),"/>
   <result pre="1 INTRODUCTION In late December 2019, clusters of patients with" exact="pneumonia" post="of unknown etiology were reported by the local health"/>
   <result pre="1 In early January 2020, the causative agent of mysterious" exact="pneumonia" post="has been identified as a novel coronavirus by several"/>
   <result pre="seen outbreaks caused by two other highly pathogenic coronaviruses, the" exact="severe acute respiratory syndrome" post="coronavirus (SARS‐CoV) and the Middle East respiratory syndrome coronavirus"/>
   <result pre="presentations, which can vary from asymptomatic infection to severe disease;" exact="severe acute respiratory syndrome." post="5 , 6 Therefore, our current knowledge of the"/>
   <result pre="MERS‐CoV infection include exudative diffuse alveolar damage with hyaline membranes," exact="pulmonary edema," post="type II pneumocyte hyperplasia, interstitial pneumonia (which was predominantly"/>
   <result pre="with hyaline membranes, pulmonary edema, type II pneumocyte hyperplasia, interstitial" exact="pneumonia" post="(which was predominantly lymphocytic), and multinucleate syncytial cells. 22"/>
   <result pre="22 These bronchial lesions comprise the pathologic basis for the" exact="respiratory failure" post="and radiologic abnormalities of MERS‐CoV infection. 24 Target cells"/>
   <result pre="ultrastructural findings in the kidney, renal biopsies demonstrated acute tubulointerstitial" exact="nephritis" post="and acute tubular sclerosis with proteinaceous cast formation. 26"/>
   <result pre="also developed dyspnea and lymphopenia. Complications of 2019‐nCoV infections included" exact="acute respiratory distress syndrome," post="RNAaemia, acute cardiac injury, and secondary (super‐)infections. 38 All"/>
   <result pre="for Viral Immunology. References REFERENCES 1 http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. Report of clustering" exact="pneumonia" post="of unknown etiology in Wuhan City. 2019. 2 Chen"/>
   <result pre="W , et al. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med. 2020 10.1056/NEJMoa2001017"/>
   <result pre=", Kok KH , et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person‐to‐person transmission:"/>
   <result pre=", Lee KC , et al. Lung pathology of fatal" exact="severe acute respiratory syndrome." post="Lancet. 2003; 361( 9371): 1773‐ 1778. 12781536 8 Ding"/>
   <result pre=", Shen H , et al. The clinical pathology of" exact="severe acute respiratory syndrome" post="(SARS): a report from China . J Pathol. 2003;"/>
   <result pre="Bradley BT , Bryan A . Emerging respiratory infections: The" exact="infectious disease" post="pathology of SARS, MERS, pandemic influenza, and Legionella ."/>
   <result pre="of SARS‐associated coronavirus in lung of a fatal case of" exact="severe acute respiratory syndrome" post="in Taiwan . Hum Pathol. 2005; 36( 3): 303‐"/>
   <result pre="AKL , et al. Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome." post="Clin Exp Immunol. 2004; 136( 1): 95‐ 103. 15030519"/>
   <result pre="B , Salto‐Tellez M . Elucidating the molecular physiopathology of" exact="acute respiratory distress syndrome" post="in severe acute respiratory syndrome patients . Virus Res."/>
   <result pre="Elucidating the molecular physiopathology of acute respiratory distress syndrome in" exact="severe acute respiratory syndrome" post="patients . Virus Res. 2009; 145( 2): 260‐ 269."/>
   <result pre=". Temporal changes in cytokine/chemokine profiles and pulmonary involvement in" exact="severe acute respiratory syndrome" post=". Respirology. 2006; 11( 6): 715‐ 722. 17052299 18"/>
   <result pre=", et al. Analysis of serum cytokines in patients with" exact="severe acute respiratory syndrome." post="Infect Immun. 2004; 72( 8): 4410‐ 4415. 15271897 19"/>
   <result pre="with atypical innate and adaptive immune responses in patients with" exact="severe acute respiratory syndrome" post=". J Virol. 2007; 81( 16): 8692‐ 8706. 17537853"/>
   <result pre=", Eisfeld AJ , Schäfer A , et al. Pathogenic" exact="influenza" post="viruses and coronaviruses utilize similar and contrasting approaches to"/>
   <result pre="Dysregulated type I interferon and inflammatory monocyte‐macrophage responses cause lethal" exact="pneumonia" post="in SARS‐CoV‐infected mice . Cell Host Microbe. 2016; 19("/>
   <result pre=", et al. Identification of a novel coronavirus causing severe" exact="pneumonia" post="in human: a descriptive study . Chin Med J."/>
   <result pre="Zhou P , Yang XL , Wang XG . A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study . Lancet. 2020;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7167536/results/search/disease/results.xml">
   <result pre="serotype formerly named coronavirus disease (COVID)-19 and now identified as" exact="severe acute respiratory syndrome" post="(SARS)-COV-2 [ 1]. The disease has been firstly reported"/>
   <result pre="2020, SARS-COV-2 carried a mortality rate around 6.1% compared to" exact="influenza" post="that is supposed be around 1% [ 3]. All"/>
   <result pre="by those cases where the severe form of SARS-COV-2 interstitial" exact="pneumonia" post="occurs, with acute respiratory distress syndrome (ARDS) that might"/>
   <result pre="where the severe form of SARS-COV-2 interstitial pneumonia occurs, with" exact="acute respiratory distress syndrome" post="(ARDS) that might lead to fatal events [ 5]."/>
   <result pre="treatment in a series of patients affected by severe interstitial" exact="pneumonia" post="by Zhang et al. [ 7] which observed an"/>
   <result pre="medical literature, SARS coronavirus is associated with the occurrence of" exact="hemophagocytic lymphohistiocytosis" post="(sHLH) which represents a life-threatening hyperinflammatory syndrome leading to"/>
   <result pre="retina [ 8]. This model was identified as experimental coronavirus" exact="retinopathy" post="(ECOR) [ 8]. Few months later, the same group"/>
   <result pre="system, while the second phase is likely to be an" exact="autoimmune disease" post="where the role of the severe postviral inflammation represents"/>
   <result pre="TNF-alpha signaling [ 12]. The clinical picture offered by SARS-COV-2" exact="pneumonia" post="seems to present a series of similarities to so-called"/>
   <result pre="seems to present a series of similarities to so-called interstitial" exact="pneumonia" post="with autoimmune features (IPAF) recently described by the European"/>
   <result pre="appears quite risky due to the possible occurrence of fulminant" exact="tuberculosis" post="or might play a very limited role, other new"/>
   <result pre="addressed several times for more common diseases like herpes virus" exact="encephalitis" post="[ 15], which is universally recognized as a postviral"/>
   <result pre="cost-effectiveness compared to other therapies like monoclonals. Moreover, the SARS-COV-2" exact="pneumonia" post="animal model described in 2010 by Smits et al."/>
   <result pre="MS Detrick B Hooks JJ Retinal degeneration in experimental coronavirus" exact="retinopathy" post="(ECOR) is associated with increased TNF-alpha, soluble TNFR2 and"/>
   <result pre="An official European respiratory society/American thoracic society research statement: interstitial" exact="pneumonia" post="with autoimmune features Eur Respir J 2015 46 4"/>
   <result pre="Y et al. On the use of corticosteroids for 2019-nCoV" exact="pneumonia" post="Lancet 2020 395 10225 683 684 10.1016/S0140-6736(20)30361-5 32122468 16."/>
   <result pre="10.1016/S0140-6736(20)30361-5 32122468 16. Stahl JP Mailles A Herpes simplex virus" exact="encephalitis" post="update Curr Opin Infect Dis 2019 32 3 239"/>
   <result pre="17. Chaudhuri A Kennedy PGE Diagnosis and treatment of viral" exact="encephalitis" post="Postgrad Med J 2002 78 575 583 10.1136/pmj.78.924.575 12415078"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7167615/results/search/disease/results.xml">
   <result pre="are a common cause of infection in immunosuppressed children undergoing" exact="cancer" post="therapy. Pulmonary sequelae have been documented following respiratory viral"/>
   <result pre="morbidity of respiratory viral infections during chemotherapy in children with" exact="acute lymphoblastic leukemia" post="(ALL). Methods Childhood ALL survivors, aged 7 to 18"/>
   <result pre="of respiratory viral infections during chemotherapy in children with acute" exact="lymphoblastic leukemia" post="(ALL). Methods Childhood ALL survivors, aged 7 to 18"/>
   <result pre="respiratory viral infections during chemotherapy in children with acute lymphoblastic" exact="leukemia" post="(ALL). Methods Childhood ALL survivors, aged 7 to 18"/>
   <result pre="to evaluate the etiology and clinical significance of these findings." exact="cancer" post="survivors child neoplasms respiratory function tests respiratory traction infections"/>
   <result pre="most prevalent causes of morbidity and premature mortality in pediatric" exact="cancer" post="survivors. 1, 2 Long‐term follow‐up studies have found respiratory‐related"/>
   <result pre="before the age of 50 years. Of all childhood cancers," exact="acute lymphoblastic leukemia" post="(ALL) is the most common and carries an excellent"/>
   <result pre="the age of 50 years. Of all childhood cancers, acute" exact="lymphoblastic leukemia" post="(ALL) is the most common and carries an excellent"/>
   <result pre="age of 50 years. Of all childhood cancers, acute lymphoblastic" exact="leukemia" post="(ALL) is the most common and carries an excellent"/>
   <result pre="general population‐based studies, respiratory syncytial virus (RSV) and rhinovirus (HRV)" exact="bronchiolitis" post="during infancy have been associated with subsequent wheeze and"/>
   <result pre="HRV (culture only); adenovirus; parainfluenza virus 1, 2, and 3;" exact="influenza" post="A and B. Testing for human metapneumovirus (hMPV) became"/>
   <result pre="sensitivity to peripheral airway function. 26 Based on a previous" exact="asthma" post="study, 27 a difference of 0.99 cm H 2O/L/s was considered"/>
   <result pre="RSV (25 of 81), PIV 3 (9 of 81) and" exact="influenza" post="A (9 of 81), parainfluenza type 3 (7 of"/>
   <result pre="A (9 of 81), parainfluenza type 3 (7 of 81)," exact="influenza" post="B (6 of 81), hMPV (6 of 81), adenovirus"/>
   <result pre="nocturnal cough (45% vs 26%; OR, 2.7; P = .11). As underlying" exact="asthma" post="could be an intervening variable, subgroup analysis in the"/>
   <result pre="atopic disease was similar between the viral and control groups:" exact="asthma" post="4 of 31 vs 2 of 23 ( P = 1.00);"/>
   <result pre="asthma 4 of 31 vs 2 of 23 ( P = 1.00);" exact="allergic rhinitis" post="4 of 31 vs 2 of 23 ( P = 1.00);"/>
   <result pre="4 of 31 vs 2 of 23 ( P = 1.00); allergic" exact="rhinitis" post="4 of 31 vs 2 of 23 ( P = 1.00);"/>
   <result pre="long‐term pulmonary morbidity of respiratory viruses during chemotherapy in childhood" exact="cancer" post="survivors. Compared to controls, children with RVIs during chemotherapy"/>
   <result pre="and HRV bronchiolitis, where RVIs have been associated with subsequent" exact="asthma" post="and atopy. 12, 13 While the pathogenesis of early‐life"/>
   <result pre="cohort, who were older but more severely immunosuppressed. We hypothesize" exact="cancer" post="survivors may have suffered direct tissue damage or neuroimmune"/>
   <result pre="important negative finding that supports conservative management of RVIs during" exact="cancer" post="therapy and suggests viral infections do not confer long‐term"/>
   <result pre="decline associated with RVIs in HSCT recipients, independent of alloimmune" exact="lung disease." post="14 Here, prolonged viral‐shedding and subsequent airway inflammation were"/>
   <result pre="studies have previously reported on the pulmonary function of childhood" exact="leukemia" post="survivors, none of which analyzed the impact of respiratory"/>
   <result pre="pulmonary‐toxic therapies (HSCT or chest radiation). A recent study of" exact="leukemia" post="and lymphoma survivors has been conducted in an Egyptian"/>
   <result pre="(HSCT or chest radiation). A recent study of leukemia and" exact="lymphoma" post="survivors has been conducted in an Egyptian institution with"/>
   <result pre="paucity of literature describing the long‐term lung function in contemporary" exact="cancer" post="survivors treated without established pulmonary‐toxic therapies. Although it was"/>
   <result pre="is one of the largest cross‐sectional lung function studies in" exact="leukemia" post="survivors, and the only report to examine the late"/>
   <result pre="recruited to test R5, power calculations were based on an" exact="asthma" post="study, and this study was not powered to evaluate"/>
   <result pre=", et al. A revised definition for cure of childhood" exact="acute lymphoblastic leukemia." post="Leukemia. 2014; 28( 12): 2336‐ 2343. 24781017 4 Dietz"/>
   <result pre="et al. A revised definition for cure of childhood acute" exact="lymphoblastic leukemia." post="Leukemia. 2014; 28( 12): 2336‐ 2343. 24781017 4 Dietz"/>
   <result pre="Analysis of risk factors for abnormal pulmonary function in pediatric" exact="cancer" post="survivors. Pediatr Blood Cancer. 2016; 63( 7): 1264‐ 1271."/>
   <result pre="et al. Acute respiratory infections in children and adolescents with" exact="acute lymphoblastic leukemia" post=". Cancer. 2016; 122( 5): 798‐ 805. 26700662 8"/>
   <result pre="al. Acute respiratory infections in children and adolescents with acute" exact="lymphoblastic leukemia" post=". Cancer. 2016; 122( 5): 798‐ 805. 26700662 8"/>
   <result pre="Acute respiratory infections in children and adolescents with acute lymphoblastic" exact="leukemia" post=". Cancer. 2016; 122( 5): 798‐ 805. 26700662 8"/>
   <result pre=", et al. Wheezing rhinovirus illnesses in early life predict" exact="asthma" post="development in high‐risk children . Am J Respir Crit"/>
   <result pre="the Liverpool Respiratory Symptom Questionnaire (LRSQ) in well children with" exact="cystic fibrosis" post="(CF) . J Cyst Fibrosis. 2010; 9: S57. 26"/>
   <result pre="spirometry in a long‐term study of controller therapy for pediatric" exact="asthma" post=". J Allergy Clin Immunol. 2009; 123( 4): 861‐"/>
   <result pre="of forced oscillatory resistance in poorly controlled or persistent pediatric" exact="asthma" post=". Chest J. 2014; 146( 4): 974‐ 981. 28"/>
   <result pre="A , Zimmermann M , et al. Risk‐adjusted therapy of" exact="acute lymphoblastic leukemia" post="can decrease treatment burden and improve survival: treatment results"/>
   <result pre=", Zimmermann M , et al. Risk‐adjusted therapy of acute" exact="lymphoblastic leukemia" post="can decrease treatment burden and improve survival: treatment results"/>
   <result pre="Zimmermann M , et al. Risk‐adjusted therapy of acute lymphoblastic" exact="leukemia" post="can decrease treatment burden and improve survival: treatment results"/>
   <result pre="Pozza L , Sutton R , et al. High‐risk childhood" exact="acute lymphoblastic leukemia" post="in first remission treated with novel intensive chemotherapy and"/>
   <result pre="L , Sutton R , et al. High‐risk childhood acute" exact="lymphoblastic leukemia" post="in first remission treated with novel intensive chemotherapy and"/>
   <result pre=", Sutton R , et al. High‐risk childhood acute lymphoblastic" exact="leukemia" post="in first remission treated with novel intensive chemotherapy and"/>
   <result pre=". Association between respiratory infections in early life and later" exact="asthma" post="is independent of virus type . J Allergy Clin"/>
   <result pre="A , et al. Lung function in survivors of childhood" exact="acute lymphoblastic leukemia." post="Chest J. 1999; 116( 5): 1163‐ 1167. 39 Miller"/>
   <result pre=", et al. Lung function in survivors of childhood acute" exact="lymphoblastic leukemia." post="Chest J. 1999; 116( 5): 1163‐ 1167. 39 Miller"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7167874/results/search/disease/results.xml">
   <result pre="cell protein 16 (CC16): Utility of its assay during acute" exact="bronchiolitis" post="EGRON et al. Egron Carole MD http://orcid.org/0000-0001-5832-3572 1 Labbé"/>
   <result pre="duration of the public health emergency. file:PPUL-55-490.pdf Abstract Abstract Acute" exact="bronchiolitis" post="is responsible for high morbidity in infants. Club cell"/>
   <result pre="in asthma. However, its value as a marker of acute" exact="bronchiolitis" post="severity and later recurrent wheezing are uncertain, especially the"/>
   <result pre="Hospital to correlate serum CC16 level with clinical severity of" exact="bronchiolitis" post="in hospitalized infants aged less than 1 year. We analyzed"/>
   <result pre="In 166 infants, serum CC16 did not correlate with acute" exact="bronchiolitis" post="severity ( P = .49), but urinary CC16 did ( P &amp;lt; .001)."/>
   <result pre="year. Urinary CC16 could be a useful biomarker in acute" exact="bronchiolitis" post="for specific indications. This noninvasive assay would be particularly"/>
   <result pre="function. Further studies are needed to assess these factors. acute" exact="bronchiolitis" post="club (Clara) cell protein infant morbidity severity Funding hospital"/>
   <result pre="early childhood and a major health problem worldwide. 3 Severe" exact="bronchiolitis" post="is characterized by extensive inflammation and edema of the"/>
   <result pre="necrosis of airway epithelial cells. 4 Admission to hospital with" exact="bronchiolitis" post="at a young age is associated with an increased"/>
   <result pre="identify novel biological markers measurable during the course of acute" exact="bronchiolitis" post="for clinically effective prediction of disease severity and later"/>
   <result pre="receptor for advanced glycation end‐product, 11 and severity of acute" exact="bronchiolitis" post="and risk of wheezing bronchitis. Club cell protein (CC16)"/>
   <result pre="its urinary assay. 14 The link between its levels and" exact="asthma" post="has already been studied, 15, 16, 17 but its"/>
   <result pre="been studied, 15, 16, 17 but its relation to acute" exact="bronchiolitis" post="has received less attention. 18 We set out to"/>
   <result pre="could be a severity biomarker of epithelial damage during acute" exact="bronchiolitis" post="and of recurrent wheezing in the sequelae. We also"/>
   <result pre="to evaluate the correlation between serum CC16 level and acute" exact="bronchiolitis" post="clinical severity in hospitalized children aged under 1 year."/>
   <result pre="Cases All infants aged under 1 year hospitalized for acute" exact="bronchiolitis" post="at Clermont‐Ferrand University Hospital from 1 November 2015 to"/>
   <result pre="included. Infants born before 34 weeks of amenorrhea, or with" exact="cystic fibrosis," post="bronchopulmonary dysplasia, suspected primary ciliary dyskinesia, congenital heart disease,"/>
   <result pre="weeks of amenorrhea, or with cystic fibrosis, bronchopulmonary dysplasia, suspected" exact="primary ciliary dyskinesia," post="congenital heart disease, immune deficiency or acute renal failure"/>
   <result pre="or with cystic fibrosis, bronchopulmonary dysplasia, suspected primary ciliary dyskinesia," exact="congenital heart disease," post="immune deficiency or acute renal failure were excluded. Acute"/>
   <result pre="with cystic fibrosis, bronchopulmonary dysplasia, suspected primary ciliary dyskinesia, congenital" exact="heart disease," post="immune deficiency or acute renal failure were excluded. Acute"/>
   <result pre="disease, immune deficiency or acute renal failure were excluded. Acute" exact="bronchiolitis" post="severity was rated mild, moderate or severe by Wainwright's"/>
   <result pre="before 34 weeks, ongoing pulmonary infection, treated eczema or first‐degree" exact="asthma" post="were excluded. 2.5 Viral detection for cases Nasopharyngeal samples"/>
   <result pre="short‐stay wards; a multiplex PCR panel (adenovirus, coronavirus, metapneumovirus, enterovirus/rhinovirus," exact="influenza" post="A and B, parainfluenza virus, RSV, Bordetella pertussis, Chlamydophila"/>
   <result pre="( r = 0.43; P &amp;lt; .001). CC16, club cell protein 16 3.3.2 Acute" exact="bronchiolitis" post="severity CC16s levels were not correlated with the immediate"/>
   <result pre="were not correlated with the immediate clinical severity of acute" exact="bronchiolitis" post="( P = .89; Figure 2). Median levels were 9.2 (5.5‐14.3)"/>
   <result pre="in moderate acute bronchiolitis, 7 (6.8‐8.9) μg/L in severe acute" exact="bronchiolitis" post="according to the Wainwright score, and 10.3 ± 3.6 μg/L in controls."/>
   <result pre="and gestational age at birth) showed no impact of acute" exact="bronchiolitis" post="severity on CC16s levels. Figure 2 LogCC16s according to"/>
   <result pre="μg/L vs 11.2 [3.4–28.8] μg/L; P = .04) and in superinfected acute" exact="bronchiolitis" post="(28.2 [17.1‐118.6] μg/L vs 11.5 [3.4‐31.7] μg/L; P = .02). CC16u"/>
   <result pre="Figure 4). The logCC16u/logRBPu ratio was significantly correlated with acute" exact="bronchiolitis" post="severity according to the Wainwright score ( P = .02), but"/>
   <result pre="and those with recurrent wheezing 1 year after the acute" exact="bronchiolitis" post="(median CC16s level 8.5 [5.6‐13.6] vs 8.9 [4.5‐15.5], P = .94;"/>
   <result pre="their hospitalization. Multivariate analysis showed an impact of first‐degree family" exact="asthma" post="on CC16s levels (regression coefficient = 0.18; 95%CI [0.06,0.3]; P = .003). 4"/>
   <result pre="and demonstrated an accelerated aging profile in lungs similar to" exact="chronic obstructive pulmonary disease." post="20 Several studies have been conducted on the relationship"/>
   <result pre="relationship between CC16 and asthma, but its relation to acute" exact="bronchiolitis" post="has received less attention. The only available pediatric study,"/>
   <result pre="significantly increased CC16s in those infected with RSV compared to" exact="influenza" post="virus (IV)/parainfluenza virus (PIV) viruses. Our results for serum"/>
   <result pre="for the most severe cases. Increased CC16 levels during acute" exact="bronchiolitis" post="could be the result of viral damage on the"/>
   <result pre="marker such as urinary creatinine. LogCC16u/logRBPu was correlated to acute" exact="bronchiolitis" post="severity, evaluated by the Wainwright score. Likewise, hydration status"/>
   <result pre="chose was admittedly too short to analyze the risk of" exact="asthma" post="in the long term. It is also still unclear"/>
   <result pre="It is also still unclear whether low CC16 levels induce" exact="asthma" post="in the long term or whether chronic inflammation is"/>
   <result pre="function. A reasoned use of CC16u assay in category‐specific acute" exact="bronchiolitis" post="could thus be considered, for example most severe cases,"/>
   <result pre=", et al. In very young infants severity of acute" exact="bronchiolitis" post="depends on carried viruses. PLOS One. 2009; 4( 2):"/>
   <result pre="A , Labbé A . Predicting the severity of acute" exact="bronchiolitis" post="in infants: should we use a clinical score or"/>
   <result pre="Oxidative stress and inflamatory plasma biomarkers in respiratory syncytial virus" exact="bronchiolitis" post=". Clin Respir J. 2017; 11( 6): 839‐ 846."/>
   <result pre="al. Serum soluble receptor for advanced glycation end‐products during acute" exact="bronchiolitis" post="in infant: Prospective study in 93 cases . Pediatr"/>
   <result pre="enzyme immunoassay and its importance as an indicator of bronchial" exact="asthma" post="in children . J Pharm Biomed Anal. 2004; 34("/>
   <result pre=", Laing IA , Khoo S‐K , et al. Acute" exact="asthma" post="in children: relationships among CD14 and CC16 genotypes, plasma"/>
   <result pre="double‐blind, controlled trial of nebulized epinephrine in infants with acute" exact="bronchiolitis" post=". N Engl J Med. 2003; 349( 1): 27‐"/>
   <result pre="Infant swimming in chlorinated pools and the risks of bronchiolitis," exact="asthma" post="and allergy. Eur Respir J. 2010; 36( 1): 41‐"/>
   <result pre="et al. Association of urine CC16 and lung function and" exact="asthma" post="in Chinese children. Allergy Asthma Proc. 2015; 36( 4):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7167964/results/search/disease/results.xml">
   <result pre="usually suffer from recurrent bacterial respiratory infections, resulting in progressive" exact="bronchiectasis" post="and chronic lung disease. 2, 3, 4, 5 Immunoglobulin"/>
   <result pre="recurrent bacterial respiratory infections, resulting in progressive bronchiectasis and chronic" exact="lung disease." post="2, 3, 4, 5 Immunoglobulin replacement therapy (IRT) reduces"/>
   <result pre="11 Human herpesvirus 8 (HHV‐8) has been associated with granulomatous/lymphocytic" exact="interstitial lung disease" post="(GLILD) in patients with common variable immunodeficiency (CVID), 8"/>
   <result pre="Human herpesvirus 8 (HHV‐8) has been associated with granulomatous/lymphocytic interstitial" exact="lung disease" post="(GLILD) in patients with common variable immunodeficiency (CVID), 8"/>
   <result pre="associated with granulomatous/lymphocytic interstitial lung disease (GLILD) in patients with" exact="common variable immunodeficiency" post="(CVID), 8 and enterovirus is a known cause of"/>
   <result pre="(CVID), 8 and enterovirus is a known cause of fatal" exact="meningoencephalitis" post="in patients with X‐linked agammaglobulinemia (XLA). 9, 10 In"/>
   <result pre="detected by using previously described primer sets only to amplify" exact="influenza" post="viruses in a multiplex PCR assay. 12 A second"/>
   <result pre="RV (September) Yes 14 Secondary HID after rituximab for refractory" exact="nephrotic syndrome" post="No NA Male 4.7 RV (December) Yes AD‐HIES, autosomal"/>
   <result pre="delta syndrome; ARA, autosomal recessive agammaglobulinemia; CID, combined immunodeficiency; CVID," exact="common variable immunodeficiency;" post="HID, humoral immunodeficiency; HSCT, hematopoietic stem cell transplantation; NA,"/>
   <result pre="However, viral testing is routinely performed only in children with" exact="severe combined immunodeficiency" post="(SCID). 1, 4 Regarding HID, protocols present a great"/>
   <result pre="22 Although bacteria are detected in 44% of respiratory exacerbations," exact="viral pneumonia" post="has also been reported. 22 Lung sequelae in these"/>
   <result pre="Although bacteria are detected in 44% of respiratory exacerbations, viral" exact="pneumonia" post="has also been reported. 22 Lung sequelae in these"/>
   <result pre="no PID, but he developed persistent B‐cell lymphopenia with secondary" exact="hypogammaglobulinemia" post="requiring IRT 1 year after receiving rituximab for treating"/>
   <result pre="requiring IRT 1 year after receiving rituximab for treating steroid‐resistant" exact="nephrotic syndrome." post="Rituximab was the first anti‐CD20 monoclonal antibody, and the"/>
   <result pre="a clinical condition similar to CVID, with the degree of" exact="hypogammaglobulinemia" post="being directly associated with infection rates. 23 These infections,"/>
   <result pre="of anti‐CD20 monoclonal antibodies. 25 However, the clinical impact of" exact="hypogammaglobulinemia" post="induced by CD20‐targeted therapy remains unclear. Our study has"/>
   <result pre="S , et al. Respiratory infections and antibiotic usage in" exact="common variable immunodeficiency." post="J Allergy Clin Immunol Pract. 2018; 6: 159– 168.e3."/>
   <result pre="and persistent respiratory tract viral infections in patients with primary" exact="hypogammaglobulinemia" post=". J Allergy Clin Immunol. 2010; 126: 120– 126."/>
   <result pre="126. 20541246 8 Park JH , Levinson AI . Granulomatous‐lymphocytic" exact="interstitial lung disease" post="(GLILD) in common variable immunodeficiency (CVID) . Clin Immunol."/>
   <result pre="20541246 8 Park JH , Levinson AI . Granulomatous‐lymphocytic interstitial" exact="lung disease" post="(GLILD) in common variable immunodeficiency (CVID) . Clin Immunol."/>
   <result pre=", Levinson AI . Granulomatous‐lymphocytic interstitial lung disease (GLILD) in" exact="common variable immunodeficiency" post="(CVID) . Clin Immunol. 2010; 134: 97– 103. 19900842"/>
   <result pre=", Garcia ML , Casas I . Simultaneous detection of" exact="influenza" post="A, B, and C viruses, respiratory syncytial virus, and"/>
   <result pre="Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of" exact="chronic obstructive pulmonary disease" post=". Am J Respir Crit Care Med. 2013; 188:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7172565/results/search/disease/results.xml">
   <result pre="data on anesthetic management. Other viral diseases, such as H1N1" exact="influenza" post="and severeacuterespiratorysyndrome(SARS), have been associated with severe respiratory compromise"/>
   <result pre="pregnancy. Because anesthesiologists must take into account the risk of" exact="meningitis" post="or encephalitis associated with neuraxial procedures in the setting"/>
   <result pre="anesthesiologists must take into account the risk of meningitis or" exact="encephalitis" post="associated with neuraxial procedures in the setting of untreated"/>
   <result pre="before the neuraxial procedure. Computed tomographyor chest X-ray evidence of" exact="pneumonia" post="was reported in all patients before delivery. Clinical severity"/>
   <result pre="138 COVID-19–positive nonpregnant patients reported about one-third of patients had" exact="thrombocytopenia" post="(&amp;lt;150,000 × 10 6/L) regardless of severity of illness."/>
   <result pre="(100%) Epidural a 7 (78%) 5.07–10.61 NR CT evidence of" exact="pneumonia" post="9 (100%); clinical details NR No Li et al"/>
   <result pre="dayof delivery: NR for any patient Worsening CT evidence of" exact="pneumonia" post="in 2 (67%), clinical details NR No Wang et"/>
   <result pre="cesarean delivery be needed. In general, the risk of causing" exact="meningitis" post="or encephalitis is extremely low with neuraxial procedures, even"/>
   <result pre="be needed. In general, the risk of causing meningitis or" exact="encephalitis" post="is extremely low with neuraxial procedures, even in infected"/>
   <result pre="lumbar punctures. It is thought that patients who subsequently developed" exact="meningitis" post="following lumbar puncture were early in the progression of"/>
   <result pre="disease (before cerebrospinal fluid [CSF] evidence of disease) or the" exact="meningitis" post="was due to the pathogenic nature of the specific"/>
   <result pre="of patients with COVID-19 infection have been reported to have" exact="thrombocytopenia" post="compared with 7%–12% of patients during pregnancy alone. 7"/>
   <result pre="R Zheng S et al. Lack of vertical transmission of" exact="severe acute respiratory syndrome" post="Coronavirus 2, China. Emerg Infect Dis J. 2020 [Epub"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus–infected" exact="pneumonia" post="in Wuhan, China. JAMA. 2020; 323: 1061– 1069. 6."/>
   <result pre="NH Wald ER Chiponis D Risk factors for development of" exact="bacterial meningitis" post="among children with occult bacteremia. J Pediatr. 1986; 109:"/>
   <result pre="Wald ER Chiponis D Risk factors for development of bacterial" exact="meningitis" post="among children with occult bacteremia. J Pediatr. 1986; 109:"/>
   <result pre="on Practice Bulletins, Turrentine M. ACOG practice bulletin no. 207:" exact="thrombocytopenia" post="in pregnancy. Obstet Gynecol. 2019; 133: e181– e193. 30801473"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7172913/results/search/disease/results.xml">
   <result pre="doi: 10.1016/S1473-3099(20)30248-6 : Article Safety and immunogenicity of a modified" exact="vaccinia virus" post="Ankara vector vaccine candidate for Middle East respiratory syndrome:"/>
   <result pre="Background The Middle East respiratory syndrome coronavirus (MERS-CoV) causes a" exact="respiratory disease" post="with a case fatality rate of up to 35%."/>
   <result pre="aimed to assess safety and tolerability of an anti-MERS-CoV modified" exact="vaccinia virus" post="Ankara (MVA)-based vaccine candidate that expresses the MERS-CoV spike"/>
   <result pre="MVA-MERS-S, a novel vaccine candidate based on the recombinant modified" exact="vaccinia virus" post="Ankara (MVA) vaccine vector platform, has been reported to"/>
   <result pre="for protection. In this study, we used the recombinant modified" exact="vaccinia virus" post="Ankara (rMVA) vaccine vector platform, which has been shown"/>
   <result pre="sequence. A phytohemagglutinin pool and a cytomegalovirus, Epstein-Barr virus, and" exact="influenza" post="peptide pool (JPT Peptide Technologies, Berlin, Germany) served as"/>
   <result pre="in the appendix (p 9). MERS=Middle East respiratory syndrome. MVA=modified" exact="vaccinia virus" post="Ankara. PFU=plaque-forming unit. S=spike. *One participant had to move"/>
   <result pre="dropped out received no booster immunisation because of an unrelated" exact="urinary tract infection" post="on day 27. This person was not replaced at"/>
   <result pre="MVA-MERS-S in each dose group. MERS=Middle East respiratory syndrome. MVA=modified" exact="vaccinia virus" post="Ankara. S=spike. Solicited local reactions were the most common"/>
   <result pre="the low-dose and high-dose groups. MERS=Middle East respiratory syndrome. MVA=modified" exact="vaccinia virus" post="Ankara. S=spike. Table 2 Haematological changes Low-dose group (n=14)"/>
   <result pre="immune absorbent spot assay. MERS-CoV=Middle East respiratory syndrome coronavirus. MVA=modified" exact="vaccinia virus" post="Ankara. RBD=receptor binding domain. S=spike. SFCs=spot-forming cells. PBMCs=peripheral blood"/>
   <result pre="to those observed in a phase 1 trial testing the" exact="influenza" post="vaccine MVA-H5-sfMR, 18 in which participants received the same"/>
   <result pre="context of MERS-CoV infections, which has been previously discussed for" exact="severe acute respiratory syndrome" post="(SARS) coronavirus. 29 Future studies in animal models, possibly"/>
   <result pre="RAM Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi Arabia N Engl J Med 367 2012"/>
   <result pre="Middle East respiratory syndrome coronavirus spike protein delivered by modified" exact="vaccinia virus" post="Ankara efficiently induces virus-neutralizing antibodies J Virol 87 2013"/>
   <result pre="984 992 30060038 11 Gilbert SC Clinical development of modified" exact="vaccinia virus" post="Ankara vaccines Vaccine 31 2013 4241 4246 23523410 12"/>
   <result pre="2013 4241 4246 23523410 12 Volz A Sutter G Modified" exact="vaccinia virus" post="Ankara: history, value in basic research, and current perspectives"/>
   <result pre="A Kupke A Song F Protective efficacy of recombinant modified" exact="vaccinia virus" post="Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"/>
   <result pre="Goeijenbier M Moesker FM Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based" exact="influenza" post="A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7173093/results/search/disease/results.xml">
   <result pre="Disease 2019 (COVID19) cases due to efficient human-to-human transmission of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) in the United States, preparation for"/>
   <result pre="with Coronavirus Disease 2019 (COVID-19) due to human-to-human transmission of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) requires quite unique considerations—from caring for"/>
   <result pre="and neonatal outcomes with COVID-19 infection compared with the 2002–2003" exact="severe acute respiratory syndrome" post="(SARS) outbreak from SARS CoV 1 infection. 1– 3"/>
   <result pre="patients from China were fever (99%), fatigue (70%), cough (59%)," exact="shortness" post="of breath (31%), myalgias (35%), headache (6.5%), sore throat"/>
   <result pre="of breath (31%), myalgias (35%), headache (6.5%), sore throat (17%)," exact="diarrhea" post="(10%), nausea (10%), and vomiting (4%). 4 An additional"/>
   <result pre="may include myalgias and diarrhea; preeclampsia can present with headache;" exact="shortness" post="of breath is perceived during pregnancy and labor; and"/>
   <result pre="infection usually include the following: (1) fever, (2) cough or" exact="shortness" post="of breath, (3) diarrhea, and (4) any possible exposure"/>
   <result pre="anesthesiologists, obstetricians, labor and delivery nurses, neonatologists, critical care experts," exact="infectious disease" post="and infection control experts, employee health services, environmental health"/>
   <result pre="The benefits of neuraxial analgesia in the setting of COVID-19" exact="pneumonia" post="are 2-fold: (1) for the patient, it will help"/>
   <result pre="before neuraxial analgesia placement. Early studies from China suggested that" exact="thrombocytopenia" post="may be associated with COVID-19 infection; in a cohort"/>
   <result pre="COVID-19 infection; in a cohort of 1099 patients, 36.2% had" exact="thrombocytopenia" post="(&amp;lt;150,000 × 10 6/L). 19 A meta-analysis of 1779"/>
   <result pre="of epidural or subarachnoid space seeding with viremic blood, causing" exact="encephalitis" post="or meningitis, is exceedingly rare. At the time of"/>
   <result pre="14 1 CSE, 13 epidural CT or radiological evidence of" exact="pneumonia" post="14 (100%), 1 patient on maximal noninvasive ventilation at"/>
   <result pre="al 26 14 14 epidural 14 (100%) CT evidence of" exact="pneumonia" post="4 (29%) None Xia et al 28 1 1"/>
   <result pre="Sp o 2 =92% on room air, CT evidence of" exact="pneumonia" post="1 (100%) None Song et al 27 1 1"/>
   <result pre="Sp o 2 =86%–90% on room air, CT evidence of" exact="pneumonia" post="1 (100%) None Breslin et al 6 a 2"/>
   <result pre="al 29 45 Spinal Mild symptoms, no cases of severe" exact="pneumonia" post="While hospitalized, 5 (11%) of entire cohort including 4"/>
   <result pre="little evidence for vertical transmission in women who develop COVID-19" exact="pneumonia" post="in late pregnancy. 2, 31– 35 However, cases of"/>
   <result pre="Although most women with COVID-19 infection will not present with" exact="pneumonia" post="and respiratory decompensation during labor, escalation of care and"/>
   <result pre="MPH. FOOTNOTES GLOSSARY ACE xxx ACOG xxx AGP xxx ARDS" exact="acute respiratory distress syndrome" post="CD cesarean delivery COVID-19 Coronavirus Disease 2019 CSE combined"/>
   <result pre="SOAP xxx SOGC xxx Sp o 2 pulse oximetry SARS" exact="severe acute respiratory syndrome" post="SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 SPG sphenopalatine"/>
   <result pre="o 2 pulse oximetry SARS severe acute respiratory syndrome SARS-CoV-2" exact="severe acute respiratory syndrome" post="coronavirus 2 SPG sphenopalatine ganglion Funding: None. The authors"/>
   <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected" exact="pneumonia" post="in Wuhan, China. JAMA. 2020. 5. collab: American Academy"/>
   <result pre="12. Haines CJ Chu YW Chung TK The effect of" exact="severe acute respiratory syndrome" post="on a hospital obstetrics and gynaecology service. BJOG. 2003;"/>
   <result pre="patients and neonates born to mothers with suspected or probable" exact="severe acute respiratory syndrome" post="(SARS). J Obstet Gynaecol Can. 2009; 31: 358– 364."/>
   <result pre="L Karakiulakis G Roth M Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection? Lancet Respir Med."/>
   <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version). Mil Med Res. 2020; 7: 4. 32029004"/>
   <result pre="R Zheng S et al. Lack of vertical transmission of" exact="severe acute respiratory syndrome" post="coronavirus 2, China. Emerg Infect Dis. 2020; 26. 33."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="covidseq/PMC7173777/results/search/disease/results.xml">
   <result pre="In late December 2019, patients in Wuhan, China, reported having" exact="viral pneumonia" post="due to an unknown microbial pathogen. A new coronavirus"/>
   <result pre="late December 2019, patients in Wuhan, China, reported having viral" exact="pneumonia" post="due to an unknown microbial pathogen. A new coronavirus"/>
   <result pre="infection [ 6]. Many studies have demonstrated the impact of" exact="infectious disease" post="outbreaks on public mental health, such as severe acute"/>
   <result pre="of infectious disease outbreaks on public mental health, such as" exact="severe acute respiratory syndrome" post="(SARS) in 2003 [ 7, 8], and the 2009"/>
   <result pre="(SARS) in 2003 [ 7, 8], and the 2009 novel" exact="influenza" post="A (HIN1) epidemic [ 9, 10]. These types of"/>
   <result pre="epidemics lead the public to experience psychological problems such as" exact="post-traumatic stress disorder," post="psychological distress, depression and anxiety [ 11]. Some studies"/>
   <result pre="depression and anxiety [ 11]. Some studies have shown that" exact="post-traumatic stress disorder" post="is closely related to depression and other psychological problems"/>
   <result pre="of education can improve one’s understanding of issues related to" exact="post-traumatic stress disorder" post="and psychological distress, leading one to take positive measures"/>
   <result pre="Yiu MG Ho SC Chan VL Risk factors for chronic" exact="post-traumatic stress disorder" post="(PTSD) in SARS survivors Gen Hosp Psychiat 2010 32"/>
   <result pre="Republic of China. Update on epidemic situation of novel coronavirus-infected" exact="pneumonia" post="by 24:00 on Feb 18, 2020. http://www.nhc.gov.cn/xcs/s3574/202002/2db5729cfb674b37b48820a098c8bf88.shtml. Accessed 18"/>
   <result pre="JY Yang MJ Psychosocial impact among the public of the" exact="severe acute respiratory syndrome" post="epidemic in Taiwan Psychiat Clin Neuros 2006 60 397"/>
   <result pre="Griffiths S Population responses during the pandemic phase of the" exact="influenza" post="a(H1N1)pdm09 epidemic, Hong Kong China Emerg Infect Dis 2017"/>
   <result pre="Aguilar-Soto M Borja-Aburto VH Aguilar-Soto M Borja-Aburto VH Prevalence of" exact="post-traumatic stress disorder" post="and depression after the September 19th, 2017 earthquake in"/>
   <result pre="Wang Y Xu J Lu Y Associations among trauma exposure," exact="post-traumatic stress disorder," post="and depression symptoms in adolescent survivors of the 2013"/>
   <result pre="SM Markuzon N Incorporating media data into a model of" exact="infectious disease" post="transmission PLoS One 2019 14 e0197646 10.1371/journal.pone.0197646 30716139 34."/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
